<SEC-DOCUMENT>0000886163-21-000130.txt : 20211109
<SEC-HEADER>0000886163-21-000130.hdr.sgml : 20211109
<ACCEPTANCE-DATETIME>20211109170609
ACCESSION NUMBER:		0000886163-21-000130
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		66
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211109
DATE AS OF CHANGE:		20211109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		211393145

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c,d:6bd315758f674d32a271d739b654f8a7--><html xmlns:lgnd="http://www.ligand.com/20210930" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV8yLTEtMS0xLTA_c8dd2b81-335b-40c0-8d90-ea7cf8ae8fbb">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV8zLTEtMS0xLTA_9f03d29e-712f-4d14-829e-22ee77ee0235">2021</ix:nonNumeric><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV80LTEtMS0xLTA_a47219a4-6e8f-4d20-9605-b7cc890ff725">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV81LTEtMS0xLTA_ce29a229-d1bc-42e2-8556-8747f06c9846">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV82LTEtMS0xLTA_ac21bbf4-e3ce-4f5c-9b28-8e6aa43db9a3">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i884da06b4bd14a7fb79a03bb4da156cf_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS0wLTEtMS0w_7e5cfe48-374e-473f-971c-bd2c1bc9a38d">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180Ni9mcmFnOjkwMGFmMTNlMTU2MDRjOWY5MWZlZWFlNTQ5OWMzYzY5L3RhYmxlOjFkNTM2NzY5YzAyYTRkNjY5ZmU3NWIxMjRmZWY3ZjM4L3RhYmxlcmFuZ2U6MWQ1MzY3NjljMDJhNGQ2NjlmZTc1YjEyNGZlZjdmMzhfMi0xLTEtMS0w_c5e60c25-c37c-4acc-875e-64b47b9d70fc">0.0040244</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i7ab881cb617a4e59b38742bf90e782ca_I20211105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5e66a6b4d374ca2982d0e908c81c057_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65684440034d4351bbb21abccb7fca41_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4670676853e4b26a40950b991482733_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a6e84a61d1143bcacd2e9bc175b9653_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f271f1a4be4452910a076e9e38a6b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id27dffce40b144a3bbcefdd5cdb11b20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a809d62daa64f1f84d03e014e249993_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4953df0e32ff45209345ad4e8b35fb8a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3900ef9761864a5da679ba7019815ea2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22edb6dc65c04766b217ddab8475edd8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbba22d1af0c4452af7b0fe4b452c084_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15280da5985442f1b70dfcfa3a99ba5f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e91036a56e048da812d1bbbff52ea15_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf86e369b16b4f3d80c4a30e22e652cc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a4a9f3d2bb74346a035eb74bdbf6297_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id39bf6178fe24db2893e758597f0029c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i889f7f0228dd4a588bb93484a5eccbf0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360c33d3bf9d4071a521470504bb754a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5d0533630774219a96e8ae0dd341679_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c6430609ca42e2af4e70d120723e15_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0669b1b589ed4c0aa5c0f53d9af109bd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8ef6df76594ccf9ac7aa43bca3d664_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd7d1d9820346ebbdd910ea23ae5fb5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cb3e3ce39174efb90c579734662ca3c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c504584f2b44bccbb4c98df81a0c187_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40e9fc954e0f4c6fac4befb25a43a7e8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d0b1e6a3e246f8a27e20041ff8cda9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb20171945fd40e794706d8def23874e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77dec1bdfce142efad4f356566506009_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350b26fa15fe439082f315dc8c0738d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9e33b34b6a4201ae924131d1884ef5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a4a953d5304f198ee6f152d7aeea35_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaada7c634ba8474da512d18baf189633_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia085df13296843368baeb5805a91e5d8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884da06b4bd14a7fb79a03bb4da156cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51a04f07e094d73b253c1b38304f355_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24fe1222cc784553a37d8ab3fd25236d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa5703dfd6f42c5a03262f6a827081a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id70967578d4d40a9bde681ed44e00bf3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2271fc765142b1beb4cf28d365bb6a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91f3032f13b419e96960180df7a57a0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia056a39a1d1646b08db6232475f0fe3d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if07b2a7f22b749b2b75f7867f5ca9d61_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e955a2670f14c5589acd8fae1849f37_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7133362acc234799828e1697270f098b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f36701c729b4ca08acd79e998f584cf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af9313f05af401bb4da9b72af20c7bc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3084043063c5478084965f63fc694456_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70eb5532b8c24ecf95a7e0ba1196f93b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2891e29ad7f442385683c6dfa1a990e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iede4b1a3266f4aa58150416db0b81f06_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c5045f7c634a6ab1162b5156068143_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f74d78b3bfd465285b4b70819f120ae_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b76151e50a6468f9778c0f3285a6571_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i575ac8d86a424cc58611058fbd63c5d1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i187e0f90eac444ea9e476b4465539595_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37bf04a171f0407a9f1eae38a860495c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefcbd9042e284860925ad7c76171bca1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1beb885c5fe44118a5ef2fec26cf4658_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1812aa7c1c1b4a55a887fd5a81b76005_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i338e6d6b14a34c75b7c70afa3376340b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6cdf3e9b474d958a8885100478e940_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ab67b2c0b5427699d1f2b18bf6cf19_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41307110e644f0fa0ec6bccf02baa95_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99683383c51c4f64a11dd4f2001eed52_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c5115227a34d9b8c71c751709c5dc9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d50949db3fb4c8aaa647abb0dbf5f7a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e9177b057824c699d52a5f241543660_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54af25c4d01847cf80e2bfe3bc7d5119_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f737ae0746f4857a06c25988e3ad3d7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbb87c5273d146209b4f863fa73a6737_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16580774194c4717bd816e227f16cca5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75ed1e446ea84220b26d564c3e4eb9c9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76396c119fc8437783313ddfc6cfdce7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461496e85d77458ab7ad2e0d7ef7035a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b56fbe0a9734483b1566fbe6d710406_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccff4fa6edd34cabbf684004d8ce7bb6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46272602a5184253a54dc8e71c5e30ca_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c95e2f17f3492394642693fb62d437_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic079e130627446e2a4e0b9df6ba59cb4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf39d65d4fbb4562aa99ab8d91883b55_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2328ebe1a164a53b66ea3c341bceda4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id40d8cfc06804c0eb44c421fe185a680_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02ec86bd000d4ef392d002af71a86521_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1a8e7f867144aaa2ecf955647862c6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bbbf8570b35483cb6acbd8cd74c10ba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b324e462494e6681ed114f944bd643_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3a84cd253749ea9fae2626a480c65a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa74fac6c40441aa82875bbb7072f25c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13fb0509abe448b48aa3be427fb2214b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee78cc743adc4dee82bb5d8535f1915c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24164d9e30c34985b56c25ee4de80416_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac4a748fde44c7aa04060686b7378eb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b3650ee47e452aa4bc7e9df71daf81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic429da61955a4b0a825e11e538db02fc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60fb236ee191431e8dfccfe51b11abf9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3227affd81a14c3eae170a2fd39475dd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74019a59687e417d98beaf331bbdb8f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb7eed4859c41008e742eb80e557048_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7cdf10102d42dd915fbd5b67034260_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i9bec6bae658f4fa7839b638d3604a63a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fa6499d48549af8abfb01bffe3a576_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d1d2fa5d245408d983a4eb034d356e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1294789ba14efbb689b8629eb271e2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic31bf65152af4864ae4e36dee4c10d04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e028d5aaf364cd69142f7dd1151088f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i484d55887cae433799cc6b8679c28aa4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib8bc73161fcc4ebc8b15c8add0abbd14_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id89c1cb7076440ad94b910f7aabb5992_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec7576b07ee146738bfb748a0c5802e7_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic56a2e7b63464878884da9238110c721_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13653d6cd24412d8f8718d38b9e8dd6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04aa132902b04c0394bce82d31a3aea7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38b3b2a600a4d90a5c8c264715751ed_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a5c0b007c8b4715b662376286f1223b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2639d0217d149f5a491911c423590de_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a349547525942fc9fe678c81267030c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5adab605aa64ca4a227d25b36436eb0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd91366449ba49d1aa56a98935674623_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i209bcfbff39f4fdaa13d185301232981_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45bb77fbcc47480fa1a19f213a179fca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id664afa77ed0445894209a436e750c43_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36100db0e0244c6aab5bd1dbbe08da68_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3ffe50d97d4d3b8818bb0bb6714741_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d127590aa94e20919836ce48cf0d97_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389fe86124f84f77a8cf5138a6d5f5cf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6406808991da4d8689a188fd3b01c562_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42236ee785824a1fb48480728bac6789_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27307c85e21e4232ae8eaa32a61b7cc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70323bb3497a4894a0db2dbb77b08b1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6381e6f32971476bad6e8099cd489312_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5724a75532a4b8aa3826f98fb49e10f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f8ca28e64840a497f16c8486d31fb2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i337849ef0f8b47ed813360d98632e23a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4feeb449c4040e18a03705d479e0b73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39511b4bf4784d1ab377144f67fa01de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id65d2a27498648b69fe545f62a7d5f0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d827596d8a47a3824b013dc8178a8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ecd386015e54ceabc014a87406ce863_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b7b001fd454c5589ff4e2973cd3067_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9135bb25b9b145eab714c4c7ad20594b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i564faa262c604481a02c2694f4fb73f3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ecbea11385c435cbb9af9cce9cfa738_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b74fc269564f20a9b090e4b7124600_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ac63adf2bb546c4ac1aba900b398602_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785d8e5ecc03429cab75cc6262c02576_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4355ca159edc4fa99ebca7d202c8bce3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327b2c0b89c844f99e545089828c950b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb44ca12568c4d3c9fa23dbe60549105_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a65f889aa34725ad89d69cd8592c90_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7a388749dd0497c8d72fc543e8ad75a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb97d5feddd466b911da2f1c55fb194_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227b26c77357461d805f1d914f51e920_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6329169fbc411e8411d28d90ca9499_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a1b93f4a934aabbecad2ea88faedbe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic536e4be36ac4c8db8f4378ad775ac07_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d989500a4b14828af3c71491fd9283e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i610ac4aaf38a415c8790607ee1e3c93f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bebc96ed6eb487a9164a823ad5cf0f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b076ad76aa4482185948f46fd1db7af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06afbcfccbc64bc492f4c8c17e3822a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21eb2218a714e87a27850a3da35a362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0745304b68584347a2623a146af292f6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd7b4e075dc6495e89f3147135f0148b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i231808f85c2e4134b7396905d29aba89_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8416b02586494b9c68ce1aaeefd509_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78104f24516b4de29f3df2b385f1639f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234d3d3b2e13452b972aad1617983de9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbd5e7581044241879711dfbcd50002_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9850a097083942e0afabbbac0b9129f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i359cff11df50436c9bb95a65ae993fd1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a4d6516a3084dba85ee9f2d9965e059_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic73643b6707d4e4c9a71b01e7b7dcf93_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d90de4a6434ddbb1f5058962f04c17_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed9ab31d41044b192fcdb3349f39fb3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa31522c2e4a440db343ae979020b192_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5ff1254de64bb8b8d9981154c1f445_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65b70c37f9aa42fe9d9b2c0a5569f3ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17521c0433c44b8a80fc0dd1145be9e6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ec3cae99b848a1b973526b515df54a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2126d7fd9f75438580dfe001ae6fa752_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97fcc3aebae546f7a142fac3cc2c0745_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ec7efead9b4761baa234b4bfb65a32_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92d652ad5604f02a1b2e862f88b1646_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia655880e41b0499a8b88d4a727ed9eab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic40690754d3a44cc8d92472abaff4f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb63d9bffe134ab4a8487fdb45a691f8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i861dcf90c1e74fe880857a9b4b3c9a79_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750b151cf9fe4b5bacc45d083dfefabc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9efb83e898004cea87bab8cb9c0988da_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieda651849d114d4abd488d8ecfe42755_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b6a4eeb00954ec987c7739f3c9775dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f9c1943c5c42278fc70e863c8ee407_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i025eaa94559140439e978745a70ab345_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103235a0480d438fb3c8952921afef6d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ceaecbf981d488e903c7845de55f9ce_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103f057e0945407ba3313d8490b9be67_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53807a156d9c4b8a877570a1cad4e9d2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if97d00b4fc204934b6f74c46e2902d97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f9e34d26c64081a716e4ad38102b2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i116e95e42f624c0ebdee627175c1f44b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32596f59df27404580fe06db3f0a6a33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582ba6e6a3d048fa858bc097e375efbb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb687c8f41345a1b1a390788c8b3eab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20539e1cd2eb4b4990f8905b457891fe_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ed509cd26a488e8fc504b51723e946_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i653b721956384c858144b850891af87b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i577bc815500b4aa4bc23468486976592_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bda237598d54cafa9c0a35ab7f63129_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fe0e390a595409686d2fee6e8fe8450_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right_series"><xbrli:measure>lgnd:contingent_value_right_series</xbrli:measure></xbrli:unit><xbrli:context id="i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a7423268c1947ffaad3d4a234a16758_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7fe0d08f8814b26bb6d850aefa0bf38_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefccc513badf4ac697660d63ce351a27_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i845a05cd969041fba7ad46f78c0e09ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75913a021dca4a82866b4b9298cecb68_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785fd0e4a68b40ff8674243d934db225_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="pure"><xbrli:measure>lgnd:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib1a044c5eca64972a0b2cca378908568_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa5a82595b87414eb6672c3977e9fe8f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47943aab20d4716931dd955f73d9f68_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49460a614c3741bd9dcb93c1082e254c_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2e38018c524066aae124ee0322449c_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d097ca8d274dba82a4146da4cefe5c_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b99f5d261b2424984f7c2048cf94154_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee708bc3f874ea4a64ff9eab6bc8b78_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a5667057b941dcbffe8705e96b7a08_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23982d6bb19f46ada4a2da4c208bef75_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b604edf45a4273b85b6a9dd018b41b_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1107fe7113ce41d3aebe65bed5bc350f_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica1eb82f11c04cea9b0171a30ecb9c64_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a9860367d34127b2a08e3c03d11f2e_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d4e4d3980d4dff9c9d86c7ec2dcb16_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64d969dd64874a7db0f0480d82e40efc_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b57fd5414fe448ca4dc3bd49c273738_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60b6d14d66a4cb9ba4bd253315c186c_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d9c69e09e534351bc10468027e76940_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b376b9aa5864554bbc41743970ed458_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1575170f30d94fd0bbbe0cee59a6431f_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09d2bdfc41645b2b379612921c6d7c5_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c2b96408b9c412a9768198f8e8f606a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="i0685149320e54ff89544d4e3f7a97265_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a008f555614be384f97c9b5a03d5a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9674c13420bc41deb65d3656daee3f18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37978277e2ef4b739181ad403af7290d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3896ae5368254d08ac76230cffd63481_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideff198686944e55a0cc2ee1e0f927b5_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e665f31d61e468db6b421188680776a_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf23659d72440e581b8103b1bb8431a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="company"><xbrli:measure>lgnd:company</xbrli:measure></xbrli:unit><xbrli:context id="i1c555247c8274906932e6bde7b7a204a_I20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8779d8bb6434411d8ba83dacb2886ad1_I20211109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:OmniAbMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-09</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6bd315758f674d32a271d739b654f8a7_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8xNzI_e291e53a-6230-47d4-8541-41c90387fb4f">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6NTZhNjU1MGI3MTUzNDczNjlkNzU1ZjA0ODBmNTBjZDAvdGFibGVyYW5nZTo1NmE2NTUwYjcxNTM0NzM2OWQ3NTVmMDQ4MGY1MGNkMF8wLTAtMS0xLTA_4f0a6521-1868-493b-bf25-6aa07ee58dc5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yOTY_52f32836-ac6d-4a2a-9a88-1d4987121d12">September&#160;30, 2021</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6ZmZjNTdjNTA3MjBhNDc0NWE5OWFiOGQ3ZTczZTM0OWQvdGFibGVyYW5nZTpmZmM1N2M1MDcyMGE0NzQ1YTk5YWI4ZDdlNzNlMzQ5ZF8wLTAtMS0xLTA_3204c4a4-8435-4058-b404-340e82e2b291">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE0_71f14c71-9aa5-454a-983f-81837dadcbb9">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20210930_g1.jpg" alt="lgnd-20210930_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8zOTg_18e50b9c-afaa-4d03-b0dc-205f2ef327ba">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8wLTAtMS0xLTA_71ae09a3-6fcc-4ae2-936f-802151df7c9b">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8wLTEtMS0xLTA_b5fecb61-5b3f-4d6e-9888-17829d9577e8">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8zLTAtMS0xLTA_a7073950-bded-4d87-bca8-7cf9cb37272b">5980 Horton Street, Suite 405</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV80LTAtMS0xLTA_5b1647ab-56df-48a5-b58d-984eb5b71315">Emeryville</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV81LTAtMS0xLTA_e9a0a722-1b4d-4ed8-aa45-a8b8bc33a09f">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV81LTEtMS0xLTA_819c7d6b-1e50-4772-9426-b7cec2344ed8">94608</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE1_89d1ffc0-9fd3-47a1-99cc-39073ee69283">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE2_554b9056-c25c-4575-866a-951bc73f233b">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTAtMS0xLTA_dd269d1e-1912-4757-80c8-62da1a8fa080">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTEtMS0xLTA_999039f5-3452-4893-adc0-99cf6e24ac08">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTItMS0xLTA_38698b1b-d736-44b1-b54c-06c687e9b34d">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzIx_94da4e81-ec69-42a1-909a-9268dc528a71">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzEz_fca28036-7eca-481f-8b61-6cb2c621a62f">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8wLTAtMS0xLTA_83c05d98-3924-4b64-adff-ffa0d083f829">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8xLTQtMS0xLTA_ede73804-565c-4418-925d-24aed39bd97c">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8yLTEtMS0xLTA_c1023d7d-f7f9-42f0-a0d2-0bb7a006bfed">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt:fixed-false" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzIy_dfdc1e7f-93e2-4619-93cc-156ef9a49ad3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of November&#160;5, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i7ab881cb617a4e59b38742bf90e782ca_I20211105" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMjc0_257ab17c-9b0d-432d-8fbb-e25953e29da4">16,711,641</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_58">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_58">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_70">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_70">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_73">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_73">33</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_79">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_79">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_82">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_82">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_85">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_85">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_88">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_88">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_91">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_91">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_94">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_94">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_97">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_100">39</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_100">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6bd315758f674d32a271d739b654f8a7_100">39</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on February 24, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CE</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol-enabled</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals (Suzhou) Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IND</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investigational New Drug</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Contingent value rights agreement, dated September 30, 2020, by and between Ligand and Pfenex</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taurus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Taurus Biosciences, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Actavis, LLC, collectively</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i6bd315758f674d32a271d739b654f8a7_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i6bd315758f674d32a271d739b654f8a7_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMy0xLTEtMS0w_d3e220e7-872d-44e4-8666-7047506b1e3d">23,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMy0zLTEtMS0w_48f4fe77-543e-4890-bb87-722580e40cf3">47,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNC0xLTEtMS0w_68968f6b-6706-4df1-8986-7f5263b72d8c">299,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNC0zLTEtMS0w_6905e1ac-14e7-41db-91a1-17672ec598c8">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNS0xLTEtMS0w_e1744f93-647c-4efa-a1bb-b9bc4fd71338">64,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNS0zLTEtMS0w_a7d6de1c-ae65-4e2e-b470-eee20d2f3f22">56,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNi0xLTEtMS0w_c31b5a3f-0433-49ec-8ee8-584d63b9bfc3">32,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNi0zLTEtMS0w_648e8c29-f1ca-498f-99aa-0ea067176116">26,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNy0xLTEtMS0w_bc7e53c2-b819-4469-a338-95fc9cf6ac63">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNy0zLTEtMS0w_350e5256-763a-4cbf-abd6-8843a95b2a09">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOC0xLTEtMS0w_938cf480-18a7-4754-943f-67709b63856f">5,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOC0zLTEtMS0w_ec79bd69-77e9-42d8-83a3-09d6a6d27f5e">3,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOS0xLTEtMS0w_e36f57b8-35e3-4aa9-b2de-e2e81c10968c">432,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOS0zLTEtMS0w_daaea6c2-4f26-41dd-9a78-bb44a9103d1d">500,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTAtMS0xLTEtMA_400c9625-f75c-4170-8e33-fb7478c3a3a6">26,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTAtMy0xLTEtMA_7d366db5-dfee-4f61-9e91-799ab6a5a005">24,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTEtMS0xLTEtMA_eb7a35c9-d3f0-4672-bb32-cd45ee87d046">562,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTEtMy0xLTEtMA_2d1e7f59-480e-43ae-8465-599401036746">595,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTItMS0xLTEtMA_a904b888-66a2-468d-a9e0-2de581f671c5">190,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTItMy0xLTEtMA_0526cfb9-799d-4d3f-83e1-517834d92084">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial license and other economic rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTMtMS0xLTEtMA_618ea646-cc6f-40d2-b22e-e0d0e8ef5859">10,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTMtMy0xLTEtMA_df7636f9-739e-41c0-b24d-8244fd4b5ba7">10,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTQtMS0xLTEtMA_eb590857-2808-40b6-908a-493e08077813">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTQtMy0xLTEtMA_8828eebf-7f1c-487a-9a30-012b2a4fe9da">14,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTUtMS0xLTEtMA_24143c5b-77d4-4966-ad50-0f32820cbfac">12,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTUtMy0xLTEtMA_07b65cc0-4eb0-412a-90dd-8b3bca1e764a">6,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTYtMS0xLTEtMA_4771be63-6632-4149-91be-340c08d705e6">16,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTYtMy0xLTEtMA_4cc85bf2-b49c-413b-a2e1-d849e9c9ce40">15,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTctMS0xLTEtMA_73cf6fd2-d6d9-4d60-a310-c36e35522b8d">3,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTctMy0xLTEtMA_78efba8d-f65a-4086-8786-9b7508838ce7">4,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTgtMS0xLTEtMA_592017ae-4b1e-4ce4-b824-c1120de588a1">1,273,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTgtMy0xLTEtMA_ea22ee87-a27b-4c10-9da5-28dc2a505a5d">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjEtMS0xLTEtMA_2f16cdc7-45dc-4915-8da7-b62ab7df2dcd">7,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjEtMy0xLTEtMA_e0aae9c2-cc77-4eca-aed2-a7aa20184ddc">3,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjItMS0xLTEtMA_bf668153-bbe4-41b2-8461-99d6910b1d8d">12,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjItMy0xLTEtMA_2461ceb0-4ba1-4c40-aa53-278648c2c1af">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjMtMS0xLTEtMA_d1a03270-8eb9-477b-8b0e-8555fb24fd0f">2,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjMtMy0xLTEtMA_45fdd229-00d6-4a74-a9ad-a46689629020">39,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjQtMS0xLTEtMA_fd9068cc-00bd-4767-b423-f6b39607f2df">12,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjQtMy0xLTEtMA_e319b42d-4dd7-4d24-8ccd-a3f8daaf20dd">29,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjUtMS0xLTEtMA_65e4eb7e-9466-468e-8c5e-92e1a0e04fb8">2,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjUtMy0xLTEtMA_0485ee35-47e8-4317-99f1-358d8e879b86">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjYtMS0xLTEtMA_15b21f60-8eaf-4365-95dc-57de9c376e6d">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjYtMy0xLTEtMA_44fc5ec2-d161-416c-9bbd-0a1446e9546b">6,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjctMS0xLTEtMA_8c9cc5a3-5362-4ff0-841e-cf9501720a66">36,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjctMy0xLTEtMA_8dc5561b-754d-4a81-b593-32ade2851154">100,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjgtMS0xLTEtMA_15fe66f4-c9b1-413a-8ef1-d7b63a4a11ff">316,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjgtMy0xLTEtMA_e199d34a-c1c0-46b3-a274-7fd777e5efd7">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjktMS0xLTEtMA_05a4327b-f968-4890-9a52-f0f60737d046">6,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjktMy0xLTEtMA_f988ac91-8415-4a7e-822c-4e3eb57dd513">9,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzAtMS0xLTEtMA_ea741e01-e27b-4387-8a41-2c5ee7f9518a">63,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzAtMy0xLTEtMA_8f5a9998-d5cd-405f-b185-068f6d7cd900">64,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzEtMS0xLTEtMA_14fc541d-dcb5-41d1-a254-212a89093b1b">11,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzEtMy0xLTEtMA_c2fe509e-7828-4604-81a0-526854277a9a">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzItMS0xLTEtMA_35a3c3ab-ad56-4d32-a723-056e715e5058">27,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzItMy0xLTEtMA_42c4cc01-cd7e-4c05-8490-eb64c35ed5f7">30,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzMtMS0xLTEtMA_b39ebf54-61b1-46a1-b7be-976dd7732642">461,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzMtMy0xLTEtMA_ba36ff0c-eab8-4f0c-a5ce-f990eba03b7c">652,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzQtMS0xLTEtMA_f4a1fb77-86be-4e1a-9b4e-97a0e2958c54"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzQtMy0xLTEtMA_8e8cd217-d7e8-4e10-b1bc-b1e6a58d2385"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzI0_c44a7adf-5ec9-4b32-91e2-f4d5a84f29d5"><ix:nonFraction unitRef="usdPerShare" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzI0_ee7f374e-17f1-40ef-86c3-6ab667891fa5">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzM4_701decf6-9fbf-4d2d-a3cd-7820b69a78ce"><ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzM4_f027113f-d906-4d17-9f89-e27bcd57f079">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_2deb7c53-ab35-499f-ada8-997eff6e35a7"><ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_38af3857-67f7-4d09-86cf-8ff6b0112e6f"><ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_85c7237d-524f-49af-9086-4edcd7580363"><ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_ac677f7f-59fc-48bf-a95e-184f2ba11a61">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMS0xLTEtMA_0ca80b77-9b72-421c-8185-1e8aca5481a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMy0xLTEtMA_9982ab60-cee6-41bd-9358-0e788f490815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzIx_7b523ca4-4d68-4462-b9cd-e19954c87fbf"><ix:nonFraction unitRef="usdPerShare" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzIx_c25dd3a4-f489-4362-9345-b75155154a13">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzM1_938f2f3e-1447-41e4-98e7-c6ac245bf82b"><ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzM1_df03e072-c1c5-4de6-88c0-b5932adb9ce7">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzU3_35284cb0-fdad-42da-905d-ae1eecf93e46"><ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzU3_e0d63792-adba-4a3f-b519-82ee9abb6e8c">16,707</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzY0_59d87f4d-7494-46cd-8d69-50b7c332bb48"><ix:nonFraction unitRef="shares" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzY0_c959aee5-165a-4753-a979-4bfd013e5eeb">16,080</ix:nonFraction></ix:nonFraction>  shares issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMS0xLTEtMA_7d5aeb38-79c6-4382-bceb-17b6f35d0aa4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMy0xLTEtMA_e9f6b208-4339-4b3c-b0c7-78aa43fb9462">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzgtMS0xLTEtMA_7741229e-2197-4826-bfaa-8e09233ca15a">358,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzgtMy0xLTEtMA_35c96a92-3df6-40e4-a5ba-29a06622b0e3">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzktMS0xLTEtMA_44e53dad-c1e7-4f4e-8651-02b9e95c3b16">875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzktMy0xLTEtMA_5f1aa5b3-6aa9-4b21-b3d5-043ab55ea1cb">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDAtMS0xLTEtMA_b30c33d2-4c1d-4286-accc-f408e9f796da">454,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDAtMy0xLTEtMA_ebf42bc4-8054-466d-999f-75beb15a53b5">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDEtMS0xLTEtMA_c3a7c4e9-a5e1-4ad4-b6f6-fa4697d124e6">812,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDEtMy0xLTEtMA_c6b74fb2-3e3a-40a0-b3c5-4b083d39f122">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDItMS0xLTEtMA_ea971f3e-a06c-4f66-abaf-7233e591bf44">1,273,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDItMy0xLTEtMA_7a3d1a66-1161-4618-a42f-8dd7e5dbda9b">1,362,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC0xLTEtMS0w_07b91d9f-a6be-4c44-86e7-84c847fa2186">15,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC0zLTEtMS0w_73cb0a2a-a353-4096-8188-20d533d16246">9,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC01LTEtMS0w_59defe78-107c-48fa-94c5-42b9dbb6c0a1">31,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65684440034d4351bbb21abccb7fca41_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC03LTEtMS0w_df0e125d-3663-4d63-90f6-b409b55f18ce">22,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS0xLTEtMS0w_d019b96f-acdf-4d48-b0b6-6ee122274c8e">35,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS0zLTEtMS0w_c75bc198-6320-46e4-992f-b1bb9e96b408">23,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS01LTEtMS0w_0a151fb9-2cae-45ff-9a75-592bd08dc415">128,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4670676853e4b26a40950b991482733_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS03LTEtMS0w_82f1bfd8-7f8e-4915-90ec-aa1321aa9573">68,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi0xLTEtMS0w_1ae28e74-d3c3-4222-a868-aae9464e3aa3">14,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi0zLTEtMS0w_13fdec2b-2698-4823-8a8c-22defb4498db">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi01LTEtMS0w_ab5f4cd2-8dce-4b90-b957-9dcb73e1a2fa">44,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi03LTEtMS0w_ddb7b15c-03b7-46cd-aa05-86b849920a75">24,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy0xLTEtMS0w_a17198cb-d513-45c6-929f-9189e734df28">64,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy0zLTEtMS0w_bcb1ce1e-1a86-4de1-b463-5ee07b8e11ba">41,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy01LTEtMS0w_fa524a00-ee77-4eac-ba89-e619a4df8a84">204,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy03LTEtMS0w_653f381a-0239-44f7-8bfd-780639ef5513">116,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS0xLTEtMS0w_784dd07b-969c-4fb0-9b75-23d6c03426e1">11,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS0zLTEtMS0w_4f1a190a-7d92-4a34-b5a7-93bcb2b9a577">6,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS01LTEtMS0w_b1e9ce8e-96e1-40b4-a61e-4c2c24cba8a7">50,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS03LTEtMS0w_74335d90-b49e-44bc-b38c-590a141f32e1">18,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtMS0xLTEtMA_a70ef5d9-33bd-48bc-87bd-4ce1345a91e6">11,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtMy0xLTEtMA_35307989-3d25-4a1a-8066-d89aae8957d8">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtNS0xLTEtMA_dc89e906-3a75-4820-b6e6-5c1ed50a2b3d">35,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtNy0xLTEtMA_f794c7ef-05ff-45cb-a16d-7d8c509f0007">11,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtMS0xLTEtMA_921b5be4-095c-47b0-9edd-d1b2010b9a68">16,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtMy0xLTEtMA_e90034ad-d16f-42c4-8de6-7653e46fbb38">12,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtNS0xLTEtMA_bc95fd69-117e-46dd-be65-8d2af6cfb48f">50,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtNy0xLTEtMA_cc176ca9-25c1-44dd-8ec7-96f971fed29f">37,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItMS0xLTEtMA_5a163cd8-8a71-46f5-88b5-7f60842bbf34">12,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItMy0xLTEtMA_5a2f219a-4a75-49ac-91ee-abc668fdd19e">15,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItNS0xLTEtMA_a0c7f2a3-45c1-4df1-98df-e83748f66cd0">39,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItNy0xLTEtMA_eaf2b3c1-2d08-4e01-b446-502c474d1859">34,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtMS0xLTEtMA_6df8551c-d5fe-4867-97dc-569c3bbd1330">3,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtMy0xLTEtMA_b0fae43a-fc8b-4f85-96c6-8abd50aceb77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtNS0xLTEtMA_62207610-d319-4056-86cb-c162b0b26aa7">37,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtNy0xLTEtMA_76583598-fe76-49d3-9a6a-c1b6cd240cff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtMS0xLTEtMA_83e24685-5e6b-43ea-ba84-9f432f56d9f5">49,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtMy0xLTEtMA_3fb8c34b-7115-4bc5-b745-37287eec0e23">38,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtNS0xLTEtMA_5bc3b4f2-35ae-4fd1-a612-d7681db25f22">138,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtNy0xLTEtMA_c9a33c80-aebb-483b-974a-aa3aef8271b5">101,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtMS0xLTEtMA_335b2da8-2011-4d98-b1da-3162444b2142">15,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtMy0xLTEtMA_82eb8de4-da4a-4d52-b5aa-bda6e61b3c4d">3,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtNS0xLTEtMA_d1207552-0764-42e7-8511-d64f0998eefe">66,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtNy0xLTEtMA_de0976a2-a3a9-4b71-9268-12e19b8d071f">14,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctMS0xLTEtMA_7d03335d-5c1d-4945-a1ff-e10acabe13d2">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctMy0xLTEtMA_9f7cd697-2843-48e6-b098-54a0a07ff168">9,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctNS0xLTEtMA_64538605-ef4e-4ce1-985f-a4fe390bc586">8,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctNy0xLTEtMA_a6585aff-5bb8-4e9d-92d5-5ef5a025e3ce">17,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtMS0xLTEtMA_45bddb9b-cf7e-46c3-ba44-aa2e1c943ea0">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtMy0xLTEtMA_ec11ff44-651d-4efc-9653-f02a50c7af72">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtNS0xLTEtMA_048a7612-271a-4549-8742-868cf450c5ca">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtNy0xLTEtMA_259a7227-704f-4096-a0d5-977e3e564428">7,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktMS0xLTEtMA_fa6d1323-40a1-4932-8997-fa947fe9f0e3">4,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktMy0xLTEtMA_e66aa34d-d4a2-4ddc-b1d7-a7468d825d0b">6,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktNS0xLTEtMA_bee2ad7d-dae0-48ef-8794-0fd0e8ca5340">15,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktNy0xLTEtMA_f4647e1d-fe9a-4f36-b8ae-0c62dd99085f">21,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtMS0xLTEtMA_3ac9cd2b-a625-4581-b79c-0c9ed5cdef66">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtMy0xLTEtMA_33bc43bb-640d-4612-9298-0427d27e108c">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtNS0xLTEtMA_f326a173-7127-451e-a44b-f2be8fac0f7b">5,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtNy0xLTEtMA_0c705b73-8172-4193-9001-1da544da6e9d">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtMS0xLTEtMA_a4c058f2-8117-408e-8502-366b8b05384c">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtMy0xLTEtMA_3b2527af-4400-4653-a79a-d8929755d579">15,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtNS0xLTEtMA_d1402c1e-2cbc-42b3-bc8f-241f34a9df8c">11,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtNy0xLTEtMA_6fe21d0c-1b4b-441b-a06a-8ec3b9f970e5">28,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItMS0xLTEtMA_f5092021-6036-4bab-b05e-ac09b4312615">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItMy0xLTEtMA_349055e4-4898-4b36-8dbf-f8821f4f1dc9">11,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItNS0xLTEtMA_ae50c7d9-81c3-4fd9-8faa-c96868173fe0">54,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItNy0xLTEtMA_27e657eb-7eca-4d30-a144-c41289d4e8a8">13,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtMS0xLTEtMA_b64273cb-13fc-486e-8731-3eb502c2680d">1,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtMy0xLTEtMA_11d3d868-aaa8-4409-877f-ecf3e9782335">4,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtNS0xLTEtMA_fe3ebd4f-ecfe-48e3-8a49-9409af05f351">8,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtNy0xLTEtMA_48145f6b-75a6-484c-8259-6f6516178810">5,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtMS0xLTEtMA_b283494e-24e9-4ff8-a3a4-335c672525ba">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtMy0xLTEtMA_2ff27c57-d5aa-49c6-9604-c0efe01b0a30">6,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtNS0xLTEtMA_e33857d6-c624-4751-8688-c7f9047dd13e">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtNy0xLTEtMA_388c5292-95bf-44a9-9da6-0726c136f84e">8,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtMS0xLTEtMA_a6b2c22d-b537-49fc-811f-d95cd8352429">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtMy0xLTEtMA_00bcb5ba-2a2a-4e7c-88e9-9179a2524efb">0.42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtNS0xLTEtMA_18513e21-c3fc-45bc-ab07-6660f211b2ae">3.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtNy0xLTEtMA_9fa0ebdc-947b-4cf0-baf8-07d9254ebd28">0.54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctMS0xLTEtMA_0150144c-58cf-470b-8e37-2216dc65ddb2">16,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctMy0xLTEtMA_fb7f9353-7346-46b6-9109-d2c8d1e5cfba">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctNS0xLTEtMA_2515663d-e35d-4958-8613-31023ec76713">16,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctNy0xLTEtMA_970d173b-4275-4773-b14b-e02f865f3d62">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktMS0xLTEtMA_6173bb06-b369-421b-9395-d448dad37016">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktMy0xLTEtMA_3e7ad77a-6118-4c9d-a384-253017dd3296">0.42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktNS0xLTEtMA_fbdc0b6e-0183-4fb7-b291-5e8544ac0192">3.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktNy0xLTEtMA_daebe81c-c19f-4ba4-8d70-9296f18c9a8b">0.54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtMS0xLTEtMA_8ca28295-3672-44ba-b0e2-9542b364713f">17,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtMy0xLTEtMA_a03ac432-b965-4524-a8ea-58e4d27e7506">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtNS0xLTEtMA_7c2f5bb1-6a06-4483-aff3-7927b7623799">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtNy0xLTEtMA_aede1396-7c47-41bd-aa01-97734c396e66">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy0xLTEtMS0w_b0a1d0cf-8745-4dd5-873f-3dfef5538ac7">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy0zLTEtMS0w_45bbfd18-c30c-4281-8345-08f4a8cedb27">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy01LTEtMS0w_e5c03746-34f5-4be6-a11a-2e72102c1fe2">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy03LTEtMS0w_b8b67be3-2553-4e9b-9092-01ad90195a16">8,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC0xLTEtMS0w_dd5b21f0-7e62-4433-ad50-b39e4e0b9057">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC0zLTEtMS0w_eaa1a986-ac1a-42a2-85bc-2dccb3120297">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC01LTEtMS0w_0497e17a-3a77-4875-a887-3fd261483ce8">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC03LTEtMS0w_61b4f5b9-b732-4ce3-ba29-1c283a370a52">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS0xLTEtMS0w_ab666839-06e3-4e86-b7be-20b3b02e9346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS0zLTEtMS0w_0132cd63-bc90-4884-b354-d0a5eae76691">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS01LTEtMS0w_997c0d08-27a3-4724-9913-1ebc2f815af7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS03LTEtMS0w_f477a5ca-6b86-4a53-97a7-f45465012956">1,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy0xLTEtMS0w_3b2d6f90-c4cd-4cd7-952d-925c3aea7787">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy0zLTEtMS0w_6c0af412-1d70-40c4-a272-7b9be6e28b8a">5,832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy01LTEtMS0w_954b1540-59f1-40ca-8a7a-2a302ed690a9">62,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy03LTEtMS0w_0e150cbc-81f4-409b-ae23-17d5134ab8cd">9,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0xLTEtMS0w_2c18483d-ea82-4188-a206-18fa6722dc09">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0yLTEtMS0w_45c8d0a1-27fa-478b-b2e2-51ceedcac134">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6e84a61d1143bcacd2e9bc175b9653_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0zLTEtMS0w_b3e483bc-8bbb-475c-a39a-6325540a3c6a">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85f271f1a4be4452910a076e9e38a6b4_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi00LTEtMS0w_7a71375e-e7aa-470d-8b96-112f0ec21519">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id27dffce40b144a3bbcefdd5cdb11b20_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi01LTEtMS0w_e1a4d580-a80a-438e-a6c9-9ce994738ece">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi02LTEtMS0w_97f5aa42-8fe8-4846-a6c2-c429a53e5c2a">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0xLTEtMS0w_04686d2c-6c09-4a73-845b-264ae79edb4e">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0yLTEtMS0w_6033f445-c87c-42a0-b1b4-6963004be5c0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0zLTEtMS0w_ddacecef-71cd-4956-a65a-ab786d820d56">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy02LTEtMS0w_5d486bff-53f0-4564-990f-1e17b37263c2">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNC0zLTEtMS0w_fbdc82c7-2f4c-486c-be23-6bd015c3b984">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNC02LTEtMS0w_44b5f166-c4bd-4fec-9038-701965da6b3b">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a809d62daa64f1f84d03e014e249993_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNS00LTEtMS0w_9abd9ee6-601f-46ae-979c-bfa25c64b940">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNS02LTEtMS0w_a25042f4-b5cf-4b8b-870f-5728da0ed07a">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNi0zLTEtMS0w_782c7667-e1e6-4688-9489-7f05a21b482d">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNi02LTEtMS0w_22f76b75-eb82-49e8-bb64-3083301e5787">9,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNy0zLTEtMS0w_c2e7430a-00a3-4673-b4b3-ce40b4ea8f2e">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNy02LTEtMS0w_5d7211d0-2f77-4c74-9b95-97288c0b7594">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOC0zLTEtMS0w_8ceba7db-6df9-4d2b-b52b-1e778f92f75e">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOC02LTEtMS0w_3d189678-9e29-466a-9e2e-5a08f62d68fb">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4953df0e32ff45209345ad4e8b35fb8a_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOS01LTEtMS0w_2229073e-d07c-4cb1-a697-983d8425ad46">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOS02LTEtMS0w_8da2c93b-db0a-4661-8489-cc1b352d9a61">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3900ef9761864a5da679ba7019815ea2_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMS0xLTEtMA_e16059dd-8c21-4fef-a3d0-1a167df48f9e">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3900ef9761864a5da679ba7019815ea2_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMi0xLTEtMA_dcf41b09-4faa-4a46-a4be-5bdc1c4337f3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22edb6dc65c04766b217ddab8475edd8_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMy0xLTEtMA_1492ddf7-a3fe-411e-b866-7d69819fa7de">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbba22d1af0c4452af7b0fe4b452c084_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNC0xLTEtMA_d1522b25-9bca-4805-b5d7-ae475587dd05">856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15280da5985442f1b70dfcfa3a99ba5f_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNS0xLTEtMA_e78164e6-fc70-4a41-bf30-15cd86b9f9fe">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e91036a56e048da812d1bbbff52ea15_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNi0xLTEtMA_7df2fb6a-463d-4ef2-8b6a-3080062a1946">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf86e369b16b4f3d80c4a30e22e652cc_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtMS0xLTEtMA_82ec2216-7d4d-4157-afac-9edaa0ce9337">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtMy0xLTEtMA_f7ea1b14-fe30-4772-8271-0056ba95bfa4">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtNi0xLTEtMA_8588222c-cb82-4d92-9f52-ff5917628b3c">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTItMy0xLTEtMA_61de69b3-cb2e-40e5-a6b4-b8c4670c439e">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTItNi0xLTEtMA_9f66c41f-e12b-4f0c-9684-04ed9dc23d6e">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a4a9f3d2bb74346a035eb74bdbf6297_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTMtNC0xLTEtMA_528b1a6e-cb1b-456e-98b8-741046293759">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTMtNi0xLTEtMA_e733759d-3680-4670-ae71-87d768b3517c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTQtMy0xLTEtMA_85518aa8-c785-40b4-b0e3-d82b768f4b58">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTQtNi0xLTEtMA_fdf225e0-00cd-4685-aa43-8364fad51fca">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTUtMy0xLTEtMA_dc1109fa-0823-460b-a883-ff78a785b65f">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTUtNi0xLTEtMA_11a342c3-c957-4eb1-8205-1dc2b1d77666">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39bf6178fe24db2893e758597f0029c_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTYtNS0xLTEtMA_072c6fc2-6dd8-4e5f-af08-ffd0e0058de1">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTYtNi0xLTEtMA_9b1eab27-aa8f-4c95-8da8-971f2f6723e3">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i889f7f0228dd4a588bb93484a5eccbf0_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMS0xLTEtMA_4498fc68-f156-4b98-952f-d52fa50683fd">16,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i889f7f0228dd4a588bb93484a5eccbf0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMi0xLTEtMA_46b90b9e-33b6-4ab0-a83f-faf07203e35d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i360c33d3bf9d4071a521470504bb754a_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMy0xLTEtMA_00de3e6c-e852-47f4-8902-9ff841187e30">346,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5d0533630774219a96e8ae0dd341679_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNC0xLTEtMA_dbcfd820-7956-40be-a4dc-4f3119622f72">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c6430609ca42e2af4e70d120723e15_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNS0xLTEtMA_ba16bad4-1982-4bb5-9c68-04d6a422187c">440,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0669b1b589ed4c0aa5c0f53d9af109bd_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNi0xLTEtMA_6a5b5763-92f7-458c-8cb5-e24c7aea7ab4">786,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c8ef6df76594ccf9ac7aa43bca3d664_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtMS0xLTEtMTY1_4f2b1139-f508-4c03-92bc-d37fd6d9566b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtMy0xLTEtMTc1_e3c39f7f-7a7c-463f-891a-702aab1d8814">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtNi0xLTEtNDM2_cf93770a-f241-437e-b975-b23733a23e57">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTktMy0xLTEtMTc1_88e789e2-2ef0-4379-9fbc-7f3ed5bb2d37">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTktNi0xLTEtNDM5_99b0d25b-93ff-43c5-b01b-286fa397cfd4">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjAtNC0xLTEtMTc5_9ce2c5a7-8964-43b7-9fac-aec93f121528">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjAtNi0xLTEtNDM5_bd0c6560-fe39-42e8-a5cf-37b1325bc50a">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMjg1Njc_e5ad5331-5a0f-41cd-b724-9b30ecfcd190">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtMjg1OTA_38665fac-32e5-4a71-a6bb-ad82e6370fcf">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMjg1MTI_22bd8440-b622-4a34-8bf1-69e55d08fdc7">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtMjg1MzM_b00b238e-6312-4a88-8960-30d7e822f7ab">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMTc1_39eed239-0358-4318-8cbb-6131429bcaaf">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNC0xLTEtMTc5_d03d22a1-4972-4893-930c-eea095ab6992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtNDM5_05b187ec-6fdb-4d0e-8ec8-cdca0e924ddd">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd7d1d9820346ebbdd910ea23ae5fb5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjItNS0xLTEtMTgy_fb42a169-246a-40c5-aa67-f01d4370b7b7">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjItNi0xLTEtNDM5_7f80e2ec-be3e-4891-bb88-d6cec9bc6a7f">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cb3e3ce39174efb90c579734662ca3c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMS0xLTEtNDQy_a9c6d457-8355-4c45-a2a8-b4dce4adec7b">16,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cb3e3ce39174efb90c579734662ca3c_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMi0xLTEtNDQ1_db420cf3-604f-4bb0-9621-521785fc1911">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c504584f2b44bccbb4c98df81a0c187_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMy0xLTEtNDQ3_289a20f9-c1fc-48ea-9cce-d42e55e8c357">358,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40e9fc954e0f4c6fac4befb25a43a7e8_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNC0xLTEtNDQ5_26a67c2d-b4cd-46dc-b22e-0a3548e0a4c0">875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d0b1e6a3e246f8a27e20041ff8cda9_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNS0xLTEtNDUz_dea911cc-a629-46bc-816e-5fa814a8b5d1">454,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNi0xLTEtNDM5_4d3a0598-5df5-43d5-b173-d32f23dfc66a">812,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (Accumulated deficit)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb20171945fd40e794706d8def23874e_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0xLTEtMS0w_2cccc8e4-da45-417c-b0d5-cada14d25787">16,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb20171945fd40e794706d8def23874e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0yLTEtMS0w_597e0df1-d78d-47ea-a076-311a42c7b479">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77dec1bdfce142efad4f356566506009_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0zLTEtMS0w_1d7311e7-4da8-4576-b5f9-01561a9c5a63">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350b26fa15fe439082f315dc8c0738d1_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi00LTEtMS0w_c2d21567-4cc8-4053-bb3f-076751769b3d">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9e33b34b6a4201ae924131d1884ef5_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi01LTEtMS0w_079faa88-d389-4b1d-9314-7c6f433d4439">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a4a953d5304f198ee6f152d7aeea35_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi02LTEtMS0w_dc2371e0-c046-446c-a4c6-4410d7aa504b">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy0xLTEtMS0w_a55ef00b-43c0-4c3f-b039-ac5272a0e5e7">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy0zLTEtMS0w_e4f586d6-2fa6-4c36-b57d-cdb1532d7d5b">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy02LTEtMS0w_4fe78e7c-ddb9-4a3f-a305-bc244fffc061">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNC0zLTEtMS0w_46877318-a33b-41d5-91c2-ef0f1148d5a1">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNC02LTEtMS0w_f683c0e6-16b5-45d9-85d6-ab18aff1e376">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0xLTEtMS0w_276cee97-d841-423c-a068-e8fecf2a7e0d">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0yLTEtMS0w_f32a312b-740b-4880-8020-7af940da4114">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0zLTEtMS0w_ee485937-3cec-48b1-8641-a43e1211d744">73,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS02LTEtMS0w_8332d2b7-db3c-45db-8e86-5111f201829a">73,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia085df13296843368baeb5805a91e5d8_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNi00LTEtMS0w_d80680ac-9d35-4a5f-a7f5-5a02b54f0b44">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNi02LTEtMS0w_7e4ffd23-7777-4374-b4b4-b22464a418d8">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia085df13296843368baeb5805a91e5d8_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNy00LTEtMS0w_129675ea-24c7-4742-950a-bb56358a5b4a">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNy02LTEtMS0w_5058c678-9ba4-4e96-b748-82dd3a103a11">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOC0zLTEtMS0w_70337904-5763-44e8-9336-f4e2c124f228">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOC02LTEtMS0w_23bfaee6-c670-47b1-a9f6-ce2d51790b8d">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS0wLTEtMS0w_7e5cfe48-374e-473f-971c-bd2c1bc9a38d">Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51a04f07e094d73b253c1b38304f355_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS01LTEtMS0w_dca2d9f6-fa0b-450a-b0ee-16c9277bde03">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24fe1222cc784553a37d8ab3fd25236d_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS02LTEtMS0w_524391ba-b86c-48e4-9030-19daee8f72ba">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fa5703dfd6f42c5a03262f6a827081a_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTAtNS0xLTEtMA_46f7b893-f45b-4114-bc23-8d722b6bc666">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTAtNi0xLTEtMA_16313fd8-bc52-41cf-bee6-2d5d53e9d0ce">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id70967578d4d40a9bde681ed44e00bf3_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMS0xLTEtMA_0ba53c08-bca5-4311-ae7d-b9e2733a8334">16,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70967578d4d40a9bde681ed44e00bf3_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMi0xLTEtMA_54eb8fc4-95c3-48bf-8fc2-7f6a84afa4dc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2271fc765142b1beb4cf28d365bb6a_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMy0xLTEtMA_79145239-400f-4e43-9454-d8931ddb867e">295,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib91f3032f13b419e96960180df7a57a0_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNC0xLTEtMA_1be8da91-e69c-4a78-8b4e-b02ac895595a">4,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia056a39a1d1646b08db6232475f0fe3d_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNS0xLTEtMA_10990d89-aff8-456e-8f2b-dce37d84cc6d">370,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07b2a7f22b749b2b75f7867f5ca9d61_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNi0xLTEtMA_ab089060-6a57-44da-98db-58af1a270b96">661,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e955a2670f14c5589acd8fae1849f37_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItMS0xLTEtMA_00d1c02f-7a82-4662-97a9-bcebe4395e40">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItMy0xLTEtMA_12ca323f-8d2f-48b9-948b-0f9122f83f36">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItNi0xLTEtMA_dba39d93-3853-48ab-b5b0-92bfa63758cf">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTMtMy0xLTEtMA_2cd19119-d606-4eef-96ca-ef0b25aa147d">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTMtNi0xLTEtMA_83a3be18-fd30-49d2-93cc-cac0ea22ce56">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7133362acc234799828e1697270f098b_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTQtNC0xLTEtMA_9102a8bb-8477-4dd3-8205-ef84807b5fac">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTQtNi0xLTEtMA_0ee0d2b0-f4df-4f52-ad01-decfbc58c82b">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7133362acc234799828e1697270f098b_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTUtNC0xLTEtMA_bbc6c204-596c-4bbb-a93f-225b4cab389b">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTUtNi0xLTEtMA_70d343ce-28bf-4201-ac1a-10ec160694d7">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTYtMy0xLTEtMA_10e22ed5-3330-47f5-9882-a48106fb40c4">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTYtNi0xLTEtMA_971b5c16-1e40-4dc9-82d8-0bdbf8cc9a36">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f36701c729b4ca08acd79e998f584cf_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTctNS0xLTEtMA_b32b8f57-9731-4192-8684-e6f608eb8d1d">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTctNi0xLTEtMA_797ede9b-d21e-443d-b366-9c0f1aef01f1">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0af9313f05af401bb4da9b72af20c7bc_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMS0xLTEtMA_8f35cc47-bdc8-4da5-98cd-264a13a29aa5">16,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af9313f05af401bb4da9b72af20c7bc_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMi0xLTEtMA_997d5465-9632-4353-8a9c-b58b9d41b664">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3084043063c5478084965f63fc694456_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMy0xLTEtMA_f7d4af22-d451-4540-a47c-932f2c27e221">304,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70eb5532b8c24ecf95a7e0ba1196f93b_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNC0xLTEtMA_c52eee97-6fe3-4487-8ffc-adf1764cfc4a">2,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2891e29ad7f442385683c6dfa1a990e_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNS0xLTEtMA_b3fbca6f-fae5-414d-9fb1-14641fb336ea">392,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede4b1a3266f4aa58150416db0b81f06_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNi0xLTEtMA_638d9993-9135-4f15-b344-c1ca1a79446a">695,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94c5045f7c634a6ab1162b5156068143_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktMS0xLTEtMTI3_ea1dd252-7b80-4ce4-bdd7-ad48cb7d2f89">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktMy0xLTEtMTMz_f065cbda-9bee-4924-b9ad-404fbb81b115">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktNi0xLTEtNDYx_6007dad2-e0fe-4d8c-90ef-a55014559fe2">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjAtMy0xLTEtMTMz_2a1f71e8-b705-4233-8c4e-b8a9d5241be7">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjAtNi0xLTEtNDYx_b7611f80-eb58-41f9-b694-bee1ee44bb8d">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjEtNC0xLTEtMTQw_9319ed17-7b37-4656-9de2-3d55a1f8cdc7">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjEtNi0xLTEtNDYx_80ea1552-c49f-4885-9175-2f88e03817e8">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjItNC0xLTEtMTQw_1d2a7bc6-7e47-444c-8996-b9cdf9ee19d1">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjItNi0xLTEtNDYx_8f508f77-8ad1-4403-b445-0697f13fc1f5">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjMtMy0xLTEtMTM3_0fa4dc06-bacc-4cbc-965c-a1d5cc7ca378">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjMtNi0xLTEtNDYx_304737e1-ed21-4543-95f6-4f0b5e654bf5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f74d78b3bfd465285b4b70819f120ae_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjQtNS0xLTEtMTE1_3ae17eb0-21d7-4587-ab3e-af9a07aa6a25">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjQtNi0xLTEtNDYx_2fca15d5-8849-4f21-8707-265ee8b009af">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b76151e50a6468f9778c0f3285a6571_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMS0xLTEtOTA_7f5813e6-a7d8-4d4b-8661-cdcb90a60f4b">16,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b76151e50a6468f9778c0f3285a6571_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMi0xLTEtOTE_d28effb5-c7e0-49b5-a57c-ab474175cb38">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i575ac8d86a424cc58611058fbd63c5d1_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMy0xLTEtNDY4_0424320a-1ef4-4399-883f-19236126499d">313,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i187e0f90eac444ea9e476b4465539595_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNC0xLTEtNDcx_cba490f8-a213-4c95-abeb-786c09510d9d">1,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37bf04a171f0407a9f1eae38a860495c_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNS0xLTEtNDc1_fa53d935-aee1-4749-9f98-880cfb2a5a1d">386,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNi0xLTEtNDYx_60162d59-941f-45d7-af4a-c096ab488f59">697,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) (in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNC0xLTEtMS0w_c0e00740-6572-4a7d-8599-02a5f5ceec42">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNC0zLTEtMS0w_67d3df48-1245-4128-b884-314a1de1940f">8,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNi0xLTEtMS0w_3c8b36bc-6810-4b03-904a-b9a5be1acc01">39,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNi0zLTEtMS0w_4d07ee97-7d87-47d1-991f-3947dd3612d7">397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNy0xLTEtMS0w_8b27db70-8e46-431e-a9dc-58ea98ed3b3b">37,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNy0zLTEtMS0w_b52d652d-ac7e-429f-a311-7a03dde28baa">12,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of premium on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOC0xLTEtMS0w_b614ef6a-32ab-418a-9ff5-5dde8640adf2">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOC0zLTEtMS0w_f67540e9-0725-4359-b386-99093cb6c8ac">1,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOS0xLTEtMS0w_9e525a26-7d69-46f6-8305-3ae37025c73c">12,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOS0zLTEtMS0w_639dec98-487e-47bd-86e8-417536f33ee4">17,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of commercial license and other economic rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTAtMS0xLTEtMA_964c5391-2cc1-48f2-ba92-6ca4eebf5628">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTAtMy0xLTEtMA_520a960b-3382-47c8-a8bf-6213b5926415">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTEtMS0xLTEtMA_a30ebaee-ad30-44c0-a7e7-b0b80a8fe5f3">7,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTEtMy0xLTEtMA_451ca436-b11e-4ac6-aa1a-f434176e1b74">659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTItMS0xLTEtMA_64702d19-6f4c-4844-af02-f47568efa0f0">28,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTItMy0xLTEtMA_69cefb8a-74a9-4dbb-bed9-639f34af6067">20,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTMtMS0xLTEtMA_b9ca859f-144d-4916-adc8-4f347a9a26cc">8,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTMtMy0xLTEtMA_6f3a2b7e-e537-42ab-8316-28ffd5681476">19,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTQtMS0xLTEtMA_7d5c3403-131b-419e-b708-83ea9c7bf420">8,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTQtMy0xLTEtMA_b5cdb3ec-168b-4a45-9837-e84f2cc2443e">17,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTUtMS0xLTEtMA_2e445de8-8b54-4485-9c8b-06cd18526315">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTUtMy0xLTEtMA_be161cb1-b7af-4092-b981-a780b7238fe0">1,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTctMS0xLTEtMA_14de75fc-5de5-463c-b562-41ba4fbe7266">8,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTctMy0xLTEtMA_e3af3eeb-b4cc-48e8-8d69-020b5537c3aa">5,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTgtMS0xLTEtMA_f8ae679a-9712-4641-97cc-cc09cefdceee">3,103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTgtMy0xLTEtMA_2ba44d2f-a806-444e-a08b-14d746714f22">4,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTktMS0xLTEtMA_56725997-d452-4104-8b0a-ad21d8b80d7d">3,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTktMy0xLTEtMA_1f8b332c-b80a-4015-99bf-57c359644af2">9,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjAtMS0xLTEtMA_26387ee2-fbfb-46bf-91ed-fdaf385d80ba">4,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjAtMy0xLTEtMA_6d4e618a-4d00-4067-aefc-7e5835d9ec14">12,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjEtMS0xLTEtMA_970d8036-dd0c-413a-b145-7e2437fd6841">20,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjEtMy0xLTEtMA_54416046-972f-4650-9aec-71487c0201d9">5,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating lease liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMS0xLTEtMzQzMTU_ae26d705-df7d-43cf-8e4e-a5a314013565">6,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMy0xLTEtMzQ1NTA_8b5627b3-8cfb-4fdf-a8f2-1d2f7b786481">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMS0xLTEtMA_fd534e4a-798d-4557-9706-83411df31f71">8,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMy0xLTEtMA_7575d426-c1f4-4d92-aa87-0b0ed37065cf">4,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjMtMS0xLTEtMA_ac9163c3-3c17-438e-b7a4-955c58024ba1">51,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjMtMy0xLTEtMA_2b495cc9-3f3d-4a4f-b017-67601d2464b0">54,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjYtMS0xLTEtMA_607cbc65-98eb-42c2-ab1f-bd59427915bd">116,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjYtMy0xLTEtMA_4ed82fd5-f700-4975-9ce5-495aa4365939">337,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjctMS0xLTEtMA_fff6d96a-21e0-46f2-82f6-164dcf353b3f">152,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjctMy0xLTEtMA_21ea7bb7-c191-43f1-a666-a0e4e1e1ede2">389,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjgtMS0xLTEtMA_22d7ce61-df4a-4d76-bb6e-e966374f0a1e">37,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjgtMy0xLTEtMA_4541f872-9228-4017-b95a-47f5c705d1c4">589,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjktMS0xLTEtMA_02edcff4-497e-4e9d-8e67-39389d06790a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjktMy0xLTEtMA_cb44bd9a-6512-4662-a9b1-9e3b695de0ae">26,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzAtMS0xLTEtMA_54ab2ccb-c736-43ab-9788-7917be4f4f81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzAtMy0xLTEtMA_c86bae91-7f67-4139-a1e3-5f01aaee13bc">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzEtMS0xLTEtMA_06482211-5cb7-4bfb-861a-640df426edb3">6,566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzEtMy0xLTEtMA_52986e7c-a972-4b69-a17e-898b7dd0eb1f">2,828</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzItMS0xLTEtMA_4296218c-e944-4d0b-8011-0d547b19647f">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzItMy0xLTEtMA_33a652d3-f9cd-472a-869c-81d0252b6562">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzMtMS0xLTEtMA_639d335b-49ae-4012-ac55-4c495b47d652">66,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzMtMy0xLTEtMA_d576f785-6314-4fd1-9567-9284c4e9576d">613,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzYtMS0xLTEtMA_8d636661-72cd-4e6b-a81e-ea97c6d65832">155,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzYtMy0xLTEtMA_07d8b248-f723-4128-903a-53d539777df5">203,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzctMS0xLTEtMA_af3e6da1-99e8-4517-b558-08519c7d1fe0">9,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzctMy0xLTEtMA_445acef4-7650-4dc3-9c3e-288dd34772aa">5,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzgtMS0xLTEtMA_8a1bbacf-c940-404a-aa5c-620653950bd2">18,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzgtMy0xLTEtMA_631292de-fc91-4595-8098-3b037edb7f0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzktMS0xLTEtMA_d36e4add-7f57-4727-b89f-629a69b7f020">18,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzktMy0xLTEtMA_abeca20a-6c8d-4e61-a53b-0091d0ee6cdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDAtMS0xLTEtMA_d9a4a047-111f-4ae6-862c-0dca44d3439a">29,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDAtMy0xLTEtMA_e39ae222-d486-451e-bb68-0ee2692ff1c2">2,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDEtMS0xLTEtMA_f990d56e-9524-405f-895e-2206ac6bdbd3">5,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDEtMy0xLTEtMA_c79ad91f-93ea-49ef-a68b-ca7d0ae02c3a">1,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDItMS0xLTEtMA_713e32dc-eefb-49f9-857b-fdbec3bbf26b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDItMy0xLTEtMA_a5b3f870-5d4d-44f4-bd74-74dd7f7b3e9b">73,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDMtMS0xLTEtMA_7bde4de8-6858-41cf-b069-e972822ac93f">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDMtMy0xLTEtMA_9d22de39-fb1a-4476-9490-4011d6dbf030">2,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDUtMS0xLTEtMA_b4864678-8f18-4e3a-b27f-610f7fe00d84">141,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDUtMy0xLTEtMA_f38a7a17-90cc-4a8e-88e9-e4b2e9a015ef">283,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDYtMS0xLTEtMA_274083b7-24c9-40cc-ba7d-4f5326a80d5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDYtMy0xLTEtMA_c317b9bf-4c28-4862-9269-95f255662965">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDctMS0xLTEtMA_02a91144-4b02-4d2b-ba82-5f1b6a416bc0">24,533</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDctMy0xLTEtMA_76b6f258-2654-476f-a994-ca477be0e6dd">384,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDgtMS0xLTEtMA_67115e36-beb5-4c9e-ad01-4229c663cfc0">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a4a953d5304f198ee6f152d7aeea35_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDgtMy0xLTEtMA_587837de-d52c-40d6-8e60-601145c7052a">72,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDktMS0xLTEtMA_50a53a0b-42d2-4622-bd29-4077a6b4039a">23,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDktMy0xLTEtMA_95ef2118-c090-4d2c-86e7-31d42b713bd3">457,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMS0xLTEtMS0w_10eef2bd-3986-4464-a014-38c7420dcfb2">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMS0zLTEtMS0w_b06bee74-62b7-49e0-ae5f-929c983c9a27">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMi0xLTEtMS0w_85bd1dba-3d62-420c-b48e-b8dedb2db48d">3,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMi0zLTEtMS0w_cf60e57e-73a2-4aad-8fb8-b0092302d23c">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMy0xLTEtMS0w_05dba053-5187-4e17-92b5-c5714a1a2acb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMy0zLTEtMS0w_61ae38b9-93c8-40e0-8b32-192a8f296c49">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfOS0xLTEtMS0w_e9c28c5a-f79b-433f-a044-45126524f2b0">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfOS0zLTEtMS0w_7861255e-9fa1-4531-9e1a-6a6f4eaf0ea9">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTEtMS0xLTEtMA_c7a67f37-c389-4764-ac7d-2c46a9248544">4,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTEtMy0xLTEtMA_fee62e09-d9ac-4713-aba9-c2eaefb1404e">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued financing lease payment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="lgnd:AccruedLeasePurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTItMS0xLTEtMA_68e88eb4-66f2-401f-8546-39a72c590b29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedLeasePurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTItMy0xLTEtMA_88d37a79-9fa8-4109-bcc3-dd9b637c404d">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTMtMS0xLTEtMA_5576ced4-1695-4fea-8164-13cf5b886ef4">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTMtMy0xLTEtMA_51f7f85a-4490-4904-b255-21f547245fb0">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_34"></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDk_c4b97b41-129b-4612-853b-9bf69556cbff" continuedAt="i0ea8492f60e94d3b886b77fa599619cb" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0ea8492f60e94d3b886b77fa599619cb" continuedAt="i89275b8e995c47a1b684e0e85300815d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjA_591b41c7-ca8f-473a-9225-a3bd8631348c" continuedAt="i75455adef33b4eea90a3bd73bdb9a255" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i75455adef33b4eea90a3bd73bdb9a255">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMzk_b9e645fc-8b44-470b-9e58-902e5c3205cb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjI_c22db029-9e87-4e30-8508-d1e63ed2a712" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjM_9ac55efe-ca55-4306-9a3f-e4c1392e0249" continuedAt="i6098929be3f34435973ab9f640419974" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i89275b8e995c47a1b684e0e85300815d" continuedAt="i82b817e063fe45eb95702e27258d86a7"><ix:continuation id="i6098929be3f34435973ab9f640419974" continuedAt="i4531e034462b43c88dec1453064f601a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4531e034462b43c88dec1453064f601a">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three and nine months ended September&#160;30, 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI0MDY_7b7409c1-6fb6-46bc-9656-39be4b3fdc4d">7.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI0MTQ_8052a439-37b9-46f4-98e3-6f92d1648913">22.8</ix:nonFraction> million, respectively. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI1MTY_4e868e60-1fef-49a5-98d6-9baa4c799360">5.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI1MjM_76fc498b-c6bf-42b5-bb63-6aae7344a39c">8.3</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTE_55c5a9d8-369b-407d-ab80-c8e5273d6d50" continuedAt="i765f9549edcd4ceb8e194af4221f9ab7" escape="true">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i82b817e063fe45eb95702e27258d86a7" continuedAt="ib8492ecc886142cf90af7cba4638a0b8"><div style="text-align:center"><ix:continuation id="i765f9549edcd4ceb8e194af4221f9ab7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1beb885c5fe44118a5ef2fec26cf4658_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC0yLTEtMS0w_52f1e3bc-5ba3-4f4b-a7ec-3663c234ec89">8,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1812aa7c1c1b4a55a887fd5a81b76005_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC00LTEtMS0w_2ebc3669-5e12-465f-b2eb-f69b5b6910ab">6,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338e6d6b14a34c75b7c70afa3376340b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC02LTEtMS0w_e26071f3-cc50-4fa8-8a25-edefd8827480">18,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6cdf3e9b474d958a8885100478e940_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC04LTEtMS0w_f129899a-feec-4c05-adbb-67a036043ac3">16,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ab67b2c0b5427699d1f2b18bf6cf19_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS0yLTEtMS0w_ed1df367-1b16-4e1c-a02c-6ee1c7cb8996">2,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41307110e644f0fa0ec6bccf02baa95_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS00LTEtMS0w_fa929aa4-5619-4658-afc4-f615528b9109">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99683383c51c4f64a11dd4f2001eed52_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS02LTEtMS0w_29e42eeb-b06b-4224-af5f-bac3d141151d">7,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c5115227a34d9b8c71c751709c5dc9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS04LTEtMS0w_fe2f38f3-d588-47d8-a066-85d5c259f789">4,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d50949db3fb4c8aaa647abb0dbf5f7a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi0yLTEtMS0w_4bde14a8-b20f-4b3b-a83c-16a2dd0c1fb1">4,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9177b057824c699d52a5f241543660_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi00LTEtMS0w_118bea3a-45e5-423c-8858-6862a58cb59a">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54af25c4d01847cf80e2bfe3bc7d5119_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi02LTEtMS0w_867d2a4c-13d5-42c4-9829-3df01547bf2b">5,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f737ae0746f4857a06c25988e3ad3d7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi04LTEtMS0w_7a475acd-47f2-4804-ba22-76b825614171">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy0yLTEtMS0w_3bab0ffe-d6d2-40b3-8471-e788b2501fa3">15,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy00LTEtMS0w_c92ecdce-3335-4f53-8242-f9f0401ff69e">9,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy02LTEtMS0w_6c15de90-7628-4624-bb92-2cc2bc2d888c">31,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65684440034d4351bbb21abccb7fca41_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy04LTEtMS0w_08bf7759-ce9c-415a-815f-317a48809648">22,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS0yLTEtMS0w_d019b96f-acdf-4d48-b0b6-6ee122274c8e">35,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS00LTEtMS0w_717e217d-ef26-4766-9308-508793b859c3">23,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS02LTEtMS0w_0591e5db-c23a-447a-99bd-efe3926a7541">128,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4670676853e4b26a40950b991482733_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS04LTEtMS0w_d2e8f328-9a70-43a9-89ed-94987d98fdb5">68,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb87c5273d146209b4f863fa73a6737_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItMi0xLTEtMA_9976b9f7-3e4a-4bc3-82ed-0ae32fdb5f2a">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16580774194c4717bd816e227f16cca5_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItNC0xLTEtMA_f7ccf8e8-477e-4b69-b18d-94ef5f9e567c">7,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ed1e446ea84220b26d564c3e4eb9c9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItNi0xLTEtMA_c3b197b2-4812-4c2c-9ed3-6cf7ca81d666">17,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76396c119fc8437783313ddfc6cfdce7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItOC0xLTEtMA_16e354b1-e762-467f-8765-7d016deea4fa">15,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461496e85d77458ab7ad2e0d7ef7035a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtMi0xLTEtMA_fcaea7f4-5a49-4a43-ab00-0f41a9bb788c">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b56fbe0a9734483b1566fbe6d710406_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtNC0xLTEtMA_5630a5c3-0a66-44da-81f2-618cca630689">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccff4fa6edd34cabbf684004d8ce7bb6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtNi0xLTEtMA_2e571611-3cca-4666-adfc-74a2096a1710">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46272602a5184253a54dc8e71c5e30ca_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtOC0xLTEtMA_c16a7da3-fff2-41e1-83f2-197461b7ff3c">1,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c95e2f17f3492394642693fb62d437_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtMi0xLTEtMA_3c9796ca-d2f1-4dce-9529-03fb9aec07de">7,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic079e130627446e2a4e0b9df6ba59cb4_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtNC0xLTEtMA_b9159ca9-71d8-4b20-85bf-3d750417cea9">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf39d65d4fbb4562aa99ab8d91883b55_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtNi0xLTEtMA_0866bf9a-430a-4534-8bfe-2d03fc62b375">19,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2328ebe1a164a53b66ea3c341bceda4_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtOC0xLTEtMA_d184c128-e2ce-4fb7-ae68-57f8d14d15ee">4,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40d8cfc06804c0eb44c421fe185a680_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtMi0xLTEtMA_42bce28c-fe60-4992-ae62-d54c3cf57ee1">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ec86bd000d4ef392d002af71a86521_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtNC0xLTEtMA_de6709a8-1b20-4938-82a5-3db1c24d8070">995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1a8e7f867144aaa2ecf955647862c6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtNi0xLTEtMA_b107d702-343a-446a-a8f8-16ee72e2bb40">5,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bbbf8570b35483cb6acbd8cd74c10ba_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtOC0xLTEtMA_d6b7c6d8-1ad8-4c3b-923d-d588742164e7">2,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtMi0xLTEtMA_72af334c-a3be-4a46-a249-79487b85ee00">14,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtNC0xLTEtMA_09f281ec-165c-41f8-a581-b35ae2502987">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtNi0xLTEtMA_77d07fe4-9d57-4bb9-ae96-e6c2589ae25f">44,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtOC0xLTEtMA_bb9fa316-4565-4c56-8de4-1d2080f9f376">24,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtMi0xLTEtMA_b67cee7e-0ad2-4b8f-802d-ae0ebb2d7344">64,835</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtNC0xLTEtMA_c8f3ef2b-21e6-4707-a6bf-f77a99505473">41,848</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtNi0xLTEtMA_b6919173-e1cb-43f6-80dd-a3a431bf9bd9">204,660</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtOC0xLTEtMA_9f45e9fb-58fc-4599-af02-e4be4750487b">116,429</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDU_81e04c5c-0bc5-484c-8c30-fc2d87a2c535" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:21.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.909%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.509%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b324e462494e6681ed114f944bd643_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xLTEtMS0w_fa7e6e4b-ae2e-492a-bef0-381e9e446524">47,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b324e462494e6681ed114f944bd643_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0zLTEtMS0w_d5eb8f21-0f3d-4d87-b066-0935ec64ed3a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52b324e462494e6681ed114f944bd643_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy01LTEtMS0w_56b409a7-8e0c-442e-8b1f-e34985f24d83">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b324e462494e6681ed114f944bd643_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy03LTEtMS0w_a4cef8a3-c7d1-4da5-9af6-20c9aa225fc3">47,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy05LTEtMS0w_f7a9fa5e-e88c-4ca4-b576-44517d30b7cb">84,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xMS0xLTEtMA_aa265dc6-d736-44ff-8ed1-7627232263db">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xMy0xLTEtMA_321f151a-396c-40c1-9f72-fcc43ef0e59e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xNS0xLTEtMA_cc75707d-235e-463f-8b21-bbbc69e1d3d2">84,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xLTEtMS0w_a585cacb-4d94-4313-9efe-bb0a48c28f71">25,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0zLTEtMS0w_16d8c6a0-147d-4211-a03a-2308582232a6">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC01LTEtMS0w_676d4724-e0c7-466d-a1c1-f0949faa4439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC03LTEtMS0w_bdfdfe2c-7f82-4cea-a9b2-2f1922b21423">25,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC05LTEtMS0w_3dd93098-b6dd-4c12-b9e0-cedfa8799bdc">30,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xMS0xLTEtMA_e69fd9af-1eff-42e3-86ff-16e6816b278b">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xMy0xLTEtMA_25c6fbfc-df2d-41cb-b16d-ae167bb13006">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xNS0xLTEtMA_678f7dc9-ae79-402d-ba74-47486d6e615f">30,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xLTEtMS0w_b7d6c6db-7c70-4c70-8cfd-2e1af8560320">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0zLTEtMS0w_5775b085-265f-4fa2-ad21-8a6a2767cce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS01LTEtMS0w_ebcf4d7d-b53e-49cb-a38f-909f7d92a69f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS03LTEtMS0w_05eb0a1c-8fac-4826-8a69-f80f2751c6d5">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS05LTEtMS0w_78d851e6-6f4c-4dcb-b164-1b509044e810">4,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xMS0xLTEtMA_2378ebce-ef91-47e6-a612-a7bc0669ea8a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xMy0xLTEtMA_9f49b0c5-8d66-4ca8-ab2d-89eb4a6dd8c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xNS0xLTEtMA_45fdbfc2-552f-428e-aa30-077f02d06cae">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xLTEtMS0w_c6895d92-8ada-4207-81e9-51eb731a3dae">23,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0zLTEtMS0w_91efdefd-9ffd-4fb3-8dc0-2e6e735bd4a6">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi01LTEtMS0w_d7b05e0f-11d8-4040-9b2d-6d4f6b1f048e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi03LTEtMS0w_4cbc75bd-474d-4e4d-8e64-d51615d6f111">23,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi05LTEtMS0w_50d494fb-146e-4a17-b88d-abcbbb2f5077">45,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xMS0xLTEtMA_7bebeecd-50f8-4500-9062-1d985cde5e12">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xMy0xLTEtMA_fb6026fc-5d9f-4709-8c0f-6c9a2eb9fa6b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xNS0xLTEtMA_8d8557ab-9c43-486c-bccb-2300515f7d35">45,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xLTEtMS0w_d96e1707-60d8-4d15-8f9d-34bf9558dcd8">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0zLTEtMS0w_4ed1ed05-d2d4-44aa-8372-4d4840db4c44">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy01LTEtMS0w_9cdb9afd-3cf8-4de6-abeb-740507f2c5fb">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy03LTEtMS0w_2218bc61-3919-454e-b664-7c8d12c1b069">5,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy05LTEtMS0w_e28c4ab9-11e7-44e6-8dd1-f11905e6cbe1">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xMS0xLTEtMA_31b21941-7bba-49d3-bdd6-983258acf4d7">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xMy0xLTEtMA_90f0575d-bf84-4293-9f45-08fae2899d33">1,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xNS0xLTEtMA_9e3c1dc0-f59a-4583-83db-d6f673ad4f1a">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xLTEtMS0w_de155b3b-3fea-463e-aebb-7aa1d8f5011d">152,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0zLTEtMS0w_701e442c-c05d-41b9-829d-e85701523bf4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC01LTEtMS0w_ff33b4a6-ed0c-4cb1-a02f-78ea62a24095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC03LTEtMS0w_c00af69f-34ae-4699-86c9-a87bd04b93b9">152,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC05LTEtMS0w_4814ad00-be6e-4c8d-bab8-9f6f91fcded4">151,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xMS0xLTEtMA_beb47f9c-823e-431c-9b01-27c4c22d0969">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xMy0xLTEtMA_d1e2af73-4f5c-4704-b622-b6aabfe58520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xNS0xLTEtMA_e461b28f-916b-4660-b24b-b8df4788e01b">151,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xLTEtMS0w_be4f0c27-4bf2-4386-a889-277818b8b944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0zLTEtMS0w_98231950-cc06-45fa-a76e-569ec307f86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS01LTEtMS0w_2fb47e35-dbd7-4acd-9683-60598d14e9f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS03LTEtMS0w_b872dd3b-c297-41eb-bbcd-4d4439b32253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS05LTEtMS0w_c3f5b528-5271-4b5b-9692-cfac80fa7f32">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xMS0xLTEtMA_62e24ec8-8b5d-4323-94ef-ac2790d4fd5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xMy0xLTEtMA_95ecf6ac-c043-4f16-9cd0-35e9a379cc64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xNS0xLTEtMA_277599a5-d4f6-45a2-930c-d4ab4b6d2850">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMS0xLTEtMA_53c3fbd6-7dcc-4881-938b-6dce04146f93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMy0xLTEtMA_c18ffcdc-899b-4643-94c6-232090ba1f28">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtNS0xLTEtMA_d198f9ad-b8ce-4720-8270-6f81fc647130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtNy0xLTEtMA_c9f0af27-1c27-4dd7-8f3f-bb525723608e">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtOS0xLTEtMA_7e6604ba-0cf6-4802-a933-2c1e99c5f5c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTEtMS0xLTA_deb17076-409b-4e67-a7ab-b6f44a795b23">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTMtMS0xLTA_de34ceb4-b952-4f9e-afa8-911520c713a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTUtMS0xLTA_848a5526-dcbc-4960-bb29-2908d5d283b1">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMS0xLTEtMA_52b828bd-95c0-40ad-9b1f-ca0c4320076d">257,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMy0xLTEtMA_3bbe7757-590e-49b9-bb1a-0550f7cf82d0">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtNS0xLTEtMA_353e3a02-98ed-4d37-8000-37e1e9c41894">726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtNy0xLTEtMA_f6d2a183-4545-4dfe-99b9-0e6056c6de76">257,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtOS0xLTEtMA_55c38161-c1f7-43e4-a06f-e1404b3b03d8">324,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTEtMS0xLTA_2521b5c4-781d-42ca-9be6-be2f673a87ed">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTMtMS0xLTA_e9f1139c-949c-4a04-b3d1-89940c3ca04e">1,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTUtMS0xLTA_cfec76da-b6e6-4eda-b81d-fda3d3e4b377">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3227affd81a14c3eae170a2fd39475dd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTItNy0xLTEtMA_97683091-df94-45d0-a629-f17fdbc89adc">42,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74019a59687e417d98beaf331bbdb8f8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTItMTUtMS0xLTA_397d56a9-583d-488d-b3da-889b0266da93">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTMtNy0xLTEtMA_3e1a0a49-406a-4ea0-8bfa-e9ed7f6f5230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTMtMTUtMS0xLTA_3b146934-deeb-44bd-bb67-041d3d31d4c5">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTQtNy0xLTEtMA_8518028b-1c8b-4f04-bc15-cc789c39ccb6">299,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTQtMTUtMS0xLTA_be366bdf-8977-4178-90f7-6d4e3a91f3f2">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we exercised all outstanding Viking warrants to purchase <ix:nonFraction unitRef="shares" contextRef="idfb7eed4859c41008e742eb80e557048_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI4NjI_8b22b902-28d6-4129-a416-c1604642fef7">1.5</ix:nonFraction> million shares of Viking's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9b7cdf10102d42dd915fbd5b67034260_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI5MjE_ff36658c-3c6f-4527-8541-4dc81f9ab6d7">1.50</ix:nonFraction> per share. As of September&#160;30, 2021, we have <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI5NTM_fc6a75fb-b2fe-4004-85ce-8261c950bd12">zero</ix:nonFraction> Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjQ_318eb3bd-1363-4730-af4b-8a52b197b14d" continuedAt="i69fe779fd8494e11a6fbd3e6aeeaafe3" escape="true">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib8492ecc886142cf90af7cba4638a0b8" continuedAt="ibe8e57b5c8c44db4b554a02ef85b3ea3"><div><ix:continuation id="i69fe779fd8494e11a6fbd3e6aeeaafe3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMi0xLTEtMS0w_5f52438e-d580-4b37-b9d3-273492cf36ec">76,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMi0zLTEtMS0w_a23af999-3ae1-4972-b5dd-c0da70a6f4ee">76,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMy0xLTEtMS0w_bf5c5480-f204-4572-acaa-20b4baddfb04">23,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMy0zLTEtMS0w_2395cd1c-e413-4886-858e-c81e4a79ca8c">23,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfNC0xLTEtMS0w_3f3d2a62-c476-4eda-a2d3-19f9ed0db29c">99,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfNC0zLTEtMS0w_a908908c-2e31-4294-9393-5f8c29512ab6">99,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTM5MTk_dcbea56a-d6f1-40ee-84f7-63ab3ce3492e">eleven</ix:nonFraction> positions which were in an unrealized loss position as of September&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTQ1Mzk_66bb7107-e8b4-4acc-8210-455c37355d35">no</ix:nonFraction> credit losses were recognized for the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTI_a8e7e253-8001-4878-8aeb-bfad70fe6dd9" continuedAt="i5af0806432bd43b4901a3890687a945d" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5af0806432bd43b4901a3890687a945d">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three and nine months ended September&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-4" format="ixt:num-dot-decimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU1NzQ_75812d8c-fce5-4fd3-8496-b79868478d4d">0.01</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU1ODE_7d55b93d-b585-43bf-8e24-282f99da80ad">0.1</ix:nonFraction> million of allowance for credit losses, respectively, as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdvancesOnInventoryPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU5NzU_21191e98-28d2-456a-bfd9-ba3c8c434317">50.2</ix:nonFraction>&#160;million. We have applied credits for such inventory purchases of $<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTYwMzU_7bf3c588-3bfa-4487-9700-1ea26c2a489d">24.4</ix:nonFraction>&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ibe8e57b5c8c44db4b554a02ef85b3ea3" continuedAt="i223179ebb8b049ae80a2f07389f70018"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTc_ce901d55-1d29-4069-81ec-d4f333747e2b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMy0xLTEtMS0w_a904b888-66a2-468d-a9e0-2de581f671c5">190,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMy0zLTEtMS0w_8c7b2601-2775-4ddb-a5bc-79e12a7b7d54">189,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bec6bae658f4fa7839b638d3604a63a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNS0xLTEtMS0w_29cf1a35-35a3-4099-ba03-250dbdef9e72">280,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fa6499d48549af8abfb01bffe3a576_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNS0zLTEtMS0w_093e9b7d-4407-4f12-8b7e-a5fe2cf250eb">277,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bec6bae658f4fa7839b638d3604a63a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNi0xLTEtMS0w_55916860-0d29-4bf2-bd29-d0903b229d29">75,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fa6499d48549af8abfb01bffe3a576_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNi0zLTEtMS0w_2de8f8a0-43d8-47c4-aab0-4abff606415a">63,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNy0xLTEtMS0w_1777f6dd-aa79-4015-a215-51fd3ea8ce12">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1d2fa5d245408d983a4eb034d356e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNy0zLTEtMS0w_a4dd6711-cd14-450d-a9c8-c151e4469820">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOC0xLTEtMS0w_83cf3daa-45da-422f-94f5-008ef66911e6">1,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d1d2fa5d245408d983a4eb034d356e5_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOC0zLTEtMS0w_5cbd8b0a-f52f-4a0a-9ca9-e4e8af137e80">1,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1294789ba14efbb689b8629eb271e2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOS0xLTEtMS0w_f1a44e68-e0d3-49c3-af97-bb70860ab756">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31bf65152af4864ae4e36dee4c10d04_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOS0zLTEtMS0w_dad38452-e319-417e-ac1a-ede3a3a49a3b">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf1294789ba14efbb689b8629eb271e2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTAtMS0xLTEtMA_b693144d-249d-48a5-838c-b546712505f4">17,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic31bf65152af4864ae4e36dee4c10d04_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTAtMy0xLTEtMA_2cdcee13-0d47-4b4f-be88-2d28431edec6">15,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTEtMS0xLTEtMA_cef7992f-e880-4532-808c-656ee8b278dd">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTEtMy0xLTEtMA_08c92637-52c6-450e-97f5-b3f3d66bf97d">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTItMS0xLTEtMA_20dedc17-7536-4b17-9565-1ad18dc74b92">28,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTItMy0xLTEtMA_89e94731-8b6d-4da0-a300-b38e1b265048">7,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTMtMS0xLTEtMA_6d177599-adb5-48d0-8cea-7a88d6736e2c">752,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTMtMy0xLTEtMA_e1a85c16-c82e-4dd7-8fd9-09f293a2320e">784,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTg_49e44675-f4cc-44ea-85d9-7751d748dfdf" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial license rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0yLTEtMS0w_e1fe2a43-e6af-4bc1-92ca-817310347e88">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC00LTEtMS0w_6d8e1303-6a7f-42d2-b931-cdcd2b38c2be">17,550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC02LTEtMS0w_ec9254c4-794a-4a8b-b8e1-6af7e96a8217">10,748</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC04LTEtMS0w_0885e684-aaf2-4b96-9517-60a9265543c9">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0xMC0xLTEtMA_0726e391-4a4c-4878-8935-9abe6b86e5ce">17,319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0xMi0xLTEtMA_27c0c328-9752-4e20-947d-b5170e764be9">10,979</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY1MDE_22c5f4ee-8559-47ad-a0ee-79cefcdfd2fa">11.6</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY1MzU_5c2b04d9-ea9c-4de7-a863-bfa4cb43cbb4">6.0</ix:nonFraction> million as of September&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY2MTE_2dce6ed9-ac00-47e3-8d2d-676352163ae3">11.3</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY2NDU_299aa4d3-e83e-4aa1-a649-f1c4334b4395">6.0</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, we entered into a Royalty Agreement with Aziyo Med, LLC (Aziyo) pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2021 is <ix:nonFraction unitRef="number" contextRef="ib8bc73161fcc4ebc8b15c8add0abbd14_D20210101-20210930" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTc4Mjc_85bcb145-adca-4324-adcf-de468b399d5b">23</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of September&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of September&#160;30, 2021 is <ix:nonFraction unitRef="number" contextRef="id89c1cb7076440ad94b910f7aabb5992_D20210101-20210930" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTg4NTU_75adad8c-b5a1-4889-ba22-751de2444ce0">21</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="iec7576b07ee146738bfb748a0c5802e7_I20200101" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTkxMjc_89ed3653-6186-4a22-a242-3d632fa47e28">5.5</ix:nonFraction> million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2021, we further considered the current and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i223179ebb8b049ae80a2f07389f70018" continuedAt="i253df9d585624272a2f051cc742525bc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjE_ebc20442-e14e-4bbc-9d02-5f957a16025b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMi0xLTEtMS0w_afe35258-cbe4-425e-a243-77d253288f74">4,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMi0zLTEtMS0w_bf22f793-7b27-4c22-b1e2-403c7e24fe72">8,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMy0xLTEtMS0w_26e0eaed-a9c7-48f6-b191-8a92852d51fd">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMy0zLTEtMS0w_5b9cba67-5294-4c7e-84c9-bf609961016b">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNC0xLTEtMS0w_cfafbe2e-2f99-442e-b54b-cea0631ca6c2">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNC0zLTEtMS0w_96335860-62ef-43a4-8cca-7e57c60fd409">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNS0xLTEtMS0w_fb734edd-7e22-44b1-ab1f-012a661f0f15">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNS0zLTEtMS0w_b74e4b03-c8c9-4874-a1ab-3c934afd745a">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNi0xLTEtMS0w_dbdcf782-b2d8-4b27-991b-64e41c54d2ba">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNi0zLTEtMS0w_d6446b21-4f8f-41b9-ab35-9adec3df1f86">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNy0xLTEtMS0w_4b3be0eb-4474-4e39-8d83-5372f4ac0f88">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedAssetAcquisitionsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNy0zLTEtMS0w_e4fbca12-a6a4-44b2-ac55-35adf51bb84f">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:fixed-zero" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOC0xLTEtMS0w_aea0daa0-022a-472c-b532-416cbff46729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOC0zLTEtMS0w_dab283e2-22cf-47df-9d66-8348de737b8a">733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOS0xLTEtMS0w_e5378bd8-de38-4fb6-9470-61d4a71a1122">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOS0zLTEtMS0w_0d2edb28-c837-415a-aab5-d5ccb04c0d86">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTAtMS0xLTEtMA_e9d0b4c7-bfc4-47d8-a752-6ebca9663cc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTAtMy0xLTEtMA_dcd5dbdd-953c-4c8e-a97d-773974f38ef3">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTEtMS0xLTEtMA_bfb3010e-63aa-4b87-9240-39190cb16cb6">3,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTEtMy0xLTEtMA_753c89eb-ffb0-499e-a3a9-e8b074c4cb1c">3,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTItMS0xLTEtMA_9f3ce905-6c1a-46b3-b0cd-10b294b62d87">12,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTItMy0xLTEtMA_f3f2bd04-6f13-4ecb-ba41-730b48407b57">18,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjk_96878290-42bb-444c-9a6b-86e069dd8383" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTQ_b14846be-fef6-4385-a475-ed5eb48d3558" continuedAt="i8d8c7cef941948ed99ac8378547a6518" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span><ix:continuation id="i8d8c7cef941948ed99ac8378547a6518"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56a2e7b63464878884da9238110c721_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy0xLTEtMS0w_ca09cd18-d8bd-4fa2-912d-bf68fdd904ef">4,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia13653d6cd24412d8f8718d38b9e8dd6_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy0zLTEtMS0w_7334a074-f8e0-42ab-afb0-13fcf99f1b6e">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04aa132902b04c0394bce82d31a3aea7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy01LTEtMS0w_db25b16c-73cd-46f6-a364-3e865a8c2f95">12,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if38b3b2a600a4d90a5c8c264715751ed_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy03LTEtMS0w_d87851ed-e573-4164-9053-ac3979198bb3">8,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5c0b007c8b4715b662376286f1223b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC0xLTEtMS0w_0b9abf12-439c-4bd9-8a79-2a48243a7b7f">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2639d0217d149f5a491911c423590de_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC0zLTEtMS0w_975e84ff-8bba-4bc1-bd6f-2069aea2dd15">4,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a349547525942fc9fe678c81267030c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC01LTEtMS0w_45ab426e-7fea-4c0e-99c1-a45601d9f25a">15,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5adab605aa64ca4a227d25b36436eb0_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC03LTEtMS0w_5e3f9eb1-f508-4029-ace5-71b163225c94">12,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS0xLTEtMS0w_cc6dbc5e-39da-4a86-83c0-13ed0f27fe5a">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS0zLTEtMS0w_ffe70062-787f-4546-9043-ee2f6c0e9afd">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS01LTEtMS0w_c5da2292-2109-41a3-9710-a5b740e745f5">28,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS03LTEtMS0w_0f75191d-2123-4b3a-8087-f812a85ba346">20,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMTQ_38c814ad-2afb-4c11-8de2-bdc57f2025a1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy0xLTEtMS0w_aca4396c-be4b-4c66-844c-fb315b81e126">0.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy0zLTEtMS0w_1355e86f-85df-4b92-9c5d-62dfb5979f26">3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy01LTEtMS0w_09e53beb-cdbb-4063-8c3a-062dca6f2f42">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy03LTEtMS0w_1fac4981-8101-46d9-98de-1638df3b9a1a">1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC0xLTEtMS0w_60a84986-315a-4116-b624-7ac98e12eca2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC0zLTEtMS0w_80b69fbf-b583-43f3-9c77-6ff6b427a4a3">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC01LTEtMS0w_63ca7535-088e-4f98-95d1-deead6eca5c5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC03LTEtMS0w_bef835e2-92eb-4f0a-bcfb-b68cee9a313f">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS0xLTEtMS0w_69323045-15c2-4afe-b103-a19ca098cf71">48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS0zLTEtMS0w_1354e588-f68b-4260-9320-f45c30d24568">59</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS01LTEtMS0w_6f6051c7-bb71-40fd-bc47-d4fa96d9007a">61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS03LTEtMS0w_bf01c77b-209c-4b7e-96d0-2dc34bddbe0c">55</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi0xLTEtMS0w_d5dd8b9f-f048-4d8b-b28b-bf566e9d4cc7">4.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi0zLTEtMS0w_8fab3976-5661-4e80-a549-a914381d9dee">4.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi01LTEtMS0w_43c5f538-7f06-4d26-85bc-5234f5e24ba3">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi03LTEtMS0w_b5e1b678-2431-491d-a8a2-3172dca3fb3c">4.8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMTU_b9775161-d13b-47b9-be6b-566a00a27863">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="idd91366449ba49d1aa56a98935674623_D20210101-20210930" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjA5OTk_a4b9f471-e69b-48d1-911a-9bc18134216c">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i209bcfbff39f4fdaa13d185301232981_D20210101-20210930" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjEwMDU_40798669-1501-4bc7-91ac-4cd5f8da7fdd">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMzg_e8dde48b-9ea8-44d9-a8f6-7300bea6e7c8" continuedAt="i9ae73bca3f0844189678ab816aabca48" escape="true">Net Income (Loss) Per Share</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i253df9d585624272a2f051cc742525bc"><ix:continuation id="i9ae73bca3f0844189678ab816aabca48"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the conversion price. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:continuation><div><span><br/></span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDg_a0f09750-bbe0-4f35-9dd5-ff19d3045def" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy0xLTEtMS0w_ba2cf2ec-704f-4223-8de5-9c0f93d7ddd6">16,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy0zLTEtMS0w_c8074097-006f-45ff-8a39-f140bde8b0c7">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy01LTEtMS0w_dc149213-d6fb-4a8a-a335-9e4f482f77d9">16,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy03LTEtMS0w_76d06dbf-834a-4e37-ab39-d12bd3b80326">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS0xLTEtMS0w_a3bebfb6-3432-400c-a485-ce6b7735e621">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS0zLTEtMS0w_327f6562-188e-4158-ad50-6bf5bb00c11b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS01LTEtMS0w_a20a8db3-7bb4-4d64-9f09-7e0cdb535133">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS03LTEtMS0w_67af817e-693d-4775-8f08-0301cb820177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi0xLTEtMS0w_f0b9ee33-73f4-4531-8901-d00c633d4a7f">379</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi0zLTEtMS0w_80b127cc-7ea4-42d3-b704-024ee2719f40">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi01LTEtMS0w_96c2b393-c92a-4c10-adaf-7eeb415befee">507</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi03LTEtMS0w_df3e9201-94ad-47ed-bb7f-f079d99ccb52">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy0xLTEtMS0w_13da8bb8-bcab-4e0c-b057-ab5020a97013">17,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy0zLTEtMS0w_b3f2ef2a-b8fc-43be-bd06-982c63c6f2ed">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy01LTEtMS0w_8dec8628-6090-4501-91a7-700dc3c879ce">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy03LTEtMS0w_a19e19fe-080c-4a5f-8356-27f80caf6f40">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC0xLTEtMS0w_71d52cf5-6b23-4ffe-a38c-f36976a0611d">5,574</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC0zLTEtMS0w_411071cc-28f6-4d1d-9e8f-cde602eb131c">7,028</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC01LTEtMS0w_53869f7b-23a6-443a-82d2-cca80f7df3e5">4,984</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC03LTEtMS0w_2ad23376-e4b1-455b-ae57-e947b51bd948">8,330</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2020, all of the <ix:nonFraction unitRef="shares" contextRef="i45bb77fbcc47480fa1a19f213a179fca_D20200701-20200930" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTA5OTUxMTY1MDg5Ng_04ccda35-b9af-4d44-b377-50bc7de82de2">0.70</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="id664afa77ed0445894209a436e750c43_D20200101-20200930" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjI4OTI_c2c983fe-9a9b-469d-a231-3466e461873c">0.65</ix:nonFraction>&#160;million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzNQ_c8fefde3-7907-473c-87aa-234b2337c316" continuedAt="ifd5032445e7d44a3978c392f5b69ff5e" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifd5032445e7d44a3978c392f5b69ff5e" continuedAt="i950278b1c2174b00860263fb1df07ebc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzMA_9c5c84be-14af-492b-8185-b0c26e402799" continuedAt="id0f04fb56390420bbaff1a1d9bb7e96f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36100db0e0244c6aab5bd1dbbe08da68_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0yLTEtMS0w_eb53769d-34d1-466e-aa38-4280dd5fd542">5,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3ffe50d97d4d3b8818bb0bb6714741_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy00LTEtMS0w_1e97897b-2b33-414b-ad07-3f8ff0e75b60">251,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d127590aa94e20919836ce48cf0d97_I20210930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy02LTEtMS0w_139fefdb-29c8-461a-bf53-072c5903a6b0">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389fe86124f84f77a8cf5138a6d5f5cf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy04LTEtMS0w_01bb9e08-f4d4-424b-bf39-c35578ac3ddd">257,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6406808991da4d8689a188fd3b01c562_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xMC0xLTEtMA_5b54c438-1f52-4c3a-8270-1dc9e5626b14">3,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42236ee785824a1fb48480728bac6789_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xMi0xLTEtMA_c1b79252-f1a6-4132-8864-3e8259574199">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27307c85e21e4232ae8eaa32a61b7cc2_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xNC0xLTEtMA_01380bb7-c0f1-4f7f-99db-7db26726b15e">393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70323bb3497a4894a0db2dbb77b08b1e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xNi0xLTEtMA_3eea7df4-3afa-4c6c-9c49-31fc90a3b72e">324,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6381e6f32971476bad6e8099cd489312_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0yLTEtMS0w_237af760-f2fc-424e-820c-2f9117fb662c">42,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5724a75532a4b8aa3826f98fb49e10f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC00LTEtMS0w_7ed797bd-1549-4032-b799-13145d33060f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f8ca28e64840a497f16c8486d31fb2_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC02LTEtMS0w_3f60e5b3-22bd-402e-9b38-a1a516a20306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i337849ef0f8b47ed813360d98632e23a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC04LTEtMS0w_d60b5991-3872-4c64-8ca8-1ad0421e1683">42,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4feeb449c4040e18a03705d479e0b73_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xMC0xLTEtMA_07f290f6-a91f-46ae-8771-a634e3e8d8f1">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39511b4bf4784d1ab377144f67fa01de_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xMi0xLTEtMA_f834ae06-5d8f-4130-8bae-3c138ab756be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d2a27498648b69fe545f62a7d5f0d_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xNC0xLTEtMA_4b7cb295-db79-42a3-be80-6b9b977812bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d827596d8a47a3824b013dc8178a8e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xNi0xLTEtMA_a0a6372c-eac4-44d5-8f4b-8f77d24e4b75">32,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ecd386015e54ceabc014a87406ce863_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0yLTEtMS0w_7b1a9dae-d7ab-4127-b94f-2652a5a2daa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b7b001fd454c5589ff4e2973cd3067_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS00LTEtMS0w_df925ce9-e6a5-4bcc-93a3-8fbf79bd64e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9135bb25b9b145eab714c4c7ad20594b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS02LTEtMS0w_71279f6f-5fa0-4a26-920f-b5f88b0f2f55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i564faa262c604481a02c2694f4fb73f3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS04LTEtMS0w_cf1b99b7-c8b7-4fc0-bedc-04c24b299b4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ecbea11385c435cbb9af9cce9cfa738_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xMC0xLTEtMA_c2638fbe-ee7c-4a90-a612-9c6dba5f6a3c">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b74fc269564f20a9b090e4b7124600_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xMi0xLTEtMA_7f6b41c1-0df0-45ad-ad4f-7004d4805dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac63adf2bb546c4ac1aba900b398602_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xNC0xLTEtMA_16ab9a11-ae29-424d-a065-4193ece61793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785d8e5ecc03429cab75cc6262c02576_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xNi0xLTEtMA_8701cb5f-6b20-4b29-b390-4c79e343cfe2">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4355ca159edc4fa99ebca7d202c8bce3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0yLTEtMS0w_52a2a274-98c2-4a7e-a70a-754f1c0e701f">47,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327b2c0b89c844f99e545089828c950b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi00LTEtMS0w_93fef31c-243a-45d4-87de-13f749e1d45c">251,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb44ca12568c4d3c9fa23dbe60549105_I20210930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi02LTEtMS0w_2ebf6361-9c70-4b40-8d6d-e664ae17a679">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a65f889aa34725ad89d69cd8592c90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi04LTEtMS0w_558cf96f-4e33-411e-8c59-0e63cfd50037">299,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a388749dd0497c8d72fc543e8ad75a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xMC0xLTEtMA_5fe30d37-7d28-4df8-a8a1-002370fd209b">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb97d5feddd466b911da2f1c55fb194_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xMi0xLTEtMA_bb8e727b-f1ff-4648-8da8-d818eeac7094">320,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i227b26c77357461d805f1d914f51e920_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xNC0xLTEtMA_202f2dbe-a66e-421b-8792-435922c20dc2">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6329169fbc411e8411d28d90ca9499_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xNi0xLTEtMA_57c8613a-dd18-4445-9aaa-00adcc29d71a">363,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a1b93f4a934aabbecad2ea88faedbe_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0yLTEtMS0w_bce7d413-d14c-4818-9277-7d96f5f20b76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic536e4be36ac4c8db8f4378ad775ac07_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC00LTEtMS0w_87d052f4-3d8f-460f-8084-4f5be0057599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d989500a4b14828af3c71491fd9283e_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC02LTEtMS0w_b2e5f804-dd59-422e-8a85-f61d04856118">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i610ac4aaf38a415c8790607ee1e3c93f_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC04LTEtMS0w_18a60981-2e05-4c8d-96d9-8939a9d0cdd9">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bebc96ed6eb487a9164a823ad5cf0f1_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xMC0xLTEtMA_a135a2e7-55a5-4388-8ff6-86d6f39fe35f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b076ad76aa4482185948f46fd1db7af_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xMi0xLTEtMA_a02c0fde-bc95-4ec8-b41e-54685fe22fe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06afbcfccbc64bc492f4c8c17e3822a3_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xNC0xLTEtMA_c7dfe92f-eb01-4b17-a022-bfc0575b4d62">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21eb2218a714e87a27850a3da35a362_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xNi0xLTEtMA_704620a7-447c-40d8-a757-fd7fa115bb2a">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0745304b68584347a2623a146af292f6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0yLTEtMS0w_5b9cd086-1277-4f0a-b511-383db13471e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7b4e075dc6495e89f3147135f0148b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS00LTEtMS0w_56b13529-2c74-4555-81ab-96e49b15f54e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231808f85c2e4134b7396905d29aba89_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS02LTEtMS0w_215e80fa-204d-407e-9383-92ff27c0a524">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8416b02586494b9c68ce1aaeefd509_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS04LTEtMS0w_ca86d98e-7ddb-4ece-a5d5-3be91fe5e6e5">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78104f24516b4de29f3df2b385f1639f_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xMC0xLTEtMA_1bacae25-780a-4237-b5ad-f71c95f76177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d3d3b2e13452b972aad1617983de9_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xMi0xLTEtMA_c5d6525a-4c64-4fbe-a9dc-18fcb9ec1686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbd5e7581044241879711dfbcd50002_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xNC0xLTEtMA_1f110a3f-07c8-4c5d-afd5-8bfc34dca18d">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9850a097083942e0afabbbac0b9129f1_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xNi0xLTEtMA_b9e1697f-1658-4453-83a3-c35b55ccdf32">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i359cff11df50436c9bb95a65ae993fd1_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMi0xLTEtMA_860203ab-0ca4-4a91-8dd9-a627d78402b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4d6516a3084dba85ee9f2d9965e059_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtNC0xLTEtMA_349edce5-42b4-4b5a-8c50-53f0754cf63c">2,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73643b6707d4e4c9a71b01e7b7dcf93_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtNi0xLTEtMA_3eac9856-e6a4-4877-91b7-06ff5e7bf128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d90de4a6434ddbb1f5058962f04c17_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtOC0xLTEtMA_26fb37f7-9b27-42d8-826b-631b5bd2e6eb">2,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed9ab31d41044b192fcdb3349f39fb3_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTAtMS0xLTA_36e327a2-45d7-495f-9d67-604e386f2de5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa31522c2e4a440db343ae979020b192_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTItMS0xLTA_c87e2761-b4f7-40c3-a4a3-09856694e313">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5ff1254de64bb8b8d9981154c1f445_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTQtMS0xLTA_3fbc64b6-7d66-481d-a967-2fd5f63758e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b70c37f9aa42fe9d9b2c0a5569f3ad_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTYtMS0xLTA_b4f9161a-2c3a-46ca-9993-f4374855da87">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17521c0433c44b8a80fc0dd1145be9e6_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMi0xLTEtMA_197fd744-966e-4486-afdf-2629b381ea4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ec3cae99b848a1b973526b515df54a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtNC0xLTEtMA_18fc8940-0ecd-46ea-9966-7ed1711ae097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126d7fd9f75438580dfe001ae6fa752_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtNi0xLTEtMA_3b5631b7-4212-4c96-bb71-87608f1b5f81">4,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fcc3aebae546f7a142fac3cc2c0745_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtOC0xLTEtMA_b643e38c-8954-4146-b3d5-5c6af662208b">4,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ec7efead9b4761baa234b4bfb65a32_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTAtMS0xLTA_4315598b-599e-4237-a0a8-a076b5108edd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92d652ad5604f02a1b2e862f88b1646_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTItMS0xLTA_7b148f73-8f94-4833-921b-851bf1b621e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia655880e41b0499a8b88d4a727ed9eab_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTQtMS0xLTA_b00e6856-9bb8-4ed9-a380-d77778e51663">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40690754d3a44cc8d92472abaff4f6a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTYtMS0xLTA_6083b1cf-c1b1-4904-a5cc-2d9d841bb54f">6,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb63d9bffe134ab4a8487fdb45a691f8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMi0xLTEtMA_3de02a85-3840-4d28-99ec-a01c2e2d8ac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861dcf90c1e74fe880857a9b4b3c9a79_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItNC0xLTEtMA_37c6c3ef-5bd0-446b-8898-75a8f0d3045d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750b151cf9fe4b5bacc45d083dfefabc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItNi0xLTEtMA_f4550257-9dad-4080-a8cc-f35b36f9ae47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9efb83e898004cea87bab8cb9c0988da_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItOC0xLTEtMA_c6059c3e-173c-42cd-9844-04860b8b5fe1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda651849d114d4abd488d8ecfe42755_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTAtMS0xLTA_85ebec0c-5218-4579-bae9-c5ee6e89819b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b6a4eeb00954ec987c7739f3c9775dd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTItMS0xLTA_592b39ec-87b2-49af-b58f-b4a6a634bb34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f9c1943c5c42278fc70e863c8ee407_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTQtMS0xLTA_7f58ba96-4f01-40ea-9cb6-c678996c55e3">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025eaa94559140439e978745a70ab345_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTYtMS0xLTA_a3be0829-1efc-4c17-b38f-6ab74c56616f">37,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103235a0480d438fb3c8952921afef6d_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMi0xLTEtMA_761728c0-be0f-4b3a-beb0-1e441f90b536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ceaecbf981d488e903c7845de55f9ce_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtNC0xLTEtMA_42e86adf-a0fb-4517-a2af-299e38b6dddf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103f057e0945407ba3313d8490b9be67_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtNi0xLTEtMA_03871f62-67fd-4053-9915-836d20ff2aa7">720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53807a156d9c4b8a877570a1cad4e9d2_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtOC0xLTEtMA_015a84df-2721-4316-b4d8-91b6b02b0596">720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97d00b4fc204934b6f74c46e2902d97_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTAtMS0xLTA_0a7cf327-04f6-4bb2-ba5b-3cdc7fc97aad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f9e34d26c64081a716e4ad38102b2b_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTItMS0xLTA_1c3f09f0-a188-44be-b321-ba8202d517ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i116e95e42f624c0ebdee627175c1f44b_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTQtMS0xLTA_de04256a-0829-4d2d-ad26-c2bca87d8c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32596f59df27404580fe06db3f0a6a33_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTYtMS0xLTA_a29913e9-1372-4a36-9798-c0664a24413c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582ba6e6a3d048fa858bc097e375efbb_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMi0xLTEtMA_78f0ee9f-7b93-4cc4-9b63-45656a00e03f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb687c8f41345a1b1a390788c8b3eab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtNC0xLTEtMA_5473e3fc-7bb1-426e-a1ec-18878006688f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20539e1cd2eb4b4990f8905b457891fe_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtNi0xLTEtMA_b7b783f1-c827-4bc7-a3d5-adeccac82877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ed509cd26a488e8fc504b51723e946_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtOC0xLTEtMA_7d39fe6e-8119-4df3-af71-5e7b9aab1459">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i653b721956384c858144b850891af87b_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTAtMS0xLTA_7005599b-2c5f-4f3b-968e-f08b5a667cad">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i577bc815500b4aa4bc23468486976592_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTItMS0xLTA_383fb821-183f-4537-9ed5-e75c0b61e665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bda237598d54cafa9c0a35ab7f63129_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTQtMS0xLTA_4b20326c-4e80-4b6c-9aa1-dd67a126ce67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe0e390a595409686d2fee6e8fe8450_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTYtMS0xLTA_55e56d70-41a9-4fdc-8d9e-e4be2238ca38">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4355ca159edc4fa99ebca7d202c8bce3_I20210930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMi0xLTEtMA_6263c9ee-c432-4a09-8fd9-34d6f0ea306a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i327b2c0b89c844f99e545089828c950b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtNC0xLTEtMA_5ddb02e0-5907-4b17-a0a7-47b39605d710">2,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb44ca12568c4d3c9fa23dbe60549105_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtNi0xLTEtMA_43b22391-55e3-4caa-bab3-5183c52fd84a">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a65f889aa34725ad89d69cd8592c90_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtOC0xLTEtMA_8ccdba90-6238-4fec-925a-becd3b0da0f0">9,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a388749dd0497c8d72fc543e8ad75a_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTAtMS0xLTA_a650afbe-be18-4baa-aa9f-20c3f58bff9d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb97d5feddd466b911da2f1c55fb194_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTItMS0xLTA_07ce2ed1-0eff-4d28-bff0-bd052c7e33fc">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i227b26c77357461d805f1d914f51e920_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTQtMS0xLTA_3e590793-993b-448a-8735-1561b9fb3297">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6329169fbc411e8411d28d90ca9499_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTYtMS0xLTA_0260d5d8-948f-425c-ad99-fd429d978e43">49,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the nine months ended September&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjQ5Nw_8027aeed-cd68-4639-a4e8-a2e9da2606d5">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjUxNQ_93df1670-aaac-4c5d-99aa-f2b9c25732bf">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right_series" contextRef="i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfContingentValueRightsSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjUzNQ_60fde0ad-aa89-494f-8e31-6e08c757fbf5">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131" format="ixt-sec:durwordsen" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjY3MA_720e39ae-4fb5-4639-8f2c-847548ca1f2c">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="i4a7423268c1947ffaad3d4a234a16758_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMzQ3Mg_733224cd-d072-457f-b17e-6c7d1208ee89">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="ia7fe0d08f8814b26bb6d850aefa0bf38_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMzU4Nw_c06d2b6c-43ea-4cf2-9cca-0ec4ab02d19c">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2021, we paid $<ix:nonFraction unitRef="usd" contextRef="iefccc513badf4ac697660d63ce351a27_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDE5OA_30261a2a-491f-4e63-a300-b8d00e959c6c">1.1</ix:nonFraction>&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and nine months ended September&#160;30, 2021, we reduced the contingent liability by $<ix:nonFraction unitRef="usd" contextRef="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDU5OA_51a21d21-e6a6-43d5-97d1-29fd097112e2">3.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDYwNQ_192734ee-1c7f-4b5e-bd98-a020f8f5e9aa">37.6</ix:nonFraction>&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="id0f04fb56390420bbaff1a1d9bb7e96f" continuedAt="id1b1eacfb12e401e960724ba682f2a65">7.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="id1b1eacfb12e401e960724ba682f2a65">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the nine months ended September&#160;30, 2021, management recorded $<ix:nonFraction unitRef="usd" contextRef="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjE5OTAyMzI2MjYzMQ_5b0050fe-602b-436e-b5b0-56eb7f628bf4">0.7</ix:nonFraction> million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i950278b1c2174b00860263fb1df07ebc" continuedAt="i6a169be5a7844a288bdd4168722cfbe7"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzNA_340525a9-8b3f-457b-b140-182344458b87" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i845a05cd969041fba7ad46f78c0e09ac_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMC0xLTEtMS0w_13e18699-4c11-4023-880c-f1d93c57b7bc">45,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:PaymentsToContingentValueRightHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMS0xLTEtMS0w_d836767e-5da4-4ec1-9742-390f5c3bb019">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMi0xLTEtMS0w_216cc976-de13-4d16-a0c4-1af670e5c2e8">38,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMy0xLTEtMS0w_9ac03ac7-27a9-49b3-b6f7-a38f96583343">720</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75913a021dca4a82866b4b9298cecb68_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfNC0xLTEtMS0w_ee35b1cd-b32e-4fc1-a6d8-379f72a7ccb8">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In anticipation of our plan related to the OmniAb business, additional aspects of resource allocation and performance assessment may be made at the OmniAb business level and it is possible that the OmniAb business could become a separate operating segment in the future. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9. Subsequent Event.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i6a169be5a7844a288bdd4168722cfbe7">At September 30, 2021, there were no indicators of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets.</ix:continuation> </span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDg_053a57d3-1e99-4fc1-a653-b1ec2f4fb813" continuedAt="ifd2bb93bda214f6981eb557fbf53410b" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifd2bb93bda214f6981eb557fbf53410b" continuedAt="i5d9b0725f6a14ee98c12ea793d20aef2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $<ix:nonFraction unitRef="usd" contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzQx_f31e2cbf-a1e1-4dd3-adb0-2924d61816b9">465.1</ix:nonFraction>&#160;million included $<ix:nonFraction unitRef="usd" contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzUz_7f02a9f8-d65d-46f3-b287-89198d829aea">429.6</ix:nonFraction>&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDM2_f41a2b7d-4e2b-4574-bb96-441f779ab7f2">77.8</ix:nonFraction>&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTI2_8caa6eb2-bc17-4c6f-82cb-34274543217b">37.0</ix:nonFraction>&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjY4_662a3270-443b-443d-9e0f-33600d69e385">1.5</ix:nonFraction>&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was <ix:nonFraction unitRef="pure" contextRef="ib1a044c5eca64972a0b2cca378908568_I20201001" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc3_503ce969-775f-42a2-97b2-a198cf8ef0a1">7.1</ix:nonFraction>%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the nine months ended September&#160;30, 2021, we wrote off the entire CVR liability primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $<ix:nonFraction unitRef="usd" contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTU5MQ_bc833bc9-b917-41cf-933e-189b7292d6de">17.3</ix:nonFraction>&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $<ix:nonFraction unitRef="usd" contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTc0NQ_7f02a9f8-d65d-46f3-b287-89198d829aea">429.6</ix:nonFraction>&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $<ix:nonFraction unitRef="usd" contextRef="iaa5a82595b87414eb6672c3977e9fe8f_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTg1Ng_4d6ecd8f-3ea4-4c87-91d2-1c232d748550">8.7</ix:nonFraction>&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MTA_963f9033-c56b-464e-bd48-797edf86e7f1" continuedAt="ic095b3e6c2c94ed683c64c154c014f0e" escape="true">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i5d9b0725f6a14ee98c12ea793d20aef2" continuedAt="ib90f0804f85247dda499ae5bb3b619b0"><div><ix:continuation id="ic095b3e6c2c94ed683c64c154c014f0e" continuedAt="i1dc2b4bc5c3e4ff1aa8dcaac651283c6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMC0xLTEtMS0w_791dc8df-4150-4a27-8631-a8302d7d6f2f">51,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMS0xLTEtMS0w_9f838ba6-0e3e-45f2-8e85-bfd566836e8c">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMi0xLTEtMS0w_cbb6e53a-9346-40d8-8b77-a831d495d302">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMy0xLTEtMS0w_901c7d2c-8f7f-482e-b609-fd475c5ad39c">7,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNC0xLTEtMS0w_a16eb1fe-85d2-4711-99d0-664b547a2846">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNS0xLTEtMS0w_0b897304-3428-4558-b3a9-ec250c1aa8cf">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNi0xLTEtMS0w_5cab5962-620e-4f74-acc5-f90ebd509bae">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNy0xLTEtMS0w_4a2e6283-f519-4e23-aed2-6460f0258d14">91,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfOC0xLTEtMS0w_0602800d-8d95-48c0-b0eb-353eac9d0ac9">6,814</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfOS0xLTEtMS0w_1af4bf51-5e02-4374-a51b-b8df3e13477a">8,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTAtMS0xLTEtMA_8aea4a5d-8ad2-40f9-bee9-d1f97db2e3f2">3,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTEtMS0xLTEtMA_ba4d38af-42cd-4d5f-8fdb-9d2bf0cd0c4f">3,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTItMS0xLTEtMA_87bba8f2-e5ff-47e3-bcee-5c08f6583aaa">1,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTMtMS0xLTEtMA_90727e00-0b7c-40c6-8643-7be59eb5a541">52,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTQtMS0xLTEtMA_14508372-24de-45a5-b699-1530d18b7d9f">465,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"><ix:continuation id="i1dc2b4bc5c3e4ff1aa8dcaac651283c6">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. <ix:nonFraction unitRef="usd" contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001" decimals="INF" format="ixt:fixed-zero" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjU3OQ_2bab1e44-0274-4e8a-8a5a-3cb2931fa171">None</ix:nonFraction> of the goodwill is expected to be deductible for tax purposes.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="if47943aab20d4716931dd955f73d9f68_I20201001" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjY3Ng_fc7bd076-8da0-4cf9-b771-8356c3886e98">362</ix:nonFraction>&#160;million of contractual relationships and $<ix:nonFraction unitRef="usd" contextRef="i49460a614c3741bd9dcb93c1082e254c_I20201001" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjcxMg_5e7f68b7-2e8e-4c0e-abbf-7661f5f4d6c9">23</ix:nonFraction>&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="iac2e38018c524066aae124ee0322449c_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzE5NQ_357811bc-486c-4d5b-a8c2-9deeb0d0e2bf">12.9</ix:nonNumeric> years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using a discount rate, which varies from <ix:nonFraction unitRef="number" contextRef="i24d097ca8d274dba82a4146da4cefe5c_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzU5Mg_46947624-58ee-4407-a0f8-63f6abe01aee">12</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i3b99f5d261b2424984f7c2048cf94154_D20201001-20201001" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzU5OA_d922018e-eb39-4b4a-8d2c-f1179c392d17">15</ix:nonFraction>%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzcyOQ_153dad6d-be23-45e0-b5e7-d321482fc850">13.0</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDc_56ec5f28-8a7e-4a77-839b-75f72ffb866f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share-based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMS0xLTEtMS0w_51d12930-7ec7-4be9-99b1-9de6501e7687">43,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMS0zLTEtMS0w_69069b18-8ebc-4508-a719-23ba471e6ecf">119,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMi0xLTEtMS0w_20932d3d-1843-4260-b541-63df2669fef0">46,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMi0zLTEtMS0w_b6b70f9e-4148-4445-8846-4b56e253b7e3">77,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0xLTEtMS0w_2285e63d-a70b-4735-9d82-04c429689f4b"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0xLTEtMS0w_3f5da870-8f75-44be-a33a-944e01946806">2.91</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0zLTEtMS0w_44d40396-5892-42ff-b1c4-cf0c2ab13584"><ix:nonFraction unitRef="usdPerShare" contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0zLTEtMS0w_d4a14896-cba5-4b23-918f-339b0bc75624">4.77</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $<ix:nonFraction unitRef="usd" contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk0Nw_6090fac0-8610-47f2-aa16-25f75c1757dd">5.1</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk1OQ_442c223e-c679-4c67-b496-8d0cfe6f6e8b">4.6</ix:nonFraction> million in cash, and a $<ix:nonFraction unitRef="usd" contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk3Nw_3f3751e9-2773-4d93-9736-b87baec9579c">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which was settled and paid in September 2021.  We also issued nontransferable CVRs for up to $<ix:nonFraction unitRef="usd" contextRef="i6ee708bc3f874ea4a64ff9eab6bc8b78_I20200909" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTExNg_0246a052-eb5d-4830-b9d6-a53859a3e636">4.5</ix:nonFraction> million tied to partnered and internal research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="i24a5667057b941dcbffe8705e96b7a08_I20200909" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTE4OQ_4b4fda6d-f62d-4118-9a1a-bc3629b67f08">25.0</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i23982d6bb19f46ada4a2da4c208bef75_D20200909-20200909" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTE5Nw_800a8c1e-857c-4db4-8ab6-21c1dc5736e9">25</ix:nonFraction>% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTY3NQ_ba75dfda-078c-48e6-a809-d61ab80b6055">5.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="i62b604edf45a4273b85b6a9dd018b41b_I20200909" decimals="-4" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTcyMw_6f4ea727-ac4e-4c92-a5a3-cb04c82f0fd5">0.05</ix:nonFraction> million of tangible assets acquired, and (2) $<ix:nonFraction unitRef="usd" contextRef="i1107fe7113ce41d3aebe65bed5bc350f_I20200909" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTc2Mw_e5911218-a986-41e3-9d31-14077b2e4d42">5.0</ix:nonFraction> million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="ica1eb82f11c04cea9b0171a30ecb9c64_D20200909-20200909" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTkxNQ_a0f68587-3324-4108-b563-27b05a0bf9b3">10</ix:nonNumeric> years. We account </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib90f0804f85247dda499ae5bb3b619b0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="i62b604edf45a4273b85b6a9dd018b41b_I20200909" decimals="-5" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjA1NA_6a6b860f-0f3e-4e60-aa05-200829f487ba">None</ix:nonFraction> of the CVRs are recognized as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $<ix:nonFraction unitRef="usd" contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjE5Ng_e1f46a20-e47d-4cf1-a430-53acb8e4bd93">7.1</ix:nonFraction> million in cash (including a $<ix:nonFraction unitRef="usd" contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjIyMA_e4ac62ec-cbf5-4018-bb60-7abba31e892a">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations to be settled by September 2021), and issued earnout rights for up to $<ix:nonFraction unitRef="usd" contextRef="i86a9860367d34127b2a08e3c03d11f2e_I20200908" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjM0OQ_f6136d40-5328-4c3d-b024-c1caff6ad753">5.0</ix:nonFraction> million tied to our use of the xCella technology for partnered research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="i08d4e4d3980d4dff9c9d86c7ec2dcb16_I20200908" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjQ0Ng_1e4906fb-fa25-4729-b40e-efb021ff40e3">25.75</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i64d969dd64874a7db0f0480d82e40efc_D20200908-20200908" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjQ1NA_fc7f04aa-e085-4351-a526-c66a4ae99df4">25</ix:nonFraction>% share of any future milestone payments we received under a certain existing xCella partner arrangement. The holdback was not settled as of September&#160;30, 2021, and we expect to have it settled by the end of 2021. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjk0Mg_3c8d2460-28d4-404c-ab15-e26fd7ba81a8">7.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjk5MA_79716420-5881-49cf-98e4-aa0096df2bc9">0.2</ix:nonFraction> million of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzAyNg_992f125f-2ca5-4232-a431-2da6b9efa92f">0.1</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i3b57fd5414fe448ca4dc3bd49c273738_I20200908" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzA1Nw_f24fd343-c80e-4ff1-b8b8-1dcac5e264e9">7.8</ix:nonFraction> million of core completed technology acquired, and (4) $(<ix:nonFraction unitRef="usd" contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzEwNw_9cbcf09f-a74b-46c4-9306-a145ade8b8e9">0.8</ix:nonFraction>) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="if60b6d14d66a4cb9ba4bd253315c186c_D20200908-20200908" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzIzNQ_db806582-9eff-46b3-b4c6-d11b0d3a2069">15</ix:nonNumeric> years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908" decimals="INF" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzM4NA_cedc2304-8bf4-4b4f-99b2-6f62370f98aa">None</ix:nonFraction> of the earnout rights are recognized as of the acquisition date. During the three and nine months ended September&#160;30, 2021, we recognized $<ix:nonFraction unitRef="usd" contextRef="i6d9c69e09e534351bc10468027e76940_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzU1Mg_10d2d13c-4f31-4ec6-9704-3fff34a3c1ab">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjE5OTAyMzI2NjQzOA_ffc4e785-0a2a-4f10-a893-5be920d3337a">0.7</ix:nonFraction> million, respectively, in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did <ix:nonFraction unitRef="usd" contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401" decimals="INF" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODA5MQ_54103e29-d73f-4a16-8426-595dfda79e25">no</ix:nonFraction>t incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODE2NA_85d87495-47f1-45ed-aab8-d8ac9570b98b">19.9</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODE3Ng_eec8abf7-ebe7-4dd3-9525-9430f9d3a7e8">15.1</ix:nonFraction> million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODI2NA_cd3ec1b8-80ae-40b4-a422-e5e4e78a864a">25.0</ix:nonFraction>&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODM1Mg_66c5802e-d0b7-4dcb-88c0-2f3deb897774">4.8</ix:nonFraction> million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and the actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTM2Ng_02775db3-84ae-428e-ad27-38131041a6a1">1.8</ix:nonFraction> million of fair value of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQxNg_f0da373c-6aaf-4db4-8384-5b4631300893">0.8</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQ0Nw_2606e9b3-362d-43b8-b2f3-d37768b45bbd">12.8</ix:nonFraction> million of acquired intangibles, (4) $(<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQ3OQ_4d25c9fb-c817-4a48-a7fd-2be2318d90e4">3.7</ix:nonFraction>) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $<ix:nonFraction unitRef="usd" contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTU5MA_769f87a8-a72a-4f00-9bfc-cd8d7e8e2018">0.8</ix:nonFraction> million of deferred tax asset associated with the deferred revenue, and (6) $<ix:nonFraction unitRef="usd" contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTY2MQ_c4f5020b-1035-490c-881d-dc0601487284">9.0</ix:nonFraction> million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="i1575170f30d94fd0bbbe0cee59a6431f_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc2Mg_d9a87501-9747-4806-8b57-6ca720b71cf4">11.1</ix:nonFraction> million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="ia09d2bdfc41645b2b379612921c6d7c5_I20200401" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc5NQ_83772ad7-f791-4621-877d-463c557ce280">1.7</ix:nonFraction> million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTAwOTA_3a09871c-9a33-49b9-9422-59fdf51e5c22">17</ix:nonFraction>%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTAyMzQ_aeefd7b6-027d-4177-8ef0-bbba7062921b">9.6</ix:nonNumeric> years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA1Njk_fbd5ffcf-5bd2-4371-9b9e-2d8cd393d8a3">17</ix:nonFraction>%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA2ODk_d3e293b3-8b80-4642-a7fc-200ac250caaf">10</ix:nonNumeric> years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDM_4e6906aa-93ef-401b-bd2f-9441dde27c04">9.7</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjU5Mg_16dce038-42a2-4ad9-b32d-5e8fa211cf8e" continuedAt="i6cb298e5b5624fa5909cc20dc422ce55" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6cb298e5b5624fa5909cc20dc422ce55" continuedAt="ifcf47f7ef1144614a8bb7be69aecec6b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTk_e2485164-1a64-4ba1-90a6-f216aa45e63b">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTMy_6036bb54-381f-4738-8655-31cdcb5bc957">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjg4_614b1d27-1749-4a3f-a74b-2b9a61543842">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ifcf47f7ef1144614a8bb7be69aecec6b" continuedAt="i533dc681803147f1b71ace7fffe2d4a7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjA5_766100fa-0e93-41fc-8d9f-8a8be16de1b9">248.48</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTQy_1d79eb97-dd4a-4b75-acb4-64298277ca64">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTk4_f1ffbeae-562f-433c-9af9-2a9598b67620">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTE5Mw_63732639-d234-4521-9714-878577b3a76f">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTI1OA_66cf770b-75d9-47ed-8b8e-370a5d451cf9">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTMwNw_793a3a9e-4e2c-4e0b-9b97-f27e77a91f6b">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTQxNg_37f9a231-6410-4359-9dc9-7abadaaa0714">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTg0MA_d9525996-9b4e-4170-b921-5917b7693155">248.48</ix:nonFraction>. As of September&#160;30, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTk5Nw_5667898d-71cc-4949-a54e-e50a9f07aae1">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $<ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjE3MA_2c1c5ffe-06b8-487b-99af-e85871e50d7e">13.7</ix:nonFraction> million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjU5MA_af0c1950-35ec-4dbc-8e73-64d45611fa53">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjYyOA_f44279d3-4637-48a3-82fa-2199f29e182b">156.0</ix:nonFraction> million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjY3MA_aae24fa3-fa4b-479d-9902-0f45837571ca">0.3</ix:nonFraction> million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjc2NA_ae82d265-4443-4915-bb16-b694afdcc890">7.3</ix:nonFraction> million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2021, (2) a $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="lgnd:IncreaseDecreaseInDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjg4NA_0e3558bf-7947-4737-a169-c2547aefbc3f">13.7</ix:nonFraction> million reduction in debt discount, and (3) a $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjkyNQ_34d6632b-d165-4d1a-a718-614d1a02eaf9">10.2</ix:nonFraction> million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzI1NQ_c3f0e45e-9491-477d-ba77-a29fb22e9189">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzUyOQ_fc8f6550-455d-462a-8d4d-e026982bb9b7">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:PaymentsForConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzYxMg_4b21a259-f1b9-4bb0-94fd-64c26eefa3f9">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDUxMg_5fa1a401-3a42-4f20-888f-4cdbce344a94">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDU3OA_58cc6a0b-1f31-42b2-bf7b-e9996210f73b">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDYzNg_d8c6cb68-7ce1-46f7-93d1-5489587f1ca6">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i533dc681803147f1b71ace7fffe2d4a7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTY3NQ_b071912d-90c8-4c01-b643-f44b6f785eeb">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTcxMw_a612b44f-0a31-48f3-aa3a-b7568ab1b3c1">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTc1NQ_a14d7f8b-3f52-44aa-9bda-5ed66ac245fa">0.3</ix:nonFraction>&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:PaymentsToUnwindWarrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjEwMA_27248dd9-5ec2-4542-b8da-3486636a5079">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIwOQ_c3f0e45e-9491-477d-ba77-a29fb22e9189">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIxNQ_77956590-90eb-462f-b506-66f91c870569">2,559,254</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIzMQ_dd7ec1be-041f-4ca7-8c82-6ca59d2cdc72">18.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjM1Mg_81617da2-ad1a-4550-8ae1-306170ec4fe3">598,021</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjM5Ng_a1fde391-33ef-46e1-9485-04712fd5ffdd">0.5</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjU5MA_ae99a59b-6e36-4e1e-9d5e-dc80e2a837e2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMS0xLTEtMS0w_01edfbb5-bb22-40ed-84c9-71db44bff960">343,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMS0zLTEtMS0w_924c5969-7b89-4132-9c89-0b03b0d71161">495,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMi0xLTEtMS0w_d0662955-485b-4ce2-973e-0b51be068f56">26,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMi0zLTEtMS0w_e09f53ce-3178-4a6c-b336-26c2c8eaf98e">52,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMy0xLTEtMS0w_077ca9f1-2f18-47f0-b2b6-9c0cacc9e41c">316,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMy0zLTEtMS0w_afd80167-fbfa-4042-aad1-8621a5ed4293">442,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNS0xLTEtMS0w_62828e96-0f5b-4c3b-bc1c-364676cfadbf">24,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNS0zLTEtMS0w_05eac557-3f79-4162-bbd2-23f972ad5afd">48,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNi0xLTEtMS0w_b2b3cbca-a0e1-404f-9c6c-079636f01be9">343,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNi0zLTEtMS0w_62abadd6-133e-4462-b26e-4f7c37392dff">466,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTQ1NQ_575d59fe-593f-4626-b4bc-781c751187c4" continuedAt="ie701b7912d2b4749961129cd09fdcff3" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ie701b7912d2b4749961129cd09fdcff3">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2021 was <ix:nonFraction unitRef="number" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNDI5_2b3bd783-caba-4980-b761-8352aaf13aa3">10.1</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNDM2_6e6df7bd-e9ed-4688-91bc-acbba7f341b1">15.1</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2021 was due primarily to the $<ix:nonFraction unitRef="usd" contextRef="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNTg5_51a21d21-e6a6-43d5-97d1-29fd097112e2">3.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMjE5OTAyMzI1OTQ5Mg_192734ee-1c7f-4b5e-bd98-a020f8f5e9aa">37.6</ix:nonFraction>&#160;million tax benefits associated with the Pfenex CVR adjustment recorded during the second and third quarters of 2021, respectively, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR.  Also contributing to the variance from the federal statutory rate are excess tax windfalls from share-based compensation due to increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and nine months ended September 30, 2020 was <ix:nonFraction unitRef="number" contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTA3MQ_cba4b309-dba1-48a0-8cd6-e0cac474773b">42.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTA3OA_c42af22a-4f40-4ae7-b59c-339ac5bff95f">37.1</ix:nonFraction>%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income.</ix:continuation></span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU2Mg_1f9ace3d-5a24-4423-9da8-323596f8e604" continuedAt="ibed0d5c9786e4400a718256d6775dcb0" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibed0d5c9786e4400a718256d6775dcb0" continuedAt="i16a576256b7545e7a4ff6c91e04c62ea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU1Nw_99c221f3-3c38-4eb0-9998-964f4f984e8b" escape="true"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU2MA_4908283d-9445-42bf-b5c3-6df54bfb2aee" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4a008f555614be384f97c9b5a03d5a3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi0xLTEtMS0w_37f57766-5dde-4a1e-bc76-654a9e5a6bf2">2,561,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4a008f555614be384f97c9b5a03d5a3_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi0zLTEtMS0w_52e9934c-9aba-455f-87d9-6336f82d5e61">85.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9674c13420bc41deb65d3656daee3f18_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi01LTEtMS0w_b28bf875-069f-48b0-b25b-cc1c9e853b37">206,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9674c13420bc41deb65d3656daee3f18_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi03LTEtMS0w_20058f38-bf5d-4c61-8c2a-c04ca445a409">106.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy0xLTEtMS0w_07838e3c-56e7-4403-9360-3856c32ac2a7">363,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy0zLTEtMS0w_70380d9f-988a-46c6-ab45-776972dd7126">160.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy01LTEtMS0w_06e74de2-1726-4607-bb5e-2c9ff9b956a1">165,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy03LTEtMS0w_71e6a55d-aacb-4584-a698-87962f75e3de">170.04</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC0xLTEtMS0w_b4d3e3a4-a0fe-40b3-a6f7-c3bc34065883">564,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC0zLTEtMS0w_95f13b50-d1b8-476f-a948-b7a513117ece">52.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC01LTEtMS0w_c4a2245b-a484-4dd6-bf24-ad7091ce8e79">95,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC03LTEtMS0w_4008323b-82d0-4049-a13d-0329bc57e017">126.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS0xLTEtMS0w_4d762ced-52fc-4050-9dde-b0948acd7a7c">121,472</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS0zLTEtMS0w_cf1ea7c6-2c87-44b7-9744-33ac8b6b1feb">109.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS01LTEtMS0w_13f8bfc7-5c05-4ae3-87da-7005522e6d42">9,575</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS03LTEtMS0w_a7358957-3f81-4d92-ab1a-3e11cf259fba">138.81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi0xLTEtMS0w_a18d7091-d2b5-4c2e-918e-05bb79f4be13">2,239,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi0zLTEtMS0w_6414db6d-8311-4d1d-af24-607fef4029ae">104.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37978277e2ef4b739181ad403af7290d_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi01LTEtMS0w_fe71a06b-09b4-475d-8e81-ec1f0696c1e9">266,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i37978277e2ef4b739181ad403af7290d_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi03LTEtMS0w_e6966a34-7a46-48f7-97ee-deeede47e3b4">137.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i16a576256b7545e7a4ff6c91e04c62ea" continuedAt="i01c07a34185340469797903f2dc7b637"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNDUw_3cdf23b2-b53e-418a-945f-1d84d51a0978">1.4</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNTI5_9ac77917-5aad-4840-8a7b-6f8b3b808715">95.53</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i3896ae5368254d08ac76230cffd63481_D20210101-20210930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNjc4_913d9ced-93cb-4050-8578-74ce4972ff7e">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2021, <ix:nonFraction unitRef="shares" contextRef="i3896ae5368254d08ac76230cffd63481_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfODA1_135388cc-0777-4f79-aa8f-71f332b4855a">46,866</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfODk0_a3e9e324-a6c1-4b20-bf5c-ba987cd4e295">no</ix:nonFraction>t have any share repurchases during the nine months ended September&#160;30, 2021.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i01c07a34185340469797903f2dc7b637">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ideff198686944e55a0cc2ee1e0f927b5_I20190911" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTA4Mw_d5270c98-5c66-46d2-8abc-1b754baaa14d">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="i1e665f31d61e468db6b421188680776a_D20190911-20190911" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTEzOA_18f7e3bc-72a4-4c48-bc50-faa389b19f6e">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTUwNQ_bf4ef881-fac0-42a4-8631-4a7fd1ab6893">248.8</ix:nonFraction> million of our common stock remained available as of September&#160;30, 2021.</ix:continuation> </span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfNzY2Ng_3349222d-0ad0-4d7d-acc6-21a3aa60e6e1" continuedAt="i96be218b198f4e8dbde7688682e5e504" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i96be218b198f4e8dbde7688682e5e504" continuedAt="i259d6c1545a246108f32500f5e157754"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revise our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfMjU2MA_e70b46c1-d103-4474-a3f5-084c5e8d4017">three</ix:nonFraction> civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfMzE0NQ_93305f56-ff46-435a-b73a-8334208b3d26">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div></ix:continuation><div><span><br/></span></div><div><ix:continuation id="i259d6c1545a246108f32500f5e157754" continuedAt="i9ab8b4c5197440f79dde6de84d4005aa"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i9ab8b4c5197440f79dde6de84d4005aa">technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayments and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties&#8217; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.</ix:continuation> </span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_459"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzEyNjQ0MzgzNzIzOTI3_287f5d32-1a1e-4629-83b4-d5762671cf25" continuedAt="i2095498fe3a04638bbe46eabf58fdd8c" escape="true"><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzEyNjQ0MzgzNzIzOTI3_eaaa8572-f978-46a7-a904-6539062af8fc" continuedAt="i4ee1f9af6a9a4324b0fbc5101ea78eb1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2095498fe3a04638bbe46eabf58fdd8c" continuedAt="i36f7f885325f4cda861a7b1932ea7039"><ix:continuation id="i4ee1f9af6a9a4324b0fbc5101ea78eb1" continuedAt="i888b4d6a38ba485bbba002c3a7f6356e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <ix:nonNumeric contextRef="ibdf23659d72440e581b8103b1bb8431a_I20210930" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDE2ODM_a7155e42-7f99-4e8a-b6a4-d6d1be2ac00f">ten years</ix:nonNumeric>, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ibdf23659d72440e581b8103b1bb8431a_I20210930" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDE3MDM_5948ed33-cae8-4ba1-8cdc-088fa846d752">five years</ix:nonNumeric>. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i36f7f885325f4cda861a7b1932ea7039"><ix:continuation id="i888b4d6a38ba485bbba002c3a7f6356e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="lgnd:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUxOTc_5c5f3225-19c6-455b-b913-3a04da160267" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEtMS0xLTEtMzA3MjQ_d962354b-6728-41d9-bba2-33d0e101619a">12,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEtMy0xLTEtMzEzMDQ_c668b71b-490b-4f45-93a1-ea7a96a99e36">6,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzItMS0xLTEtMzA3MjQ_873ded3b-c4af-4155-a1af-f719720ca9dc">16,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzItMy0xLTEtMzEzMDQ_7fd32253-120f-4e7c-a90f-3ace75d2d1ba">15,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzMtMS0xLTEtMzEzMDQ_f92d1c7d-c547-49ed-a39e-ec3ef6e5dcc5">29,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzMtMy0xLTEtMzEzMDQ_82814548-04d2-4533-b9d2-233ab957345b">22,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzYtMS0xLTEtMzA3NTk_b4e6a13c-e599-4e59-b253-3f6c07e5928f">2,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzYtMy0xLTEtMzEzMDQ_5017a4fc-7ae0-401a-abc3-ac4ec30f2fc5">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzctMS0xLTEtMzA3NTk_72c525b8-28df-4178-9fa8-41373980f8df">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzctMy0xLTEtMzEzMDQ_17fcb238-381e-42e2-bffb-5e852fa96ae0">6,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzgtMS0xLTEtMzEzMDQ_7673a6ad-96f3-40e8-bee7-c5f63589530e">2,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzgtMy0xLTEtMzEzMDQ_35f121aa-52b3-40d7-b5f9-6d9661c8de71">8,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzktMS0xLTEtMzA3NjU_3dcda3ad-9eeb-4347-9cf1-220d9a9ce993">11,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzktMy0xLTEtMzEzMDQ_3e6267cd-a0f4-4d4b-8b03-4c148a5bd9e0">5,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEwLTEtMS0xLTMwNzY1_1d1ab282-0da8-4e48-b654-51e4bee4421e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEwLTMtMS0xLTMxMzA0_f6ff72a8-c305-425d-a319-c6abb071a7f6">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzExLTEtMS0xLTMxMzA0_8232708f-462d-48e2-ba9c-1e6bf8998cfe">13,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzExLTMtMS0xLTMxMzA0_61504e26-a7e4-4fea-861d-db5f11e2deaa">14,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, we entered into several new lease agreements including our Emeryville headquarter expansion and a new Icagen office lease, which resulted an increase in operating lease assets and liabilities of $<ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMTQ_a37ebdd0-97b1-4d8f-a061-ddbc110c1174"><ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMTQ_d183efa0-2bab-467f-983c-29b58de5fe78">8.7</ix:nonFraction></ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:OperatingLeaseLiabilityAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMDA_9567ee04-0b86-46db-9f3f-2cf6d6cc3476"><ix:nonFraction unitRef="usd" contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="lgnd:OperatingLeaseLiabilityAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMDA_ee1cae79-8e42-4057-89b0-edbda38a456a">9.2</ix:nonFraction></ix:nonFraction>&#160;million, respectively, for the portion of the leases with a starting accounting lease commencement date during the period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUxOTg_f50fd8de-c8fd-4f2d-b03c-a403e1c26046" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzEtMS0xLTEtMzA5MTY_482f85bc-9f69-48f9-a6fd-2c458a44bce5">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzItMS0xLTEtMzA5MTY_90abd252-c652-4b22-acf8-74eedfb267b5">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzMtMS0xLTEtMzA5MTY_6c4cb7d3-8646-4fd6-bf24-a90155b037af">2,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzQtMS0xLTEtMzA5MTY_b595472b-e0d0-4e54-a377-6778b1cbf3fe">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzUtMS0xLTEtMzA5MTY_57cb8ac5-ec0a-47a5-82e3-c313111aa316">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="lgnd:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzYtMS0xLTEtMzA5MTY_7175b233-6785-4c85-b2ac-ddfb75c5a5e0">9,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzctMS0xLTEtMzA4MjM_ea02bf02-bc1a-4d5e-b63f-12d326e2b99d">16,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzgtMS0xLTEtMzA4NDQ_322140bb-809e-46a4-a7bc-172a200ee54b">2,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzktMS0xLTEtMzA4NDQ_dae55be4-1a41-4917-a045-150500bdcdb8">13,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_466"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MDE2ODE_b1e7ebca-f113-4145-ac4e-b222a0daf068" continuedAt="i33c6799a31374d47848d245f37fe40c7" escape="true">Subsequent Event</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i33c6799a31374d47848d245f37fe40c7" continuedAt="i959141cd34ba4dba84b57809771af669">On November 9, 2021, we announced we are pursuing plans to split Ligand into <ix:nonFraction unitRef="company" contextRef="i1c555247c8274906932e6bde7b7a204a_I20211109" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfEntitiesIntoWhichEntityPlansToSplit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MTI0MjQ_d642ab68-9049-4faa-b61c-3d16a5c3c19f">two</ix:nonFraction> separate, publicly traded companies with one featuring the OmniAb platform and its large and growing customer base, and the other featuring Ligand&#8217;s existing collection of core royalties and the technologies, pipeline and contracts associated with the Pelican protein expression platform and the Captisol business. Based on initial management and advisor review, an IPO and eventual distribution of OmniAb shares to Ligand shareholders is the leading option under consideration at this time. The IPO would be of newly issued shares of OmniAb, Inc. (formerly OMT), including Ab Initio computational antigen design, Icagen&#8217;s ion channel technology, xPloration </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i959141cd34ba4dba84b57809771af669">high-throughput screening technology, and the suite of OmniAb animals used for antibody discovery. In an IPO, we expect OmniAb to issue less than <ix:nonFraction unitRef="number" contextRef="i8779d8bb6434411d8ba83dacb2886ad1_I20211109" decimals="INF" name="lgnd:SaleOfStockPercentageOfCommonStockExpectedToBeSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MTI0MTU_8c78d766-a396-4d24-b13a-64e184ccf6bb">20</ix:nonFraction>% of its common stock, with us retaining the remaining interest, which would eventually be distributed to our stockholders in a manner generally intended to qualify as a tax-free transaction. Our Board of Directors has not approved a specific course of action, and we will continue to evaluate other options to optimize value and ensure flexibility to invest in growth. There can be no assurance that this process will result in us pursuing a particular transaction or consummating any such transaction. We do not expect to disclose further developments relating to this strategic review process, unless and until our Board of Directors approves a specific transaction or otherwise concludes this review. There can be no assurance that this process will result in the Company pursuing a particular transaction or consummating any such transaction.</ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis and other product royalty revenues, the impact of COVID-19, product returns, product development, and the potential separation of the OmniAb business. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 130 pharmaceutical and biotechnology companies. Over 300 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,400 issued patents worldwide.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs, which we refer to as "shots on goal," are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on the various risks to our business posed by the COVID-19 pandemic, please read Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Risk Factors"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this report and in our 2020 Annual Report.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Platform Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb is our industry-leading, BI- (Biological Intelligence&#8482;) powered multi-species antibody platform for the discovery of monospecific and bispecific therapeutic human antibodies. 2020 was a year of major investment in OmniAb with the acquisition and development of multiple technologies that enhance the offering for partners, including the addition of antigen-generation services as well as deep-sequence analysis of functional antibody repertoires. As of September 30, 2021, 19 different OmniAb-derived antibodies have been studied in approximately 84 active or completed clinical trials.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gloria Biosciences received approval from China&#8217;s National Medical Products Administration (NMPA) for zimberelimab (GLS-010), an OmniAb-derived anti-PD-1 monoclonal antibody for the treatment of recurrent or refractory classical Hodgkin&#8217;s lymphoma. Gloria Biosciences holds development and commercialization rights in China with respect to zimberelimab through a sublicense agreement with Ligand's licensee Wuxi Biologics Ireland Limited. Zimberelimab is the first OmniAb-derived antibody to receive regulatory approval.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CStone Pharmaceuticals presented the clinical data in a late-breaking abstract at ESMO Congress 2021 from the GEMSTONE-301 trial, a registrational study of OmniAb-derived sugemalimab in the treatment of patients with stage III non-small cell lung cancer (NSCLC). The data for sugemalimab as a consolidation therapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS). Sugemalimab was well-tolerated with no new safety signals.  CStone also presented updated data from the registrational study of sugemalimab in patients with stage IV NSCLC in a late-breaking oral presentation at the IASLC 2021 World Conference on Lung Cancer. The final analysis confirmed the efficacy and safety demonstrated in the interim analysis,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">showing that sugemalimab plus chemotherapy was associated with a significant improvement of PFS as first-line treatment in patients with both squamous and non-squamous metastatic NSCLC. Additionally, the estimated 2-year overall survival rate was nearly 50%. NDAs for sugemalimab in patients with metastatic stage IV NSCLC and in patients with locally advanced/unresectable stage III NSCLC have been accepted by China's NMPA and are currently under review.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aptevo Therapeutics announced positive Phase 1 data showing some patients with relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) achieved a remission with APVO436 after failing 1-8 lines of prior therapies. Aptevo Therapeutics presented a poster at the Congress on Controversies in Leukemias on the Phase 1B data obtained so far. Additional data was published in the peer-reviewed journal, Cancers, showing the risk of cytokine release syndrome is low for blood cancer patients treated with APVO436. APVO436 is an OmniAb-derived bispecific antibody targeting CD123 and CD3 for the treatment of hematological malignancies.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harbour BioMed announced dosing of the first patient in the registrational Phase 3 trial with batoclimab (HBM9161), its OmniAb-derived anti-FcRn monoclonal antibody, for the treatment of generalized myasthenia gravis (gMG). This study aims to assess the efficacy and safety of batoclimab in patients with gMG in China. Harbour BioMed also announced dosing of the first patient in the Phase 2 clinical trial in China of batoclimab for the treatment of thyroid eye disease. Harbour BioMed licensed batoclimab from HanAll Biopharma and has the right to develop, manufacture and commercialize in Greater China (including Hong Kong, Macau and Taiwan).</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb partnered with LandingAI to incorporate an industry leading LandingLens&#8482; visual inspection software platform to strengthen the xPloration&#8482; deep screening platform using AI and computer vision.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we entered into an OmniAb licensing agreement with Pierre Fabre.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pelican Platform Updates</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pelican Expression Technology&#8482; is our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> protein expression technology that has major collaborations with Jazz Pharmaceuticals, Merck, Serum Institute of India and Alvogen, each of which has potential to contribute meaningfully to our royalty revenue.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck announced VAXNEUVANCE&#8482; met key immunogenicity and safety endpoints in a Phase 3 pivotal trial evaluating use in infants. The FDA approved VAXNEUVANCE for adults 18 years of age and older in July and Merck has submitted a supplemental regulatory licensure application to the FDA for use in children. On October 20, 2021, the Center for Disease Control&#8217;s committee on immunization practices provisionally recommended vaccination either with a sequential regimen of VAXNEUVANCE followed by PNEUMOVAX23, or with a single dose of 20-valent pneumococcal conjugate vaccine for adults 65 years and older, and for adults ages 19 to 64 with certain underlying medical conditions or other disease risk factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jazz Pharmaceuticals announced the National Comprehensive Cancer Network added Rylaze&#8482; to its Clinical Practice Guidelines in Oncology as a treatment option for both pediatric and adult acute lymphoblastic leukemia patients with hypersensitivity to E. coli asparaginase products as a component of the multi-agent chemotherapeutic regimen.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Captisol&#174; Business Updates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marinus announced a collaboration with Orion Corporation for European commercialization of Captisol-enabled ganaxolone. Ganaxolone IV is being investigated in a randomized, placebo-controlled Phase 3 trial for refractory status epilepticus, with data readout expected in the second half of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Takeda announced the Phase 3 PANTHER trial studying pevonedistat plus azacytidine as first-line treatment for patients with higher-risk MDS, chronic myelomonocytic leukemia and low-blast AML did not achieve pre-defined statistical significance for the primary endpoint of event-free survival. Takeda plans to submit full data results for presentation at an upcoming medical conference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Other Business Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Travere Therapeutics announced positive topline interim results from the ongoing Phase 3 PROTECT study of sparsentan in IgA nephropathy. Sparsentan treatment demonstrated a statistically significant mean reduction of proteinuria from baseline after 36 weeks, more than threefold the reduction of active comparator irbesartan (p&lt;0.0001). Travere held a Type A meeting with the U.S. FDA for sparsentan in focal segmental glomerulosclerosis (FSGS) confirming plans to submit additional data in the first half of 2022 as part of an accelerated approval submission. Travere also announced the FDA concurred that the interim analyses from the PROTECT Study support submission of an application for accelerated approval, and that they expect to submit the NDA of sparsentan for IgAN in the first quarter of 2022. Additionally, Travere and Vifor Pharma entered into a licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand. Travere plans to submit a combined IgAN and FSGS MAA application for conditional marketing authorization of sparsentan in Europe in mid-2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a collaboration agreement with China Resources Double-Crane for exclusive Asia rights to develop a novel investigational oral COVID-19 antiviral therapeutic compound using our BEPro technology. BEPro is a proprietary prodrug technology for the development of compounds with improved product profiles. We had generated preclinical pharmacokinetics data showing its oral BEPro-enabled COVID-19 antivirals have favorable blood concentration profiles and generated lower levels of active nucleotide in the kidney, a potential site for toxicity, compared with other oral and intravenous compounds.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix Pharmaceuticals announced completion of  enrollment in the Phase 2 ELAINE 1 randomized trial assessing oral lasofoxifene versus intramuscular fulvestrant for the treatment of ER+/HER2- breast cancer in patients with an ESR1 mutation. Sermonix expects data from the trial to be reported in the first half of 2022. Lasofoxifene is also being studied in a separate fully-enrolled trial, ELAINE 2, in combination with Eli Lilly and Company's CDK4 and 6 inhibitor Verzenio&#174; (abemaciclib). Topline data are also expected in the first half of 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:14pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31,376</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35,093</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">128,875</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">44,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">64,835</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">204,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">312.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">59.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">385.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">842.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">131.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,010.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">987.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q3 2021 vs. Q3 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue increased by $23.0 million, or 55%, to $64.8 million in Q3 2021 compared to $41.8 million in Q3 2020 primarily reflecting higher sales of Captisol for use in the manufacturing of remdesivir. Royalties and contract revenue increased in Q3 2021 compared to Q3 2020, with the increase primarily attributable to the additional revenue from our Pfenex acquisition in October 2020 as well as an increase in partner product sales of Kyprolis and Evomela.  </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue increased by $88.2 million, or 76%, to $204.7 million in YTD 2021 compared to $116.4 million in the same period last year primarily reflecting higher sales of Captisol for use in the manufacturing of remdesivir. Contract revenue increased in YTD 2021 compared to the same period last year, with the increase primarily attributable to the additional contract revenue of $8.0 million and $8.5 million from the acquisitions of Icagen in April 2020 and Pfenex in October 2020, respectively.  An increase in partner product sales of Kyprolis and Evomela as well as the acquisition of Pfenex contributed to the increase in royalty revenue from the same period in 2020. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35,391</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50,769</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,718</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(3,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49,129</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">138,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,794&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q3 2021 vs. Q3 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses during Q3 2021 increased by $11.0 million, or 29%, compared to Q3 2020 primarily due to additional operating costs attributable to Pfenex, which we acquired on October 1, 2020, as well as an increase in Captisol sales for the current period. The increase was partially offset by a $3.8 million non-cash valuation adjustment recorded in the third quarter of 2021 to eliminate the remaining Pfenex CVR liability. See additional information on the Pfenex CVR liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2, Fair Value Measurements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of Captisol increased primarily due to higher Captisol sales during Q3 2021 compared to Q3 2020. Cost of Captisol as a percentage of Captisol revenue was 33% in Q3 2021 compared to 27% in Q3 2020, with the increase primarily due to amortization of capacity expansion payments to our supplier of Captisol during Q3 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased in Q3 2021 compared to the same period in 2020 primarily due to the amortization of contractual relationships and technologies acquired from Pfenex in October 2020. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased year over year in Q3 2021 due to the $3.8 million costs associated with our Pfenex acquisition, which primarily consisted of salaries and lab costs.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased in Q3 2021 compared to the same period in 2020 primarily due to the acquisition and integration costs incurred in Q3 2020, partially offset by the additional expenses from the Pfenex acquisition as well as increased share-based compensation expense.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in Q3 2021 included a $3.8 million non-cash valuation adjustment to reduce the Pfenex CVR liability. The decrease in Pfenex CVR liability is due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement, which provides for payment to Pfenex CVR holders upon notice from the FDA that teriparatide injection receives an &#8220;A&#8221; therapeutic equivalence designation relative to the listed drug FORTEO by December 31, 2021. Based on feedback from the FDA, our commercial partner, Alvogen, will perform and submit to the FDA the results from an assessment to address concerns relating to potential innate immunogenicity, reducing the probability of achieving the milestone by December 31, 2021. There were no items recorded in other operating income in Q3 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses during YTD 2021 increased by $36.7 million, or 36%, compared to YTD 2020 primarily due to additional operating costs attributable to Icagen and Pfenex, as well as higher Captisol sales during YTD 2021. The increases were partially offset by a $37.6 million non-cash valuation adjustment to reduce the Pfenex CVR liability. See additional disclosure on the Pfenex CVR liability in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2, Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of Captisol increased primarily due to higher Captisol sales during YTD 2021 compared to YTD 2020. Cost of Captisol as a percentage of Captisol revenue was 39% in YTD 2021 compared to 27% in YTD 2020, with the increase primarily due to the significant sales to the Gilead consortium partners in India who had sales prices lower than other customers during the second quarter of 2021.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles increased in YTD 2021 compared to the same period in 2020 primarily due to the amortization of contractual relationships and technologies acquired from Icagen in April 2020 and Pfenex in October 2020. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased year over year in YTD 2021 due to the $13.0 million costs associated with our Pfenex acquisition, which primarily consisted of salaries and lab costs.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased in YTD 2021 compared to the same period in 2020 primarily due to the additional expenses from the Pfenex and Icagen acquisitions as well as increased share-based compensation expense.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income in YTD 2021 primarily included a $37.6 million non-cash valuation adjustment to eliminate the Pfenex CVR liability during YTD 2021 as mentioned above. There were no items recorded in other operating income in YTD 2020.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,937</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">169</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(822)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,690&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,992)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(4,439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,886</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(219)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(5,516)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,456)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(447)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,359)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,837)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,706&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Q3 2021 vs. Q3 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants (an unrealized gain of $1.6 million in Q3 2021 as compared to an unrealized loss of $11.7 million in Q3 2020). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior period was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the three months ended September&#160;30, 2021. The decrease was primarily due to a lower average debt outstanding balance during Q3 2021 as compared to Q3 2020. During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q3 2021 increased by $2.1 million as compared to Q3 2020, due primarily to a $2.0 million reduction in fair value adjustment of Metabasis and Icagen CVRs during Q3 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2, Fair Value Measurements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2021 vs. YTD 2020</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants (an unrealized gain of $2.4 million in YTD 2021 as compared to an unrealized loss of $17.9 million in YTD 2020). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior period was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the nine months ended September&#160;30, 2021. The decrease was primarily due to a lower average debt outstanding balance during YTD 2021 as compared to YTD 2020. During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in YTD 2021 included a $7.3 million loss on debt extinguishment in connection with the 2023 Notes repurchase during the nine months ended September&#160;30, 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,259</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54,324</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,536)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,447)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,230</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,723</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">62,554</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,746)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three and nine months ended September&#160;30, 2021 was 10.1% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three and nine months ended September&#160;30, 2021 was significantly impacted by tax benefits related to (1) a $3.8&#160;million and $37.6&#160;million associated with the Pfenex CVR adjustment recorded during the third and second quarters of 2021, respectively, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity. The effective tax rate for the three and nine months ended September 30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income tax credits.</span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, our cash, cash equivalents, and short-term investments totaled $323.2 million, which decreased by $88.0&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. In conjunction of the 2023 Notes offering, we used a portion of the proceeds from such issuance totaling $49.7 million to repurchase 260,000 shares of our common stock. During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. After the repurchases, $343.3 million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plans to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of September&#160;30, 2021. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had $9.4 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases and Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our office facilities under operating lease arrangements with varying terms through March 2032. In addition, we signed our new Emeryville headquarter expansion leases and Icagen leases during the nine months ended September&#160;30, 2021 as discussed below under the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" section. The lease agreements provide for increases in annual rents based on changes in the Consumer Price Index or fixed percentage increases between 3.0% to 4.0%. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8, Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no off-balance sheet arrangements at September&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">613,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141,925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(283,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. During the nine months ended September&#160;30, 2020, we repurchased $234.4 million in principal of the 2023 Notes for $203.8 million in cash, including accrued interest of $0.6 million, used $73.3 million to repurchase our common stock, paid $15.1 million in cash for the Icagen acquisition, and a total of $11.6 million in cash for xCella and Taurus acquisitions.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes outside the ordinary course of business to the Contractual Obligations table set forth in our 2020 Annual Report, other than the addition to our operating lease liabilities (adjusted for the lease incentives) for the portion of the new leases with a starting accounting commencement date during the nine months ended September&#160;30, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8, Leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2020 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to allowance for credit losses.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_70"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the three and nine months ended September&#160;30, 2021, when compared to the disclosures in Item 7A of our 2020 Annual Report.</span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_73"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of September&#160;30, 2021 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_76"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2020 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors included in Part I. Item 1A. Risk Factors in our 2020 Annual Report, other than as set forth below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future revenue from sales of Captisol material to our license partners may be lower than expected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenues from sales of Captisol material to our collaborative partners, including Amgen, Gilead and the Gilead consortium, represent a significant portion of our current revenues. Any setback that may occur with respect to Captisol could significantly impair our operating results and/or reduce the market price of our stock. Setbacks for Captisol could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, competition with existing or new products and physician or patient acceptance of the products using Captisol. In addition, revenue from Captisol sales related to remdesivir may not continue or materially increase due to a number of factors, including: if Gilead successfully develops or manufactures an alternative formulation of remdesivir that does not incorporate Captisol or uses less Captisol in such formulation; if remdesivir is later shown to not be effective or safe for the treatment of COVID-19; the FDA revises or revokes its approval of remdesivir; if alternative therapies or vaccines are approved, including potential treatments for COVID-19 in pill or other forms that are being developed or which may be developed by other companies; or the risk of COVID-19 infection significantly diminishes, in which case the commercial opportunity could be materially and adversely affected. For example, Gilead has announced plans to develop an inhaled dosage form of remdesivir that uses less Captisol than the current formulation and expects result from an ongoing proof-of-concept study later this year.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If products or product candidates incorporating Captisol material were to cause any unexpected adverse events, the perception of Captisol safety could be seriously harmed. If this were to occur, we may not be able to sell Captisol unless and until we are able to demonstrate that the adverse event was unrelated to Captisol, which we may not be able to do. Further, the FDA could require us to submit additional information for regulatory review or approval, including data from extensive safety testing or clinical testing of products using Captisol. This would be expensive and it may delay the marketing of Captisol-enabled products and receipt of revenue related to those products, which could significantly impair our operating results and/or reduce the market price of our stock.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol from Hovione, our third party manufacturer, primarily at their facilities in Ireland and Portugal. If Hovione were to cease to be able, for any reason, to supply Captisol to us in the amounts we require, or decline to supply Captisol to us, we would be required to seek an alternative source, which could potentially take a considerable length of time and impact our revenue and customer relationships. In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers, although there is no assurance that we could do so timely or at an acceptable cost, if at all. In addition to manufacturing at Hovione&#8217;s facilities in Ireland and Portugal, we have now added final step processing capacity for Captisol in both the United States and England.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain inventory of Captisol, which has a five year shelf life, at three geographically dispersed storage locations in the United States and Europe. If we were to encounter problems maintaining our inventory, such as natural disasters, at one or more of these locations, it could lead to supply interruptions. In addition, we will rely on Hovione to expand manufacturing capacity of Captisol and any failure by Hovione to timely implement such increased capacity could adversely affect our ability to supply Captisol to our partners. While we believe we maintain adequate inventory of Captisol to meet our current partner needs, and our planned expansion of Captisol capacity will be sufficient to meet future partner needs, our estimates and projections for Captisol demand may not be correct and any supply interruptions could materially adversely impact our operating results. In addition, our plan to invest additional capital for the expansion of Captisol manufacturing capacity may not yield a return on investment if future Captisol sales fall below our expectations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on our arrangements with our partners and licensees to sell products using our Captisol technology. These agreements generally provide that our partners may terminate the agreements at will. If our partners discontinue sales of products using Captisol, fail to obtain regulatory approval for products using Captisol, fail to satisfy their obligations under their agreements with us, choose to utilize a competing product, or if we are unable to establish new licensing and marketing relationships, our financial results and growth prospects would be materially affected. Furthermore, we maintain significant </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts receivable balances with certain customers purchasing Captisol materials, which may result in the concentration of credit risk. We generally do not require any collateral from our customers to secure payment of these accounts receivable. If any of our major customers were to default in the payment of their obligations to us, our business, operating results and cash flows could be adversely affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under most of our Captisol outlicenses, the amount of royalties we receive will be reduced or will cease when the relevant patent expires. Our low-chloride patents and foreign equivalents are not expected to expire until 2033, our high purity patents and foreign equivalents are not expected to expire until 2029 and our morphology patents and foreign equivalents are not expected to expire until 2026 in the United States, but the initially filed patents relating to Captisol expired starting in 2010 in the United States and in 2016 in most countries outside the United States. If our other intellectual property rights are not sufficient to prevent a generic form of Captisol from coming to market and if in such case our partners choose to terminate their agreements with us, our Captisol revenue may decrease significantly.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our OmniAb antibody platform faces specific risks, including the fact that only one product using antibodies from the platform has been approved by a foreign regulatory agency.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, only one of our collaboration partners using our OmniAb antibody platform has received regulatory approval for marketing, with such approval coming from China&#8217;s National Medical Products Administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our other partners have received FDA or similar regulatory agency approval to market a product discovered from our platform. In addition, only a subset of our collaboration partners&#8217; product candidates have been tested in late stage clinical trials. If one of our OmniAb collaboration partners&#8217; product candidates fails during preclinical studies or clinical trials, our other OmniAb collaboration partners may decide to abandon product candidates using antibodies generated from the OmniAb platform, whether or not such failure is attributable to the platform. OmniAb collaboration partners may terminate their programs without penalty. In addition, our OmniAb platform is covered by 309 patents worldwide (including 62 patents within the U.S. and 15 patents in the European Union)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are subject to the same risks as our patent portfolio discussed elsewhere in this report and our 2020 Annual Report, including the risk that our patents may infringe on third party patent rights or that our patents may be invalidated. As of a result of these factors, the future revenue generated from this platform may be materially lower than what we currently anticipate. Further, we face significant competition from other companies selling human antibody-generating rodents, especially mice which compete with our OmniMouse platform, including the VelocImmune mouse, the AlivaMab mouse, the Alloy mouse and the Kymouse. Many of our competitors have greater financial, technical and human resources than we do and may be better equipped to develop, manufacture and market competing antibody platforms. Our competitors may render our OmniAb antibody platform obsolete, or limit the commercial value of any product candidates developed using our platform, by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages that we believe our platform offers.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Third party intellectual property may prevent us or our partners from developing our potential products; our and our partners&#8217; intellectual property may not prevent competition; and any intellectual property issues may be expensive and time consuming to resolve.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, use or sale of our potential products or our licensees' products or potential products may infringe the patent rights of others. If others obtain patents with conflicting claims, we may be required to obtain licenses to those patents or to develop or obtain alternative technology. We may not be able to obtain any such licenses on acceptable terms, or at all. Any failure to obtain such licenses could delay or prevent us from pursuing the development or commercialization of our potential products.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, our success will depend on our ability and the ability of our partners to obtain and maintain patents and other intellectual property rights for our and their potential products.  Our patent position is uncertain and involves complex legal and technical questions for which legal principles are unresolved.  Even if we or our partners do obtain patents, such patents may not adequately protect the technology we own or have licensed. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We permit our partners to list our patents that cover their branded products in the Orange Book. If a third party files an NDA or ANDA for a generic drug product that relies in whole or in part on studies contained in our partner&#8217;s NDA for their branded product, the third party will have the option to certify to the FDA that, in the opinion of that third party, the patents listed in the Orange Book for our partner&#8217;s branded product are invalid, unenforceable, or will not be infringed by the manufacture, use or sale of the third party&#8217;s generic drug product. A third party certification that a new product will not infringe Orange Book-listed patents, or that such patents are invalid, is called a paragraph IV patent certification. If the third party submits a paragraph IV patent certification to the FDA, a notice of the paragraph IV patent certification must be sent to the NDA owner and the owner of the patents that are subject to the paragraph IV patent certification notice once the third-party&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NDA or ANDA is accepted for filing by the FDA. A lawsuit may then be initiated to defend the patents identified in the notice. The filing of a patent infringement lawsuit within 45 days of the receipt of notice of a paragraph IV patent certification automatically prevents the FDA from approving the generic NDA or ANDA until the earlier of the expiration of a 30-month period, the expiration of the patents, the entry of a settlement order stating that the patents are invalid or not infringed, a decision in the infringement case that is favorable to the NDA or ANDA applicant, or such shorter or longer period as the court may order. If a patent infringement lawsuit is not initiated within the required 45-day period, the third-party&#8217;s NDA or ANDA will not be subject to the 30-month stay.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several third-parties have challenged, and additional third parties may challenge, the patents covering our partner&#8217;s branded products, including Kyprolis and Evomela, which could result in the invalidation or unenforceability of some or all of the relevant patent claims. We may from time to time become party to litigation or other proceedings as a result of Paragraph IV certifications. For example, as a result of the settlement of one such matter, Teva will be permitted to market a generic version of Evomela&#174; in the United States on June 1, 2026 or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential. Also, as noted above, Amgen has settled patent litigation related to Kyprolis on confidential terms with several parties, but it has been publicly reported that the U.S. launch date for at least Breckenridge Pharmaceuticals&#8217; applicable generic product will be &#8220;on a date that is held as confidential in 2027 or sooner, depending on certain occurrences&#8221;.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we cannot assure you that all of the potentially relevant prior art information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention-relating to our and our partners&#8217; patents and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent from issuing from a pending patent application, and we or our partners may be subject to a third party pre-issuance submission of prior art to the United States Patent and Trademark Office. Even if patents do successfully issue and even if such patents cover our or our partner&#8217;s products or potential products, third parties may initiate litigation or opposition, interference, re-examination, post-grant review, inter partes review, nullification or derivation action in court or before patent offices, or similar proceedings challenging the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed or invalidated, may allow third parties to commercialize our or our partners&#8217; products and compete directly with us and our partners, without payment to us or our partners, or limit the duration of the patent protection of our and our partners&#8217; technology and products.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation or other proceedings to enforce or defend intellectual property rights are often very complex in nature, may be very expensive and time-consuming, may divert our management&#8217;s attention from our core business, and may result in unfavorable results that could adversely impact our ability to prevent third parties from competing with our partner&#8217;s products. Any adverse outcome of such litigation or other proceedings could result in one or more of our patents being held invalid or unenforceable, which could adversely affect our ability to successfully execute our business strategy and negatively impact our financial condition and results of operations. However, given the unpredictability inherent in litigation, we cannot predict or guarantee the outcome of these matters or any other litigation. Regardless of how these matters are ultimately resolved, these matters may be costly, time-consuming and distracting to our management, which could have a material adverse effect on our business.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to the U.S. and various foreign patent offices at various points over the lifetime of our and our licensees&#8217; patents and/or applications. We have systems in place to remind us to pay these fees, and we rely on our outside patent annuity service to pay these fees when due. Additionally, the U.S. and various foreign patent offices require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with rules applicable to the particular jurisdiction. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. If such an event were to occur, it could have a material adverse effect on our business.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conflicts with the patent rights of others could significantly reduce the coverage of our patents or limit our ability to obtain meaningful patent protection. For example, our European patent related to Agglomerated forms of Captisol was limited during an opposition proceeding, and the rejection of our European patent application related to High Purity Captisol was upheld on appeal. In addition, any determination that our patent rights are invalid may result in early termination of our agreements with our license partners and could adversely affect our ability to enter into new license agreements. We also rely on unpatented trade secrets and know-how to protect and maintain our competitive position. We require our employees, consultants, licensees and others to sign confidentiality agreements when they begin their relationship with us. These </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements may be breached, and we may not have adequate remedies for any breach. In addition, our competitors may independently discover our trade secrets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also need to initiate litigation, which could be time-consuming and expensive, to enforce our proprietary rights or to determine the scope and validity of others' rights. If this occurs, a court may find our patents or those of our licensors invalid or may find that we have infringed on a competitor's rights. In addition, if any of our competitors have filed patent applications in the United States which claim technology we also have invented, the United States Patent and Trademark Office may require us to participate in expensive interference proceedings to determine who has the right to a patent for the technology.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any of the foregoing problems could be time-consuming and expensive and could adversely affect our financial position, liquidity and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The occurrence of a catastrophic disaster could disrupt our business, damage our facilities beyond insurance limits or increase our costs and expenses.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are vulnerable to damage and business disruptions from natural or man-made disasters, such as earthquakes, tornadoes, severe weather conditions, power loss, fire, floods and similar events, as well as from accidental loss or destruction. If any disaster were to occur, our ability to operate our business could be seriously impaired. We have property, liability, and business interruption insurance which may not be adequate to cover our losses resulting from disasters or other similar significant business interruptions, and we do not plan to purchase additional insurance to cover such losses due to the cost of obtaining such coverage. Any significant losses that are not recoverable under our insurance policies could seriously impair our business, financial condition and prospects. Our ability to obtain Captisol supply from our third-party manufactures could be disrupted if the operations of these manufacturers were affected by a natural or man-made disaster or other business interruption. In addition, we rely on our partners to generate most of our revenues through royalties, Captisol sales and development activities and any disruptions to their business as a result of such disasters could negatively impact our revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our plan to separate into two independent, publicly traded companies is subject to various risks and uncertainties and may not be completed in accordance with the expected plans or anticipated timeline, or at all and may not achieve the intended benefits, and will involve significant time, expense and management attention, any of which could negatively impact our businesses, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we announced our intention to split Ligand into two separate, publicly traded companies with one featuring the OmniAb business, including Ab Initio computational antigen design, Icagen&#8217;s ion channel technology, xPloration high-throughput screening technology, and the suite of OmniAb animals used for antibody discovery and the other featuring Ligand&#8217;s existing collection of core royalties, technologies, pipeline and contracts associated with the Pelican protein expression platform and the Captisol business. Based on an initial review, an IPO and eventual distribution of OmniAb shares to Ligand shareholders is the leading option under consideration at this time. Our Board of Directors has not approved a specific course of action, and we will continue to evaluate other options to optimize value and ensure flexibility to invest in growth. The separation, including the IPO and the distribution, if pursued, will be subject to market, tax and legal considerations, final approval by our Board of Directors and other customary requirements, and may not occur on the expected timeframe, or at all. Unanticipated developments, including difficulty in separating the assets and resources of our OmniAb business from the rest of our assets and resources, changes to the competitive environment for OmniAb&#8217;s or our respective businesses, possible delays in obtaining or failure to obtain tax opinions, regulatory or other approvals or clearances to approve or facilitate the separation, including the IPO and the distribution, uncertainty in financial markets and other challenges in executing the separation, including the IPO and the distribution, as planned, could delay or prevent the IPO or the distribution, or cause the separation, including the IPO and the distribution to occur on terms or conditions that are different or less favorable than expected. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executing the proposed separation also requires significant time and attention from management and other employees, which could distract them from other tasks in operating our business. Our plans to pursue the separation may also have negative effects on relationships with our employees, partners, suppliers, and other third parties, disruptions in operations and ultimately harm our businesses, financial condition, results of operations and prospects.  Even if the separation is completed, we may not realize some or all of the anticipated strategic, operational and financial benefits from the separation.  Following the proposed separation, the combined value of the common stock of the two publicly-traded companies may not be equal to or greater than what the value of our common stock would have been had the proposed separation not occurred.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q does not constitute an offer to sell or a solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_85"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i6bd315758f674d32a271d739b654f8a7_88"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i6bd315758f674d32a271d739b654f8a7_91"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i6bd315758f674d32a271d739b654f8a7_94"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i6bd315758f674d32a271d739b654f8a7_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.108%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93021exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93021exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93021exhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2021, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.*</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">          </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Filed herewith.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i6bd315758f674d32a271d739b654f8a7_100"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lgnd_93021exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5b94e2327b5b42c29c2963f05800d070_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;November&#160;9, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lgnd_93021exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i96c1004b765a434faf10bb2826e80305_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;November&#160;9, 2021 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lgnd_93021exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i15dea70caba44a63a008c96a7a3760e3_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lgnd-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2114102 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2315302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.ligand.com/role/Acquisitions">
        <link:definition>2118103 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.ligand.com/role/AcquisitionsTables">
        <link:definition>2319303 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2420413 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaFinancialInformationDetails" roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails">
        <link:definition>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2123104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2324304 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2127105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>2428418 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2129106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2330305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails">
        <link:definition>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>2135108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ligand.com/role/LeasesTables">
        <link:definition>2336306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>2437422 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails">
        <link:definition>2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails">
        <link:definition>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.ligand.com/role/SubsequentEvent">
        <link:definition>2140109 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.ligand.com/role/SubsequentEventDetails">
        <link:definition>2441425 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AmortizationOfOtherEconomicRights" abstract="false" name="AmortizationOfOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" abstract="false" name="NumberOfEntitiesIntoWhichEntityPlansToSplit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OperatingLeaseLiabilityAdditions" abstract="false" name="OperatingLeaseLiabilityAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" abstract="true" name="LiabilityForContingentValueRightsCompanyXCellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" abstract="false" name="SaleOfStockPercentageOfCommonStockExpectedToBeSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_IcagenMember" abstract="true" name="IcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" abstract="false" name="ForecastedCashFlowsEffectiveInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" abstract="false" name="CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedLeasePurchases" abstract="false" name="AccruedLeasePurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationConsiderationTransferredHoldback" abstract="false" name="BusinessCombinationConsiderationTransferredHoldback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContingentValueRightOnProductRevenuesMember" abstract="true" name="ContingentValueRightOnProductRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_TaurusBiosciencesLLCMember" abstract="true" name="TaurusBiosciencesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" abstract="true" name="ContingentValueRightForInternalResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" abstract="false" name="PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MilestonePaymentsMember" abstract="true" name="MilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisMember" abstract="true" name="SelexisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" abstract="false" name="CreditsAppliedOnAdvancesOnInventoryPurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCrystalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoMember" abstract="true" name="AziyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyPfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OmniAbMember" abstract="true" name="OmniAbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lgnd-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48ceeaeb-1acf-4fe3-90f3-1f0a7c09cb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_48ceeaeb-1acf-4fe3-90f3-1f0a7c09cb9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3bec41c7-3c29-4d27-aa22-3d5e7b83ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_ShortTermInvestments_3bec41c7-3c29-4d27-aa22-3d5e7b83ceec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5d90a4f0-2fa9-4ecf-bce0-13416b645735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5d90a4f0-2fa9-4ecf-bce0-13416b645735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aa418782-d7a9-470d-9e8e-3f2de37aae72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_InventoryNet_aa418782-d7a9-470d-9e8e-3f2de37aae72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_8ab8aa42-0dfb-41fa-b968-11b3aaa7168f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_IncomeTaxesReceivable_8ab8aa42-0dfb-41fa-b968-11b3aaa7168f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1658744a-4d9a-4cdf-b2e6-783c0e095e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e23d4643-a4b0-4e38-85a9-25788acb66d6" xlink:to="loc_us-gaap_OtherAssetsCurrent_1658744a-4d9a-4cdf-b2e6-783c0e095e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3ae5ad87-3f5f-4072-afa1-28ee9cf50d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_us-gaap_LiabilitiesCurrent_3ae5ad87-3f5f-4072-afa1-28ee9cf50d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_6dd35dd8-1efa-4c80-9f66-cde106e63e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_6dd35dd8-1efa-4c80-9f66-cde106e63e5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_3706961c-f605-4c08-8458-2b3b757d5846" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_lgnd_LiabilityForContingentValueRights_3706961c-f605-4c08-8458-2b3b757d5846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_61fd0982-2138-44af-8b8f-4725d060686c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_61fd0982-2138-44af-8b8f-4725d060686c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8856a92f-e4ea-4ceb-a8cc-e6d852eb73d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8856a92f-e4ea-4ceb-a8cc-e6d852eb73d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6ea56803-1bff-4c5c-ac50-076caedc66a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_669002d0-3b4c-4d19-a0c4-652c93934533" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6ea56803-1bff-4c5c-ac50-076caedc66a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66eb43-5efb-4801-98d6-ee418680a3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2ad8d912-2134-4098-8978-2078f2348a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66eb43-5efb-4801-98d6-ee418680a3d9" xlink:to="loc_us-gaap_Liabilities_2ad8d912-2134-4098-8978-2078f2348a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_32cae859-d760-4155-a7aa-9ac2acf57474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66eb43-5efb-4801-98d6-ee418680a3d9" xlink:to="loc_us-gaap_StockholdersEquity_32cae859-d760-4155-a7aa-9ac2acf57474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_4c68fb61-d2ea-477c-addd-8dbefa9900e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66eb43-5efb-4801-98d6-ee418680a3d9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_4c68fb61-d2ea-477c-addd-8dbefa9900e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8bd8d3ba-d0e2-488b-b96b-cc0a5cd1bdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_Goodwill_8bd8d3ba-d0e2-488b-b96b-cc0a5cd1bdaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ddc7fcd3-bf6e-4fdd-a435-2140759416e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ddc7fcd3-bf6e-4fdd-a435-2140759416e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a0d42cb5-60d8-46c5-a647-cd53d99baf21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a0d42cb5-60d8-46c5-a647-cd53d99baf21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3ff570d9-cd33-4b32-b278-ebb22da8d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3ff570d9-cd33-4b32-b278-ebb22da8d831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_d4d2b900-4655-4cb7-8b12-0267014cdd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_d4d2b900-4655-4cb7-8b12-0267014cdd47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_45546a57-b004-49dc-b899-0bf03b5b70bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_45546a57-b004-49dc-b899-0bf03b5b70bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_894577f2-8280-4eb4-b8ae-1c1267460f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_AssetsCurrent_894577f2-8280-4eb4-b8ae-1c1267460f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_fb2c920d-ffd1-4be2-b633-5cb47711ad1d" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_lgnd_CommercialLicenseRights_fb2c920d-ffd1-4be2-b633-5cb47711ad1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f886707f-767d-4cd5-9030-8a29c91f4e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_85f747ba-c102-491f-a9ba-252f4ccd3918" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f886707f-767d-4cd5-9030-8a29c91f4e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b37916bb-9c80-4ccd-ade4-19c05ed2f4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_us-gaap_AccountsPayableCurrent_b37916bb-9c80-4ccd-ade4-19c05ed2f4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_467d57d2-3c26-4461-9b4b-354f8e9983f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_467d57d2-3c26-4461-9b4b-354f8e9983f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_3505aaf5-42b2-4bd5-96cd-232d683a28c7" xlink:href="lgnd-20210930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_3505aaf5-42b2-4bd5-96cd-232d683a28c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f2d6217c-bc8c-4b28-9082-8cd0e369a5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f2d6217c-bc8c-4b28-9082-8cd0e369a5c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e52783b3-e7b2-4500-b0b2-ad98ae3133dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e52783b3-e7b2-4500-b0b2-ad98ae3133dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ba813238-edba-4368-83de-e8cf7f510fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4f404b6d-2bf3-4ad0-b248-fb2f5ae6f4bf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ba813238-edba-4368-83de-e8cf7f510fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d0ba91e8-ec2d-42bb-ba08-3ddae568d864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d0ba91e8-ec2d-42bb-ba08-3ddae568d864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_67778b32-fb8b-4698-b5b7-13eec1cd3681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:to="loc_us-gaap_CommonStockValue_67778b32-fb8b-4698-b5b7-13eec1cd3681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a5c6dffa-5e7f-4401-9706-d41f0dbec4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a5c6dffa-5e7f-4401-9706-d41f0dbec4ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_87135b7d-3276-40d7-87a8-fbecdbd76fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_87135b7d-3276-40d7-87a8-fbecdbd76fd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f55586b2-f8bb-4301-9f85-d6d0c981dd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_cdf0c0eb-9a62-413e-899f-ee2c088664aa" xlink:to="loc_us-gaap_PreferredStockValue_f55586b2-f8bb-4301-9f85-d6d0c981dd7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_94f47904-8b7c-4ea0-be54-cf775b59cc07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7259b6e9-1d19-4574-9ae1-f1115811a6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_94f47904-8b7c-4ea0-be54-cf775b59cc07" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7259b6e9-1d19-4574-9ae1-f1115811a6e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_432ee142-618a-4390-b50f-fd294c54a2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_94f47904-8b7c-4ea0-be54-cf775b59cc07" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_432ee142-618a-4390-b50f-fd294c54a2fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ecb14b73-5a8e-4b56-851d-094645df69e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eaf3726a-ab72-4f4f-8ef8-f0723a6915c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ecb14b73-5a8e-4b56-851d-094645df69e0" xlink:to="loc_us-gaap_OperatingIncomeLoss_eaf3726a-ab72-4f4f-8ef8-f0723a6915c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_43266887-88e7-4396-83ca-f41d430d0395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ecb14b73-5a8e-4b56-851d-094645df69e0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_43266887-88e7-4396-83ca-f41d430d0395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9bdb0e1f-62a1-4d1e-94f1-e0298d9a04ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_083dff3b-b24b-4800-85fe-3aaff636f778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bdb0e1f-62a1-4d1e-94f1-e0298d9a04ff" xlink:to="loc_us-gaap_GainLossOnInvestments_083dff3b-b24b-4800-85fe-3aaff636f778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0a3a94f0-2825-4fc0-ba25-1135819f2794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bdb0e1f-62a1-4d1e-94f1-e0298d9a04ff" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0a3a94f0-2825-4fc0-ba25-1135819f2794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_689b695c-3df5-476c-a6a2-5a96e9541634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bdb0e1f-62a1-4d1e-94f1-e0298d9a04ff" xlink:to="loc_us-gaap_InterestExpense_689b695c-3df5-476c-a6a2-5a96e9541634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d6de5f15-98a9-4c02-97a7-b57a0f572893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_9bdb0e1f-62a1-4d1e-94f1-e0298d9a04ff" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d6de5f15-98a9-4c02-97a7-b57a0f572893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_86f14cd2-b0f2-458b-8861-a047999b21b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_86f14cd2-b0f2-458b-8861-a047999b21b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_393be8fb-923c-479f-93d9-a0b539f90b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_393be8fb-923c-479f-93d9-a0b539f90b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3298d63c-983a-461d-a9db-198c2ef05522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3298d63c-983a-461d-a9db-198c2ef05522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_d8cdd9c8-76da-403e-b686-7705430e3d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:to="loc_us-gaap_CostDirectMaterial_d8cdd9c8-76da-403e-b686-7705430e3d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_f8c26c0f-18f5-4664-8bfe-e45b05df3839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_9b029396-f392-46c9-b36c-ca97ca825319" xlink:to="loc_us-gaap_OtherOperatingIncome_f8c26c0f-18f5-4664-8bfe-e45b05df3839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5cea6182-3b8e-46dc-97a7-d4bca6e34cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_83e738bb-708b-4c8d-a760-d17862fe69bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5cea6182-3b8e-46dc-97a7-d4bca6e34cf9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_83e738bb-708b-4c8d-a760-d17862fe69bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a80e762-cce5-4ab3-b2f5-75b66882d051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5cea6182-3b8e-46dc-97a7-d4bca6e34cf9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a80e762-cce5-4ab3-b2f5-75b66882d051" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1640c838-1ae8-4fc9-ad5b-75db3eb0a963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3cf41fe2-ad15-4ccf-9c63-4e2734959176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1640c838-1ae8-4fc9-ad5b-75db3eb0a963" xlink:to="loc_us-gaap_NetIncomeLoss_3cf41fe2-ad15-4ccf-9c63-4e2734959176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2dc3fc83-f060-461f-86bf-dbd36077431a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1640c838-1ae8-4fc9-ad5b-75db3eb0a963" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2dc3fc83-f060-461f-86bf-dbd36077431a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a21b8040-b42f-47a5-a3f6-86ec7368a751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1640c838-1ae8-4fc9-ad5b-75db3eb0a963" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a21b8040-b42f-47a5-a3f6-86ec7368a751" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c2418183-08e5-4b3d-bc95-b1227bdb763e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_ProfitLoss_c2418183-08e5-4b3d-bc95-b1227bdb763e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f669a343-d193-4719-a9e0-b969653e61c4" xlink:href="lgnd-20210930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f669a343-d193-4719-a9e0-b969653e61c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b6f7a52d-721d-4bc5-983b-8638eabc6743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b6f7a52d-721d-4bc5-983b-8638eabc6743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_571361b6-4dc0-45d8-a426-f08baae209a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_571361b6-4dc0-45d8-a426-f08baae209a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f207cc2b-1015-401d-8073-8f102f496823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f207cc2b-1015-401d-8073-8f102f496823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_d540b257-076c-4733-9c56-80fc8ee3e2ab" xlink:href="lgnd-20210930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_d540b257-076c-4733-9c56-80fc8ee3e2ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f4d6450a-35f2-450b-8ca2-72136c06dd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f4d6450a-35f2-450b-8ca2-72136c06dd6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fb3a72ad-9c57-4597-8fc1-4f97892ebac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_ShareBasedCompensation_fb3a72ad-9c57-4597-8fc1-4f97892ebac4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f61dfdc8-3add-460b-86a7-1da14cb00312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f61dfdc8-3add-460b-86a7-1da14cb00312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_af31eff2-d321-4eec-b108-eb47614e466f" xlink:href="lgnd-20210930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_af31eff2-d321-4eec-b108-eb47614e466f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_63df9186-6af6-4f92-b31b-9e75b5dc148b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_63df9186-6af6-4f92-b31b-9e75b5dc148b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7fd7109b-ad53-490b-8232-ead6355ec0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7fd7109b-ad53-490b-8232-ead6355ec0b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_47b7b62c-df56-42dd-882a-1abf4cbb60eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_47b7b62c-df56-42dd-882a-1abf4cbb60eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9baa1d4f-77ac-4009-b009-6c3741c2b122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9baa1d4f-77ac-4009-b009-6c3741c2b122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2c014816-922a-416c-9050-efd4500e839e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2c014816-922a-416c-9050-efd4500e839e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d54b8f00-5f7e-4d02-bdec-b8272c12541c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d54b8f00-5f7e-4d02-bdec-b8272c12541c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07fe205c-d91a-4836-b6fb-fb69f7c41c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07fe205c-d91a-4836-b6fb-fb69f7c41c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_516fed66-7998-41d8-90bb-bac2cff4efe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bb8304c3-27e3-4e0b-a491-2b26cead7be5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_516fed66-7998-41d8-90bb-bac2cff4efe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5662e838-9a31-4366-b860-016915eb53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5662e838-9a31-4366-b860-016915eb53f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b11cc70d-c60b-4f48-9b83-b5c5f445bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b11cc70d-c60b-4f48-9b83-b5c5f445bb4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_5818059b-057c-467f-91c7-3fd6a316bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_5818059b-057c-467f-91c7-3fd6a316bfa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_11dcbac8-189f-4afe-b966-71c346bef088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_11dcbac8-189f-4afe-b966-71c346bef088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_00bdd64c-fb5b-43b8-9b16-d0acd2d94ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_00bdd64c-fb5b-43b8-9b16-d0acd2d94ce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ff1afbf2-6792-4ef7-84ea-58b12c2a35ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ff1afbf2-6792-4ef7-84ea-58b12c2a35ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_04f74d1d-627e-421c-901b-cb42ffd70778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d75ef229-c3c0-4919-92ac-5804ebf3cab7" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_04f74d1d-627e-421c-901b-cb42ffd70778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73544ede-c0bf-408d-9927-1ef974a08b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_790f6adf-62a3-4843-902e-bb3cf9393e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73544ede-c0bf-408d-9927-1ef974a08b9a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_790f6adf-62a3-4843-902e-bb3cf9393e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1dea5187-55a1-4b49-a795-737794d1a41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73544ede-c0bf-408d-9927-1ef974a08b9a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1dea5187-55a1-4b49-a795-737794d1a41a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a996b783-996b-426d-b7f0-3b56f60db769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73544ede-c0bf-408d-9927-1ef974a08b9a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a996b783-996b-426d-b7f0-3b56f60db769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad32e056-852a-4fd4-b78e-833f942a55de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73544ede-c0bf-408d-9927-1ef974a08b9a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad32e056-852a-4fd4-b78e-833f942a55de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cf0d486f-369a-4403-bce6-7cd925681a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cf0d486f-369a-4403-bce6-7cd925681a42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_cfd2510b-75a8-4182-9c36-5e3f76c3cad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_cfd2510b-75a8-4182-9c36-5e3f76c3cad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_a3467c26-8943-4466-bef5-f2b568ac1322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_a3467c26-8943-4466-bef5-f2b568ac1322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_cf9a63a4-3aad-4852-a913-87c54880d14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_cf9a63a4-3aad-4852-a913-87c54880d14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_db2e7a61-7576-4d43-ac61-8b1a9b30ce9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_db2e7a61-7576-4d43-ac61-8b1a9b30ce9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e4cf6972-a3d9-4d56-b050-9907392c3419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e4cf6972-a3d9-4d56-b050-9907392c3419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_d01bd547-f11f-43fd-94eb-93e4e8d9cc72" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_d01bd547-f11f-43fd-94eb-93e4e8d9cc72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0057c9f3-0be6-4eee-9dcf-00cc96a1cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b73e9544-39f1-43fc-81a2-c30fe189612c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0057c9f3-0be6-4eee-9dcf-00cc96a1cbdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_cebf7df4-ecbf-430a-b0eb-481e18d51620" xlink:href="lgnd-20210930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_76d7ab26-6405-4097-b43f-6adc9f2a62ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_cebf7df4-ecbf-430a-b0eb-481e18d51620" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_76d7ab26-6405-4097-b43f-6adc9f2a62ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a2bac3d6-aa18-450b-a964-72ba350cb4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_cebf7df4-ecbf-430a-b0eb-481e18d51620" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a2bac3d6-aa18-450b-a964-72ba350cb4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f87db649-4d86-4125-bc29-e4c7b0cf1a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_fe06b12e-969d-4a5e-93ef-7e95f23966ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f87db649-4d86-4125-bc29-e4c7b0cf1a9d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_fe06b12e-969d-4a5e-93ef-7e95f23966ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_79ccfe86-a9fc-48ba-bc60-48434726e578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f87db649-4d86-4125-bc29-e4c7b0cf1a9d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_79ccfe86-a9fc-48ba-bc60-48434726e578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ed9c2023-2276-41f6-bad8-468559cf4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f87db649-4d86-4125-bc29-e4c7b0cf1a9d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ed9c2023-2276-41f6-bad8-468559cf4f26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0229f361-59fc-4a95-b938-832d21a544dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_d9e958e4-2323-44eb-9ef2-b85881d5d092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0229f361-59fc-4a95-b938-832d21a544dd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_d9e958e4-2323-44eb-9ef2-b85881d5d092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_6c40792d-72ff-4d53-ab53-80adc2471761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0229f361-59fc-4a95-b938-832d21a544dd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_6c40792d-72ff-4d53-ab53-80adc2471761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_af71f502-71b7-42fd-868a-76e8b2c37c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_72e602ce-b9a5-4493-9263-38dd55a6702d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_af71f502-71b7-42fd-868a-76e8b2c37c29" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_72e602ce-b9a5-4493-9263-38dd55a6702d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_56a7c1cd-2a16-4358-923c-02648cc18bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_af71f502-71b7-42fd-868a-76e8b2c37c29" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_56a7c1cd-2a16-4358-923c-02648cc18bec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8983ce9-a647-48fc-b4d6-7ff47afdf962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a6fddd26-4368-49af-873c-3fde23635071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8983ce9-a647-48fc-b4d6-7ff47afdf962" xlink:to="loc_us-gaap_Goodwill_a6fddd26-4368-49af-873c-3fde23635071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab2b4c7f-379d-4173-a06e-561828e0a4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8983ce9-a647-48fc-b4d6-7ff47afdf962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab2b4c7f-379d-4173-a06e-561828e0a4ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c5a8d8b2-763a-44a9-b18d-2bdaada1bd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c8983ce9-a647-48fc-b4d6-7ff47afdf962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c5a8d8b2-763a-44a9-b18d-2bdaada1bd50" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6f4b02e1-51b3-4eaa-ad48-5806f6d3e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_62bdf130-bc78-406f-8751-bde439d176f8" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6f4b02e1-51b3-4eaa-ad48-5806f6d3e50c" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_62bdf130-bc78-406f-8751-bde439d176f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ac6252eb-4061-48a2-9296-2f07096ba9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6f4b02e1-51b3-4eaa-ad48-5806f6d3e50c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ac6252eb-4061-48a2-9296-2f07096ba9a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cb4ca09c-5acd-44c0-9af1-6dc4729f63ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cb4ca09c-5acd-44c0-9af1-6dc4729f63ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_a060532b-7f20-4101-b51d-9276bf9015a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_a060532b-7f20-4101-b51d-9276bf9015a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_0166a7c9-7f3d-43df-b8af-e996eada3e68" xlink:href="lgnd-20210930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_lgnd_LicenseeAccrualCurrent_0166a7c9-7f3d-43df-b8af-e996eada3e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_67c5c15e-58ab-4661-84de-a1f5c22bbb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_67c5c15e-58ab-4661-84de-a1f5c22bbb4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_2275f40b-5228-4314-80ee-2b96375ce375" xlink:href="lgnd-20210930.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_lgnd_ReturnsAccrual_2275f40b-5228-4314-80ee-2b96375ce375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_357b3679-4cb1-43d7-843b-925f4963030d" xlink:href="lgnd-20210930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_357b3679-4cb1-43d7-843b-925f4963030d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_76098504-fee7-4c99-a3be-f24421406fb4" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_76098504-fee7-4c99-a3be-f24421406fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_15860de6-4f56-4e13-92fd-c9cece159abc" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_15860de6-4f56-4e13-92fd-c9cece159abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_9fc41e4e-ad11-4030-b89c-290e1a9a8afd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_us-gaap_InterestPayableCurrent_9fc41e4e-ad11-4030-b89c-290e1a9a8afd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ec6694c-a780-4842-abaa-1607bdb2da06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ecfd8def-a084-42ad-a2ea-a62633425a1b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6ec6694c-a780-4842-abaa-1607bdb2da06" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b79f0313-3732-4827-8a01-751969d51833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_52f4514f-c866-43d6-9f9f-968db9f8f34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b79f0313-3732-4827-8a01-751969d51833" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_52f4514f-c866-43d6-9f9f-968db9f8f34a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_76d5363e-8013-45d9-964c-b087255c0053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b79f0313-3732-4827-8a01-751969d51833" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_76d5363e-8013-45d9-964c-b087255c0053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_96d254f2-0879-461d-ab7b-bd684515e6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b79f0313-3732-4827-8a01-751969d51833" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_96d254f2-0879-461d-ab7b-bd684515e6d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_92debbd2-59ca-4be8-9569-7a34313eb010" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_92debbd2-59ca-4be8-9569-7a34313eb010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_0821f3ec-7be8-4549-ae67-dbdffbf46fe0" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_0821f3ec-7be8-4549-ae67-dbdffbf46fe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8ba6a3b2-57a5-4059-b5d6-ea4366f0cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_8ba6a3b2-57a5-4059-b5d6-ea4366f0cf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_928c7799-a013-4f25-b6fd-3ed89801225c" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_928c7799-a013-4f25-b6fd-3ed89801225c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_165d2df9-83c0-456e-8e5a-13370540b56d" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_165d2df9-83c0-456e-8e5a-13370540b56d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_367c73f9-806c-4547-bd07-f5df78c65a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_367c73f9-806c-4547-bd07-f5df78c65a88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5f19766f-0562-4169-9486-761531416135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5f19766f-0562-4169-9486-761531416135" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b6452877-12ea-4e6e-9d0b-34f285b119a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_b6452877-12ea-4e6e-9d0b-34f285b119a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcbe50b1-ba85-4da0-9979-ae9775916280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_fcbe50b1-ba85-4da0-9979-ae9775916280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_14246aaa-9f26-4017-ae28-ed701488b241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_14246aaa-9f26-4017-ae28-ed701488b241" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_08ac6d35-757f-44d5-901f-a860576def8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_08ac6d35-757f-44d5-901f-a860576def8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c3614aa-5483-4e2c-8345-df44a7418015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_Goodwill_3c3614aa-5483-4e2c-8345-df44a7418015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_77bc1b84-c291-4224-962e-6e60af0f7b5d" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_77bc1b84-c291-4224-962e-6e60af0f7b5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a944eb6f-99f6-4dbf-b1d8-cace4da50247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_75e684b6-3174-48ca-9b26-a889c46f9643" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a944eb6f-99f6-4dbf-b1d8-cace4da50247" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_b8722739-2f72-4478-b9f9-c9277360ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_702831d5-56a3-4ca4-a30d-b90e46871546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_b8722739-2f72-4478-b9f9-c9277360ea6b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_702831d5-56a3-4ca4-a30d-b90e46871546" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b1fd0875-250f-484b-9c01-d32d22fed616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_b8722739-2f72-4478-b9f9-c9277360ea6b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b1fd0875-250f-484b-9c01-d32d22fed616" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_808debe2-29af-4d01-af5e-c2208fb4d551" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c8f6029a-b094-4ccf-abcb-e40467fc3e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_808debe2-29af-4d01-af5e-c2208fb4d551" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c8f6029a-b094-4ccf-abcb-e40467fc3e41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_2d277b40-a178-430f-aabd-37761523bc0d" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_808debe2-29af-4d01-af5e-c2208fb4d551" xlink:to="loc_lgnd_LeaseLiabilityCurrent_2d277b40-a178-430f-aabd-37761523bc0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b8f90f7-ba27-4f8a-a7df-99331a962bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_808debe2-29af-4d01-af5e-c2208fb4d551" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0b8f90f7-ba27-4f8a-a7df-99331a962bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_cf3f5e13-0214-400f-8918-55da7f69dba9" xlink:href="lgnd-20210930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f5b5463-e65e-452d-a2cd-08c22c783a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_cf3f5e13-0214-400f-8918-55da7f69dba9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f5b5463-e65e-452d-a2cd-08c22c783a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f2e16a4e-7bbf-4278-a102-95bacbfec247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_cf3f5e13-0214-400f-8918-55da7f69dba9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f2e16a4e-7bbf-4278-a102-95bacbfec247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_b013be91-ddee-48b8-9db0-ba759a7dafce" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c42586c1-7128-46f5-a25b-64ba1e610985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_b013be91-ddee-48b8-9db0-ba759a7dafce" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c42586c1-7128-46f5-a25b-64ba1e610985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_fad3f818-5882-43ab-827d-c9a7b30562a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_b013be91-ddee-48b8-9db0-ba759a7dafce" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_fad3f818-5882-43ab-827d-c9a7b30562a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_68551d44-3327-40df-bf19-0944fc1d4200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_68551d44-3327-40df-bf19-0944fc1d4200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b5b2df5-4891-438a-b2ae-1187bba128e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b5b2df5-4891-438a-b2ae-1187bba128e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8a9c95bf-7767-4999-a28c-e26d8556850a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8a9c95bf-7767-4999-a28c-e26d8556850a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b090d3e5-0751-497e-9516-fda530142f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b090d3e5-0751-497e-9516-fda530142f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6b87dfe8-ebe5-4107-94c1-8f936ff12225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6b87dfe8-ebe5-4107-94c1-8f936ff12225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_ee764aa9-cee8-483b-81ce-715a2b99cbb7" xlink:href="lgnd-20210930.xsd#lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2a50fb-5655-48b0-abba-3c08f1d8f88b" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_ee764aa9-cee8-483b-81ce-715a2b99cbb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ea64fae-6bd1-463a-b9e8-806ad8ae368b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_441a3f84-2f25-410b-8013-ab1f55c8d73d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ea64fae-6bd1-463a-b9e8-806ad8ae368b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_441a3f84-2f25-410b-8013-ab1f55c8d73d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4850757f-a9f8-4b0d-90ce-aeef22e32164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7ea64fae-6bd1-463a-b9e8-806ad8ae368b" xlink:to="loc_us-gaap_OperatingLeaseLiability_4850757f-a9f8-4b0d-90ce-aeef22e32164" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lgnd-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i2b8f2315dc6348b6a6b26277a0bc6481_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_89d55a87-c2e4-4288-8bdf-aa65e61cfdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_89d55a87-c2e4-4288-8bdf-aa65e61cfdd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_91ca9065-de6e-4cdd-80d2-5c52ca1a7efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_CostDirectMaterial_91ca9065-de6e-4cdd-80d2-5c52ca1a7efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6ac7f060-b982-46a9-b092-5c95c7b9987b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6ac7f060-b982-46a9-b092-5c95c7b9987b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d98a7eea-5dee-4995-9c26-0e59a277c041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d98a7eea-5dee-4995-9c26-0e59a277c041" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_34aed7b9-7848-45da-80ae-a51c383a456b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_34aed7b9-7848-45da-80ae-a51c383a456b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_0343b1df-0320-4c5b-9c87-c914e5ce80c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_OtherOperatingIncome_0343b1df-0320-4c5b-9c87-c914e5ce80c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_76b3d177-d8f9-4602-9aa7-f4e596a50c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_76b3d177-d8f9-4602-9aa7-f4e596a50c49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e0c409a-69a2-45dd-992d-4662165648e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e0c409a-69a2-45dd-992d-4662165648e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7fb96123-7695-41d2-94dc-0aa4510ecf90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_GainLossOnInvestments_7fb96123-7695-41d2-94dc-0aa4510ecf90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c64339af-4ea6-458b-8921-d6555328295d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c64339af-4ea6-458b-8921-d6555328295d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e754537a-77c7-4fe4-b4a9-cbacb544bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_InterestExpense_e754537a-77c7-4fe4-b4a9-cbacb544bd39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b552032c-6f07-420b-bf7d-900349a88cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b552032c-6f07-420b-bf7d-900349a88cbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e11d3c56-4057-4830-a6ed-82fa0bfc8757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e11d3c56-4057-4830-a6ed-82fa0bfc8757" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc2fb3e-6c72-42a8-8005-36d7d9c4e105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc2fb3e-6c72-42a8-8005-36d7d9c4e105" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1c864bb-e42f-4493-b883-0f59f9f50b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1c864bb-e42f-4493-b883-0f59f9f50b77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fda17029-29a7-4569-874c-c2975416ce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_NetIncomeLoss_fda17029-29a7-4569-874c-c2975416ce1a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_215df6b5-e310-4762-ae6d-10a7bc9718f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_EarningsPerShareBasic_215df6b5-e310-4762-ae6d-10a7bc9718f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16685ae4-ef8a-49be-985d-74673a468d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16685ae4-ef8a-49be-985d-74673a468d95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c0d0db48-cd53-4a12-bb7f-d91ecec222d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c0d0db48-cd53-4a12-bb7f-d91ecec222d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd472b51-17b0-4d11-ae03-5bef2d0472aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd472b51-17b0-4d11-ae03-5bef2d0472aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:to="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2a66523d-bd0e-4cc6-b15a-a1e690994837_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:to="loc_srt_ProductsAndServicesDomain_2a66523d-bd0e-4cc6-b15a-a1e690994837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:to="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_e67dec66-9098-4382-936d-c539711fe648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_us-gaap_RoyaltyMember_e67dec66-9098-4382-936d-c539711fe648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_0683e56b-c0e0-4e11-ab36-6e94a60e64bb" xlink:href="lgnd-20210930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_0683e56b-c0e0-4e11-ab36-6e94a60e64bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_359c0834-52d8-4864-8d5d-f56267443506" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_lgnd_ContractRevenueMember_359c0834-52d8-4864-8d5d-f56267443506" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i3b88a0836b8b4dd3bacf77fff92aeff7_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_617e35cc-6bb6-41b4-8d3c-e1f770ded4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_SharesIssued_617e35cc-6bb6-41b4-8d3c-e1f770ded4cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e51d5b0d-14a1-4f42-899e-75765720084c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockholdersEquity_e51d5b0d-14a1-4f42-899e-75765720084c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_11adbc2a-88a2-4afd-a161-e5cff65b761d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_11adbc2a-88a2-4afd-a161-e5cff65b761d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f0e2fc38-a2d5-4ebb-8611-9bb171b6ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f0e2fc38-a2d5-4ebb-8611-9bb171b6ee00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b9818d90-d9a5-4246-9ee3-b950904c2c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b9818d90-d9a5-4246-9ee3-b950904c2c45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8557e6d5-2f3a-4a4a-80a7-37dc92621d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8557e6d5-2f3a-4a4a-80a7-37dc92621d9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cc6ad44d-446a-48e8-8143-120e3dff4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cc6ad44d-446a-48e8-8143-120e3dff4bc7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_0f2361e5-e121-4ed5-8730-f9d7b3470f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_0f2361e5-e121-4ed5-8730-f9d7b3470f79" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_808d87f7-6912-4f6d-bddf-bd82057b6321" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_808d87f7-6912-4f6d-bddf-bd82057b6321" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5a74c654-133e-4c20-a76a-a032ceb32ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5a74c654-133e-4c20-a76a-a032ceb32ae9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_0075a2db-a172-42e7-94f9-2d088516caaa" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_0075a2db-a172-42e7-94f9-2d088516caaa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_affb9496-46cf-4130-8b8f-7baca7e3ea83" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_affb9496-46cf-4130-8b8f-7baca7e3ea83" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8549b9cc-fe45-4a54-823e-7ed7aa4761b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8549b9cc-fe45-4a54-823e-7ed7aa4761b3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_91518af5-a2ce-4c9c-9a47-1eff92fec7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockholdersEquityOther_91518af5-a2ce-4c9c-9a47-1eff92fec7cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_53409cb6-5914-4875-b3d5-e1ca4296a73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_53409cb6-5914-4875-b3d5-e1ca4296a73c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c800eba4-1927-489e-9838-56bb94c64ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_NetIncomeLoss_c800eba4-1927-489e-9838-56bb94c64ae1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c02b9a17-f5f7-4fe7-8bd2-8bd5ed9b10ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7d8dc3c-84a0-4bfc-9ac8-420b233b9c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:to="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_64beae1e-c345-4495-bff3-c22a41b6346e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:to="loc_us-gaap_EquityComponentDomain_64beae1e-c345-4495-bff3-c22a41b6346e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:to="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_57b3fa05-fa60-4393-b46f-36874eb6481a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_CommonStockMember_57b3fa05-fa60-4393-b46f-36874eb6481a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_16edcbfe-3409-42bb-a1fc-d7e181f72fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_16edcbfe-3409-42bb-a1fc-d7e181f72fe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_89ff5b40-c3eb-4226-a6bd-670137ca3b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_89ff5b40-c3eb-4226-a6bd-670137ca3b59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9eef47e9-33db-4dcd-9094-c14f10ed21a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_RetainedEarningsMember_9eef47e9-33db-4dcd-9094-c14f10ed21a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_763faa3d-bc8e-43e0-9421-459c5758d3dd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_763faa3d-bc8e-43e0-9421-459c5758d3dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_146b1d2c-df00-41a7-8432-b9e76aecdbde" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_146b1d2c-df00-41a7-8432-b9e76aecdbde" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i484f56a8f5604dc1a7047307ed4af773_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_617b27a0-3060-46a3-8608-47b83e0e3b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_617b27a0-3060-46a3-8608-47b83e0e3b0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ea32e013-4695-4498-9988-465262cac2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ea32e013-4695-4498-9988-465262cac2a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_39cf95ca-4308-43b7-89fd-338630a3c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_39cf95ca-4308-43b7-89fd-338630a3c7eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2fae89f1-9468-45c8-a1fc-01916b932f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2fae89f1-9468-45c8-a1fc-01916b932f66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ca11cf9a-a3a7-4f14-928c-9d8a700347e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ca11cf9a-a3a7-4f14-928c-9d8a700347e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5ac8bcf1-0ea7-4797-bb62-bb9d467a2e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5ac8bcf1-0ea7-4797-bb62-bb9d467a2e8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_18a89850-f036-4506-95ec-b0fb0ca45973" xlink:href="lgnd-20210930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_18a89850-f036-4506-95ec-b0fb0ca45973" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases_0fc43212-6f7c-42a5-a563-d0b8f0339f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_AdvancesOnInventoryPurchases_0fc43212-6f7c-42a5-a563-d0b8f0339f06" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_1a3e7ad9-05d5-456e-97a1-25c7a86bc854" xlink:href="lgnd-20210930.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_1a3e7ad9-05d5-456e-97a1-25c7a86bc854" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_0b3e253a-0c70-4a98-9706-35f46d360075" xlink:href="lgnd-20210930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_0b3e253a-0c70-4a98-9706-35f46d360075" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_31f5dcaa-b52e-4382-930f-eb909a83edeb" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_31f5dcaa-b52e-4382-930f-eb909a83edeb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_52149a9f-e230-458c-b3e8-21d09a74f676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_52149a9f-e230-458c-b3e8-21d09a74f676" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_6f3e50f1-8071-4326-8db6-c9773f83ce91" xlink:href="lgnd-20210930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_6f3e50f1-8071-4326-8db6-c9773f83ce91" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7372189c-74fc-4a02-a87c-74ddc607a3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7372189c-74fc-4a02-a87c-74ddc607a3af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_702c338d-734c-464d-8c5d-6db223c8b4ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:to="loc_us-gaap_RelatedPartyDomain_702c338d-734c-464d-8c5d-6db223c8b4ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:to="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_75f127bb-0ed9-4a64-a876-295885a817eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_75f127bb-0ed9-4a64-a876-295885a817eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_44cb241a-6f93-4c4d-9a65-34b1f40d7ded_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_44cb241a-6f93-4c4d-9a65-34b1f40d7ded_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_48273722-5507-4dfd-803f-ff2ab13b4566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:to="loc_us-gaap_CommonStockMember_48273722-5507-4dfd-803f-ff2ab13b4566" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8bc8c0d0-f1e4-4f8b-befb-0846c7b1b05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:to="loc_us-gaap_WarrantMember_8bc8c0d0-f1e4-4f8b-befb-0846c7b1b05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_34159fbd-bbd1-4a3d-939f-da389e8352ab_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:to="loc_srt_RangeMember_34159fbd-bbd1-4a3d-939f-da389e8352ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:to="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23c73fc0-febe-4419-9d2f-7cd9a39bcfa7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:to="loc_srt_MaximumMember_23c73fc0-febe-4419-9d2f-7cd9a39bcfa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82b79f75-a437-4aa0-99f3-c8bafa5a5bef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:to="loc_srt_MinimumMember_82b79f75-a437-4aa0-99f3-c8bafa5a5bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_49cc7078-9adb-401e-80f3-cd52e350616c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_49cc7078-9adb-401e-80f3-cd52e350616c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_002a3897-8a6b-4cb5-bcff-25b1e0f1067d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_002a3897-8a6b-4cb5-bcff-25b1e0f1067d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_24644cf0-bc22-46b1-9bb4-4f2a91d2f5ec" xlink:href="lgnd-20210930.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:to="loc_lgnd_AziyoMember_24644cf0-bc22-46b1-9bb4-4f2a91d2f5ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_04ee2405-7828-4bdb-93b4-1ee1de555b9f" xlink:href="lgnd-20210930.xsd#lgnd_SelexisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:to="loc_lgnd_SelexisMember_04ee2405-7828-4bdb-93b4-1ee1de555b9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_18afffc0-7826-4157-afa6-d16926e40837_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_18afffc0-7826-4157-afa6-d16926e40837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8be9b4aa-8dee-40e8-9809-8db5c33febe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:to="loc_us-gaap_RestrictedStockMember_8be9b4aa-8dee-40e8-9809-8db5c33febe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_251cc309-ae79-488b-b1b2-89ad1a65090f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_251cc309-ae79-488b-b1b2-89ad1a65090f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_ef518120-609b-4ce7-95ce-1a3cec784720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:to="loc_us-gaap_StockCompensationPlanMember_ef518120-609b-4ce7-95ce-1a3cec784720" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="i71ce4753022f4eb0a353ce7e67fa3cc0_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_decb41f2-540f-4634-87ff-376034cf2790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_decb41f2-540f-4634-87ff-376034cf2790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:to="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1b3795fd-5795-466c-b17b-de38f0c94943_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:to="loc_srt_ProductsAndServicesDomain_1b3795fd-5795-466c-b17b-de38f0c94943_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:to="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_ad63d6d9-7193-4a98-b46b-ad96d5e69995" xlink:href="lgnd-20210930.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_KyprolisMember_ad63d6d9-7193-4a98-b46b-ad96d5e69995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_0d9188e9-93e2-4f82-a0fe-2adfc0a54bbb" xlink:href="lgnd-20210930.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_EvomelaMember_0d9188e9-93e2-4f82-a0fe-2adfc0a54bbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_ed0c0a22-6949-43db-bd27-a3eea02832dc" xlink:href="lgnd-20210930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_RoyaltyOtherMember_ed0c0a22-6949-43db-bd27-a3eea02832dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5df9eb18-bc19-4aff-88b4-75da4e7ef2db" xlink:href="lgnd-20210930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5df9eb18-bc19-4aff-88b4-75da4e7ef2db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_05399425-1df4-4c1d-948e-d09301360d81" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_ContractRevenueServiceMember_05399425-1df4-4c1d-948e-d09301360d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_a1e701c1-ab57-4fd5-ae5b-c9a576e4384d" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_LicenseFeesMember_a1e701c1-ab57-4fd5-ae5b-c9a576e4384d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f2bf3fd9-3296-4116-b203-870b5a006d47" xlink:href="lgnd-20210930.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_MilestoneMember_f2bf3fd9-3296-4116-b203-870b5a006d47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_2b471e74-ce79-4fe6-943c-a51d5e92d3b3" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_2b471e74-ce79-4fe6-943c-a51d5e92d3b3" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i1dbe0f78334349919220188bec6c6a85_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_20f54d29-264f-4f27-b7ff-ada396ceac34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_20f54d29-264f-4f27-b7ff-ada396ceac34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_58002d6f-b43e-465f-97f6-84e2c003db3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_58002d6f-b43e-465f-97f6-84e2c003db3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_95e78566-c86d-4985-8fff-551a4df18d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_95e78566-c86d-4985-8fff-551a4df18d6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2265fe46-5fb3-4bbf-b7a8-91026edd7a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2265fe46-5fb3-4bbf-b7a8-91026edd7a80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0cc17724-8642-4241-9efd-075c14c5ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0cc17724-8642-4241-9efd-075c14c5ef44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4bf888b3-e37a-4f92-ba11-51f4537d0e9b" xlink:href="lgnd-20210930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4bf888b3-e37a-4f92-ba11-51f4537d0e9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6828819c-7c7c-4d1f-a985-ccc063c92cf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6828819c-7c7c-4d1f-a985-ccc063c92cf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_10ae6d0f-8768-4a89-9841-003806aee68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_DemandDepositsMember_10ae6d0f-8768-4a89-9841-003806aee68c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_50f1b867-d222-450e-a801-13c6b2763a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_50f1b867-d222-450e-a801-13c6b2763a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_7a67e0ae-8b3d-42b1-b0c4-ea01f159ea1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_AgencySecuritiesMember_7a67e0ae-8b3d-42b1-b0c4-ea01f159ea1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d705a0c-8019-46c6-b9b2-7b3d192672f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CommercialPaperMember_6d705a0c-8019-46c6-b9b2-7b3d192672f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4a6722a0-1737-4a60-8129-452013a1bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_EquitySecuritiesMember_4a6722a0-1737-4a60-8129-452013a1bb65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_4f18d1f2-17ba-42a0-bf73-a4d8f0d6f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_MutualFundMember_4f18d1f2-17ba-42a0-bf73-a4d8f0d6f6b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_a7c6b4e7-2f6d-4986-95a6-c67139482c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_a7c6b4e7-2f6d-4986-95a6-c67139482c5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0aa5e815-8555-4b74-abf7-8cda1ea7bd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_WarrantMember_0aa5e815-8555-4b74-abf7-8cda1ea7bd5e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ba09f237-4e42-4004-9b94-6ee777c08d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CommonStockMember_ba09f237-4e42-4004-9b94-6ee777c08d7a" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i980c9f9852484b01bc8efe455b90a6b0_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_77de7843-2b75-435c-8bcf-56a5a4271de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_Goodwill_77de7843-2b75-435c-8bcf-56a5a4271de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2a393626-3e84-4fd4-82c6-063f63cb2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2a393626-3e84-4fd4-82c6-063f63cb2c4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_beac8657-932d-40cb-bae7-6f3b4e97e151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_beac8657-932d-40cb-bae7-6f3b4e97e151" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_e5965bbd-c3db-4f2b-9848-afd458b83244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_e5965bbd-c3db-4f2b-9848-afd458b83244" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3bd9d81a-d4f3-4e86-89cb-8fd015795eef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3bd9d81a-d4f3-4e86-89cb-8fd015795eef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_9f7a25bc-0746-4425-8818-5287ab4bffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_PatentedTechnologyMember_9f7a25bc-0746-4425-8818-5287ab4bffd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_090e5489-ac7e-4240-841b-a98e902af134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_TradeNamesMember_090e5489-ac7e-4240-841b-a98e902af134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_752ed907-1b26-47e6-b7f6-9f7f3325dd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_752ed907-1b26-47e6-b7f6-9f7f3325dd7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_0aa860e1-29bd-4070-9538-7cc54a27ec6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_ContractualRightsMember_0aa860e1-29bd-4070-9538-7cc54a27ec6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_abe2c0c8-e906-476c-947b-0d98eadb60f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_LicensingAgreementsMember_abe2c0c8-e906-476c-947b-0d98eadb60f1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended" id="i18b6cff4422c46678495addd0e6c10df_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0d21dea-814e-4416-8201-39b02aa8ac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0d21dea-814e-4416-8201-39b02aa8ac7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7815f6b6-53b7-4ce6-949b-7c970b0a04c8" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7815f6b6-53b7-4ce6-949b-7c970b0a04c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7729a5c2-19e6-43b9-bda4-d1ca3702e572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7729a5c2-19e6-43b9-bda4-d1ca3702e572" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322b375a-ba40-4c32-8585-97569bb270b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322b375a-ba40-4c32-8585-97569bb270b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0f9ec0c9-a649-4c21-ad1a-de4c979f9d28" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0f9ec0c9-a649-4c21-ad1a-de4c979f9d28" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_04b9bc48-f863-46e0-ab59-764809e5f2f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_04b9bc48-f863-46e0-ab59-764809e5f2f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_c54e607e-5ff4-4bc3-9fea-ec39b3089901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:to="loc_us-gaap_LicensingAgreementsMember_c54e607e-5ff4-4bc3-9fea-ec39b3089901" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="i66cb722daa3a44949b9dfa6fd4b646d3_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3db5932e-4114-49d6-8dca-758af5abeed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3db5932e-4114-49d6-8dca-758af5abeed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:to="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_abb4cd4f-0926-491f-a70f-9e3f02e30efd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_abb4cd4f-0926-491f-a70f-9e3f02e30efd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6eb7dc59-d970-42af-848c-476bf5661b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6eb7dc59-d970-42af-848c-476bf5661b0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3eac4f95-2326-43b2-9ef0-f0382c8f96a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3eac4f95-2326-43b2-9ef0-f0382c8f96a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="i680c5da5bd4147b6a343e240cd038418_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ef2dfac5-057d-4aaf-a64a-2f3fc1139e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ef2dfac5-057d-4aaf-a64a-2f3fc1139e77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_24d6aa97-1c30-4d62-8729-6da6d40bf770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_24d6aa97-1c30-4d62-8729-6da6d40bf770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_48f2fd90-8e8c-4a75-8b2e-7ab64c2918e2" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_48f2fd90-8e8c-4a75-8b2e-7ab64c2918e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f76b74e6-8f9c-4082-8ac2-f9f8617a2aab" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f76b74e6-8f9c-4082-8ac2-f9f8617a2aab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_04ab6871-b4b4-4aa3-98b2-596b5fcefb8c" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_04ab6871-b4b4-4aa3-98b2-596b5fcefb8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_309357bf-9c35-401f-b663-0e6ee7ada0b2" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_309357bf-9c35-401f-b663-0e6ee7ada0b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_0f14f42e-210a-4166-86c7-31da2a5a2df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_Investments_0f14f42e-210a-4166-86c7-31da2a5a2df5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_a2544f85-e031-4a47-b2d0-b944a494f19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_a2544f85-e031-4a47-b2d0-b944a494f19a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_227886c5-31de-4b70-a844-5d5cb5f2fd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_227886c5-31de-4b70-a844-5d5cb5f2fd9b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_14b3b90a-ee0c-4382-9388-3875266bf0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_14b3b90a-ee0c-4382-9388-3875266bf0d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_be638d4f-d15a-4bdf-804b-01ab6a9013ae" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_be638d4f-d15a-4bdf-804b-01ab6a9013ae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_efa3f223-0d8d-4e18-ad35-e6555440a0aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_efa3f223-0d8d-4e18-ad35-e6555440a0aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_955e2d7a-0aa0-46a4-9ce2-531fb3008bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_955e2d7a-0aa0-46a4-9ce2-531fb3008bc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83fce496-3225-4fe6-8af2-87c227195083_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83fce496-3225-4fe6-8af2-87c227195083_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3a59368b-5892-4f66-b04f-0d54815e1879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3a59368b-5892-4f66-b04f-0d54815e1879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2487e4ae-5c27-4848-883b-94abd81f7b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2487e4ae-5c27-4848-883b-94abd81f7b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_25875e85-6506-4b6a-b78d-77e1e94f7564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_25875e85-6506-4b6a-b78d-77e1e94f7564" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b867c458-7605-4983-a8f1-fcbafeff3b00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b867c458-7605-4983-a8f1-fcbafeff3b00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a34e6bab-c60d-4afd-9368-4967129ef180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a34e6bab-c60d-4afd-9368-4967129ef180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_49668717-31a2-4c90-9c23-039cb60377e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_EquitySecuritiesMember_49668717-31a2-4c90-9c23-039cb60377e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_23478767-d193-4397-bea9-fa8cd09f8519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_WarrantMember_23478767-d193-4397-bea9-fa8cd09f8519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_929a6312-e0d6-4bcc-a199-01859339c7a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_929a6312-e0d6-4bcc-a199-01859339c7a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_6888a051-b406-4e18-8bdd-a2640cd95887" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_6888a051-b406-4e18-8bdd-a2640cd95887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_49687364-25e6-40e0-a46c-9eda4d4b72a0" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_49687364-25e6-40e0-a46c-9eda4d4b72a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_0632e252-2cc6-476f-a5fc-1b0d42decf0e" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_0632e252-2cc6-476f-a5fc-1b0d42decf0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_63d612a1-7945-4585-866a-32373212422c" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_63d612a1-7945-4585-866a-32373212422c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_b234faa6-f437-4048-a98c-2908afa21c2b" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_b234faa6-f437-4048-a98c-2908afa21c2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f3e5283b-2d1d-455d-9276-3aa82e0cbf17" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f3e5283b-2d1d-455d-9276-3aa82e0cbf17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_119fbbcb-b0b7-419f-b9ef-5fcf75d9c542" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_119fbbcb-b0b7-419f-b9ef-5fcf75d9c542" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0816c0ac-1edb-4935-9bdd-83d8df404415_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0816c0ac-1edb-4935-9bdd-83d8df404415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_ce7c1953-fd4b-448f-9474-509ed845f601" xlink:href="lgnd-20210930.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:to="loc_lgnd_MetabasisMember_ce7c1953-fd4b-448f-9474-509ed845f601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_5bb6f40d-036a-4ba1-ad5a-21de42ccb15a" xlink:href="lgnd-20210930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_5bb6f40d-036a-4ba1-ad5a-21de42ccb15a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4892cbe5-9ca5-43a7-a7ac-c968044ee96f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:to="loc_srt_RangeMember_4892cbe5-9ca5-43a7-a7ac-c968044ee96f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:to="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f12506c9-6c44-4011-903f-a08638d1b28b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:to="loc_srt_MaximumMember_f12506c9-6c44-4011-903f-a08638d1b28b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_60a4bb4a-b78c-4b2e-94e9-7e717279ed4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:to="loc_us-gaap_TransferredOverTimeMember_60a4bb4a-b78c-4b2e-94e9-7e717279ed4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_89353e9d-ed6b-48be-9645-d7121133c6b9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:to="loc_srt_ProductsAndServicesDomain_89353e9d-ed6b-48be-9645-d7121133c6b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:to="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_1ac18c9b-e335-4bd1-b9a4-6e18fe9003fc" xlink:href="lgnd-20210930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_1ac18c9b-e335-4bd1-b9a4-6e18fe9003fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_3a835838-423a-4011-a8c9-8e4ec056c8c5" xlink:href="lgnd-20210930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_3a835838-423a-4011-a8c9-8e4ec056c8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_eac7043e-58f5-43e6-bbe7-d37d52779de9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_eac7043e-58f5-43e6-bbe7-d37d52779de9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_29524527-5463-43e9-b0e6-4bb550ea076f" xlink:href="lgnd-20210930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_29524527-5463-43e9-b0e6-4bb550ea076f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="i310083752db04abb9822905d9048d4aa_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c361b8f5-ad58-4b96-a20e-3d04cd425bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c361b8f5-ad58-4b96-a20e-3d04cd425bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_052011bb-8484-45e8-b2f7-353ac73d99f8" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_052011bb-8484-45e8-b2f7-353ac73d99f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d96cbd0b-8e20-4200-9fc1-eeafa966e6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d96cbd0b-8e20-4200-9fc1-eeafa966e6d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_4337717a-dd7f-436c-9841-52f6ec639626" xlink:href="lgnd-20210930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_4337717a-dd7f-436c-9841-52f6ec639626" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0da8af7e-93a4-4a4b-a8d7-b19487637842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_075afc35-d52f-44a9-966d-d7854b3a8015_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_075afc35-d52f-44a9-966d-d7854b3a8015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6db3f70b-dcaa-48b9-977b-2f0d2a3292f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6db3f70b-dcaa-48b9-977b-2f0d2a3292f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="i10d06d53dcb14d2584241026c14740a9_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_60dbc1c5-cd8c-457a-b515-d27499b21e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_60dbc1c5-cd8c-457a-b515-d27499b21e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_90b726d5-22ce-42c2-9994-fc50be2e9ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_90b726d5-22ce-42c2-9994-fc50be2e9ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eea95896-66c0-427a-886a-dba406797ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eea95896-66c0-427a-886a-dba406797ced" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_36ad3b6d-2aab-45f0-b2c0-dde91f5dc844" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_36ad3b6d-2aab-45f0-b2c0-dde91f5dc844" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_8274c329-2cc2-4d33-a5a3-cbf4d72b15c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_8274c329-2cc2-4d33-a5a3-cbf4d72b15c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_17916239-37ef-4d5d-b581-147941c16abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_17916239-37ef-4d5d-b581-147941c16abe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_f0c3d95a-87b9-4391-b89d-38244477e4b2" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_f0c3d95a-87b9-4391-b89d-38244477e4b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_feb95f47-a4a2-4b6a-ad04-e87b0e9c8877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_feb95f47-a4a2-4b6a-ad04-e87b0e9c8877" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6ae95c6b-0240-4816-a78d-683aabc5e48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6ae95c6b-0240-4816-a78d-683aabc5e48e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_befca409-8ea2-4279-aaec-c8d06fdeecde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_befca409-8ea2-4279-aaec-c8d06fdeecde" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_5620a4a6-e8e9-41a9-bd79-ec31f06419d0" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_5620a4a6-e8e9-41a9-bd79-ec31f06419d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_163591c1-ac7f-427f-b580-92055b99f08e" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_163591c1-ac7f-427f-b580-92055b99f08e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_d972fc8e-f536-41a7-a1d5-8dc6fd8f3418" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_d972fc8e-f536-41a7-a1d5-8dc6fd8f3418" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_02c01c84-e424-4557-9f67-5edf123bc887" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_02c01c84-e424-4557-9f67-5edf123bc887" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5731a0e0-c709-46a4-888c-e857071fd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5731a0e0-c709-46a4-888c-e857071fd2dc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9fae3119-a232-4e2f-b928-327b34e263e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9fae3119-a232-4e2f-b928-327b34e263e6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_f6511cf8-ddda-41b7-b344-ff4bc43c32de" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_f6511cf8-ddda-41b7-b344-ff4bc43c32de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0292b2e-1083-4453-8987-b9d0aa4eeef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0292b2e-1083-4453-8987-b9d0aa4eeef1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0c52e0f5-d496-451a-91a8-5efb9baf1395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0c52e0f5-d496-451a-91a8-5efb9baf1395" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b6bb6b58-9da2-4a29-9913-b29aae07a057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b6bb6b58-9da2-4a29-9913-b29aae07a057" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_07f10c9c-f608-48ce-9392-c3a3a364364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_07f10c9c-f608-48ce-9392-c3a3a364364d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e01c156-27a0-4282-aa2e-ba1bae8fa257_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9e01c156-27a0-4282-aa2e-ba1bae8fa257_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_fa9b409f-9b71-414d-8732-6519dd204700" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_PfenexMember_fa9b409f-9b71-414d-8732-6519dd204700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_77f12c72-9f2c-4314-8ec1-b7906832a63c" xlink:href="lgnd-20210930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_77f12c72-9f2c-4314-8ec1-b7906832a63c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_ecb902ae-2346-4edd-8bfa-edcb6a40c6f0" xlink:href="lgnd-20210930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_ecb902ae-2346-4edd-8bfa-edcb6a40c6f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_d5e27c2f-46a7-45d7-b98a-297dfcfe8ead" xlink:href="lgnd-20210930.xsd#lgnd_IcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_IcagenMember_d5e27c2f-46a7-45d7-b98a-297dfcfe8ead" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_10547e91-8add-4065-8304-b1248c96c29a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_10547e91-8add-4065-8304-b1248c96c29a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_587444f0-ff72-466c-8f77-ead2bef42901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_587444f0-ff72-466c-8f77-ead2bef42901" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bae958a6-f6f0-42ee-8700-c15b312a2246_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bae958a6-f6f0-42ee-8700-c15b312a2246_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_6a7b6e14-fac1-46e9-8494-712551306f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_ContractualRightsMember_6a7b6e14-fac1-46e9-8494-712551306f74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e6c5046a-0b08-4b7e-8834-4e0ce28ed7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e6c5046a-0b08-4b7e-8834-4e0ce28ed7bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bb3e1767-d2f6-47ff-9ad8-95f47d54a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bb3e1767-d2f6-47ff-9ad8-95f47d54a4b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_320c4cc6-cc4e-4fc1-90bc-722748015e83_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:to="loc_srt_RangeMember_320c4cc6-cc4e-4fc1-90bc-722748015e83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:to="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4fbf91d-2657-47f7-973d-855d594c7a48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:to="loc_srt_MinimumMember_e4fbf91d-2657-47f7-973d-855d594c7a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e3b00296-c48e-48da-acbb-477474d65cb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:to="loc_srt_MaximumMember_e3b00296-c48e-48da-acbb-477474d65cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c38be2a2-dcd3-4c87-b80b-a8781b97f028_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c38be2a2-dcd3-4c87-b80b-a8781b97f028_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_5c7cc774-4ad3-418d-9eba-635842231b3a" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_5c7cc774-4ad3-418d-9eba-635842231b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_7f63af44-8e97-4055-b345-9ee425c5f7c5" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_7f63af44-8e97-4055-b345-9ee425c5f7c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_812fd02c-15da-42c0-8e64-8194bbb82f9d" xlink:href="lgnd-20210930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_812fd02c-15da-42c0-8e64-8194bbb82f9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_f7031b58-eb2b-43f2-a8bf-fc4684b8f38b" xlink:href="lgnd-20210930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_MilestonePaymentsMember_f7031b58-eb2b-43f2-a8bf-fc4684b8f38b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="ifc25806b900f40e4a2e4c52814d6e0f5_AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ab3d3ea3-6427-4208-ace2-aa6d33076c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ab3d3ea3-6427-4208-ace2-aa6d33076c3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_d4f6971e-ba4c-4491-900a-d1e1ddce476f" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_d4f6971e-ba4c-4491-900a-d1e1ddce476f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9a1fdf70-570e-48f1-8a7c-e3790ef039e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9a1fdf70-570e-48f1-8a7c-e3790ef039e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f6c88f76-3880-45e6-920b-48fcce8b1242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f6c88f76-3880-45e6-920b-48fcce8b1242" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_55691295-80f2-4863-9dbe-98410851f0a6" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_55691295-80f2-4863-9dbe-98410851f0a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f02c905c-e60f-4337-8157-59aa745302e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f02c905c-e60f-4337-8157-59aa745302e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e65235a2-bb5e-4e4f-bc0f-083b47c31a64" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e65235a2-bb5e-4e4f-bc0f-083b47c31a64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17e922d0-7ba1-474b-82db-3144b96d2ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_Goodwill_17e922d0-7ba1-474b-82db-3144b96d2ce7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_afb2f646-8c1a-4b4c-9cd9-bb1bde0ff718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_afb2f646-8c1a-4b4c-9cd9-bb1bde0ff718" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_5d823729-9a28-4c53-8bf8-59fa6d1de21d" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_5d823729-9a28-4c53-8bf8-59fa6d1de21d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_cba5a16f-80af-469f-ba76-a4456d56c6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_cba5a16f-80af-469f-ba76-a4456d56c6d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_459e8847-8ac2-4b19-9d25-666c793b9945" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_459e8847-8ac2-4b19-9d25-666c793b9945" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_30318f7c-bf8b-4bf9-ad40-88df012a698d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_30318f7c-bf8b-4bf9-ad40-88df012a698d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_86fc3b4a-bf0c-4c7f-9cf9-4766d580c069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_86fc3b4a-bf0c-4c7f-9cf9-4766d580c069" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7552fbaf-c72b-42ea-8df4-e8e938592246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7552fbaf-c72b-42ea-8df4-e8e938592246" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3717e184-6dcd-4de6-9a84-c4553e2c9e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3717e184-6dcd-4de6-9a84-c4553e2c9e5e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35b08839-5e6b-46f3-bdad-fd3c5576e279_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35b08839-5e6b-46f3-bdad-fd3c5576e279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_5929e5c5-2404-4f6a-a01c-404b8a7c42e3" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:to="loc_lgnd_PfenexMember_5929e5c5-2404-4f6a-a01c-404b8a7c42e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended" id="i7a339b9033c84154966ef5a53b967c03_AcquisitionsProFormaFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_5cb48da2-0d11-407c-b4b2-7925d4b748f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_5cb48da2-0d11-407c-b4b2-7925d4b748f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_de5c38ad-e655-42a1-bb07-eaa305f5d74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_de5c38ad-e655-42a1-bb07-eaa305f5d74d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_2f631bcc-0123-4f81-a240-6f315ee35874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_2f631bcc-0123-4f81-a240-6f315ee35874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_e23ade9f-dc32-4a56-b817-f82d2ff1ab8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_e23ade9f-dc32-4a56-b817-f82d2ff1ab8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_94c82d5c-617d-4742-b5c0-648b130d209e" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:to="loc_lgnd_PfenexMember_94c82d5c-617d-4742-b5c0-648b130d209e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i8cb21e66365e4e9cbb5744330d426b40_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bfec4da9-c462-4d75-9c13-1ffce0a3f3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bfec4da9-c462-4d75-9c13-1ffce0a3f3f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c36eeb88-a36e-454f-b726-d1713b9d076a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c36eeb88-a36e-454f-b726-d1713b9d076a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c9294440-6aeb-4c44-8320-c4534767d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c9294440-6aeb-4c44-8320-c4534767d7b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4607fa9d-3bb8-4deb-8cbd-5c2f75c590eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4607fa9d-3bb8-4deb-8cbd-5c2f75c590eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_996d7968-d858-43de-b4fa-c35558e51c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_996d7968-d858-43de-b4fa-c35558e51c58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_79f2b463-2e26-4df0-a950-4b7925205752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_79f2b463-2e26-4df0-a950-4b7925205752" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_07f95928-6d6e-4591-b417-60e6dd96e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_07f95928-6d6e-4591-b417-60e6dd96e35c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b78582ce-a100-434f-ac11-e189d14569e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b78582ce-a100-434f-ac11-e189d14569e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_27e55208-ddbe-4a33-8aff-e80534ba629b" xlink:href="lgnd-20210930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_27e55208-ddbe-4a33-8aff-e80534ba629b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_a1b5a55d-00a5-46cb-9060-9b389beb8cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_a1b5a55d-00a5-46cb-9060-9b389beb8cb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_830b81d9-45ff-40e3-b6ba-d7d012b6391d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_830b81d9-45ff-40e3-b6ba-d7d012b6391d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_69909334-4b0f-4b23-8ab1-83d1d94ed5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_69909334-4b0f-4b23-8ab1-83d1d94ed5a5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_2ad1cbd6-71f6-432a-86ec-af6658c2a01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_2ad1cbd6-71f6-432a-86ec-af6658c2a01d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_8b044605-6d1a-4f43-bf0b-eda23c3df950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_8b044605-6d1a-4f43-bf0b-eda23c3df950" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a9616a75-959c-4c4c-82c8-79118524701e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a9616a75-959c-4c4c-82c8-79118524701e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_11efd1ae-653c-438e-8d79-d03d47f4eebc" xlink:href="lgnd-20210930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_11efd1ae-653c-438e-8d79-d03d47f4eebc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0114a368-55f0-47d4-9b40-66c4124b0202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0114a368-55f0-47d4-9b40-66c4124b0202" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_708e3291-24b3-48c8-b3f9-c16f5b52175f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_708e3291-24b3-48c8-b3f9-c16f5b52175f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_f2133d50-4487-4299-a13c-29d168ad6dde" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_f2133d50-4487-4299-a13c-29d168ad6dde" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bd6a9491-d53c-4f9d-9604-9abe7d3881a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bd6a9491-d53c-4f9d-9604-9abe7d3881a2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_85b351dc-c959-4007-bd15-19885411430b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_85b351dc-c959-4007-bd15-19885411430b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_1f728c50-c252-45b4-8813-df29e359874e" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_1f728c50-c252-45b4-8813-df29e359874e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_a713f923-7635-4515-8d2f-27a92093a242" xlink:href="lgnd-20210930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_a713f923-7635-4515-8d2f-27a92093a242" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_fcef5608-98b2-449a-9d75-51618ef6d2bc" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_fcef5608-98b2-449a-9d75-51618ef6d2bc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fde79787-326d-420d-883c-74001c04c84f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fde79787-326d-420d-883c-74001c04c84f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_6809a792-127f-45f9-b66e-14ab7090b888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_6809a792-127f-45f9-b66e-14ab7090b888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_14a2c520-9551-4360-89de-5890b9f35c26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_14a2c520-9551-4360-89de-5890b9f35c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_514d6141-dd72-4e10-8e41-06c8fd844381" xlink:href="lgnd-20210930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_514d6141-dd72-4e10-8e41-06c8fd844381" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94723721-129f-42c8-924d-0e4ec8f1dc5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_94723721-129f-42c8-924d-0e4ec8f1dc5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3f297934-815c-477e-bcb6-0546b89d8e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3f297934-815c-477e-bcb6-0546b89d8e2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ac34927b-cd28-413f-8be2-8f3348815465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ac34927b-cd28-413f-8be2-8f3348815465" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="i23031c20c6414f819ff565d802a0d453_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_47141075-8073-4795-bd2c-40f255345805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_47141075-8073-4795-bd2c-40f255345805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_799b49ca-b972-4161-bd01-e3b648b1dbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_799b49ca-b972-4161-bd01-e3b648b1dbf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_c623249b-ca7f-485b-959d-97d1f385663a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_LongTermNotesPayable_c623249b-ca7f-485b-959d-97d1f385663a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_5042746b-25a0-4ff9-817b-59bcb31d28e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_5042746b-25a0-4ff9-817b-59bcb31d28e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_f46fad0f-8f4a-4369-b064-505e5c84ccce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_f46fad0f-8f4a-4369-b064-505e5c84ccce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2b4d51db-338e-4da1-9640-ab0dce166594_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2b4d51db-338e-4da1-9640-ab0dce166594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_e19e8c8d-1b0f-4bbf-8625-de5f612cf942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_e19e8c8d-1b0f-4bbf-8625-de5f612cf942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:to="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75112c8c-75a0-45a5-9e19-6aaf1ae0f461_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75112c8c-75a0-45a5-9e19-6aaf1ae0f461_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_fd3f41af-9177-44aa-9246-248504a66ac2" xlink:href="lgnd-20210930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_fd3f41af-9177-44aa-9246-248504a66ac2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#IncomeTaxDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended" id="ie1b25030b0e9454c85f261adb2624d24_IncomeTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f308275c-2cee-4edf-bdd0-a2e2952efcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f308275c-2cee-4edf-bdd0-a2e2952efcdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dfe1d1f6-63f5-4ea4-a82e-80132a76db13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dfe1d1f6-63f5-4ea4-a82e-80132a76db13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_50bf53be-0c01-4baf-97d4-0bc640af37e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_50bf53be-0c01-4baf-97d4-0bc640af37e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_5803d815-a9f0-48bc-876f-eb7c2fae20dd" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_5803d815-a9f0-48bc-876f-eb7c2fae20dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="i899a2e7439564bf7bb0501ea922844c6_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d2f96f9e-ecb7-4d30-b07c-5f1c88861c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d2f96f9e-ecb7-4d30-b07c-5f1c88861c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a0587337-e802-4d04-b12f-589d76eace79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a0587337-e802-4d04-b12f-589d76eace79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31b31e95-f6f7-4bba-aef6-c757d7301a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31b31e95-f6f7-4bba-aef6-c757d7301a2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c13e0e2-631a-4877-814c-f46c8eb3e011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c13e0e2-631a-4877-814c-f46c8eb3e011" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9359a7fa-df5e-45e4-9d3a-5cec49212e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_192c10c2-adeb-49d6-8058-6c7dd211e608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_192c10c2-adeb-49d6-8058-6c7dd211e608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b64b6884-8117-45f4-946b-82bc6b27d42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b64b6884-8117-45f4-946b-82bc6b27d42c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_573a7822-51ad-4299-8d51-33108dcbd671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_573a7822-51ad-4299-8d51-33108dcbd671" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6747999f-1fc6-44a1-b73a-529644f11870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6747999f-1fc6-44a1-b73a-529644f11870" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7a214353-74fc-445a-bacf-7fb65280978c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c5b918-4681-4e48-9641-ec8a5d4d0be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c5b918-4681-4e48-9641-ec8a5d4d0be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ed162161-7517-4d7f-851e-72806f856154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ed162161-7517-4d7f-851e-72806f856154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6bacad63-c5c8-4cc4-ab60-d3304b93e165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6bacad63-c5c8-4cc4-ab60-d3304b93e165" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f4aaa240-a874-426e-8869-a5df2b7f8c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f4aaa240-a874-426e-8869-a5df2b7f8c6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bea4eaa2-8c19-4c4f-9935-6272e6a0cb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50a0e943-fd17-44c9-a09d-c7afaf36a34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50a0e943-fd17-44c9-a09d-c7afaf36a34d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7f0d002-621d-4351-b609-242d1ee2e9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7f0d002-621d-4351-b609-242d1ee2e9c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e3a837cf-6c6b-4a84-8ae6-609724d8d2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e3a837cf-6c6b-4a84-8ae6-609724d8d2ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83aa5d9-0654-4c14-bdab-f1fe1bd00fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83aa5d9-0654-4c14-bdab-f1fe1bd00fba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03c7d32a-9d26-4e96-8b50-b8fa01990b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:to="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c15c0f2d-a6f8-4719-8344-c1350f88f2cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c15c0f2d-a6f8-4719-8344-c1350f88f2cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2eb2f97e-0f90-4175-8608-c3928c230b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2eb2f97e-0f90-4175-8608-c3928c230b81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bdb9bba0-3bbb-47d6-8b7e-b27a4fc4de2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:to="loc_us-gaap_RestrictedStockMember_bdb9bba0-3bbb-47d6-8b7e-b27a4fc4de2c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i167668534f334282ab647c58ff060012_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_93cabb23-70bd-4a7e-a963-55c2b98db420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_93cabb23-70bd-4a7e-a963-55c2b98db420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_893dda74-d155-479c-a60c-5c6c15ace0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_893dda74-d155-479c-a60c-5c6c15ace0b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_8032525f-db25-4836-a34d-80dd6f1ec430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_8032525f-db25-4836-a34d-80dd6f1ec430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_b97b7099-ac61-4ef7-86da-706073c6ca69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_b97b7099-ac61-4ef7-86da-706073c6ca69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_72a2e7d6-9a88-4498-8990-af27d6e2c615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_72a2e7d6-9a88-4498-8990-af27d6e2c615" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ccb449b-b760-45af-a797-4705be949500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ccb449b-b760-45af-a797-4705be949500" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_a2da789a-819d-4aae-8828-65db75240c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_a2da789a-819d-4aae-8828-65db75240c6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cce7c5a9-d91f-434b-8306-017d8e57338c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cce7c5a9-d91f-434b-8306-017d8e57338c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:to="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:to="loc_us-gaap_PlanNameDomain_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:to="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_234a3a32-57b5-4065-80ad-6997b153db5c" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_234a3a32-57b5-4065-80ad-6997b153db5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended" id="i3fe9971b54b1431c9dd810ebe5d5767b_CommitmentandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c8dbe80c-d757-479f-9c6b-a8e84f195ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c8dbe80c-d757-479f-9c6b-a8e84f195ff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:to="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:to="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_655ea732-1a39-49ea-a957-aa14705babb9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:to="loc_srt_LitigationCaseTypeDomain_655ea732-1a39-49ea-a957-aa14705babb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:to="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_38e2f459-0bff-4a8c-b844-c8abcaf644a3" xlink:href="lgnd-20210930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_38e2f459-0bff-4a8c-b844-c8abcaf644a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="iea344c4717234ab18426fd551a1e1696_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ce4a56fd-dd75-4a6f-90ae-0e76bd0a4199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ce4a56fd-dd75-4a6f-90ae-0e76bd0a4199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e07f8320-cef0-42f9-9b2e-7784936a83ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e07f8320-cef0-42f9-9b2e-7784936a83ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cd75c9fc-da74-4368-96eb-7023a9bde6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cd75c9fc-da74-4368-96eb-7023a9bde6f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityAdditions_a1f38c1c-a630-4934-bbfa-3ff98c2dadf4" xlink:href="lgnd-20210930.xsd#lgnd_OperatingLeaseLiabilityAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_lgnd_OperatingLeaseLiabilityAdditions_a1f38c1c-a630-4934-bbfa-3ff98c2dadf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:to="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bde6e61a-0b47-4c9c-9e7d-c37b084b6495_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:to="loc_srt_RangeMember_bde6e61a-0b47-4c9c-9e7d-c37b084b6495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:to="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_126443bb-e92b-4d95-a1dc-7bcf8631af40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:to="loc_srt_MaximumMember_126443bb-e92b-4d95-a1dc-7bcf8631af40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended" id="ic023b89319184b74a70df6dd6b2da3a3_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_9623735e-2365-4885-9dae-fd7c96ebb664" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:to="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_9623735e-2365-4885-9dae-fd7c96ebb664" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_e925d6dd-fc61-47b3-b2af-a304ac5f3329" xlink:href="lgnd-20210930.xsd#lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:to="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_e925d6dd-fc61-47b3-b2af-a304ac5f3329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:to="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3c74b5d1-c66f-4b31-ba2f-a58f53a50255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3c74b5d1-c66f-4b31-ba2f-a58f53a50255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b9571dec-0310-4dab-8891-11187a14b86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:to="loc_us-gaap_SubsequentEventMember_b9571dec-0310-4dab-8891-11187a14b86d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:to="loc_dei_EntityDomain_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:to="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember_af80d3d4-f313-4463-9647-0c3fa715b2cd" xlink:href="lgnd-20210930.xsd#lgnd_OmniAbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:to="loc_lgnd_OmniAbMember_af80d3d4-f313-4463-9647-0c3fa715b2cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9445c237-9345-4224-a44e-3010fc62df01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9445c237-9345-4224-a44e-3010fc62df01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_cb3940fd-dcb3-4a0e-942f-c51ea0adb314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:to="loc_us-gaap_IPOMember_cb3940fd-dcb3-4a0e-942f-c51ea0adb314" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_52467fd8-fdbb-4727-9be9-b996e863041f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:to="loc_srt_RangeMember_52467fd8-fdbb-4727-9be9-b996e863041f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:to="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d75938df-5c9c-4a5e-ab5b-7eee0891fc71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:to="loc_srt_MaximumMember_d75938df-5c9c-4a5e-ab5b-7eee0891fc71" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lgnd-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_lgnd_PfenexMember_d0583428-df7c-4b2a-94dd-cf1922a817a3_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_20421ab5-cfd5-41ba-bd4f-917667edd256_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_3ec8a724-ab44-469f-9531-a7ac788a9ede_terseLabel_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate for forecasted cash flows (as a percent)</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_label_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_documentation_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:href="lgnd-20210930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:to="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_221be003-6483-40af-aa59-f27776f959ca_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6c42736b-ea8c-4bac-ade3-3c8daf3aed48_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_519056f0-6e8d-472e-96dc-effb09b0aeae_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86aee5e1-f15b-48e2-9c7a-4dcfdea6d48d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3e0f51cf-9bfc-4314-9061-21c642f620c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_51b4ac8b-2009-4376-b33e-f49ada903100_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2ea20d79-0491-4714-9312-a059fadffe4d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_215c1735-e77d-4d55-914f-4383b0736e17_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_255f92f6-5cc6-4bc2-8962-0c62cdc22a80_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f3a82ca3-e6da-40a3-aee6-7a4885ae2235_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5d8adc99-23be-4172-b40a-514f73becfe9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6439d06a-9f7b-4f59-b5e1-13621baaae7a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_47dccd2d-1d83-477f-aa8c-41c8ae8a0c06_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_89246ffb-d1dd-49d5-89f8-70d784f6322f_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_50b8f1f7-4da5-4b7b-a176-e8ab75a3d337_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_ba277313-aa2e-47fe-ad3b-1ed1241ab7fc_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_f9df6ef3-558c-46f8-8fc6-cbc64624890a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e826d085-16b1-4a65-bef0-dcbc526b7008_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cc2fb97c-687e-4ca1-93ce-c42b6d3a6826_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_84ae7cc9-14c3-49aa-8470-de89dc9e45d8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ad6393b6-3878-4690-964a-e5cc8675c395_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_579266b9-c1b9-4b5b-970b-22c97ccd177a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_ac49de00-6d1a-4b3b-a472-5341b16410b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b93282ac-e4e1-4833-8fd1-6d9fef182d7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_c56ffc38-fdd4-492c-884b-23c3a42d3846_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_293d8014-be00-47c6-80af-f0410f8b73db_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6a707499-16a0-47c4-9d08-7657b6118211_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_8f19a293-8c2b-4dc2-a5ed-1ab3a68de5ce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd07ef31-92bb-4f64-9521-7dcf5a00af6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c82bf165-b411-40e0-9ece-4c71ebb28649_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3942a256-6bc3-4346-ba1f-7aa93d48200d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e9412829-db3c-49fd-95c8-1429fd6eaf10_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d94fbdfe-3444-4fb4-b89a-c035cd7db013_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a8b91270-e626-41a5-8e96-051b5f72403d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c3458c73-fa06-4d6d-8ee0-99bc98def7c9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1501e378-6c1d-4e08-be64-943034c6d2e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0f1eb0da-8e83-47c4-9fee-2796bb9ee80f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_736a4409-8ccc-407c-989b-3239378e580a_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f4f98b57-7e57-4fa6-9c7c-579d0f7e2049_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_27cd9b01-124c-41e4-845c-232910e63cf1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c61495a4-9c53-46bc-a448-bf5c8bd4496b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e45669a5-e1eb-4bf3-9b9c-fb9ad61896a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_53e0d01a-2c3d-4742-bb16-0a75b86e71ff_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability acquired in connection with the acquired intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d47aeb3e-8555-498e-9716-127701a242a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8fced7cb-ef11-445d-b9e4-96cbbd71a5c8_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average estimated useful life of finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8d138077-507a-42e6-b484-11dc0bb5d672_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84bc8da4-2eb5-495e-b35b-1bf8c464f6c9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8c9ef605-fb72-47be-a756-fdac44d9fe9a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from milestone method revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b64dadb6-5fd3-49fb-a02b-0c275f42c829_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_5cb9f986-9545-4864-a989-f608dd522259_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_0a20eec9-6ecc-4366-af85-55fb8e3fe4ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bd8c30a-2cdc-46ac-a716-3a156c5a7ccc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b2d86ec9-b289-48c7-8534-d29a8371a5db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_1bd2d620-ea2c-42e5-9ea9-74f9b817091a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_aa52f844-c394-4ec0-96e6-2b7dd516a920_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_87f82c7a-8ca8-4ae3-b31a-fa2498b76a3e_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43294134-7246-4072-a917-85b061459e46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_f1d75652-a622-4d4e-a0d6-f63f679f9671_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a0ef6acd-7e88-45cf-b487-2a0b45450fca_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_645f1fdc-6324-4723-8b3f-dab32efad424_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_34d7b6c8-8b55-4a4d-9735-ada373c6dcdf_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6ebaa5b-6269-45fe-8ca3-1dd29672590f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_294ce27c-71a5-415b-b40c-770e4a206e9a_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible assets acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7f850e0d-448a-410c-89b4-f857256dc9b2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_89f99b05-c54e-4011-a539-9c4432f6d89d_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out payment</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_57e205bd-884e-40b7-8acc-c4950c62ef4d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_3562dec7-315b-4aca-b34a-4befda9c7709_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20210930.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7d3b9dd4-10ce-4f80-af44-dedc61ada6af_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_783d0df1-98c9-44d3-acb0-9e3d800c5628_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8672ae26-3da5-4a9f-86ea-04c7e94fbf40_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a7e3923e-d9b9-4898-b294-17b654bb3b92_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d6c873e4-a795-4094-a917-1a4b9581f4a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ca0586f8-ef37-4709-8181-2e1b21c0646a_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_85a4f8f7-3844-4dfa-8eab-0d65b9148f25_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (Accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_ef33fe90-b9e9-491d-837a-08875b313820_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_dfa3b34c-8c74-4b5a-bfdd-946073e3ee6a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_1337ab73-7e6b-4ddf-8868-60af5c536f12_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_a19ab332-acb5-4cdc-abed-432fac335bdb_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementsMember" xlink:to="lab_us-gaap_RoyaltyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0c7de1ec-a366-4247-be86-d90f5e3cbed2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_78e14040-e836-4c6d-bfbb-667524da9143_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_fef4e5eb-b8af-4092-9451-8576ce200ff9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_687f5c53-ca1d-4bbc-9bb3-6690ee546b58_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_08f49b00-1bce-4525-89f8-9ab283c73551_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7a3c06a2-705f-49cc-b77a-04157f62b3a0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b8d704ee-8420-49a4-a76d-8535945d7d39_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_70db1b63-bdc0-478c-9239-476c989af06b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e2fd92e8-aa45-4a2f-94ae-0c0af0670bd0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_855939b5-2d2b-4270-83d3-755e49c36eb8_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20210930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_242a4c8f-b3c5-4cea-b253-9b7e3a3712fd_totalLabel_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset" xlink:href="lgnd-20210930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseRightOfUseAsset" xlink:to="lab_lgnd_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_494fd0fb-2af7-4675-8ad1-4ea6acb2cb89_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_de5ccca9-d870-4721-befa-738b4ae9c55e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0db92f07-656a-4f04-9aea-1ecba2878141_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3052d5c1-f77a-4692-865d-be9d660fa578_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_ac11f544-7ebd-47b6-a28a-52f24dcd9510_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_8ac8e8bd-78f7-4d63-9131-5cda9890325a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4a501c63-497a-4d0e-b01b-1d1d75ec6900_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_35067928-8825-4217-b7fe-6dd3183844ea_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_c52b3dc1-ade8-4770-9ce1-9581142b5e16_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20210930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_08171a95-723c-4e4c-8658-c4e559500b41_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:to="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1d1793bd-5a16-4fd0-97c7-18d0c0ff858b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2ea002cf-3a02-4661-8df3-6c20078eeb5e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9c4b6ab5-cf2e-47ae-b3ff-8dffd7a10709_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_71ea48b6-97a8-406c-887a-2792dc1b80f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a031861d-702b-4cf3-9c63-007bf20208b1_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of September&#160;30, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_759ec54b-dfcb-4e68-8638-521132ecde9f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_e05cf8fa-7fbd-427b-8564-dc9ce11c8bcc_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_52883b19-1903-41f6-95b2-f9eb04776405_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_07bffbc3-0ae7-4151-8215-3ba151150cad_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20210930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_2b9ae1ee-f6c5-42c3-8897-1e434bbe6de7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_731bf316-0795-424f-a406-8e250ee18c92_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_17b4de21-d72a-4535-867a-45e168478d2e_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_82aa528d-38b5-4046-b673-53443bf8d18a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_19fe6ab0-907d-4bbd-97d6-927e9e2c0fa7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9c60fef-a05c-4313-8aff-120e781de8da_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_89a131aa-7665-4828-9971-48f12dbb3b5b_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_9c927ad0-029b-47a0-af52-2f4bfdce0b2a_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20210930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0f06a7a4-c8dd-457d-bb8d-8f2fb3fc5ec7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_0e7a8507-16aa-4c82-80cc-9a2fa2f0931e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_7d946047-97ea-4d2b-bea1-849607a6154e_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_ac9c9d71-a9ed-426c-8808-fca57fa62395_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20210930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_5c40b7b5-bf1c-4c89-a34b-770f3cc84609_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_886bac5e-bc9a-4f3c-a9f7-815311d57658_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisMember_775d180c-dd16-4773-a4ae-d4ccba82f49b_terseLabel_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:label id="lab_lgnd_SelexisMember_label_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis [Member]</link:label>
    <link:label id="lab_lgnd_SelexisMember_documentation_en-US" xlink:label="lab_lgnd_SelexisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember" xlink:href="lgnd-20210930.xsd#lgnd_SelexisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisMember" xlink:to="lab_lgnd_SelexisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_c1dd5427-8829-449b-989b-e1828818acaa_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoMember_3fc6a24e-e409-430f-aefe-b8afa0da80c9_terseLabel_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo</link:label>
    <link:label id="lab_lgnd_AziyoMember_label_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AziyoMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember" xlink:href="lgnd-20210930.xsd#lgnd_AziyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoMember" xlink:to="lab_lgnd_AziyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e85b7ada-926e-4df1-87dd-4f9bb010f3bd_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a67bc5b-112d-48cc-b2e9-c32ff45f384c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97c913aa-0510-4c84-b84b-09141b853dbb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_cc564988-8d1a-4c77-b66f-f40700040483_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e7714812-49ab-43c9-bb76-6c5e47eb42b6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_74d1592e-6658-4072-856f-9e585d7acbc4_terseLabel_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits applied on advances on inventory purchases</link:label>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_label_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits Applied on Advances on Inventory Purchases</link:label>
    <link:label id="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits Applied on Advances on Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:href="lgnd-20210930.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:to="lab_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0307c841-d390-4de4-ae83-fc9b0d6d20b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_f6241a17-03c8-4f68-9dd1-eb4c1680eed9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_02f137fb-416b-470d-8758-6e538cbb2f59_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_531b16c1-5e9c-4681-863e-5e9d23196b65_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4015f278-f676-454c-9ea0-7359fbc373b6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedLeasePurchases_07f8a439-c22d-4c30-b30b-c153190550ce_terseLabel_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued financing lease payment</link:label>
    <link:label id="lab_lgnd_AccruedLeasePurchases_label_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Lease Purchases</link:label>
    <link:label id="lab_lgnd_AccruedLeasePurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Lease Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedLeasePurchases" xlink:href="lgnd-20210930.xsd#lgnd_AccruedLeasePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedLeasePurchases" xlink:to="lab_lgnd_AccruedLeasePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0fd24c6-9f1d-4bbb-a2b2-dc50c83db94e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_86e43e1b-991c-4ff2-97dd-d10ca2442126_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_46c42c2e-cafd-4b2b-9f2a-1cf829cd0d7a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_53ff3a28-7aaa-43e3-ac7f-e0fc4d9f5237_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20210930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a53ef4ac-2161-4479-89da-077ea30131df_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6411d5ff-6ae3-4a44-b3a7-61c4bcc22d75_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_ab7694b0-d291-4808-9ccc-4a66290be1bf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash to settle unvested stock options recognized as share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_373bb6d8-17d1-4a92-bcf5-29975e1c1334_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_412adb77-5287-445e-9619-11c4f913d801_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component of the 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_42923a1c-2eae-4ba7-a573-364d6042d524_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Crystal</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Crystal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_b21ff175-bd87-4dee-b79f-b1400eaf0790_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_24f77706-fd13-46da-a773-2096d38a7f9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in contingent liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d31e5e8c-9b70-46dd-9e39-78d0a83557f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_9897e5bc-fa56-441e-aed7-fcca07ca6721_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_4b2648c9-87b1-47b4-b6f0-8871e01039de_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4a94e940-029d-4772-8a26-1ba19f69d810_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c19ee2b8-84e4-4d61-a8bb-39d22e69e405_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_dd383c5c-4352-41a9-a5c8-66605644523a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_79c7817a-840c-4f08-9538-9d8945e3f701_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate used to value intangible assets acquired (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_9ad67606-9d26-482a-95a9-3c376b55a86e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_25533a21-9837-404a-80ff-9e9d859c8ebd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ce38dc48-1be0-46ea-8a8c-fac29e689ccf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_4ffbd539-8a26-4ace-91b2-22a4fd0548d3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_8fbf98a2-e57f-432d-9b04-37ff2a0a23c6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8234260c-5002-4419-b587-90a7148b0aea_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_dc6b955f-76d1-4207-97de-3e9b4c2d979a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_82386111-54bd-4460-a186-550ab58f4925_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_65f97b0f-06bd-4cba-8e5a-ad673795fc5a_netLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_45520f25-2051-462c-ba82-a8aa7f2686b0_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_d017f72f-e6d3-48e1-bf0b-1624cfd479ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_35871ad3-a80c-4740-92c2-6fa94ce5dfa1_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8e25d7d5-f30a-4d7c-9148-8091abde488f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_31e66c92-0e7f-4d11-b9cc-7a2e3a872ca7_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_37d657e3-0c9c-4b92-8f90-b86497ab868f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7c571295-c90f-4170-8ea6-eb3c66d30393_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f5f9e6f7-43be-4b37-bc2e-ea364f51b181_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_70a6aa83-88a2-4ec3-a179-88dcb34df32f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_eebc1ad6-d5f5-4668-a2ae-454f4f5aacf6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_a836eeb8-5a36-4114-95f0-45c7041fd6c1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_5621a8e6-9d2f-48e9-b116-3f465abf47f8_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_4275d40a-f7be-4443-9097-deb308064df6_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_8d65dd6e-34b1-42e0-a557-1c3b32637ca3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_cb2d5432-2471-4130-928e-0e1cc4b90255_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3028cfc9-a4c3-4496-b06e-f96afd508064_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_89e85d5f-fff6-4aa2-b45c-1c5bb9dbf3ed_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,707 and 16,080 shares issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_7d17e96e-febf-4240-b8c0-87c4ab34e13a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_cbb447a2-4bdf-4ff7-82e6-4b04e5238e72_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40ff4b8a-a8c0-410e-af9a-08347b1c65d4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fa1120be-68a4-47e4-bcbb-a0130098c965_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ed11cda9-3f6e-4776-982d-d5f1ebd2472d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6f7544c5-a0be-4011-aa3e-23a5bf230c0d_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e4e0a4f4-426c-4146-983a-70a46b948a8b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_e06abfcf-b5db-4d1d-9548-eaf75d347ae4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_8ea6ba91-0b09-47e7-9b89-14ae4e85ce7c_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_fbc3f5cd-3949-46c3-8349-1613a4a85e50_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3bd85711-cc7f-412c-ae5b-7606fd86d073_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8afd4e64-dbc5-467f-8125-c6b986685408_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_654a63db-3531-4fd1-96fb-d30aa0f64f4c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b7b5cb45-9de4-4f6e-8dec-294908c9a38b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining three months ending December 31, 2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_04fe9df3-ff9c-49f5-a9a1-5ca8bb3cdb33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_4127b086-dced-4312-9cc1-e9e9164800d5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_178d7638-b7bd-4a9f-9ab7-40e0c2a15e7e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_0e6062b3-2a75-4f0e-ad7b-8d1b699d8a7f_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiabilityCurrent" xlink:to="lab_lgnd_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_225a2096-cb12-4d76-9cb8-184a9e2ed0d5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3dbfd9d5-a8a4-49e3-8743-0f155959ce63_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_222bd8d8-ee8f-4bd8-a37a-558be4f14c68_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_95a75d5e-3b7a-4784-ab21-d239bdb0ed35_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_f3d9a11d-0da6-4835-af3a-1d4c7a237a86_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1a4745db-968b-4d0d-bcec-a03ed39276d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a06c632-2e9e-443d-ae8a-890ecb023603_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_7c9c5ab9-a110-4aa8-9b11-46debdcaf20c_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_e5ff1f60-73ea-4e9f-9ef2-631a8438009b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c08b7160-425f-4685-aaae-8e737886e446_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d218b82a-3b0c-4c7f-b17b-17a829d2600c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_59afbbae-7e11-43d2-85b5-9f9c5953e7da_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_379638aa-b74c-4c19-8df5-f24f53b5bf96_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_056224b5-0c48-40ea-9559-44dd9e6b9609_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_4f855b9b-4149-4c6f-97e7-542e5b104283_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestonePaymentsMember_81da5f6b-ed13-41f8-bd2b-cc69c6d68ba6_terseLabel_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_label_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_documentation_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember" xlink:href="lgnd-20210930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestonePaymentsMember" xlink:to="lab_lgnd_MilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7e4cc66c-b422-4704-b5e5-92c186d5b62d_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_03776055-bad6-4786-b42a-52c957e8ec06_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4c12dd93-79a0-412a-9650-ff395d092254_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d7d3fa1-782c-4581-b215-40bd6cb7a804_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_7c5a97ac-1f49-4e1a-92b6-b72ac0a874df_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_8dcd06b2-3487-465f-bc52-9c87834e3820_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_5f0a6b17-2e08-4d44-8900-173c156dfb5d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_075dce34-e380-4fe6-9736-3396fff2eda9_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_916594d1-d2ce-483e-a0c3-9b6cd1983ace_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e726bc44-a18e-4294-affa-5be67b03cd81_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_869a68bc-9846-445b-ba25-02f300c65e1c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_42a147ef-3152-4b97-affe-9280dd352fbb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_dcfe1c1a-a2a3-4d98-bca6-a3f0d025f315_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_6945dc6b-695a-4428-aeda-d0a34bf69791_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5e0214b8-3655-41dd-9f89-2c21bc84a43c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_984d7da6-63b3-4ea4-9a62-0f80ca604472_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b5259e68-b586-4de2-9bf5-86c2ab05f924_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b6abfbea-bbfb-42b6-99c8-8ba4b33a2023_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_f11b5ef6-0f96-462f-b270-2140fa503f65_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20210930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_27678af9-cc4e-428d-9764-73d7a3e8f79e_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_e1785ecc-d24c-4c08-99b8-41612120e394_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_c9186a1c-da1a-41fa-8dcc-66b2768e18a2_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect for 2023 Notes transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b33a2ca-1c30-4467-bd24-a45639831cac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cc5bc61f-2210-457c-b94a-040bdb9a223a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_1de9a44f-1e98-4eea-9c8d-71f302fc140e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityAdditions_c9d3b91d-4f30-4dd1-931a-55d41bd7c2a3_terseLabel_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease liabilities</link:label>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityAdditions_label_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability, Additions</link:label>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityAdditions_documentation_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityAdditions" xlink:href="lgnd-20210930.xsd#lgnd_OperatingLeaseLiabilityAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OperatingLeaseLiabilityAdditions" xlink:to="lab_lgnd_OperatingLeaseLiabilityAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9ec6a2c1-709c-4e89-8a2d-00e3f82056c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb8b7fbe-96cc-4713-abe9-509b1bf2b8c6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_cc2679e2-31be-40ee-967b-495eca24c98d_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of milestone payments (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_ef4cf970-49e3-4396-b03f-f781335278de_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of separate, publicly traded companies into which entity plans to split</link:label>
    <link:label id="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_label_en-US" xlink:label="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities Into Which Entity Plans To Split</link:label>
    <link:label id="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_documentation_en-US" xlink:label="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Entities Into Which Entity Plans To Split</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:to="lab_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_8b4a185f-d465-4fc1-9615-0898d77c0fd7_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_008db69d-8b8a-42e6-80fd-7a5066d492d5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f1705754-a395-462c-b102-b9ed3c2fa893_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_edcd1595-81b9-45bf-9afc-9295eee09a28_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_39595d7d-a8c4-450e-97f0-c2f521029f4d_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20210930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_68b50646-d67e-4106-a275-96a8b9c6e111_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_a51f6c24-a1a1-4552-948e-7bb657c44e22_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding warrants to purchase shares of Viking's common stock (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_a86aac93-05b9-4b0a-8335-c1dd6769d5e3_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_f7cf2ced-cb5f-4eee-a1db-39173f50095e_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingent payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_f96772c7-9d02-4e08-8d11-e9bfe48d1aef_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2e8c63ca-9c69-4a16-a504-275a2757aaa5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiability_1173b224-ccb1-4901-af6d-b09ddb02fa4d_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiability_label_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_lgnd_LeaseLiability_documentation_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiability" xlink:to="lab_lgnd_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b69ede23-aa54-4d35-8185-8175447094f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_99cceafa-7ada-42dd-9786-987bbd884593_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_94808188-3f9c-4d73-a3a6-1ce13c8bd4e2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_5f5a6c7f-9bf7-47bc-b9e0-01dacbc2bd1f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_600645a5-aae6-4968-bb54-67b0500552d9_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_87eaf0b0-36cb-401e-bfd9-c55d55dbdc59_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_62ca0298-dbf2-4e78-b9ab-63d258bffd2b_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20210930.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_d62f5257-685d-4490-9cee-4ef161e5e0ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c45396c5-fec4-498d-ba8e-b1ff7c048eb9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3514d990-124d-47da-823d-46930607efc0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50a7c109-075b-4b6f-b0cb-81fd3cb4c4aa_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b5e12b49-d764-4ac9-bd7d-ba62fb5729d7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bc9a349a-b35e-4ebb-9dde-1fb41270ce34_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_8285f2b4-08fe-4006-9125-712fd85a629f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_cb03c8a4-e475-4268-a39e-ec788c22e110_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bf172f91-455f-4546-9277-e0db473f62fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_39c8602d-ae93-46d2-83a7-1f5126251c81_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5cf80fe0-0d24-4785-a607-79dcd448a6b3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ecda1897-8bf3-425b-82e5-2a75c9b75d03_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e99265ca-2ecb-4d25-b5e6-398295162d8f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_298c587f-b02e-4b53-b5da-1d49bf5eddea_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareProFormaAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Pro Forma [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract" xlink:to="lab_us-gaap_EarningsPerShareProFormaAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_228cf310-7942-4dcb-9d53-2dc114453d50_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20210930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_f49ba54c-de7f-4104-9355-ac4c32b0c75a_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1a9687d3-a35b-42e2-af3e-9cf0fde5c060_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_836934d7-83a6-4637-a2c8-fadb6cdf40d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e153959a-7bce-427d-828a-c52e5fd82732_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ae28b6b0-ac27-4902-a972-7f801dbf844e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_a8950bab-452d-46c2-8f50-652258f01625_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_e5a6cb8f-5ccd-4399-bccf-f3afe2878780_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_7e7ef707-eb91-48b5-ae04-370aa5b1f7fb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cd9caa38-df08-4e9b-81ca-5b51bd35b06a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_135dfa75-49ca-4b44-80d5-11ef172ece00_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_fd614ab1-edde-4a7f-88df-027fc9885f68_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_45f45dea-6406-4303-a546-ac8276f8e2a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_d2858328-3c0c-4934-87e6-82682c23e6e4_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_d4d998bf-0ef0-4520-bfa1-5523b9aff5bd_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a02dbeaf-08b6-45c1-9fe5-888450a2a597_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_85f0d0bb-90b2-4078-bd69-94f71a2cfa20_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_bba7b3d1-9816-4579-be63-8d739faba61a_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_79d54eb1-87d3-441e-8d73-31a4476ecc02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f5cf1428-859b-4282-bdb2-5d1b507f6a4c_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - xCella</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0f9f89b4-e3e8-46ad-b7f1-7df2f7a81a38_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f89c7e23-bb8b-4aba-a68d-1503bff13b71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e6ad8028-2788-47fc-a016-15138a96f512_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4b66612f-62ba-4b3b-86c2-c9007afec41c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_02d7b47f-f2a3-4b7a-af4e-e4614c6bac66_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_69b5d5e6-5506-4e6c-aa91-3ff8f0aa967b_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_b9162214-0ce3-4088-907f-c19e4efd8122_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommercialLicenseRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_39173a57-eafc-4ff1-9f19-3cb81665e55a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_18f37217-54a6-46be-942a-4e4c704d3d19_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20210930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_a6790825-717c-489e-921b-4c2a0124a532_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20210930.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_33194341-25a9-4824-9508-bf8bedf5c9b4_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury bill</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ee42be05-92ba-46d4-a3f5-5617c9bc1140_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_99b9c4c0-e01e-44e4-af7d-fd28c8a0faaa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bc0001bb-2b10-4a80-93e4-228d9d2baacb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_14148727-728c-4266-a726-702ca73ed1f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8feacb58-48f4-45e5-a676-3cb4a6dfea0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6a66e55d-5e88-4c49-8bae-62bda8df10da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and unbilled receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncome_3678b9b3-5165-43d3-ae09-663ea608b988_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncome" xlink:to="lab_us-gaap_OtherOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0679c7cb-bb70-4908-97db-85624dea135b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_267e8216-0eba-4c2c-a29a-7013c26d0617_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d1537042-b121-461d-8aa9-5980c4ea54e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_182ac83e-6f1f-457b-9247-a663952db436_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6faaeb44-2b2f-4b50-9ea8-3d8f019a2d70_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_f00008ce-b873-4345-8558-4bef7d6524cf_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_4989fbe3-b0b5-4ea7-9a73-9a682095ef91_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_29d2eb01-f411-4bcc-bb85-e993589eb759_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_c32c501c-5271-42fe-952e-6051c09b3786_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20210930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_835af40d-a766-4fe0-8b6e-d37c49538d7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_c640e950-6424-4c1d-8e5b-1b3b8ee85101_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_02114d27-5137-4dd3-83c7-d08edd29052c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e216fc64-4fc9-4b5a-ac0c-78cfd072e3d8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b67392bb-7e4d-4179-88d2-f8100ffc0078_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_a1e815be-9282-416a-93e0-ff29a0f0fcaf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_17475d94-c071-4722-82dc-8d76d011958b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_24af9139-16ce-47e3-bdde-f1f39b82f0c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19648b33-c5ad-477f-b811-e9a48b39c39b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4529d475-6c0e-4259-b99b-1c982afb64a6_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_cc08001c-ac22-4d5a-befb-abe6e7bcceee_terseLabel_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Finance Lease Assets and Liabilities</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases [Table Text Block]</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="lgnd-20210930.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6b1d5a2c-1d63-4192-bc7c-84a81b1a5d45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_aa060d48-3e3f-47b6-b465-b3a2e373c4b2_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e1be916f-f61f-4810-b122-64cae3593c0b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_38ed2cc2-0e58-4bc7-a67b-c8d49b707bf5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cf36143f-837e-4284-8fb8-009928863923_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_e5ebb4f7-9239-4b97-8b05-d14396aa5d9f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_ef23e6f6-d201-44c2-9121-6688c3b77cd5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1f819ff5-a3fd-4b9d-9c15-5a79ce8dba52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f1a690d1-bb0d-4ac3-921c-66e25ff9c4e4_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a16ad667-38a9-4179-b6a0-5a4b20fdaeae_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e28628c7-36ec-44f0-98c3-eb618a2ca73c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d28311d8-2900-44d5-b6e5-6624c59644ae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_57c0ae6e-6554-4289-9b72-a7ae66a863ef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_ac416f07-8a4d-46f8-8124-53b93aa275f5_verboseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20210930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5eab68a7-1dd9-4dfd-b603-e420424d8474_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_ad4b9526-103d-492b-b395-05594726ccad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_38ea5518-c0d7-419a-a1b1-f52f9f3e54a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_15c5b57c-9eda-4dde-8be7-2990944a9eae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b73d0e70-3726-420e-8da3-990a605667e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ed2a61d4-c086-48d9-8dc5-c51b073d8bd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_aead8fbc-1ab0-4733-bb16-1611cda26818_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_2f994673-a1d2-4fdd-ad4c-040dcf45e9d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_451bf4b4-cd3f-4662-b925-a8c6e98a25e6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_56aacf4c-67db-4969-8ef0-cd1830b59311_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_9dd3f29e-a5d9-486d-8040-1b68b6e94d34_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_11efeda8-4ebd-4cce-b0da-806b2d0ee946_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20210930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_77de2eae-e0a0-4043-a199-9148081ad61c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_8dd419a6-32cd-4e2a-8b8a-4592ab314338_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3fec4666-f0ce-455c-b6aa-260ac78ebda8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_b7988adf-1911-4116-b72f-6d5bd7193e07_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_52e795e7-3e6f-4662-9735-6990aa200e71_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_962ca210-5985-4cad-80ff-9f45be2dd57e_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_b95ffa9f-4929-48b6-9c88-f597611a1940_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_f6822ec9-3dc0-4812-92e2-4f0d53a558f8_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_9e395e25-5bdd-4271-bfe6-6214a7f9ac75_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3f9378fb-1279-468d-b074-05845dde9db4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_9468ac5d-9368-4bd3-b785-b38a13ea85a7_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c0f25130-bd34-41be-8bac-70377f98cad0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_397b1c32-f8f6-4890-be4a-5fcc1209499a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_60a2d970-15c8-43ee-8541-fe2529e63fdc_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_6831b737-ae75-456c-a4ff-6ca5c31511fb_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20210930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_91500cca-9730-4146-a8df-89786ef56037_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_77ea05cc-e860-4284-83fc-e039482c071c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_67268d43-cbc0-4c8e-bff6-66561569722b_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_58b662f9-6348-42b9-b8ea-33e31d41c6e1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_9de04843-a722-4b69-9cb9-189fdcba2d88_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_862d41ab-ee8f-483b-bca2-df5187cf68da_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_eb38e1c9-dda9-4c29-b480-c85ad4b172ef_terseLabel_en-US" xlink:label="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of common stock expected to be sold (as a percent)</link:label>
    <link:label id="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_label_en-US" xlink:label="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Percentage Of Common Stock Expected To Be Sold</link:label>
    <link:label id="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_documentation_en-US" xlink:label="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Percentage Of Common Stock Expected To Be Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:href="lgnd-20210930.xsd#lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:to="lab_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_69ea8144-527a-4ef0-88a8-1159926399a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_2a35dff7-1efc-4dad-8342-8f27aa00e915_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Pfenex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_7ebd56c1-ed9d-4f2d-979c-4d87f2eebe75_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f7bceb4-64a2-46c6-9a7b-1ac56651dbc7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e30a1928-7035-48ee-8802-c4da7d4acde3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_03e07f95-b250-4939-be8d-3a4e739d300d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_84597159-bc59-4ac7-a2e6-16f69527389c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cfd8e390-714f-4d06-bf20-5ba01ecd9f99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_13d6ab8f-c8bf-46b0-913e-93dd8be4e605_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_b0f618eb-8fd2-42b8-a144-c44b53e07051_terseLabel_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_AgencySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AgencySecuritiesMember" xlink:to="lab_us-gaap_AgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3289ee0b-49d2-45b6-b23b-ec1a89d6b29a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvancesOnInventoryPurchases_8fb4490b-2c35-4dc2-80a9-9156a59dc9f7_terseLabel_en-US" xlink:label="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on inventory purchases</link:label>
    <link:label id="lab_us-gaap_AdvancesOnInventoryPurchases_label_en-US" xlink:label="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvancesOnInventoryPurchases" xlink:to="lab_us-gaap_AdvancesOnInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_462f7678-be17-482f-b58b-0513cc438ebf_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e51da513-3189-44b8-95de-77d4a6d27346_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b691fac8-f54a-4909-ba87-1d08581bc692_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_efebfc3f-64c9-4d77-aa36-d615c97e55c2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_e661adc2-551e-4926-ae0e-f8fb7a390386_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_a2e55c6e-a8b6-42ee-8fbf-8a023c18a10e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_5ee1c1a1-e60c-404f-8613-c4cf68ec0465_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_58175243-477b-4959-991d-712fc281861d_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f212f706-59e2-4ef8-84a1-8c24233b2c44_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_148335ad-a498-4c8b-b495-4086b0b6fd8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e2f8161d-175d-432d-81c8-5aba0ca6e24c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ac0dae9d-437a-4b09-bac7-1c65ed6854c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_adfd4b8b-bc3b-4324-8f37-1d4047c13ef5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3bb0bad2-3072-46d2-942c-eb42c83ab253_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dfee8393-29fc-4d5a-8a93-09240a5af9d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_1b964313-30c0-4523-9cc2-8149210b8aed_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20210930.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_efa4c64a-f9d4-4743-9784-075f43edf03a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_22dc8d41-c297-4425-8b0d-b8732ba76d47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6e281be-24da-4b35-91da-294f58bf1597_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_cc06a5b2-b7d5-4c9e-b452-21bf2c07a322_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09cd059f-1db4-47d9-94a5-7348d6fdaabd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_1110f7e3-501c-4bfc-a2a3-c79f1bb65afa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_edf0ac40-5f3a-4602-b8eb-2db43f973e16_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20210930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_28028cb8-2fa3-4f92-9a14-936f20937900_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2bccbd0c-962d-4302-b95a-e5623afbb832_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_81dfc34f-902a-4880-9485-226116d2e27c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b5b8c254-744f-4055-a173-6b0684797906_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_105d6e92-883c-454d-bf42-e3cf88d5a8d0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_a37919a5-ea03-4200-99d8-56629fdbcf58_terseLabel_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_label_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC [Member]</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_documentation_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember" xlink:href="lgnd-20210930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TaurusBiosciencesLLCMember" xlink:to="lab_lgnd_TaurusBiosciencesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_13a7d1c6-1886-4413-95de-5508142c3518_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_53322d00-78cc-492f-a9fe-60213e79dec0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniAbMember_dd79f3cd-41c4-46b9-b667-69d65452ff3e_terseLabel_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb</link:label>
    <link:label id="lab_lgnd_OmniAbMember_label_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb [Member]</link:label>
    <link:label id="lab_lgnd_OmniAbMember_documentation_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember" xlink:href="lgnd-20210930.xsd#lgnd_OmniAbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniAbMember" xlink:to="lab_lgnd_OmniAbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_efc4cfe7-4034-42a3-aefe-c78cbdd916b3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_3be1e2a4-92f6-46d1-b5a2-ae627ab1f9e3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_beff6bcf-c588-4ad6-92b5-797f3f584def_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_558e91f2-fcb6-40a7-b8dd-ae86328eec1d_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_be1230b5-e8b2-4901-9c45-e283ed3564f7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired that is expected to be deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_ff5d6194-fcf6-45a1-bb47-afaf7e9a1dc0_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_34a72c68-d05e-43f7-808e-5331d6dc66b0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_17be477d-c63e-453d-ba90-efb091744d8c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_f9ce5feb-67f4-488b-9c24-9b3586e66cd4_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ac0def07-719e-4eb1-9eeb-90419833c739_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_62cb3eeb-1f40-4138-bb5b-68261197ac6c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7d981502-15b3-4da3-a074-7e22a65b6e4b_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_529f4ded-04cd-409b-a6c6-4b983ce6c2a5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_cc3635f0-c86b-4f35-98d7-e7123500df9c_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:to="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_febab2f9-23c4-450e-9fe9-c8f59e95e4aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6c4ade37-bde2-4c1e-a967-29497f78517a_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_d4745ecf-bc54-4a8c-8531-82cdba7858c7_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_7df30d46-28de-48b0-ad13-1483d8a7e48c_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:href="lgnd-20210930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c77d4dad-1455-42a3-ac2a-a85655ebf5af_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fa2a99f0-d318-49bb-8778-15142641060a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0e019ec7-7cfc-4c54-b0bf-57adb3f064d6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_d5daccfc-ec72-4f6f-8f5f-f81a1b34789c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4bca32c9-3486-48cb-9a59-90278b574d07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6db505b2-4b04-4286-bc59-6854383e31a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3bbbf1d8-98d9-4a28-8cf5-9f5726f9271a_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_cecd48ee-193b-46a3-ac0d-1596344640eb_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_2f423e24-dee8-4a74-9152-7e7fe68d6a2b_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_b44fad2a-4439-40e9-b1ed-62240df69e17_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_36ba24c5-8591-4a36-a9b0-0d4bfe9349eb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1749f384-901b-4075-8411-882dcd0f61d0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_1e15fc38-be9e-437e-8e32-916c65cd1c58_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Icagen</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5264c39f-0a82-4a6d-bbf9-67b5c86e0bba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_db4db315-7a7c-4d3d-a8fa-8c5168f4483d_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_36091647-bb03-4b0c-8132-a7b9c0b1e644_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6a407719-f04b-4897-b2a3-dba9a10ffccb_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_612734d1-78e5-437c-b655-80c02a288bef_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_499f2e86-ac1c-498f-88c1-0f7ca3531f29_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_55eceece-dc99-455f-8331-8766852cf69b_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_9715ef1f-c23c-4bbd-995a-eb5c5c132566_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b3451418-3565-4e18-ac87-c11300b1415d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_a3834133-3a3e-4956-a7e7-cbc718a809f7_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0a5eebcb-24c3-4265-ae58-09cf0e2f052b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_d06282d0-81e5-4532-99d0-88c4fd472391_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_f80962b7-4f92-4486-8f3f-4952f16b8e6c_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_987df4b5-4355-46ac-8d3a-ee2e81126e3f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc.</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_2563cdd5-2587-4c8a-bf9e-a4cd47e4840e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_70786760-6009-4b26-87dd-419d0d8a8605_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b0ee8620-113c-478c-9272-924175791f1d_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_965be2b6-bd80-4230-9a4c-00bac69b1fdf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_43c08c02-2c18-4161-ada3-e5ddb7e792f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7c7ce8ab-f57b-4c5a-91f8-abf235b0c581_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_3bea9961-e741-40f5-b0bf-656b9c1c079e_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_fe11236e-bb4f-4db9-a535-d6fad2d38bea_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_51b70be3-0e75-4d3c-be23-c43c3ba0a709_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2f4f4331-42d8-4c13-aafc-51c85a403268_terseLabel_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="lgnd-20210930.xsd#lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_531494c5-0e1c-45e5-88a4-6e8e7acc112a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_67a6af3f-f7dc-45c4-9672-00bf490cb685_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_d3d93df9-3b0c-4e5d-b94a-9307c3016a2b_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20210930.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d4600b72-7917-42ce-ab4c-7177d1b87495_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_29f24e1c-5514-4353-bfb8-aa328c53ceeb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of computation of basic and diluted net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_988c7be9-1adf-41df-bd6e-a0b31a9a5865_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_caabc225-3b54-40fc-9f2a-b34bcd97543c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b396d0d5-82d3-4fad-9528-5aa87c5969a7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_cf420879-6133-40e6-94e6-9f4b91d39595_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback from acquisition</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_label_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:to="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_6cbfcff1-9d2e-4466-873e-f2c030996ab7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_dbdec488-49c3-480a-bc47-18eda76c34d9_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_b9f7167a-0da7-49c2-8f1f-a2f59cf6bbe6_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20210930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_22e4b5cd-cfc8-443a-b88d-e895a32c5a1a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_5330a24e-27c0-413c-8dd1-87d0dad7bc9b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_956c650f-039d-48af-a4e0-9a17093a5f9a_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a36e6c54-9347-4739-8f58-bde7a3ec7cc6_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e586c7fe-a6a2-40e2-8e83-e3e67bf4912b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_28bee652-d003-4940-8824-40c0f1379807_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_ee42f52f-a0aa-4976-baa0-36aab79735d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_912bc460-796c-4b8a-b240-7c95aae3396d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_13cc9134-ad35-4fdd-92ac-69a0ad8af504_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_514c7647-c5f6-4568-bdb8-91bdc0c95fee_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7dbc848d-f84f-46d5-a47c-9a1869f9d3d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_02af9f49-90c3-410e-9cd0-d25ba23cfc74_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4793b398-92f3-4f91-8591-eea83c6e07d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_9f4e4efd-de73-4ec8-b195-ac045c1f9c57_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e5fa6433-1369-41d6-92c7-e150baf5496a_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_11eb9ce3-807c-41f4-9589-8c2c8018b388_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1651db21-3695-40ca-9f75-6317b52b0e61_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_012af9f6-3f28-4be8-a865-2d57b4bfc385_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5beb086f-bf91-4c51-b838-9f754f1069c5_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_138cb3f5-cf45-4958-ad77-ba74af8b137e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_6a5d089a-f031-438d-9f2a-086d1fe6f237_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20210930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b869236b-95f4-416c-b870-5650b4110e9b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1e7e997c-22a2-46db-9f6d-4295e1a68774_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_03c1f83f-d4df-4d8f-8641-8233216dd379_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_7d517976-2e8d-4f24-b52c-e10cdd825834_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c50c4606-ac0c-4304-8e5a-c3469dd30eef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_0f016363-6a52-48ff-bfc9-3812dc2f9c49_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_445520e2-cd54-43a1-880f-e7b77ef6434f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9d95e2a6-d483-4192-9a54-1fc9fb2af855_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4a05a05a-3eef-43b8-8dda-30fc85fc8fe1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8b7a5ceb-97b2-41d9-a2b7-8fdb0e6892af_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_43b61755-cfae-4e67-a104-117de32d07d6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_cd5e68f3-9907-4444-acc1-c521f8a8d880_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_3526afa7-9a19-46f4-b1a7-bf90955dc1ea_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_445893db-e52e-4b6e-aa86-77fa3caccc08_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_45388332-c2e4-4d7e-85c5-d0e426dfaf9a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_cb6901f6-107b-47f2-b7b4-477da3ec5100_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid in capital, equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_fe1ef141-504b-4a78-b0b5-dde56ea992bd_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_e86f9979-eb7d-4bb8-917b-820537653bf9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_e3f88844-2a51-46e7-a1f4-9d3f00d96197_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e048448c-0cae-4253-ac71-43ac868a41af_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_0066edcb-02b5-48be-8950-465724be8f29_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_9c474f5f-b2fa-4db0-968f-45c546f5a80b_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_07919451-2682-4607-82cd-8f5635168b86_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d9a42eb3-97ec-4234-a571-e72d3f26c4c4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_4fa77beb-54e9-469c-89c8-27b4635da11f_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_995a371a-78c9-4f64-8f7d-540977ab75ec_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20210930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_675760b7-de85-4ef8-ae84-d5a13dab1f62_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_49d809c9-d3ea-496e-9ebf-dd24761176d6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_5f06eb6c-681d-489e-8636-66175856dd13_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9d047a46-c46f-4405-8525-8b6a77d87914_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_818226a6-82ed-4e44-a04a-9cdd1a3daaec_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_11d82a76-8866-4054-83f1-c879647117a6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_6e19ddf1-4f3e-451e-a3c8-24b2fa1296a9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2cc0cf53-7f49-42a3-8498-bb660f9d3ce2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_673fb6b0-5bec-459a-a6c2-412dc069ff33_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross payments to acquire business attributable to vested portion of stock options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_label_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:label id="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_documentation_en-US" xlink:label="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:to="lab_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_33e0e737-6f92-48d8-b6f1-ec554a78a8b3_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a329ac88-8dc6-4167-9d4f-2f4c0d47b5b5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b378a0df-57c0-4f20-a95c-688ebfba7594_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IcagenMember_7d1bdfe0-54ce-4c35-ae0c-0697ef4ebcc4_terseLabel_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:label id="lab_lgnd_IcagenMember_label_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen [Member]</link:label>
    <link:label id="lab_lgnd_IcagenMember_documentation_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember" xlink:href="lgnd-20210930.xsd#lgnd_IcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IcagenMember" xlink:to="lab_lgnd_IcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_4c3187ca-9a57-4403-993f-cec5d1956838_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_83634cb6-530b-4c6f-a82d-f7ec90956225_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_f5f915fa-4d98-49cb-9a2a-c8b0db4efffe_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_3f08d36d-0f55-41df-8c4e-4184d4b9cbce_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9f9f2145-06c8-4e44-aa46-bdae57bdddb4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e3b3da18-2a59-4bc2-a1a7-15d6407308aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8dd63101-997a-4695-b081-c8c8d99cf51a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_cfed9aaa-9c3c-4765-8000-720bfc781e08_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_9f6eca86-9c37-46cf-9947-ab3a3a6f3ef1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_2e5bbb39-6fd1-4a77-9e73-69b2cfbac6a9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_50ec147b-4f84-498b-8347-9dcf8aa06a3f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_b4382ad1-32a9-46f3-b678-861cdddebf1e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_7d501c0f-469f-48af-9a1e-e348208f6ecb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_d6195f4e-cb97-4ac2-9be9-794093164b8e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_38adcccd-728e-43b6-a382-7aae0fd603b7_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6d010517-11ed-4720-b506-1bb1f113ebb1_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_f1b62c7e-3342-48a9-85d6-72abaf686719_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_8f8cc578-3ba6-40ae-9ad1-60bde9a5a53c_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20210930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_56171987-4ae0-4395-af67-d2e0c11144b9_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20210930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8928be98-92ec-4e55-b0a7-b1dc17f68aa8_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5ad8c963-d0b8-45c6-9bb1-f1bc282c4e4a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7dc3134e-f914-4025-834b-49cc64d84991_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_38bae109-61df-4f63-bc7f-475e55cd6311_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20210930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_534ce192-0e0b-43b6-a84c-774715cc87b1_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_87226ad8-29ab-4d79-856d-ccb72f65cc9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_f7bc1eeb-538f-44df-91eb-c118a56f0114_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_d7824719-b8fe-4795-8cb1-acaaeeb51dff_negatedTerseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0d83d4fd-5f32-49a2-9558-30012a7f92a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_c309bd58-6b17-4704-bd59-46f975b38b84_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lgnd-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1752e1b-7d8d-4df4-a349-533c790b411b,g:10ce1a6f-8c78-4fa9-bddb-374b4e87e04c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20210930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_df3b8b2d-a9a2-4eeb-bb7f-88d1ccf18ac7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentType_df3b8b2d-a9a2-4eeb-bb7f-88d1ccf18ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_7ae629ee-7f69-4dc4-b40e-53b444a04de7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentQuarterlyReport_7ae629ee-7f69-4dc4-b40e-53b444a04de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ddc6e294-5ce8-4c86-ad8e-869a9a5dc15e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentPeriodEndDate_ddc6e294-5ce8-4c86-ad8e-869a9a5dc15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f1cfa2b0-2fc9-43ce-889d-7febb41317c3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentTransitionReport_f1cfa2b0-2fc9-43ce-889d-7febb41317c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_58f4e860-04f3-4460-a9c0-3b7309818680" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityFileNumber_58f4e860-04f3-4460-a9c0-3b7309818680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a41ebb87-2e75-40da-a4a8-5eb7fcc50048" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityRegistrantName_a41ebb87-2e75-40da-a4a8-5eb7fcc50048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13806cd5-03e4-4fe1-8f76-062e3839743f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13806cd5-03e4-4fe1-8f76-062e3839743f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_59352097-fa05-4da0-a224-caa9aaeba096" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityTaxIdentificationNumber_59352097-fa05-4da0-a224-caa9aaeba096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c864d487-ec40-472f-9359-272f95ca5309" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityAddressAddressLine1_c864d487-ec40-472f-9359-272f95ca5309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7324edab-20f9-4573-81c8-ba0df0627b02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityAddressCityOrTown_7324edab-20f9-4573-81c8-ba0df0627b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_851732c7-348d-48bf-949b-50c992225c5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityAddressStateOrProvince_851732c7-348d-48bf-949b-50c992225c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_82d91bf5-ab44-4839-90cb-db643905a030" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityAddressPostalZipCode_82d91bf5-ab44-4839-90cb-db643905a030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2a317e95-3612-4e88-a5d1-b9369968dcc4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_CityAreaCode_2a317e95-3612-4e88-a5d1-b9369968dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_eb0f747a-0a44-4c03-9724-d4dfc9d881b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_LocalPhoneNumber_eb0f747a-0a44-4c03-9724-d4dfc9d881b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e6bb2860-cace-4a0e-8121-3615be0737d5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_Security12bTitle_e6bb2860-cace-4a0e-8121-3615be0737d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7e90287b-c664-4936-b5c4-76d876f50133" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_TradingSymbol_7e90287b-c664-4936-b5c4-76d876f50133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8ce377a6-e77e-45eb-a9a5-5b1243be025d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_SecurityExchangeName_8ce377a6-e77e-45eb-a9a5-5b1243be025d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ce420d94-b31a-4dc4-8c51-318b33e04435" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityCurrentReportingStatus_ce420d94-b31a-4dc4-8c51-318b33e04435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_8dac80b0-e052-4336-a9b7-54583edbeff8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityInteractiveDataCurrent_8dac80b0-e052-4336-a9b7-54583edbeff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_72c2c39f-7f56-48cb-9f58-7c334bbe36c9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityFilerCategory_72c2c39f-7f56-48cb-9f58-7c334bbe36c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_acbe40e6-c771-4c0a-9592-a6a1bd5185d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntitySmallBusiness_acbe40e6-c771-4c0a-9592-a6a1bd5185d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_17302cdd-bca1-45a5-87f4-a2139a04ba05" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityEmergingGrowthCompany_17302cdd-bca1-45a5-87f4-a2139a04ba05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_32f17705-de37-4966-90c5-baa18747750e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityShellCompany_32f17705-de37-4966-90c5-baa18747750e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8dafc08a-2da1-4ff5-901a-90dff33e6f3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8dafc08a-2da1-4ff5-901a-90dff33e6f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c99efa6a-eb3f-4516-9308-8ba45970ecb4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_AmendmentFlag_c99efa6a-eb3f-4516-9308-8ba45970ecb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_81b8fa84-4380-4708-a3eb-a85ef0d7d5bf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentFiscalYearFocus_81b8fa84-4380-4708-a3eb-a85ef0d7d5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_736a3e5d-41ae-49a2-a1d4-6b02d77ecaab" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_DocumentFiscalPeriodFocus_736a3e5d-41ae-49a2-a1d4-6b02d77ecaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_eeb8b3da-b0c7-422e-97d3-35f35c80c636" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_EntityCentralIndexKey_eeb8b3da-b0c7-422e-97d3-35f35c80c636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_03a7a958-e6e6-432e-9726-d41fa167b96b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad511a-9b1c-41b7-9a8a-a4ea8491b535" xlink:to="loc_dei_CurrentFiscalYearEndDate_03a7a958-e6e6-432e-9726-d41fa167b96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5dc668c5-6379-4c56-8b22-32097ea06d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5dc668c5-6379-4c56-8b22-32097ea06d84" xlink:to="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2fdd67e4-8315-4c32-8005-8ba1435d2720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2fdd67e4-8315-4c32-8005-8ba1435d2720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c2170eac-fa17-490b-be8a-a2c8919f37e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_ShortTermInvestments_c2170eac-fa17-490b-be8a-a2c8919f37e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d2054b76-5d88-43ae-9eaa-3ac48c739701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d2054b76-5d88-43ae-9eaa-3ac48c739701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8551ea34-7c59-44f0-b7be-5964e29a0019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_InventoryNet_8551ea34-7c59-44f0-b7be-5964e29a0019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b7f96c1e-f076-4a9a-87cb-24c587aae3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b7f96c1e-f076-4a9a-87cb-24c587aae3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b68208ea-f2b1-42e9-903b-77da3b871177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_OtherAssetsCurrent_b68208ea-f2b1-42e9-903b-77da3b871177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc27f4c9-c342-4678-be41-fbbfca00c4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_24610475-091b-4d9f-8e50-0f82eb0406f8" xlink:to="loc_us-gaap_AssetsCurrent_fc27f4c9-c342-4678-be41-fbbfca00c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_52efb178-e695-4867-91f9-cee0d7e390ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_52efb178-e695-4867-91f9-cee0d7e390ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c22e1278-0802-4fdf-a2a6-80b5a9abca93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c22e1278-0802-4fdf-a2a6-80b5a9abca93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d884f718-3905-4306-8d93-0e3d6f85b65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_Goodwill_d884f718-3905-4306-8d93-0e3d6f85b65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_8ba7c5db-3fdb-4fe2-abb5-5054509440fc" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_lgnd_CommercialLicenseRights_8ba7c5db-3fdb-4fe2-abb5-5054509440fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6d909e04-2645-4357-afaa-44b33f2b8bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6d909e04-2645-4357-afaa-44b33f2b8bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8c82294e-1e0d-4ccb-901e-bdb5dc4ecc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8c82294e-1e0d-4ccb-901e-bdb5dc4ecc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_50dfcd4f-8a1e-4071-ac3a-a40101898398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_50dfcd4f-8a1e-4071-ac3a-a40101898398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1bf3218c-ebb9-461c-89b8-a58d4efd0c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1bf3218c-ebb9-461c-89b8-a58d4efd0c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5214c5cd-c0a2-43fb-8210-c6f9721469c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9e8eabb4-8b40-4184-a765-2f5d3a3bc2ac" xlink:to="loc_us-gaap_Assets_5214c5cd-c0a2-43fb-8210-c6f9721469c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5dc668c5-6379-4c56-8b22-32097ea06d84" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d91aa9b9-5692-46d2-8910-8355cd168517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_AccountsPayableCurrent_d91aa9b9-5692-46d2-8910-8355cd168517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f7657839-1046-49aa-a177-c18f29d9307f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f7657839-1046-49aa-a177-c18f29d9307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_02533cb9-fa72-42d2-bc9c-a3c789f816dc" xlink:href="lgnd-20210930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_02533cb9-fa72-42d2-bc9c-a3c789f816dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_478b89b0-332d-444f-a821-30f124b72cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_478b89b0-332d-444f-a821-30f124b72cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_607b8fa6-7f41-40d3-b816-c58db9de0e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_607b8fa6-7f41-40d3-b816-c58db9de0e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_99c2c498-04cd-4146-b546-38133eead4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_99c2c498-04cd-4146-b546-38133eead4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a5684744-2e4a-483a-a4bf-8747c4f9a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_602361a4-36b5-46ca-ba83-c2245bb239f8" xlink:to="loc_us-gaap_LiabilitiesCurrent_a5684744-2e4a-483a-a4bf-8747c4f9a37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_48173d1a-9eee-472a-8b88-7bcac211edf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_48173d1a-9eee-472a-8b88-7bcac211edf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_545de3a3-39dd-42cb-aacf-6f7847a35e2a" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_lgnd_LiabilityForContingentValueRights_545de3a3-39dd-42cb-aacf-6f7847a35e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e893c555-5c77-44e5-9cc8-11f0088fbb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e893c555-5c77-44e5-9cc8-11f0088fbb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8241f86e-2d5c-4ff5-9ef8-f2e50c4c93b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8241f86e-2d5c-4ff5-9ef8-f2e50c4c93b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_da3ee7ff-74da-467d-9b20-6dd9d2f222a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_da3ee7ff-74da-467d-9b20-6dd9d2f222a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b4597105-1f29-4d28-aed9-12cee7f539f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_Liabilities_b4597105-1f29-4d28-aed9-12cee7f539f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f6b45713-90e5-4393-8b9b-73dcccad4a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f6b45713-90e5-4393-8b9b-73dcccad4a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_13c06751-9131-43d8-af89-4d36a9007e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_PreferredStockValue_13c06751-9131-43d8-af89-4d36a9007e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_776d9ff9-3053-41f1-8363-9970427ebabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_CommonStockValue_776d9ff9-3053-41f1-8363-9970427ebabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e622313a-eae5-402d-82d5-65949d5c83e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e622313a-eae5-402d-82d5-65949d5c83e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e459a57-9336-4b90-b66e-bc8c1b3edd62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e459a57-9336-4b90-b66e-bc8c1b3edd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_743e6aab-a9e4-4e37-8375-6ced9d7f809c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_743e6aab-a9e4-4e37-8375-6ced9d7f809c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4f44fec4-1cdc-4e4d-8e84-d82d8097d35f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fce28276-c92b-4019-9a41-8eb8a8cdcf50" xlink:to="loc_us-gaap_StockholdersEquity_4f44fec4-1cdc-4e4d-8e84-d82d8097d35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5d4015c-5181-47bf-8a5c-6fa30f32461a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fc7f9ec4-0e7d-4ca6-a3cc-08a4d207e2ef" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5d4015c-5181-47bf-8a5c-6fa30f32461a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9fe69d27-857b-4f49-93a3-27fc2c8f24f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9fe69d27-857b-4f49-93a3-27fc2c8f24f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_36bf0de3-21cf-4cc2-b2f5-5b6734fdbf34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_36bf0de3-21cf-4cc2-b2f5-5b6734fdbf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_643d3090-5b7f-4fec-aaf8-3dc1b66b5c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_PreferredStockSharesIssued_643d3090-5b7f-4fec-aaf8-3dc1b66b5c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_61a963d5-fbbd-416d-97ed-f46c07c05a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_61a963d5-fbbd-416d-97ed-f46c07c05a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5e730655-5615-4e8a-a18d-08279fdb870b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5e730655-5615-4e8a-a18d-08279fdb870b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3305efd7-73c8-4c3c-b25d-de1de1400d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3305efd7-73c8-4c3c-b25d-de1de1400d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8b7fe35d-889f-45e3-a2b8-e7cf99cebb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_CommonStockSharesIssued_8b7fe35d-889f-45e3-a2b8-e7cf99cebb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0170e85b-059c-4ccd-af0e-4c25fa7daef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d5ba9312-7df7-439a-a877-7ae4c1cbacfa" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0170e85b-059c-4ccd-af0e-4c25fa7daef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_05dccc8b-88be-4bb9-8ae8-7c78b159bf14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_05dccc8b-88be-4bb9-8ae8-7c78b159bf14" xlink:to="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:to="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2a66523d-bd0e-4cc6-b15a-a1e690994837" xlink:to="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_e67dec66-9098-4382-936d-c539711fe648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_us-gaap_RoyaltyMember_e67dec66-9098-4382-936d-c539711fe648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_0683e56b-c0e0-4e11-ab36-6e94a60e64bb" xlink:href="lgnd-20210930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_0683e56b-c0e0-4e11-ab36-6e94a60e64bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_359c0834-52d8-4864-8d5d-f56267443506" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9dd52fce-4036-4b98-9bb2-8d31600535ce" xlink:to="loc_lgnd_ContractRevenueMember_359c0834-52d8-4864-8d5d-f56267443506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c11c2e7f-cfde-4c7b-8dd6-c40ea92bddf9" xlink:to="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_89d55a87-c2e4-4288-8bdf-aa65e61cfdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_7f3c3ec9-596c-424d-a2f2-a9b8e8d808fa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_89d55a87-c2e4-4288-8bdf-aa65e61cfdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_91ca9065-de6e-4cdd-80d2-5c52ca1a7efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_CostDirectMaterial_91ca9065-de6e-4cdd-80d2-5c52ca1a7efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6ac7f060-b982-46a9-b092-5c95c7b9987b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_6ac7f060-b982-46a9-b092-5c95c7b9987b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d98a7eea-5dee-4995-9c26-0e59a277c041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d98a7eea-5dee-4995-9c26-0e59a277c041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_34aed7b9-7848-45da-80ae-a51c383a456b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_34aed7b9-7848-45da-80ae-a51c383a456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_0343b1df-0320-4c5b-9c87-c914e5ce80c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_OtherOperatingIncome_0343b1df-0320-4c5b-9c87-c914e5ce80c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_76b3d177-d8f9-4602-9aa7-f4e596a50c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_813d956d-cf9e-4480-9c6e-435f01ea71dd" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_76b3d177-d8f9-4602-9aa7-f4e596a50c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e0c409a-69a2-45dd-992d-4662165648e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e0c409a-69a2-45dd-992d-4662165648e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_7fb96123-7695-41d2-94dc-0aa4510ecf90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_GainLossOnInvestments_7fb96123-7695-41d2-94dc-0aa4510ecf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c64339af-4ea6-458b-8921-d6555328295d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c64339af-4ea6-458b-8921-d6555328295d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e754537a-77c7-4fe4-b4a9-cbacb544bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_InterestExpense_e754537a-77c7-4fe4-b4a9-cbacb544bd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b552032c-6f07-420b-bf7d-900349a88cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b552032c-6f07-420b-bf7d-900349a88cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e11d3c56-4057-4830-a6ed-82fa0bfc8757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e8cc50b8-760a-407d-bac8-90625e693a2a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e11d3c56-4057-4830-a6ed-82fa0bfc8757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc2fb3e-6c72-42a8-8005-36d7d9c4e105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7bc2fb3e-6c72-42a8-8005-36d7d9c4e105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1c864bb-e42f-4493-b883-0f59f9f50b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1c864bb-e42f-4493-b883-0f59f9f50b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fda17029-29a7-4569-874c-c2975416ce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_NetIncomeLoss_fda17029-29a7-4569-874c-c2975416ce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_96769664-c4bd-40bd-843f-b74b1f8d06ab" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_215df6b5-e310-4762-ae6d-10a7bc9718f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_EarningsPerShareBasic_215df6b5-e310-4762-ae6d-10a7bc9718f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16685ae4-ef8a-49be-985d-74673a468d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16685ae4-ef8a-49be-985d-74673a468d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c0d0db48-cd53-4a12-bb7f-d91ecec222d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c0d0db48-cd53-4a12-bb7f-d91ecec222d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd472b51-17b0-4d11-ae03-5bef2d0472aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_07989a1b-bfb9-43c7-992f-31ac39f2e363" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd472b51-17b0-4d11-ae03-5bef2d0472aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5043467-526b-4677-a80a-36c567fb3dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a895635e-3dc3-4597-9a15-483f5f6e70a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5043467-526b-4677-a80a-36c567fb3dd2" xlink:to="loc_us-gaap_NetIncomeLoss_a895635e-3dc3-4597-9a15-483f5f6e70a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4dde7073-7493-4458-aaba-4320d3288cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5043467-526b-4677-a80a-36c567fb3dd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4dde7073-7493-4458-aaba-4320d3288cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_11cf37ad-eb52-48c2-b5ca-88e8271e9095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5043467-526b-4677-a80a-36c567fb3dd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_11cf37ad-eb52-48c2-b5ca-88e8271e9095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c57cff8-1382-4547-b1e8-01113cd88ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5043467-526b-4677-a80a-36c567fb3dd2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c57cff8-1382-4547-b1e8-01113cd88ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_05b99488-6ba4-4eb5-9d6e-a555e7a878e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_05b99488-6ba4-4eb5-9d6e-a555e7a878e7" xlink:to="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_64beae1e-c345-4495-bff3-c22a41b6346e" xlink:to="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_57b3fa05-fa60-4393-b46f-36874eb6481a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_CommonStockMember_57b3fa05-fa60-4393-b46f-36874eb6481a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_16edcbfe-3409-42bb-a1fc-d7e181f72fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_16edcbfe-3409-42bb-a1fc-d7e181f72fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_89ff5b40-c3eb-4226-a6bd-670137ca3b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_89ff5b40-c3eb-4226-a6bd-670137ca3b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9eef47e9-33db-4dcd-9094-c14f10ed21a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2e97b511-c436-4756-a9c7-c77881e742cf" xlink:to="loc_us-gaap_RetainedEarningsMember_9eef47e9-33db-4dcd-9094-c14f10ed21a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_763faa3d-bc8e-43e0-9421-459c5758d3dd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_146b1d2c-df00-41a7-8432-b9e76aecdbde" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1730932e-ca0b-4f7c-87b0-4fddcf22861d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_146b1d2c-df00-41a7-8432-b9e76aecdbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_06fa8237-970c-4e30-9aaa-78c211c04b3a" xlink:to="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f5b6c4ef-d2ae-472f-a153-27821860cb22" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_617e35cc-6bb6-41b4-8d3c-e1f770ded4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_SharesIssued_617e35cc-6bb6-41b4-8d3c-e1f770ded4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e51d5b0d-14a1-4f42-899e-75765720084c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockholdersEquity_e51d5b0d-14a1-4f42-899e-75765720084c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_11adbc2a-88a2-4afd-a161-e5cff65b761d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_11adbc2a-88a2-4afd-a161-e5cff65b761d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f0e2fc38-a2d5-4ebb-8611-9bb171b6ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f0e2fc38-a2d5-4ebb-8611-9bb171b6ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b9818d90-d9a5-4246-9ee3-b950904c2c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b9818d90-d9a5-4246-9ee3-b950904c2c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_8557e6d5-2f3a-4a4a-80a7-37dc92621d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_8557e6d5-2f3a-4a4a-80a7-37dc92621d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_cc6ad44d-446a-48e8-8143-120e3dff4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_cc6ad44d-446a-48e8-8143-120e3dff4bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_0f2361e5-e121-4ed5-8730-f9d7b3470f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_0f2361e5-e121-4ed5-8730-f9d7b3470f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_808d87f7-6912-4f6d-bddf-bd82057b6321" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_808d87f7-6912-4f6d-bddf-bd82057b6321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5a74c654-133e-4c20-a76a-a032ceb32ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_5a74c654-133e-4c20-a76a-a032ceb32ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_0075a2db-a172-42e7-94f9-2d088516caaa" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_0075a2db-a172-42e7-94f9-2d088516caaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_affb9496-46cf-4130-8b8f-7baca7e3ea83" xlink:href="lgnd-20210930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_affb9496-46cf-4130-8b8f-7baca7e3ea83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8549b9cc-fe45-4a54-823e-7ed7aa4761b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8549b9cc-fe45-4a54-823e-7ed7aa4761b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_91518af5-a2ce-4c9c-9a47-1eff92fec7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockholdersEquityOther_91518af5-a2ce-4c9c-9a47-1eff92fec7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_53409cb6-5914-4875-b3d5-e1ca4296a73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_53409cb6-5914-4875-b3d5-e1ca4296a73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c800eba4-1927-489e-9838-56bb94c64ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_NetIncomeLoss_c800eba4-1927-489e-9838-56bb94c64ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_c02b9a17-f5f7-4fe7-8bd2-8bd5ed9b10ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_SharesIssued_c02b9a17-f5f7-4fe7-8bd2-8bd5ed9b10ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c7d8dc3c-84a0-4bfc-9ac8-420b233b9c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc64e309-2866-4907-973e-755162e0e4e3" xlink:to="loc_us-gaap_StockholdersEquity_c7d8dc3c-84a0-4bfc-9ac8-420b233b9c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_67c980f3-e1a2-4598-9450-3018b66a9ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:to="loc_us-gaap_ProfitLoss_67c980f3-e1a2-4598-9450-3018b66a9ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_96637651-0333-486b-98b3-972cc38f50a5" xlink:href="lgnd-20210930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_96637651-0333-486b-98b3-972cc38f50a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1748c752-7f07-4570-9870-60d094f8104e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1748c752-7f07-4570-9870-60d094f8104e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5795bf3f-f1b3-4b35-ac27-2976a407afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5795bf3f-f1b3-4b35-ac27-2976a407afe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_018dba12-6524-4787-85db-30cbfdd13522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_018dba12-6524-4787-85db-30cbfdd13522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_63cdbdb4-d6a7-4561-8274-40e02b3fe9aa" xlink:href="lgnd-20210930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_63cdbdb4-d6a7-4561-8274-40e02b3fe9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93aca6bf-dc15-4cf2-ba4d-e7d787344427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93aca6bf-dc15-4cf2-ba4d-e7d787344427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8c9f8e54-06e5-4117-b149-1edf7c76bf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_ShareBasedCompensation_8c9f8e54-06e5-4117-b149-1edf7c76bf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_db409fbf-4e98-47ee-8665-f55c1432f922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_db409fbf-4e98-47ee-8665-f55c1432f922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_33a49c97-102e-452e-819c-cdbf6de1578c" xlink:href="lgnd-20210930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_33a49c97-102e-452e-819c-cdbf6de1578c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f78874d0-196e-4d8f-86cc-ee53400b45bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c2f33bcf-2500-445e-9ae9-93f8f016c7cc" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f78874d0-196e-4d8f-86cc-ee53400b45bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0a5e38c1-903d-413b-8e62-ed837bd24ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0a5e38c1-903d-413b-8e62-ed837bd24ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_01bd2ff6-49cd-4ebb-95d2-3aa9593f6b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_01bd2ff6-49cd-4ebb-95d2-3aa9593f6b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1fb12507-a0ab-4d05-9d14-89ef079ce5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1fb12507-a0ab-4d05-9d14-89ef079ce5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f1d4d990-63b4-487a-9f1e-a77be53a66bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f1d4d990-63b4-487a-9f1e-a77be53a66bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e3e51bba-aac4-4a9d-9ed3-7ba3c69c9ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e3e51bba-aac4-4a9d-9ed3-7ba3c69c9ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_ef20acbe-fc84-4622-8224-2c207772ef3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_ef20acbe-fc84-4622-8224-2c207772ef3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0a4c8019-3f4e-4a57-af59-0eb35b7eca07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_974b8942-f696-46e7-8fc4-23c5542d317b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0a4c8019-3f4e-4a57-af59-0eb35b7eca07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_310d3897-2b2d-4ecc-baf9-93b58c128959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_93f4373f-36e1-482e-bb0b-53fad5a59eaa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_310d3897-2b2d-4ecc-baf9-93b58c128959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0b1d13f5-21b1-4444-98a2-f59292f29add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_0b1d13f5-21b1-4444-98a2-f59292f29add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_64931052-5cce-441d-bb42-47e5c326f0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_64931052-5cce-441d-bb42-47e5c326f0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_4684575e-2693-458b-b6c6-e16f0dfcc178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_4684575e-2693-458b-b6c6-e16f0dfcc178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2e4e69c3-107b-4bb6-96c1-6ef066fc7d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2e4e69c3-107b-4bb6-96c1-6ef066fc7d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9b7c8341-f7c4-4d2d-8b75-30647d476f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9b7c8341-f7c4-4d2d-8b75-30647d476f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dc62afcf-22b8-4527-ad2e-adfd3d5b22ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dc62afcf-22b8-4527-ad2e-adfd3d5b22ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1e26191b-7aea-4687-bfc3-4890b6702f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1e26191b-7aea-4687-bfc3-4890b6702f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90c0686c-91a4-4e60-8f07-783cc6230c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_249fbcc6-f730-405f-a5d7-d3e19a58a537" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90c0686c-91a4-4e60-8f07-783cc6230c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_58572323-f613-4541-99a7-a2a780a74d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_58572323-f613-4541-99a7-a2a780a74d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_005be18f-b456-4ad1-8fd7-5ddc74e94626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_005be18f-b456-4ad1-8fd7-5ddc74e94626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_7d7a01f3-6b2a-4890-b0ba-dbe2e8154281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_7d7a01f3-6b2a-4890-b0ba-dbe2e8154281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_54218ebe-4d49-44ff-8902-189811fdf7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_54218ebe-4d49-44ff-8902-189811fdf7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_50c634ad-8e61-400f-afae-d75817d3d57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_50c634ad-8e61-400f-afae-d75817d3d57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2a01141c-3d0a-4240-a92c-282efbe215a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2a01141c-3d0a-4240-a92c-282efbe215a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f0abafa2-224b-4d35-83ed-f79577aad6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f0abafa2-224b-4d35-83ed-f79577aad6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_64eeaab1-99ab-4ad1-b069-93d35bba2e06" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_64eeaab1-99ab-4ad1-b069-93d35bba2e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8c91f32-4196-4ee5-b080-7331699025d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_32c594bc-a5c6-48e0-b4d5-973c5b35689f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8c91f32-4196-4ee5-b080-7331699025d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29dc2e0-a555-40f0-8153-286dd950a8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29dc2e0-a555-40f0-8153-286dd950a8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5de78c23-c004-468f-84e3-2183054bc7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5de78c23-c004-468f-84e3-2183054bc7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_215225dd-7238-4d9a-9aa6-0c4cc5fe4df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_215225dd-7238-4d9a-9aa6-0c4cc5fe4df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1267b886-0814-442c-963e-6bf4ec08d5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1267b886-0814-442c-963e-6bf4ec08d5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_ad11deb4-1919-430c-8cd5-86b8967b4de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_ad11deb4-1919-430c-8cd5-86b8967b4de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_7627d180-bb3e-4830-825a-d8476d861402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ad11deb4-1919-430c-8cd5-86b8967b4de1" xlink:to="loc_us-gaap_InterestPaidNet_7627d180-bb3e-4830-825a-d8476d861402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_c7219e27-1511-4ce6-87c5-a84ee4c2c53c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ad11deb4-1919-430c-8cd5-86b8967b4de1" xlink:to="loc_us-gaap_IncomeTaxesPaid_c7219e27-1511-4ce6-87c5-a84ee4c2c53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_47330fe4-7d62-40fc-8954-f257b9a20a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_ad11deb4-1919-430c-8cd5-86b8967b4de1" xlink:to="loc_us-gaap_RestrictedCashCurrent_47330fe4-7d62-40fc-8954-f257b9a20a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2746c259-e543-434b-9818-ea9496e0a522" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4a36d91e-fa8c-4d0d-8790-922b21d21ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_4a36d91e-fa8c-4d0d-8790-922b21d21ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_7aecd176-c5b2-447d-8007-110bad392233" xlink:href="lgnd-20210930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:to="loc_lgnd_AccruedInventoryPurchases_7aecd176-c5b2-447d-8007-110bad392233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedLeasePurchases_4514abf3-0a78-4e2b-a2f0-334de7e08d60" xlink:href="lgnd-20210930.xsd#lgnd_AccruedLeasePurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:to="loc_lgnd_AccruedLeasePurchases_4514abf3-0a78-4e2b-a2f0-334de7e08d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_bdd72601-c719-4845-bdbc-0cb46dd68699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c1221784-8682-4f88-a92e-b5c0eabd2a52" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_bdd72601-c719-4845-bdbc-0cb46dd68699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1e1749d-2b80-43c0-88bf-4de95d841294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_d1686f77-c0b6-429f-9a1e-419d5db31b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1e1749d-2b80-43c0-88bf-4de95d841294" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_d1686f77-c0b6-429f-9a1e-419d5db31b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6cff9494-2b5d-414b-b2f2-0f750a56fe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6cff9494-2b5d-414b-b2f2-0f750a56fe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_85d670b2-3b86-4f9f-8bc8-8c700cdc33b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_UseOfEstimates_85d670b2-3b86-4f9f-8bc8-8c700cdc33b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fb41121d-6597-468a-970e-45287d5f66b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fb41121d-6597-468a-970e-45287d5f66b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_02f16a0a-3563-4bd7-969f-4ad546921b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_02f16a0a-3563-4bd7-969f-4ad546921b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_0fe6f9a9-79df-4a43-b4a3-e52a04844349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_0fe6f9a9-79df-4a43-b4a3-e52a04844349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_08577ff6-e839-49b5-b9a2-5d96e36c1f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_08577ff6-e839-49b5-b9a2-5d96e36c1f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_93bf9da3-1d66-43a8-954f-31d004651fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_571c9d99-aa29-4e38-bf7c-f57e7a556dbf" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_93bf9da3-1d66-43a8-954f-31d004651fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6adc8d34-dffc-430a-9e12-2c071651de27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6adc8d34-dffc-430a-9e12-2c071651de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_61b8a43d-5f3d-419c-ab6b-e5b13a69663f" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_61b8a43d-5f3d-419c-ab6b-e5b13a69663f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_5ad5ea12-2927-475b-906b-7aa9962779cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_5ad5ea12-2927-475b-906b-7aa9962779cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_570fe4a0-a8ae-4763-b331-4d6a1e0b368e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_570fe4a0-a8ae-4763-b331-4d6a1e0b368e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_798e802e-79ef-45b5-939c-f412bb00f260" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_798e802e-79ef-45b5-939c-f412bb00f260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_407887dd-fb6b-4456-94b7-ece50f3f3875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_407887dd-fb6b-4456-94b7-ece50f3f3875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_f7763725-6fdc-47c7-a81c-27d7f4f10474" xlink:href="lgnd-20210930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_f7763725-6fdc-47c7-a81c-27d7f4f10474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_2cd86622-495d-46d8-b375-bdcf1e04059f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_2cd86622-495d-46d8-b375-bdcf1e04059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_80948de5-fc11-4ef1-888e-f87c8c3382c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb551201-0608-4e22-9e4b-be53707b2e78" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_80948de5-fc11-4ef1-888e-f87c8c3382c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cbf87938-d0f4-40a1-8a7e-669b67daccff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cbf87938-d0f4-40a1-8a7e-669b67daccff" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_702c338d-734c-464d-8c5d-6db223c8b4ea" xlink:to="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_75f127bb-0ed9-4a64-a876-295885a817eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_979a56db-787d-4f08-b70f-5bb70bec94ed" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_75f127bb-0ed9-4a64-a876-295885a817eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44cb241a-6f93-4c4d-9a65-34b1f40d7ded" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_48273722-5507-4dfd-803f-ff2ab13b4566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:to="loc_us-gaap_CommonStockMember_48273722-5507-4dfd-803f-ff2ab13b4566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8bc8c0d0-f1e4-4f8b-befb-0846c7b1b05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_67782cf9-340a-4f7a-b34e-1a92d747ab65" xlink:to="loc_us-gaap_WarrantMember_8bc8c0d0-f1e4-4f8b-befb-0846c7b1b05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_34159fbd-bbd1-4a3d-939f-da389e8352ab" xlink:to="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23c73fc0-febe-4419-9d2f-7cd9a39bcfa7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:to="loc_srt_MaximumMember_23c73fc0-febe-4419-9d2f-7cd9a39bcfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_82b79f75-a437-4aa0-99f3-c8bafa5a5bef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_38fb82b2-30fa-41bc-95fa-de9a9dc4ea76" xlink:to="loc_srt_MinimumMember_82b79f75-a437-4aa0-99f3-c8bafa5a5bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_49cc7078-9adb-401e-80f3-cd52e350616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_002a3897-8a6b-4cb5-bcff-25b1e0f1067d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1888579a-4664-48a1-8c7c-23db9e9c55f7" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_002a3897-8a6b-4cb5-bcff-25b1e0f1067d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_4306b9c5-c18f-4e8c-bc4b-ba3706c329fb" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_24644cf0-bc22-46b1-9bb4-4f2a91d2f5ec" xlink:href="lgnd-20210930.xsd#lgnd_AziyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:to="loc_lgnd_AziyoMember_24644cf0-bc22-46b1-9bb4-4f2a91d2f5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisMember_04ee2405-7828-4bdb-93b4-1ee1de555b9f" xlink:href="lgnd-20210930.xsd#lgnd_SelexisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_95723c98-7577-43c1-9c9f-4677a2dcd34c" xlink:to="loc_lgnd_SelexisMember_04ee2405-7828-4bdb-93b4-1ee1de555b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_18afffc0-7826-4157-afa6-d16926e40837" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8be9b4aa-8dee-40e8-9809-8db5c33febe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_63ba3526-f848-407e-8937-7f24db04c759" xlink:to="loc_us-gaap_RestrictedStockMember_8be9b4aa-8dee-40e8-9809-8db5c33febe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_251cc309-ae79-488b-b1b2-89ad1a65090f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_ef518120-609b-4ce7-95ce-1a3cec784720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_38d31594-ab55-4e8f-a045-b49b41a69665" xlink:to="loc_us-gaap_StockCompensationPlanMember_ef518120-609b-4ce7-95ce-1a3cec784720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_56c49941-0b5b-47df-9feb-02121dabe277" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_617b27a0-3060-46a3-8608-47b83e0e3b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_617b27a0-3060-46a3-8608-47b83e0e3b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ea32e013-4695-4498-9988-465262cac2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ea32e013-4695-4498-9988-465262cac2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_39cf95ca-4308-43b7-89fd-338630a3c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_39cf95ca-4308-43b7-89fd-338630a3c7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2fae89f1-9468-45c8-a1fc-01916b932f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2fae89f1-9468-45c8-a1fc-01916b932f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ca11cf9a-a3a7-4f14-928c-9d8a700347e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ca11cf9a-a3a7-4f14-928c-9d8a700347e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5ac8bcf1-0ea7-4797-bb62-bb9d467a2e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_5ac8bcf1-0ea7-4797-bb62-bb9d467a2e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_18a89850-f036-4506-95ec-b0fb0ca45973" xlink:href="lgnd-20210930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_18a89850-f036-4506-95ec-b0fb0ca45973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesOnInventoryPurchases_0fc43212-6f7c-42a5-a563-d0b8f0339f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesOnInventoryPurchases"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_AdvancesOnInventoryPurchases_0fc43212-6f7c-42a5-a563-d0b8f0339f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_1a3e7ad9-05d5-456e-97a1-25c7a86bc854" xlink:href="lgnd-20210930.xsd#lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases_1a3e7ad9-05d5-456e-97a1-25c7a86bc854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_0b3e253a-0c70-4a98-9706-35f46d360075" xlink:href="lgnd-20210930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_0b3e253a-0c70-4a98-9706-35f46d360075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_31f5dcaa-b52e-4382-930f-eb909a83edeb" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_31f5dcaa-b52e-4382-930f-eb909a83edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_52149a9f-e230-458c-b3e8-21d09a74f676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_52149a9f-e230-458c-b3e8-21d09a74f676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_6f3e50f1-8071-4326-8db6-c9773f83ce91" xlink:href="lgnd-20210930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_6f3e50f1-8071-4326-8db6-c9773f83ce91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7372189c-74fc-4a02-a87c-74ddc607a3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7990fc5a-b1a0-45f5-a36a-64a2e02d769a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7372189c-74fc-4a02-a87c-74ddc607a3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5cab8f0d-c47e-497b-9864-ae57bb71cc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5cab8f0d-c47e-497b-9864-ae57bb71cc85" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:to="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1b3795fd-5795-466c-b17b-de38f0c94943" xlink:to="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_ad63d6d9-7193-4a98-b46b-ad96d5e69995" xlink:href="lgnd-20210930.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_KyprolisMember_ad63d6d9-7193-4a98-b46b-ad96d5e69995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_0d9188e9-93e2-4f82-a0fe-2adfc0a54bbb" xlink:href="lgnd-20210930.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_EvomelaMember_0d9188e9-93e2-4f82-a0fe-2adfc0a54bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_ed0c0a22-6949-43db-bd27-a3eea02832dc" xlink:href="lgnd-20210930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_49ab24e5-81e6-4d24-a27f-523f2bfe58cf" xlink:to="loc_lgnd_RoyaltyOtherMember_ed0c0a22-6949-43db-bd27-a3eea02832dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_5df9eb18-bc19-4aff-88b4-75da4e7ef2db" xlink:href="lgnd-20210930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_5df9eb18-bc19-4aff-88b4-75da4e7ef2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a7d955e0-bb00-4f34-a605-7606694e3ac5" xlink:to="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_05399425-1df4-4c1d-948e-d09301360d81" xlink:href="lgnd-20210930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_ContractRevenueServiceMember_05399425-1df4-4c1d-948e-d09301360d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_a1e701c1-ab57-4fd5-ae5b-c9a576e4384d" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_LicenseFeesMember_a1e701c1-ab57-4fd5-ae5b-c9a576e4384d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f2bf3fd9-3296-4116-b203-870b5a006d47" xlink:href="lgnd-20210930.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_MilestoneMember_f2bf3fd9-3296-4116-b203-870b5a006d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_2b471e74-ce79-4fe6-943c-a51d5e92d3b3" xlink:href="lgnd-20210930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_c5bd0925-1d34-466e-b465-25663b32255f" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_2b471e74-ce79-4fe6-943c-a51d5e92d3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca503f43-02e0-4bf8-83ba-1080ae0c3d22" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_decb41f2-540f-4634-87ff-376034cf2790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9b4f0ed6-63ab-41d5-bd51-6d0e6f107ce9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_decb41f2-540f-4634-87ff-376034cf2790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db9ea65f-059f-415d-823a-a0767a183252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db9ea65f-059f-415d-823a-a0767a183252" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6828819c-7c7c-4d1f-a985-ccc063c92cf7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_10ae6d0f-8768-4a89-9841-003806aee68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_DemandDepositsMember_10ae6d0f-8768-4a89-9841-003806aee68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_50f1b867-d222-450e-a801-13c6b2763a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_50f1b867-d222-450e-a801-13c6b2763a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_7a67e0ae-8b3d-42b1-b0c4-ea01f159ea1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_AgencySecuritiesMember_7a67e0ae-8b3d-42b1-b0c4-ea01f159ea1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d705a0c-8019-46c6-b9b2-7b3d192672f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CommercialPaperMember_6d705a0c-8019-46c6-b9b2-7b3d192672f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4a6722a0-1737-4a60-8129-452013a1bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_EquitySecuritiesMember_4a6722a0-1737-4a60-8129-452013a1bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_4f18d1f2-17ba-42a0-bf73-a4d8f0d6f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_MutualFundMember_4f18d1f2-17ba-42a0-bf73-a4d8f0d6f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_a7c6b4e7-2f6d-4986-95a6-c67139482c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_a7c6b4e7-2f6d-4986-95a6-c67139482c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0aa5e815-8555-4b74-abf7-8cda1ea7bd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_WarrantMember_0aa5e815-8555-4b74-abf7-8cda1ea7bd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ba09f237-4e42-4004-9b94-6ee777c08d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7995e1eb-e72a-4115-bfb6-74b8df1641c4" xlink:to="loc_us-gaap_CommonStockMember_ba09f237-4e42-4004-9b94-6ee777c08d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_be0c624c-d2bf-4d4b-9a67-f7d1df198faf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_20f54d29-264f-4f27-b7ff-ada396ceac34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_20f54d29-264f-4f27-b7ff-ada396ceac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_58002d6f-b43e-465f-97f6-84e2c003db3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_58002d6f-b43e-465f-97f6-84e2c003db3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_95e78566-c86d-4985-8fff-551a4df18d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_95e78566-c86d-4985-8fff-551a4df18d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2265fe46-5fb3-4bbf-b7a8-91026edd7a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2265fe46-5fb3-4bbf-b7a8-91026edd7a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_0cc17724-8642-4241-9efd-075c14c5ef44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_0cc17724-8642-4241-9efd-075c14c5ef44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4bf888b3-e37a-4f92-ba11-51f4537d0e9b" xlink:href="lgnd-20210930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c8ad199b-2303-4b1b-9a33-997c4de2b444" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4bf888b3-e37a-4f92-ba11-51f4537d0e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ac95f04-3094-40cf-9abc-39e0fbac77b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_c3a0dca2-b222-4c94-9158-1e6c11f2124b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ac95f04-3094-40cf-9abc-39e0fbac77b4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_c3a0dca2-b222-4c94-9158-1e6c11f2124b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_465a7712-98ee-4788-a627-b0e9b0b5cb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_c3a0dca2-b222-4c94-9158-1e6c11f2124b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_465a7712-98ee-4788-a627-b0e9b0b5cb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_1f78fbaf-2fe2-47f0-8d59-6c1e2ba1a254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_c3a0dca2-b222-4c94-9158-1e6c11f2124b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_1f78fbaf-2fe2-47f0-8d59-6c1e2ba1a254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_cb6b55ef-b1e8-44ed-a398-d830e2139e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_c3a0dca2-b222-4c94-9158-1e6c11f2124b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_cb6b55ef-b1e8-44ed-a398-d830e2139e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e824e239-229f-4c6d-b2d6-ab59ac2761f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ac95f04-3094-40cf-9abc-39e0fbac77b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e824e239-229f-4c6d-b2d6-ab59ac2761f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_4774bddb-30ee-411d-ad87-219135326ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e824e239-229f-4c6d-b2d6-ab59ac2761f2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_4774bddb-30ee-411d-ad87-219135326ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_e824291b-5131-48eb-9c7a-489a61e00df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e824e239-229f-4c6d-b2d6-ab59ac2761f2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_e824291b-5131-48eb-9c7a-489a61e00df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d21acfa4-cd10-4e34-9aeb-605ebe72cd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_e824e239-229f-4c6d-b2d6-ab59ac2761f2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d21acfa4-cd10-4e34-9aeb-605ebe72cd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe956dea-1b9b-4337-94a0-8b81e74ea6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe956dea-1b9b-4337-94a0-8b81e74ea6eb" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3bd9d81a-d4f3-4e86-89cb-8fd015795eef" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_9f7a25bc-0746-4425-8818-5287ab4bffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_PatentedTechnologyMember_9f7a25bc-0746-4425-8818-5287ab4bffd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_090e5489-ac7e-4240-841b-a98e902af134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_TradeNamesMember_090e5489-ac7e-4240-841b-a98e902af134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_752ed907-1b26-47e6-b7f6-9f7f3325dd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_752ed907-1b26-47e6-b7f6-9f7f3325dd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_0aa860e1-29bd-4070-9538-7cc54a27ec6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_ContractualRightsMember_0aa860e1-29bd-4070-9538-7cc54a27ec6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_abe2c0c8-e906-476c-947b-0d98eadb60f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_522f4dbe-5717-4dff-8df6-72b5a0fb9bc7" xlink:to="loc_us-gaap_LicensingAgreementsMember_abe2c0c8-e906-476c-947b-0d98eadb60f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_483ed2d6-8250-41b1-b11a-d046d8533695" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3efee967-df68-45a6-a8bb-285aa3ee6bcd" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_77de7843-2b75-435c-8bcf-56a5a4271de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_Goodwill_77de7843-2b75-435c-8bcf-56a5a4271de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2a393626-3e84-4fd4-82c6-063f63cb2c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2a393626-3e84-4fd4-82c6-063f63cb2c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_beac8657-932d-40cb-bae7-6f3b4e97e151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_beac8657-932d-40cb-bae7-6f3b4e97e151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_e5965bbd-c3db-4f2b-9848-afd458b83244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_e528f767-d0e9-46d8-92bb-f04f684169f9" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_e5965bbd-c3db-4f2b-9848-afd458b83244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_895a4268-fec7-4aa2-95e7-229362aa5fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_895a4268-fec7-4aa2-95e7-229362aa5fc3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_04b9bc48-f863-46e0-ab59-764809e5f2f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_c54e607e-5ff4-4bc3-9fea-ec39b3089901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b2b454a-09e2-4359-8871-76c762b3efdb" xlink:to="loc_us-gaap_LicensingAgreementsMember_c54e607e-5ff4-4bc3-9fea-ec39b3089901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9689b72e-a895-408e-8ed7-27e160c35dde" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:href="lgnd-20210930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c470a5a9-6f36-432d-8880-d32bdf97d459" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0d21dea-814e-4416-8201-39b02aa8ac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d0d21dea-814e-4416-8201-39b02aa8ac7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7815f6b6-53b7-4ce6-949b-7c970b0a04c8" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_7815f6b6-53b7-4ce6-949b-7c970b0a04c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7729a5c2-19e6-43b9-bda4-d1ca3702e572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7729a5c2-19e6-43b9-bda4-d1ca3702e572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322b375a-ba40-4c32-8585-97569bb270b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322b375a-ba40-4c32-8585-97569bb270b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0f9ec0c9-a649-4c21-ad1a-de4c979f9d28" xlink:href="lgnd-20210930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_95d2af69-97ac-4867-81d2-05141f265302" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_0f9ec0c9-a649-4c21-ad1a-de4c979f9d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0766b405-512a-419e-ba66-f5d37289a1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0766b405-512a-419e-ba66-f5d37289a1f7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ff1f4ed6-6eeb-466d-a119-ab8350876207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ff1f4ed6-6eeb-466d-a119-ab8350876207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_3ec74b7b-5ada-4a8c-b579-d098764ce237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_3ec74b7b-5ada-4a8c-b579-d098764ce237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_ed5b4e33-9fd4-43a1-a210-f26227903cc7" xlink:href="lgnd-20210930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_lgnd_LicenseeAccrualCurrent_ed5b4e33-9fd4-43a1-a210-f26227903cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_37f09f76-29d5-4c1a-bb8d-25d83483064d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_37f09f76-29d5-4c1a-bb8d-25d83483064d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_4b79d2c6-f6a7-4bd7-ac36-d44e3ec0f1ec" xlink:href="lgnd-20210930.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_lgnd_ReturnsAccrual_4b79d2c6-f6a7-4bd7-ac36-d44e3ec0f1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_0d947691-8b27-4c45-b620-86705a8286e1" xlink:href="lgnd-20210930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_0d947691-8b27-4c45-b620-86705a8286e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_51dcd46f-d86f-4609-8c35-9f41c27e7942" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_51dcd46f-d86f-4609-8c35-9f41c27e7942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_cf43da50-6ef4-4f62-885a-bff6635d0d44" xlink:href="lgnd-20210930.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_cf43da50-6ef4-4f62-885a-bff6635d0d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_b6865849-7310-44db-aa6d-9a27e7c4d4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_InterestPayableCurrent_b6865849-7310-44db-aa6d-9a27e7c4d4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa10213e-f3ea-48aa-86cc-e20424545279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa10213e-f3ea-48aa-86cc-e20424545279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_70cc681a-ed66-4a4b-98e0-0cbe9fee45ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_2aab0e02-0167-4634-8360-1ef9aa96845a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_70cc681a-ed66-4a4b-98e0-0cbe9fee45ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_df79eda0-93a1-42d9-b8f4-c00a98c84eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_df79eda0-93a1-42d9-b8f4-c00a98c84eee" xlink:to="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_abb4cd4f-0926-491f-a70f-9e3f02e30efd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6eb7dc59-d970-42af-848c-476bf5661b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6eb7dc59-d970-42af-848c-476bf5661b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3eac4f95-2326-43b2-9ef0-f0382c8f96a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56dbf3bf-c3dd-4b1a-a1ad-e8b13c4aa8e1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3eac4f95-2326-43b2-9ef0-f0382c8f96a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:href="lgnd-20210930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_09b36783-10b0-42d9-ad54-093704bf1a19" xlink:to="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3db5932e-4114-49d6-8dca-758af5abeed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_48e7c37c-22bd-4c89-a4b6-c472ae294a2e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3db5932e-4114-49d6-8dca-758af5abeed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a094554b-946e-4302-b190-aae98c915207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6e696776-dd3f-45e5-ba76-f4936f6d98f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a094554b-946e-4302-b190-aae98c915207" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6e696776-dd3f-45e5-ba76-f4936f6d98f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_be87d973-f301-4761-8473-55892ceaa1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a094554b-946e-4302-b190-aae98c915207" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_be87d973-f301-4761-8473-55892ceaa1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b37d2ba0-3448-478e-bc07-4d418c778b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a094554b-946e-4302-b190-aae98c915207" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b37d2ba0-3448-478e-bc07-4d418c778b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9ba2f548-339f-4bb4-bac5-10a4b273295c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a094554b-946e-4302-b190-aae98c915207" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9ba2f548-339f-4bb4-bac5-10a4b273295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1d52b96-6225-48ba-aed7-5e07de17882a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1f793759-7fb6-4024-862d-7dfee27d2018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1d52b96-6225-48ba-aed7-5e07de17882a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1f793759-7fb6-4024-862d-7dfee27d2018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8103d4da-45bc-4fed-bbb1-3d8fb3d847bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1f793759-7fb6-4024-862d-7dfee27d2018" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8103d4da-45bc-4fed-bbb1-3d8fb3d847bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_93f83ee2-c4b0-4ad2-b30b-07294583459a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1f793759-7fb6-4024-862d-7dfee27d2018" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_93f83ee2-c4b0-4ad2-b30b-07294583459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_f6af5ddc-9e72-4e0d-bdc3-070dd974654a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_93f83ee2-c4b0-4ad2-b30b-07294583459a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_f6af5ddc-9e72-4e0d-bdc3-070dd974654a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ba16167e-cef9-45ca-9540-c0f20530a5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_93f83ee2-c4b0-4ad2-b30b-07294583459a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ba16167e-cef9-45ca-9540-c0f20530a5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9ffed6b-517f-46ff-b947-0a3923d435d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_93f83ee2-c4b0-4ad2-b30b-07294583459a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9ffed6b-517f-46ff-b947-0a3923d435d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c8d9277f-f176-4c98-8534-b4cf97818517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1f793759-7fb6-4024-862d-7dfee27d2018" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c8d9277f-f176-4c98-8534-b4cf97818517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_747d2dcb-7252-4993-9ec0-95fed012a7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_30550249-1cc6-4516-b12f-1b1d6fe68f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_747d2dcb-7252-4993-9ec0-95fed012a7f0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_30550249-1cc6-4516-b12f-1b1d6fe68f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cb3ef468-ca3e-4552-b3a3-ab8928242341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7c625e1b-7afb-4028-bc15-1420ee1645f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb3ef468-ca3e-4552-b3a3-ab8928242341" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7c625e1b-7afb-4028-bc15-1420ee1645f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_eac4494a-5f27-4fa0-9fe0-5b283e56c1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cb3ef468-ca3e-4552-b3a3-ab8928242341" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_eac4494a-5f27-4fa0-9fe0-5b283e56c1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_57732cfa-66f0-46ea-97a1-3913c18ff99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_57732cfa-66f0-46ea-97a1-3913c18ff99b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_efa3f223-0d8d-4e18-ad35-e6555440a0aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_955e2d7a-0aa0-46a4-9ce2-531fb3008bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e999c3c9-544c-4284-9044-708acf2be923" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_955e2d7a-0aa0-46a4-9ce2-531fb3008bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83fce496-3225-4fe6-8af2-87c227195083" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3a59368b-5892-4f66-b04f-0d54815e1879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3a59368b-5892-4f66-b04f-0d54815e1879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2487e4ae-5c27-4848-883b-94abd81f7b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2487e4ae-5c27-4848-883b-94abd81f7b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_25875e85-6506-4b6a-b78d-77e1e94f7564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_766ff82b-bf70-4084-b736-5b90579a2a25" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_25875e85-6506-4b6a-b78d-77e1e94f7564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b867c458-7605-4983-a8f1-fcbafeff3b00" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_a34e6bab-c60d-4afd-9368-4967129ef180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_a34e6bab-c60d-4afd-9368-4967129ef180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_49668717-31a2-4c90-9c23-039cb60377e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_EquitySecuritiesMember_49668717-31a2-4c90-9c23-039cb60377e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_23478767-d193-4397-bea9-fa8cd09f8519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bb899648-874c-4076-9007-c8c4d9e24bbf" xlink:to="loc_us-gaap_WarrantMember_23478767-d193-4397-bea9-fa8cd09f8519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_929a6312-e0d6-4bcc-a199-01859339c7a8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_6888a051-b406-4e18-8bdd-a2640cd95887" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCrystalMember_6888a051-b406-4e18-8bdd-a2640cd95887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_49687364-25e6-40e0-a46c-9eda4d4b72a0" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_49687364-25e6-40e0-a46c-9eda4d4b72a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_0632e252-2cc6-476f-a5fc-1b0d42decf0e" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_0632e252-2cc6-476f-a5fc-1b0d42decf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_63d612a1-7945-4585-866a-32373212422c" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_63d612a1-7945-4585-866a-32373212422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_b234faa6-f437-4048-a98c-2908afa21c2b" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_b234faa6-f437-4048-a98c-2908afa21c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f3e5283b-2d1d-455d-9276-3aa82e0cbf17" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f3e5283b-2d1d-455d-9276-3aa82e0cbf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_119fbbcb-b0b7-419f-b9ef-5fcf75d9c542" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2d4c100e-89ce-4b3e-9c4d-ba5e245fd43c" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_119fbbcb-b0b7-419f-b9ef-5fcf75d9c542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0816c0ac-1edb-4935-9bdd-83d8df404415" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_ce7c1953-fd4b-448f-9474-509ed845f601" xlink:href="lgnd-20210930.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:to="loc_lgnd_MetabasisMember_ce7c1953-fd4b-448f-9474-509ed845f601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_5bb6f40d-036a-4ba1-ad5a-21de42ccb15a" xlink:href="lgnd-20210930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8025539-1014-46ad-a8a5-fa3de6d9dab7" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_5bb6f40d-036a-4ba1-ad5a-21de42ccb15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4892cbe5-9ca5-43a7-a7ac-c968044ee96f" xlink:to="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f12506c9-6c44-4011-903f-a08638d1b28b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ffb0446-45d9-4ee9-9fed-9078631d4c3f" xlink:to="loc_srt_MaximumMember_f12506c9-6c44-4011-903f-a08638d1b28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ae9bf6fa-e26c-414e-8bf6-f9fe9fa4cdf1" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_60a4bb4a-b78c-4b2e-94e9-7e717279ed4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c6e26e9b-9751-4135-bbd7-d23fccb0d118" xlink:to="loc_us-gaap_TransferredOverTimeMember_60a4bb4a-b78c-4b2e-94e9-7e717279ed4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_89353e9d-ed6b-48be-9645-d7121133c6b9" xlink:to="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_1ac18c9b-e335-4bd1-b9a4-6e18fe9003fc" xlink:href="lgnd-20210930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_1ac18c9b-e335-4bd1-b9a4-6e18fe9003fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_3a835838-423a-4011-a8c9-8e4ec056c8c5" xlink:href="lgnd-20210930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_75a5b13e-b9cd-4565-ab31-591c51c3a631" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_3a835838-423a-4011-a8c9-8e4ec056c8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_eac7043e-58f5-43e6-bbe7-d37d52779de9" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_29524527-5463-43e9-b0e6-4bb550ea076f" xlink:href="lgnd-20210930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a40a2c6f-17a0-4c91-8373-71eb70b82243" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_29524527-5463-43e9-b0e6-4bb550ea076f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_bc20a918-b153-46ad-b302-30ed4f0c6b34" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ef2dfac5-057d-4aaf-a64a-2f3fc1139e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ef2dfac5-057d-4aaf-a64a-2f3fc1139e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_24d6aa97-1c30-4d62-8729-6da6d40bf770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_24d6aa97-1c30-4d62-8729-6da6d40bf770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_48f2fd90-8e8c-4a75-8b2e-7ab64c2918e2" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_48f2fd90-8e8c-4a75-8b2e-7ab64c2918e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f76b74e6-8f9c-4082-8ac2-f9f8617a2aab" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f76b74e6-8f9c-4082-8ac2-f9f8617a2aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_04ab6871-b4b4-4aa3-98b2-596b5fcefb8c" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_04ab6871-b4b4-4aa3-98b2-596b5fcefb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_309357bf-9c35-401f-b663-0e6ee7ada0b2" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_309357bf-9c35-401f-b663-0e6ee7ada0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_0f14f42e-210a-4166-86c7-31da2a5a2df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_Investments_0f14f42e-210a-4166-86c7-31da2a5a2df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_a2544f85-e031-4a47-b2d0-b944a494f19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_a2544f85-e031-4a47-b2d0-b944a494f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_227886c5-31de-4b70-a844-5d5cb5f2fd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_227886c5-31de-4b70-a844-5d5cb5f2fd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_14b3b90a-ee0c-4382-9388-3875266bf0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_14b3b90a-ee0c-4382-9388-3875266bf0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_be638d4f-d15a-4bdf-804b-01ab6a9013ae" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6da48ae2-f8e0-4bee-97a2-e996e4a3d74d" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_be638d4f-d15a-4bdf-804b-01ab6a9013ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0f9d610b-37ee-45b0-87a6-9b849081428f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0f9d610b-37ee-45b0-87a6-9b849081428f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_075afc35-d52f-44a9-966d-d7854b3a8015" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6db3f70b-dcaa-48b9-977b-2f0d2a3292f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cd820beb-326f-4514-aec0-23e01c0a6141" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6db3f70b-dcaa-48b9-977b-2f0d2a3292f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd1f68c3-2a32-41d8-aba0-95a3ba63ae58" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_161bc1e7-d19b-48b8-90b2-cc4f0edcd318" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c361b8f5-ad58-4b96-a20e-3d04cd425bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c361b8f5-ad58-4b96-a20e-3d04cd425bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_052011bb-8484-45e8-b2f7-353ac73d99f8" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_052011bb-8484-45e8-b2f7-353ac73d99f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d96cbd0b-8e20-4200-9fc1-eeafa966e6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d96cbd0b-8e20-4200-9fc1-eeafa966e6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_4337717a-dd7f-436c-9841-52f6ec639626" xlink:href="lgnd-20210930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_4337717a-dd7f-436c-9841-52f6ec639626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0da8af7e-93a4-4a4b-a8d7-b19487637842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8da6e4c1-956c-4924-83cd-ab44e7e222bd" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0da8af7e-93a4-4a4b-a8d7-b19487637842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20210930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_746e4c30-aaa0-444f-980e-acff8547fbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16bc0fbc-192a-4d2e-8cc9-f352e4c5a0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_746e4c30-aaa0-444f-980e-acff8547fbe7" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16bc0fbc-192a-4d2e-8cc9-f352e4c5a0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cfaf90df-76db-44fc-beca-c69869e57b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ff38d0ec-4bdd-4795-bcf0-f9f87535c327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cfaf90df-76db-44fc-beca-c69869e57b9d" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ff38d0ec-4bdd-4795-bcf0-f9f87535c327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ebae9a44-e790-48e7-8140-1e3bd7722b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cfaf90df-76db-44fc-beca-c69869e57b9d" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ebae9a44-e790-48e7-8140-1e3bd7722b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4c4cccb5-c442-4df5-a4aa-25ad52124ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4c4cccb5-c442-4df5-a4aa-25ad52124ba2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9e01c156-27a0-4282-aa2e-ba1bae8fa257" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_fa9b409f-9b71-414d-8732-6519dd204700" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_PfenexMember_fa9b409f-9b71-414d-8732-6519dd204700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_77f12c72-9f2c-4314-8ec1-b7906832a63c" xlink:href="lgnd-20210930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_77f12c72-9f2c-4314-8ec1-b7906832a63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_ecb902ae-2346-4edd-8bfa-edcb6a40c6f0" xlink:href="lgnd-20210930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_ecb902ae-2346-4edd-8bfa-edcb6a40c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_d5e27c2f-46a7-45d7-b98a-297dfcfe8ead" xlink:href="lgnd-20210930.xsd#lgnd_IcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3271ff8a-ad1a-4075-b9dd-aa27875662fb" xlink:to="loc_lgnd_IcagenMember_d5e27c2f-46a7-45d7-b98a-297dfcfe8ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_10547e91-8add-4065-8304-b1248c96c29a" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_587444f0-ff72-466c-8f77-ead2bef42901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_50b3d5a4-f086-4dd8-838b-c503c7a28b39" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_587444f0-ff72-466c-8f77-ead2bef42901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bae958a6-f6f0-42ee-8700-c15b312a2246" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_6a7b6e14-fac1-46e9-8494-712551306f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_ContractualRightsMember_6a7b6e14-fac1-46e9-8494-712551306f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e6c5046a-0b08-4b7e-8834-4e0ce28ed7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_e6c5046a-0b08-4b7e-8834-4e0ce28ed7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_bb3e1767-d2f6-47ff-9ad8-95f47d54a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e6a6c64-54ac-4ea7-8a4a-e69e7d6c85ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_bb3e1767-d2f6-47ff-9ad8-95f47d54a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_320c4cc6-cc4e-4fc1-90bc-722748015e83" xlink:to="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4fbf91d-2657-47f7-973d-855d594c7a48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:to="loc_srt_MinimumMember_e4fbf91d-2657-47f7-973d-855d594c7a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e3b00296-c48e-48da-acbb-477474d65cb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d86c8379-9f6b-4072-bb94-a09e901e623e" xlink:to="loc_srt_MaximumMember_e3b00296-c48e-48da-acbb-477474d65cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_c38be2a2-dcd3-4c87-b80b-a8781b97f028" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_5c7cc774-4ad3-418d-9eba-635842231b3a" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_5c7cc774-4ad3-418d-9eba-635842231b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_7f63af44-8e97-4055-b345-9ee425c5f7c5" xlink:href="lgnd-20210930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_7f63af44-8e97-4055-b345-9ee425c5f7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_812fd02c-15da-42c0-8e64-8194bbb82f9d" xlink:href="lgnd-20210930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_812fd02c-15da-42c0-8e64-8194bbb82f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_f7031b58-eb2b-43f2-a8bf-fc4684b8f38b" xlink:href="lgnd-20210930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_08398eb3-d276-4d00-a09c-f302731dd680" xlink:to="loc_lgnd_MilestonePaymentsMember_f7031b58-eb2b-43f2-a8bf-fc4684b8f38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b037a6bb-8d36-4578-a62c-7ac62e61743d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_60dbc1c5-cd8c-457a-b515-d27499b21e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_60dbc1c5-cd8c-457a-b515-d27499b21e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_90b726d5-22ce-42c2-9994-fc50be2e9ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_90b726d5-22ce-42c2-9994-fc50be2e9ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eea95896-66c0-427a-886a-dba406797ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eea95896-66c0-427a-886a-dba406797ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_36ad3b6d-2aab-45f0-b2c0-dde91f5dc844" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_36ad3b6d-2aab-45f0-b2c0-dde91f5dc844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_8274c329-2cc2-4d33-a5a3-cbf4d72b15c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_8274c329-2cc2-4d33-a5a3-cbf4d72b15c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_17916239-37ef-4d5d-b581-147941c16abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_17916239-37ef-4d5d-b581-147941c16abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_f0c3d95a-87b9-4391-b89d-38244477e4b2" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions_f0c3d95a-87b9-4391-b89d-38244477e4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_feb95f47-a4a2-4b6a-ad04-e87b0e9c8877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_feb95f47-a4a2-4b6a-ad04-e87b0e9c8877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6ae95c6b-0240-4816-a78d-683aabc5e48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6ae95c6b-0240-4816-a78d-683aabc5e48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_befca409-8ea2-4279-aaec-c8d06fdeecde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_befca409-8ea2-4279-aaec-c8d06fdeecde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_5620a4a6-e8e9-41a9-bd79-ec31f06419d0" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_5620a4a6-e8e9-41a9-bd79-ec31f06419d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_163591c1-ac7f-427f-b580-92055b99f08e" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_163591c1-ac7f-427f-b580-92055b99f08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_d972fc8e-f536-41a7-a1d5-8dc6fd8f3418" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_d972fc8e-f536-41a7-a1d5-8dc6fd8f3418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_02c01c84-e424-4557-9f67-5edf123bc887" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_02c01c84-e424-4557-9f67-5edf123bc887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5731a0e0-c709-46a4-888c-e857071fd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5731a0e0-c709-46a4-888c-e857071fd2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9fae3119-a232-4e2f-b928-327b34e263e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_9fae3119-a232-4e2f-b928-327b34e263e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_f6511cf8-ddda-41b7-b344-ff4bc43c32de" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_f6511cf8-ddda-41b7-b344-ff4bc43c32de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0292b2e-1083-4453-8987-b9d0aa4eeef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0292b2e-1083-4453-8987-b9d0aa4eeef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0c52e0f5-d496-451a-91a8-5efb9baf1395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0c52e0f5-d496-451a-91a8-5efb9baf1395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b6bb6b58-9da2-4a29-9913-b29aae07a057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_b6bb6b58-9da2-4a29-9913-b29aae07a057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_07f10c9c-f608-48ce-9392-c3a3a364364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bce6bf94-3f95-4f94-9f0b-d214ae9b4908" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_07f10c9c-f608-48ce-9392-c3a3a364364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3985683c-e40b-4fdd-9d46-c8c4e3d66406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3985683c-e40b-4fdd-9d46-c8c4e3d66406" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_35b08839-5e6b-46f3-bdad-fd3c5576e279" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_5929e5c5-2404-4f6a-a01c-404b8a7c42e3" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ea0c00b-bcb8-43b7-9d8c-ae0b3d9a72ba" xlink:to="loc_lgnd_PfenexMember_5929e5c5-2404-4f6a-a01c-404b8a7c42e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_79a3aca9-129c-4832-8bed-5558215eebd6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ab3d3ea3-6427-4208-ace2-aa6d33076c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ab3d3ea3-6427-4208-ace2-aa6d33076c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_d4f6971e-ba4c-4491-900a-d1e1ddce476f" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_d4f6971e-ba4c-4491-900a-d1e1ddce476f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9a1fdf70-570e-48f1-8a7c-e3790ef039e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_9a1fdf70-570e-48f1-8a7c-e3790ef039e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f6c88f76-3880-45e6-920b-48fcce8b1242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f6c88f76-3880-45e6-920b-48fcce8b1242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_55691295-80f2-4863-9dbe-98410851f0a6" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_55691295-80f2-4863-9dbe-98410851f0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f02c905c-e60f-4337-8157-59aa745302e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f02c905c-e60f-4337-8157-59aa745302e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e65235a2-bb5e-4e4f-bc0f-083b47c31a64" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets_e65235a2-bb5e-4e4f-bc0f-083b47c31a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17e922d0-7ba1-474b-82db-3144b96d2ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_Goodwill_17e922d0-7ba1-474b-82db-3144b96d2ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_afb2f646-8c1a-4b4c-9cd9-bb1bde0ff718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_afb2f646-8c1a-4b4c-9cd9-bb1bde0ff718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_5d823729-9a28-4c53-8bf8-59fa6d1de21d" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_5d823729-9a28-4c53-8bf8-59fa6d1de21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_cba5a16f-80af-469f-ba76-a4456d56c6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_cba5a16f-80af-469f-ba76-a4456d56c6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_459e8847-8ac2-4b19-9d25-666c793b9945" xlink:href="lgnd-20210930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities_459e8847-8ac2-4b19-9d25-666c793b9945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_30318f7c-bf8b-4bf9-ad40-88df012a698d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_30318f7c-bf8b-4bf9-ad40-88df012a698d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_86fc3b4a-bf0c-4c7f-9cf9-4766d580c069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_86fc3b4a-bf0c-4c7f-9cf9-4766d580c069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7552fbaf-c72b-42ea-8df4-e8e938592246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_7552fbaf-c72b-42ea-8df4-e8e938592246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3717e184-6dcd-4de6-9a84-c4553e2c9e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_091546c7-9d46-466b-b82e-22f6054599e6" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3717e184-6dcd-4de6-9a84-c4553e2c9e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#AcquisitionsProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_40bf0f35-5582-4df4-8ddd-76fe98e2794f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_40bf0f35-5582-4df4-8ddd-76fe98e2794f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe8f2424-03c3-48dc-a0b0-f6b4299b5cd9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_94c82d5c-617d-4742-b5c0-648b130d209e" xlink:href="lgnd-20210930.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1afd5dce-bb32-443b-827f-9ce799fe3386" xlink:to="loc_lgnd_PfenexMember_94c82d5c-617d-4742-b5c0-648b130d209e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_08f1d923-b4c6-40b6-8129-5c3d2efdba2d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_5cb48da2-0d11-407c-b4b2-7925d4b748f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_5cb48da2-0d11-407c-b4b2-7925d4b748f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_de5c38ad-e655-42a1-bb07-eaa305f5d74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_de5c38ad-e655-42a1-bb07-eaa305f5d74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareProFormaAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b923ed63-e72e-4bbd-abf2-6748c55d0a8f" xlink:to="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_2f631bcc-0123-4f81-a240-6f315ee35874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_2f631bcc-0123-4f81-a240-6f315ee35874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_e23ade9f-dc32-4a56-b817-f82d2ff1ab8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareProFormaAbstract_48b2e0f0-a430-43c2-abec-790a5d73d87c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_e23ade9f-dc32-4a56-b817-f82d2ff1ab8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_583637d0-3702-42c8-bc78-5e6f4cedca55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_4c5026ee-7aa8-47f6-a24e-56049c4c24e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_583637d0-3702-42c8-bc78-5e6f4cedca55" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_4c5026ee-7aa8-47f6-a24e-56049c4c24e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e99532db-1f7a-40ec-aad3-af20d3eff352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_f7355648-6684-464b-9bf2-e8c44137be69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e99532db-1f7a-40ec-aad3-af20d3eff352" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_f7355648-6684-464b-9bf2-e8c44137be69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_350cbb2b-f0d2-4f56-a4a6-4039fd26d818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_350cbb2b-f0d2-4f56-a4a6-4039fd26d818" xlink:to="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fde79787-326d-420d-883c-74001c04c84f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_6809a792-127f-45f9-b66e-14ab7090b888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4e81f61a-ff75-48ec-82bd-9104c934457c" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_6809a792-127f-45f9-b66e-14ab7090b888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_14a2c520-9551-4360-89de-5890b9f35c26" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_514d6141-dd72-4e10-8e41-06c8fd844381" xlink:href="lgnd-20210930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1170a7fc-86ec-4f52-8262-a76e566048f4" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_514d6141-dd72-4e10-8e41-06c8fd844381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_94723721-129f-42c8-924d-0e4ec8f1dc5a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3f297934-815c-477e-bcb6-0546b89d8e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3f297934-815c-477e-bcb6-0546b89d8e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ac34927b-cd28-413f-8be2-8f3348815465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a72e0df-6f9d-432d-bbc0-9b6a263a9998" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ac34927b-cd28-413f-8be2-8f3348815465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_26ce5665-37c0-4f10-b5fc-196128e5c197" xlink:to="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_bfec4da9-c462-4d75-9c13-1ffce0a3f3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_bfec4da9-c462-4d75-9c13-1ffce0a3f3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c36eeb88-a36e-454f-b726-d1713b9d076a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c36eeb88-a36e-454f-b726-d1713b9d076a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c9294440-6aeb-4c44-8320-c4534767d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c9294440-6aeb-4c44-8320-c4534767d7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4607fa9d-3bb8-4deb-8cbd-5c2f75c590eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4607fa9d-3bb8-4deb-8cbd-5c2f75c590eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_996d7968-d858-43de-b4fa-c35558e51c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_996d7968-d858-43de-b4fa-c35558e51c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_79f2b463-2e26-4df0-a950-4b7925205752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_79f2b463-2e26-4df0-a950-4b7925205752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_07f95928-6d6e-4591-b417-60e6dd96e35c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_07f95928-6d6e-4591-b417-60e6dd96e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b78582ce-a100-434f-ac11-e189d14569e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b78582ce-a100-434f-ac11-e189d14569e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_27e55208-ddbe-4a33-8aff-e80534ba629b" xlink:href="lgnd-20210930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_27e55208-ddbe-4a33-8aff-e80534ba629b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_a1b5a55d-00a5-46cb-9060-9b389beb8cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_a1b5a55d-00a5-46cb-9060-9b389beb8cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_830b81d9-45ff-40e3-b6ba-d7d012b6391d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_830b81d9-45ff-40e3-b6ba-d7d012b6391d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_69909334-4b0f-4b23-8ab1-83d1d94ed5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_69909334-4b0f-4b23-8ab1-83d1d94ed5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_2ad1cbd6-71f6-432a-86ec-af6658c2a01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_2ad1cbd6-71f6-432a-86ec-af6658c2a01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_8b044605-6d1a-4f43-bf0b-eda23c3df950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_8b044605-6d1a-4f43-bf0b-eda23c3df950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a9616a75-959c-4c4c-82c8-79118524701e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a9616a75-959c-4c4c-82c8-79118524701e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_11efd1ae-653c-438e-8d79-d03d47f4eebc" xlink:href="lgnd-20210930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_11efd1ae-653c-438e-8d79-d03d47f4eebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0114a368-55f0-47d4-9b40-66c4124b0202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0114a368-55f0-47d4-9b40-66c4124b0202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_708e3291-24b3-48c8-b3f9-c16f5b52175f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_708e3291-24b3-48c8-b3f9-c16f5b52175f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_f2133d50-4487-4299-a13c-29d168ad6dde" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_f2133d50-4487-4299-a13c-29d168ad6dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bd6a9491-d53c-4f9d-9604-9abe7d3881a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bd6a9491-d53c-4f9d-9604-9abe7d3881a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_85b351dc-c959-4007-bd15-19885411430b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_85b351dc-c959-4007-bd15-19885411430b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_1f728c50-c252-45b4-8813-df29e359874e" xlink:href="lgnd-20210930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_1f728c50-c252-45b4-8813-df29e359874e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_a713f923-7635-4515-8d2f-27a92093a242" xlink:href="lgnd-20210930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_a713f923-7635-4515-8d2f-27a92093a242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_fcef5608-98b2-449a-9d75-51618ef6d2bc" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08e05dc5-6a11-47d6-afca-50dc852994a1" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_fcef5608-98b2-449a-9d75-51618ef6d2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a8e7863f-b47b-4cca-9e03-b6f4bfeb3332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a8e7863f-b47b-4cca-9e03-b6f4bfeb3332" xlink:to="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2b4d51db-338e-4da1-9640-ab0dce166594" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_e19e8c8d-1b0f-4bbf-8625-de5f612cf942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9efffb27-65af-4f0c-81e8-96e407155700" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_e19e8c8d-1b0f-4bbf-8625-de5f612cf942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:to="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_75112c8c-75a0-45a5-9e19-6aaf1ae0f461" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_fd3f41af-9177-44aa-9246-248504a66ac2" xlink:href="lgnd-20210930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4dead33c-bc37-4480-b635-e7b9ee7f6498" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_fd3f41af-9177-44aa-9246-248504a66ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f49c1c50-41bd-4ed4-b125-13accdaa6cc0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_47141075-8073-4795-bd2c-40f255345805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_47141075-8073-4795-bd2c-40f255345805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_799b49ca-b972-4161-bd01-e3b648b1dbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_799b49ca-b972-4161-bd01-e3b648b1dbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_c623249b-ca7f-485b-959d-97d1f385663a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_6241f310-8566-4cad-b3e9-f859a7d982d4" xlink:to="loc_us-gaap_LongTermNotesPayable_c623249b-ca7f-485b-959d-97d1f385663a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_5042746b-25a0-4ff9-817b-59bcb31d28e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_5042746b-25a0-4ff9-817b-59bcb31d28e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_f46fad0f-8f4a-4369-b064-505e5c84ccce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44ef64bd-3e70-4e1b-aa71-5923edc653ca" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_f46fad0f-8f4a-4369-b064-505e5c84ccce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20210930.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_121f9e1a-11bf-4f15-a398-7ec58202c8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b9ad5c25-33ec-4da1-a279-a03a45a7c8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_121f9e1a-11bf-4f15-a398-7ec58202c8a6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b9ad5c25-33ec-4da1-a279-a03a45a7c8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_caca46d3-02c5-46d4-89c8-aef50d986b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_caca46d3-02c5-46d4-89c8-aef50d986b76" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_50bf53be-0c01-4baf-97d4-0bc640af37e3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_5803d815-a9f0-48bc-876f-eb7c2fae20dd" xlink:href="lgnd-20210930.xsd#lgnd_LiabilityForContingentValueRightsCompanyPfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_08f95630-a8aa-4712-b28e-f846161d104e" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyPfenexMember_5803d815-a9f0-48bc-876f-eb7c2fae20dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_a4242990-87de-4315-8c37-fe9ea1da69e9" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f308275c-2cee-4edf-bdd0-a2e2952efcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f308275c-2cee-4edf-bdd0-a2e2952efcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dfe1d1f6-63f5-4ea4-a82e-80132a76db13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_f9550f23-cf1f-490a-97e2-fa3bed3e7bdc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dfe1d1f6-63f5-4ea4-a82e-80132a76db13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ecad058-0b5d-4b7b-9f6b-31fc3b7af657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3d1b6bd2-0498-4378-b25f-bfc39a532f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ecad058-0b5d-4b7b-9f6b-31fc3b7af657" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3d1b6bd2-0498-4378-b25f-bfc39a532f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8a82cf03-5fe1-40a9-9ac4-fda214565dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca5c2850-a192-4ae4-b3bd-ebba761b4dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8a82cf03-5fe1-40a9-9ac4-fda214565dbf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca5c2850-a192-4ae4-b3bd-ebba761b4dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_6aaf71da-0031-49e1-ab74-d249cbdcf5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8a82cf03-5fe1-40a9-9ac4-fda214565dbf" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_6aaf71da-0031-49e1-ab74-d249cbdcf5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_689f3ff9-34c2-468b-a0bd-7a69e316f57f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_689f3ff9-34c2-468b-a0bd-7a69e316f57f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:to="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c15c0f2d-a6f8-4719-8344-c1350f88f2cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2eb2f97e-0f90-4175-8608-c3928c230b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2eb2f97e-0f90-4175-8608-c3928c230b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bdb9bba0-3bbb-47d6-8b7e-b27a4fc4de2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50779bb-1e0b-488e-ae76-de3e5f227982" xlink:to="loc_us-gaap_RestrictedStockMember_bdb9bba0-3bbb-47d6-8b7e-b27a4fc4de2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b87478a6-627b-471e-93bc-c0c7f98543d2" xlink:to="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d2f96f9e-ecb7-4d30-b07c-5f1c88861c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d2f96f9e-ecb7-4d30-b07c-5f1c88861c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a0587337-e802-4d04-b12f-589d76eace79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a0587337-e802-4d04-b12f-589d76eace79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31b31e95-f6f7-4bba-aef6-c757d7301a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_31b31e95-f6f7-4bba-aef6-c757d7301a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c13e0e2-631a-4877-814c-f46c8eb3e011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c13e0e2-631a-4877-814c-f46c8eb3e011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9359a7fa-df5e-45e4-9d3a-5cec49212e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_717aa6c7-9ba1-4d26-8cd3-169bdc848fd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9359a7fa-df5e-45e4-9d3a-5cec49212e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_192c10c2-adeb-49d6-8058-6c7dd211e608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_192c10c2-adeb-49d6-8058-6c7dd211e608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b64b6884-8117-45f4-946b-82bc6b27d42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b64b6884-8117-45f4-946b-82bc6b27d42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_573a7822-51ad-4299-8d51-33108dcbd671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_573a7822-51ad-4299-8d51-33108dcbd671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6747999f-1fc6-44a1-b73a-529644f11870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6747999f-1fc6-44a1-b73a-529644f11870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7a214353-74fc-445a-bacf-7fb65280978c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80b512ac-7165-4c56-8c00-5002e180a37b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7a214353-74fc-445a-bacf-7fb65280978c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c5b918-4681-4e48-9641-ec8a5d4d0be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c5b918-4681-4e48-9641-ec8a5d4d0be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ed162161-7517-4d7f-851e-72806f856154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ed162161-7517-4d7f-851e-72806f856154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6bacad63-c5c8-4cc4-ab60-d3304b93e165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6bacad63-c5c8-4cc4-ab60-d3304b93e165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f4aaa240-a874-426e-8869-a5df2b7f8c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f4aaa240-a874-426e-8869-a5df2b7f8c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bea4eaa2-8c19-4c4f-9935-6272e6a0cb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c5aa9c77-3cd9-4b6f-8c3b-0154241cdd1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bea4eaa2-8c19-4c4f-9935-6272e6a0cb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_031af229-112f-469f-a2c2-d7ad19f58595" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50a0e943-fd17-44c9-a09d-c7afaf36a34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50a0e943-fd17-44c9-a09d-c7afaf36a34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7f0d002-621d-4351-b609-242d1ee2e9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7f0d002-621d-4351-b609-242d1ee2e9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e3a837cf-6c6b-4a84-8ae6-609724d8d2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e3a837cf-6c6b-4a84-8ae6-609724d8d2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83aa5d9-0654-4c14-bdab-f1fe1bd00fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83aa5d9-0654-4c14-bdab-f1fe1bd00fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03c7d32a-9d26-4e96-8b50-b8fa01990b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_33c97677-053d-4a3c-acf2-24d0d62df667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_03c7d32a-9d26-4e96-8b50-b8fa01990b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c043f4a6-08fc-4a27-9ffc-d64609b43b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c043f4a6-08fc-4a27-9ffc-d64609b43b39" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:to="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0c5d3f4c-eccc-456c-81b4-1c3ac51103aa" xlink:to="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_234a3a32-57b5-4065-80ad-6997b153db5c" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e89f0853-81e7-49b9-9004-c4fb17ea6257" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_234a3a32-57b5-4065-80ad-6997b153db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1a9152c2-6d54-4d27-ade2-6024b98ab1aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_93cabb23-70bd-4a7e-a963-55c2b98db420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_93cabb23-70bd-4a7e-a963-55c2b98db420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_893dda74-d155-479c-a60c-5c6c15ace0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_893dda74-d155-479c-a60c-5c6c15ace0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:href="lgnd-20210930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_8032525f-db25-4836-a34d-80dd6f1ec430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_8032525f-db25-4836-a34d-80dd6f1ec430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_b97b7099-ac61-4ef7-86da-706073c6ca69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_f88bd2e3-6f17-409b-a285-1b183cc214ad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_b97b7099-ac61-4ef7-86da-706073c6ca69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_72a2e7d6-9a88-4498-8990-af27d6e2c615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_72a2e7d6-9a88-4498-8990-af27d6e2c615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ccb449b-b760-45af-a797-4705be949500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4ccb449b-b760-45af-a797-4705be949500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_a2da789a-819d-4aae-8828-65db75240c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_a2da789a-819d-4aae-8828-65db75240c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cce7c5a9-d91f-434b-8306-017d8e57338c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fea576cc-8c93-438f-ab58-55333200f587" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cce7c5a9-d91f-434b-8306-017d8e57338c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f504e309-e43d-4186-9243-d30687a06d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_427201c2-eb19-4c7e-93ae-964bb9e4fbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f504e309-e43d-4186-9243-d30687a06d92" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_427201c2-eb19-4c7e-93ae-964bb9e4fbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_646d05b3-9813-4b61-afb1-15da57f0f5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_646d05b3-9813-4b61-afb1-15da57f0f5bd" xlink:to="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:to="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_655ea732-1a39-49ea-a957-aa14705babb9" xlink:to="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_38e2f459-0bff-4a8c-b844-c8abcaf644a3" xlink:href="lgnd-20210930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d3609213-53e9-4fd5-9902-7be17767a558" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_38e2f459-0bff-4a8c-b844-c8abcaf644a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_528f3f94-531c-4684-93f8-146e7a31e196" xlink:to="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c8dbe80c-d757-479f-9c6b-a8e84f195ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_457fb7ea-8d82-4d27-bdec-78b7da996dff" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c8dbe80c-d757-479f-9c6b-a8e84f195ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20210930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_590f09a0-2168-48f0-9e25-f8caac86c465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5f386d6b-572e-4eb9-bb7b-0ccba61cd67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_590f09a0-2168-48f0-9e25-f8caac86c465" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5f386d6b-572e-4eb9-bb7b-0ccba61cd67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_d1e85942-4a3f-42c4-a8d3-03730561261d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_590f09a0-2168-48f0-9e25-f8caac86c465" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_d1e85942-4a3f-42c4-a8d3-03730561261d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesTables" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fddd3951-1296-4743-a2e3-83f1506cff28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_0fd3d830-d0fd-4938-9d9a-5f014d526b6d" xlink:href="lgnd-20210930.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fddd3951-1296-4743-a2e3-83f1506cff28" xlink:to="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_0fd3d830-d0fd-4938-9d9a-5f014d526b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_32fdfe5d-ba49-40ea-97d1-3010683f374c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fddd3951-1296-4743-a2e3-83f1506cff28" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_32fdfe5d-ba49-40ea-97d1-3010683f374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_36ddf454-d072-4ddf-bbc5-7e184054fe69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_36ddf454-d072-4ddf-bbc5-7e184054fe69" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:to="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bde6e61a-0b47-4c9c-9e7d-c37b084b6495" xlink:to="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_126443bb-e92b-4d95-a1dc-7bcf8631af40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7c5fff0-959d-4017-ad1c-5b87a6659a26" xlink:to="loc_srt_MaximumMember_126443bb-e92b-4d95-a1dc-7bcf8631af40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_81273d9b-cc38-45c5-abe1-1c11b206d8aa" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ce4a56fd-dd75-4a6f-90ae-0e76bd0a4199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ce4a56fd-dd75-4a6f-90ae-0e76bd0a4199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e07f8320-cef0-42f9-9b2e-7784936a83ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_e07f8320-cef0-42f9-9b2e-7784936a83ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cd75c9fc-da74-4368-96eb-7023a9bde6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cd75c9fc-da74-4368-96eb-7023a9bde6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityAdditions_a1f38c1c-a630-4934-bbfa-3ff98c2dadf4" xlink:href="lgnd-20210930.xsd#lgnd_OperatingLeaseLiabilityAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_765f11db-27c5-4903-960f-e0af9bba16e6" xlink:to="loc_lgnd_OperatingLeaseLiabilityAdditions_a1f38c1c-a630-4934-bbfa-3ff98c2dadf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6f9f0d7f-9ffc-4727-890a-4cf1eedbfe0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d1278661-7594-4280-af55-b0a044a6b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f9f0d7f-9ffc-4727-890a-4cf1eedbfe0f" xlink:to="loc_us-gaap_AssetsAbstract_d1278661-7594-4280-af55-b0a044a6b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e71d9f3-ca2d-4fe6-aea0-de2a8c0f57a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d1278661-7594-4280-af55-b0a044a6b6b7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1e71d9f3-ca2d-4fe6-aea0-de2a8c0f57a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_5ca7d149-015f-4d59-9fc1-a45bb4beee5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d1278661-7594-4280-af55-b0a044a6b6b7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_5ca7d149-015f-4d59-9fc1-a45bb4beee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_fa540941-ec83-4ce5-980a-147b222985c4" xlink:href="lgnd-20210930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d1278661-7594-4280-af55-b0a044a6b6b7" xlink:to="loc_lgnd_LeaseRightOfUseAsset_fa540941-ec83-4ce5-980a-147b222985c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_5fa04331-1489-4e9a-b773-6cad57470ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f9f0d7f-9ffc-4727-890a-4cf1eedbfe0f" xlink:to="loc_us-gaap_LiabilitiesAbstract_5fa04331-1489-4e9a-b773-6cad57470ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_bcaca62d-f623-4931-a6bd-125da0d0f737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5fa04331-1489-4e9a-b773-6cad57470ecc" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_bcaca62d-f623-4931-a6bd-125da0d0f737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_615fcb16-9978-4dca-82df-bd393ba10403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bcaca62d-f623-4931-a6bd-125da0d0f737" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_615fcb16-9978-4dca-82df-bd393ba10403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_46742750-f619-4870-ba80-08e577ec7244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bcaca62d-f623-4931-a6bd-125da0d0f737" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_46742750-f619-4870-ba80-08e577ec7244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_b3d6a8fa-a5b3-422d-894d-206490bf06cb" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bcaca62d-f623-4931-a6bd-125da0d0f737" xlink:to="loc_lgnd_LeaseLiabilityCurrent_b3d6a8fa-a5b3-422d-894d-206490bf06cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_d41af090-777f-42e4-8eff-cb111f80d657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_5fa04331-1489-4e9a-b773-6cad57470ecc" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_d41af090-777f-42e4-8eff-cb111f80d657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c43a17fa-a10b-499d-b9aa-b327afdb6ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_d41af090-777f-42e4-8eff-cb111f80d657" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c43a17fa-a10b-499d-b9aa-b327afdb6ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_afe812ec-ec2f-45c7-97ac-144ab2ae0573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_d41af090-777f-42e4-8eff-cb111f80d657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_afe812ec-ec2f-45c7-97ac-144ab2ae0573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_2ae6788b-7053-4687-babc-c31839874ac6" xlink:href="lgnd-20210930.xsd#lgnd_LeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f9f0d7f-9ffc-4727-890a-4cf1eedbfe0f" xlink:to="loc_lgnd_LeaseLiability_2ae6788b-7053-4687-babc-c31839874ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_da8e1229-2248-4945-9220-80dc617036ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_da8e1229-2248-4945-9220-80dc617036ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8753f536-dc4b-4474-ace8-b128c05f9159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8753f536-dc4b-4474-ace8-b128c05f9159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5f36d329-26c7-4f6a-9cd7-02e9c23ad720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5f36d329-26c7-4f6a-9cd7-02e9c23ad720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa5fa150-4064-432c-93ce-6e637e28d66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa5fa150-4064-432c-93ce-6e637e28d66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da4edc01-3a2c-4a0e-8dd6-fbd18e40e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da4edc01-3a2c-4a0e-8dd6-fbd18e40e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_42329ae4-eb34-4454-b124-7aa218a1f101" xlink:href="lgnd-20210930.xsd#lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_42329ae4-eb34-4454-b124-7aa218a1f101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24d565-8441-4040-8688-538fb4afff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d24d565-8441-4040-8688-538fb4afff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af98124c-afe5-423b-8e47-2132e710ade5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af98124c-afe5-423b-8e47-2132e710ade5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7754e20e-0fdf-4235-8b60-4b0b2ce2fc09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0628766a-c067-449f-9539-f1f957898732" xlink:to="loc_us-gaap_OperatingLeaseLiability_7754e20e-0fdf-4235-8b60-4b0b2ce2fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20210930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEvent" xlink:type="simple" xlink:href="lgnd-20210930.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_983add61-4ef5-4c5b-870c-e683f6c9d891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_730bf8ba-b629-428b-b649-c95a2e599d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_983add61-4ef5-4c5b-870c-e683f6c9d891" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_730bf8ba-b629-428b-b649-c95a2e599d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20210930.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_842595a8-319a-4296-8bdf-b59b275b9d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_842595a8-319a-4296-8bdf-b59b275b9d2c" xlink:to="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c74b5d1-c66f-4b31-ba2f-a58f53a50255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b9571dec-0310-4dab-8891-11187a14b86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a9b4c228-3039-4047-bc58-d7117719f232" xlink:to="loc_us-gaap_SubsequentEventMember_b9571dec-0310-4dab-8891-11187a14b86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c1279dfe-0c20-4aa3-a7c5-fa9f9f7e64d7" xlink:to="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember_af80d3d4-f313-4463-9647-0c3fa715b2cd" xlink:href="lgnd-20210930.xsd#lgnd_OmniAbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9975f03f-9bf5-437e-b143-561fbafcad92" xlink:to="loc_lgnd_OmniAbMember_af80d3d4-f313-4463-9647-0c3fa715b2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9445c237-9345-4224-a44e-3010fc62df01" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_cb3940fd-dcb3-4a0e-942f-c51ea0adb314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_96523858-d3e7-4703-8825-c3679d1a4402" xlink:to="loc_us-gaap_IPOMember_cb3940fd-dcb3-4a0e-942f-c51ea0adb314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_52467fd8-fdbb-4727-9be9-b996e863041f" xlink:to="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d75938df-5c9c-4a5e-ab5b-7eee0891fc71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_33c2f77b-efa7-4687-b518-ae45af330e20" xlink:to="loc_srt_MaximumMember_d75938df-5c9c-4a5e-ab5b-7eee0891fc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2f4de56e-e8da-4b35-9868-bd05584edc10" xlink:to="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_9623735e-2365-4885-9dae-fd7c96ebb664" xlink:href="lgnd-20210930.xsd#lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:to="loc_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit_9623735e-2365-4885-9dae-fd7c96ebb664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_e925d6dd-fc61-47b3-b2af-a304ac5f3329" xlink:href="lgnd-20210930.xsd#lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3d5d4830-df5b-4ff9-ae12-474aa3ce0816" xlink:to="loc_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold_e925d6dd-fc61-47b3-b2af-a304ac5f3329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lgnd-20210930_g1.jpg
<TEXT>
begin 644 lgnd-20210930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
MZD%70Y&0>JL"3<#]S**\?_8:_:GM?VO/V?M,\4*L5OJ\+&QUBVCX6WNT +;1
M_<<,KKR<!P,Y!HJ0/8**Y7XJ_''P?\#M(2^\7^)='\/6\N?*-[<K&\Y')$:?
M><CT4$U\]>-O^"S_ ,$/"<KI9ZAXA\1E#C.FZ4RAOH9S$#18#ZOHKX4U3_@O
M1\/X=WV+P7XQN,/A?/:VAROJ<2/@]..?K5:T_P""]O@M[A1/X$\41Q'.YH[F
M!V''8$C//O3LP/O2BOB_PW_P7.^$>K2*E_H_CC2F/5Y+*"6(<^J3%O\ QVO;
M?A)_P4"^#OQMO8;30?'>CF_G(6.TOM]A/(Q_A59U3>WLN:5@/8Z*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYQZ_HXK
M^<>JB 44450!1110 5^WG_!+S_DPOX=?]><__I7-7XAU^WG_  2\_P"3"_AU
M_P!><_\ Z5S4I >^4445 !1110 5P?[4/Q0D^"W[.OC7Q3 0+O1='N+BUR,C
MS]A$6?;S"N:[RO"/^"F]E+?_ +"/Q&CA0NZV$4A&<85+B)F/X*"?PH0'Y4?\
M$_?@W%^T+^V)X.T34XS=Z<UXVI:B)/F6:*!&F9'SU$C($/\ O_C7[5_&/_DD
M7BK_ + ]W_Z)>OR?_P""*VI6UC^V[:Q3A3+>Z+>PVY/42 (YQ[[$?]:_6#XQ
M_P#)(O%7_8'N_P#T2].0'XJ_\$[?A+X>^.?[8W@[PMXJT\:KH.J?;?M5KY\D
M/F^78W$J?/&RN,.BG@C.,'()%?=7[=G_  2]^$'AC]G'Q5XI\-Z6/!VL>&M/
MEU"*:.^F>"[,:Y$#I*[#+_=4KM.]ER2.*_.?]F72_'VJ_&;2E^&(OO\ A-(D
MG>Q:SDCCF5?)<2E6<A1^[+@Y/0FO0/VOY/VA]&TJQL_C!<^-%TJY?_1H[ZXW
MV$L@R1_JR8C(!DC/S 9[53W [7_@B]XEU?1_VV=/L=/:8Z=J^F7D6J(I^3RD
MB,B,PZ9$JQ@'J-Y'<@_8_P#P6G^"]M\0/V2G\3"('4_!%[%=1R!<N8)W2"5/
MH2T3G_KD*Y?_ ((G7?PNU+X=ZTWAK2+K3_']FL<6NS7]P+B>XA8Y1H'"J%@+
M*<H%!#*NXMA&/N?_  4OU&WTO]A7XCRW)41MIR0C./OO/$B=?]IEI/<#X6_X
M(E_'J#X9?%?QCH6J78MM&U?24O\ +N JW$$R(N >,LD[YQ_<'7 P5XA^P=H%
M]XC^+VI0:>;@3)H\KMY,8=MOGP#H0>,D44GN!Y]\;?C)KGQ]^)VK^*_$-Y-=
MZCJL[2?.Y9;>/)V0IZ(@PH ["N4HHJP"BBB@ HHHH _8+_@C1\;-9^+W[*4]
MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
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M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!111
M0 5^WG_!+S_DPOX=?]><_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%
M%%0 4444 %%%% !1110 4444 %%%% !1110!_./1116@!1110 4444 ?JC_P
M09_Y-T\8_P#8QG_TEAK[GKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<KXD^.
MG@CP:SC6/&/A72C'G<+S5K>#;@9YW.,<$'\: .JHKRG4/VZ?@UIDDBR?$_P.
MQB&3Y6KPS \9X*,0?PSZ5E_\/&?@?_T4KPW_ -_'_P#B: /:J*\IL_VY_@U?
M3)&GQ/\  ZL_0R:Q#&H^I9@!^-=-H/[0W@#Q44&E^.?!^I%^5^RZS;3;N<<;
M7/?B@#L**AL=0@U2U2>VGAN8),[9(G#HV#@X(X/((J:@ HHHH **** "N>^+
M/@"'XJ?##Q!X;N&"1:YI\UEO(SY1="JO]5)!_"NAHK.M2A5IRI5%=233]'N:
MT:TZ52-6F[2BTT_-:H_#7Q/X:O?!OB._TG4K=[74-,N'M;F%_O12(Q5E/T(-
M4:_3?]N'_@G9:_M%ZC)XH\,W-OI/BWRPMQ',,6VJ!1A2Y RDF,#?R"% ('4?
M WQ0_9=^(/P;N)$\0^$]8LH8SS=) 9[4_2:/<GZYK^0>*."<QR?$24J;E2O[
MLTKIKI>VS[I_*Z/[*X5XZRW.</!QJ*-6WO0;LT^MK[KLU\[/0X&BBBOC3[4*
M*6.-I9%1%+,QP !DD^E>H?"C]C'XE_&6ZC71_"FIQ6LAYO;Z,VELH]=\F-V/
M1-Q]JZ\'@,3BZGLL+3E.7:*;?X')C,?AL)3=7%5(PCWDTE^)R/PA^&>H?&/X
MF:+X8TN-GO-9ND@! R(DSEY#_LH@9C[*:_:GP[H-MX6\/V.F62>59Z=;QVL"
M?W(T4*H_  5X;^Q9^PCI/[*ME+J=Y<Q:UXNOHO*FO50K#:1G!,4(/."0,N<%
ML#A1D5[]7]/^&O"%;)<'.KC%:K5M=;\J6R]=6W;R['\J^)_&5'.\9"C@W>C2
MO9[<TGN[=M$E?S?4****_2C\P"BBB@ HHHH **** "BBB@ HJCKGBC3/#$(D
MU+4;#3HVZ-<W"0J>W5B/6N(UC]K[X4: &^V?$OP% R@,4.O6ID(/&0H?<?P%
M 'HM%>/:A_P4#^"FFJID^)GA)M_3RKT2_GLSC\:BM/\ @H=\$;VX6)/B7X75
MFS@R7!C7IGEF  _$T >S45Y;8?MO?!S4I&2/XH^ U*C)\W6[>(?F[ &NHT+X
MZ^"/%)4:9XR\*ZB7QM^RZM;S9R,C&USUH ZJBFQ2K/&KHRNC@,K*<A@>A!IU
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
MI7-7XAU^WG_!+S_DPOX=?]><_P#Z5S4I >^4445 !1110 4444 %%%% !111
M0 4444 %%%% '\X]%%%: %%%% !1110!^J/_  09_P"3=/&/_8QG_P!)8:^Y
MZ^&/^"#/_)NGC'_L8S_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!\^_M<?\ !2;X>?LB:D='U.2]UWQ.8Q)_
M96FJK/;AAE3,[$+&",''+X(.W!!KY%\9_P#!>_Q5>2R#P]X \/Z>G(C.HWLU
MX>AP2$$7?!Q]1GO7R%^U;K5UXA_:=^(=Y>S/<7$OB/4-SN<G N'50/0   #L
M !7 5:0'V3??\%R?C'=S[X]-\"6JXQLBTVX*_7YIV/ZU$O\ P7 ^,P8'[+X)
M..QTR7G_ ,C5\=T460'W+H'_  7D^)%M< ZIX0\$7D6>5M4NK9L?5II/Y5[Y
M^S]_P6Z\ _$K6;73/&.C7_@:ZNF$:WC3B\T]6Z#?(%1XP3W*%1W8 9K\GJ*+
M(#^C6WN([N!)8G26*50Z.A#*X(R"".H(I]>!?\$NO%%YXO\ V"_AW=W\S3SQ
M6MQ9JS')\N"[G@B'X1QH/PKWVH **** "BBB@ HHHH **** "BBN,^./[0?@
M_P#9P\&OKOC'6[31[(96%9#NGNW SLBC'S2-[*#@<G R: .SKC/C%^T1X'_9
M_P!(^V^,O$^DZ!$R[XX[B;,\X_Z9PKF23_@"FOS<_:K_ ."UOB[XBR7.E?#:
MU;P=HS90ZC,%EU2X'J.J0@CLNYAU#CI7Q7XD\3:EXQUNXU/5[^]U34;Q_,GN
MKN9IIIF]6=B23]35*('Z:?&G_@NWX6T!YK7P)X4U+Q#*ORK>ZE*+*VS_ '@@
M#2,/8[#_ %^7/B?_ ,%?OC?\1I)%M=>L/"UH_!@T>Q2/_P B2^9*#]'%?,%%
M.R ZCQQ\;O&?Q-9CXC\6>)=>WG)&H:G-<K^3L0![5R]%%, HHHH **** -3P
MMXYUOP/>?:-$UC5-'N/^>MC=R6[_ )H0>U>Y_"W_ (*G_'#X6/&J>,I]?M$Z
MV^MPK?"3ZRM^^_*05\\44 ?I;\$_^"\>FZA+#:_$'P;/IQ;A[_1)?.C!QU,$
MA#*,^DC'!Z<<_9WP2_:?\ ?M%Z:;GP9XITK6RJ[I+>.3R[J >KP.!(H]RH!P
M<5^ E6M#UV^\,:M;ZAIMY=Z??VK^9!<VTS130M_>5U((/N#2Y0/Z+J*_*']E
M+_@M+XR^%\EMI7Q$@D\:Z&N$^W(5CU2V7UW<+/@=GVL3U>OTH^!7[1/@W]I+
MP>FM^#=<M-7M.!-&IVW%HY_@EC/S(WU&#U!(YJ6@.VHHHI %%%% &-KGPX\/
M>)W=M2T'1M1:3[YN;**8MSGG<ISSS69_PH/P+_T)?A+_ ,%%O_\ $5UE%<T\
M'AYOFG!-^B.J&-Q$%RPJ22\FS,T+P3HWA?']F:1IFG;0%'V6UCAP , ?*!VK
M3HHK:$(P7+!67D83J2F^:;N_,****L@**** "BBN3^+WQV\'_ 3PZ=5\8>(M
M,T"R_@-S+^\F/I'&,O(?9%)H ZRBOSR_:#_X+LV&GM/8_#/PP]_(/E75=;S'
M#GU6W0[F'H6=#ZK7Q7\;_P!M_P"*?[0SS)XF\8ZM/83==/M9/LEECI@PQ[5;
M [L">O/-/E _7_XP?M^?"#X'/+#KOCG1S>PY#65@YOKE6_NLD(8H?]_;7S)\
M4?\ @O1X9TSS(O!W@C6-7?E5N-5N8[*,'^\$3S&8>Q*GZ5^8E%5R@?6_Q$_X
M+3_&GQEO32KCP]X4B8_*=/TY9I /0M<&09]P![8KQ'QQ^V+\5?B1*[:S\0_%
M]VDAR85U.6&#/M$A5!^"UYM13L!)=7<M]<-+-+)-*_+.[%F;ZDU'110 4444
M %%%% &QX6^(6O\ @:;S-$US6-'D!W;K&\DMSGURA%>N> ?^"EOQQ^'3+]D^
M(>M7T8QE-5\O40X'8M.KL/J"#[UX710!][?"G_@O'XMT=XH?&?@W1-<@&%:X
MTR9[&?']XJWF(Q]AL'TKZM^!_P#P5D^#/QH>&VEUZ3PCJ<N!]FUZ,6J9[XG!
M:'&>FYU)R..U?BY12L@/Z-+.\AU&TCGMY8YX)E#QR1L&1U/(((X(/K4E?@S^
MSS^V?\1_V7]0C?PGXDO(+!7WR:7<L;C3YL]<PL< G^\FUO\ :K](?V0?^"PW
M@OXZS6VB>-(X/ _B67")+++G3+QO]B5N8F/]V3CD .Q.*EH#[%HI%8,H(((/
M(([TM( HHHH **** "BBB@ HHHH ^:OVRO\ @I_X'_9$UE]!:VNO%/BU(UDD
MTRSE6*.T##*^?,01&2.0H5FP02 ""?D3Q-_P7F^(EU>,VC>#O!=A;YX2]%S=
MN!Z;DEB&??;7RI^U3JUQKG[3?Q#N[J5YIYO$NH%G8Y/_ !\R #V    [  5P
M56D!]B/_ ,%P?C,[DBT\$J"<X&F2X'MS-4EG_P %Q_C):W =].\"W*C_ )9R
M:;.%/_?,X/ZU\;T460'WYX!_X+V^*K.]B'BGP)X?U"W)Q(=*N9K-P/4"0R@X
M]"1GU%?>'[+O[6?@[]KGP(VM^$[R1FMF6.^L+E0EWI\A&0LB D8/.&4E6P<'
M(('X)U]G?\$--<NK#]KG5K**5EM;_P .7!GCS\KE)H"IQZC)P?1CZTF@/UJH
MHHJ0"BBB@ IES<QV5M)--(D4,2EW=V"JB@9))/  '>OF+]L+_@JGX!_9@DNM
M'TUU\8^,(<HVGV4P%O9OZ3S8(4@]44,^1@A<YK\R_P!IG]O+XE?M5WDJ>)-=
MDMM&8Y31=.+6^GH,Y&Y 29"#T:0L1V('%-(#],OV@?\ @KI\(_@D\UGIVI3>
M-M7BX^SZ+MDMU/\ M7!/EX_W"Y'I7QE\9/\ @MO\5?'DDL/A>UT7P39-PAAA
M%]=@>\DHV=.XB4_ICXVHJD@.S^(_[17CWXO2R-XG\8^)=<24DF&[U"62%<]0
ML>=BCV  KC***8!1110 5?\ #OBO5/"%^+K2=2O]+NE((FM+AX) 1T^92#5"
MB@#WKX8?\%-OC=\*YH_LWCK4M7MD^];ZR%U%9!Z%Y09!_P !<5]4_ W_ (+Q
MPW$T-I\1O!WV<-P^HZ#(64'WMY6R!ZD2D^BU^;E%*R _?[X'_M,>!/VC]&:]
M\%^)=.UM8E#301N4N;8'_GI"P$B>F2H![$UW5?SL>$_%^J^ _$%MJVB:E?:1
MJED^^"[LYVAFB;U5E((K[]_8Z_X+8W6G26N@_%^$W=N2(X_$5E !+'R.;B%1
MA@.<O& V /D8Y-)Q _2JBL_PIXLTSQUX<L]7T;4+/5=+U",2VUW:RK+#.A[J
MPX/_ -:M"I **** "BBB@ HHHH **** "BBB@ HHHH **** "BBOG;]L#_@I
M9X _9*CGTZ2?_A)?%R#"Z-82KN@;&1]HDY$(Y'!!?D$*1S0!]$.ZQH68A549
M))P *^=?V@O^"I?P@^ $L]G)KQ\4:S!E38:$%NRC=,/+D1*0>"-^X<_+VK\Q
M_P!J#_@HI\3?VJ)+BUU?6&TCP[*2%T72RT%J5["4YWS=OODKD9"K7A54H@?=
M7Q@_X+K^.?$<DL'@OPSHGAFU)(6>]9M0NL=B/N1J>^"K?4]3\W?$;]NSXP_%
M:27^V?B'XF>*;(>"TNS8V[#T,4&Q"/J*\FHIV EOK^?5+M[BYFFN)Y3EY)7+
MNY]R>345%%, HHHH *[WX:_M2?$?X/O'_P (UXW\3:1%&<BWAOY#;GZQ,3&?
MQ4UP5% 'VM\%_P#@N'\2O!4L,'C#2]%\:62\22A!I]ZWOOC!B_#RN<=1UK[8
M_9T_X*B_"7]HB6"RBUH^&-<F(5=.UO;;-(Q[1RY,3DG@ -N/]VOQ1HI- ?T<
M45^*_P"R7_P4_P#B-^RV]MISW9\6>$X<*=(U*5B8$]()N6B]A\R<GY,\U^I/
M[*G[<'@']KS0O-\-:EY&L01A[S1KS$5[:^IVYQ(G^VA(Y&<'BI: ]?HHHI %
M?SCU_1Q7\X]5$ HHHJ@"BBB@ K]O/^"7G_)A?PZ_Z\Y__2N:OQ#K]O/^"7G_
M "87\.O^O.?_ -*YJ4@/?****@ HHHH **** "BBB@ HHHH **** "BBB@#^
M<>BBBM "BBB@ HHHH _5'_@@S_R;IXQ_[&,_^DL-?<]?#'_!!G_DW3QC_P!C
M&?\ TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#^?S]I/_ ).+\??]C'J/_I5)7%5VO[2?_)Q?C[_L8]1_]*I*
MXJM$ 4444 %%%% '[5?\$D_^4?/P_P#^XC_Z<KJOHZOG'_@DG_RCY^'_ /W$
M?_3E=5]'5# ****0!1110 4444 %%%?&G_!3[_@I+'^S?I<O@CP5=03^.[^+
M_2KE2'&@1, 0Q'0SL#E5/W1AB.5# '3?M[?\%./#O[)-M/H&B):^(_'KIQ9;
M\VVF9&5>Y*G.<$$1 AB.25!!/Y+?&/XV>*?C]XWN?$/B[6;O6=4N#C?,WR0+
MG(CC0?+&@[*H _$FN=U75;K7=3N+V^N;B\O;R1II[B>0R2SR,<L[,<EF))))
MY)-5ZM*P!1113 **** "BBB@ HHHH **** "BBB@ HHHH *ZCX0?&?Q/\!?&
M]MXB\):Q=Z-JMJ>)(6^65<Y*2(<K(AP,JP(/I7+T4 ?LA^P-_P %.?#_ .UI
M;P>'M=2V\.^/HT_X] ^+;5< EGMR3G( ),9)('(+ $CZHK^<W3M1N-(OX;JT
MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!_/Y^TG_R<7X^_[&/4?_2J2N*KM?VD_P#DXOQ]_P!C'J/_ *52
M5Q5:( HHHH **** /VJ_X))_\H^?A_\ ]Q'_ -.5U7T=7SC_ ,$D_P#E'S\/
M_P#N(_\ IRNJ^CJA@%%%%( HHHH X#]JKXHM\%OV;_&WBB.017.CZ/<2VK$X
M'V@H5A'XR,@_&OP&)+$DDDGJ:_7_ /X+7>-SX6_8JETY6&?$NM6=@R[L$JA>
MY)QW&;=?S%?D!51 ****H HHHH W?AC\/K_XK_$70_#.EKOU#7KZ&P@XR%:1
MPNX^PSD^@!K]^_A5\-M,^#OPVT/PMHT0ATS0;..S@&.6"+@LWJS'+$]R2:_*
M?_@BA\)U\=_M=OKMQ%OMO!VES7J,1E1<2X@C!]]KRL/0I7Z\5,F 4445(!11
M10 4444 %%%% !1110 5ROQO^$^G_'3X1>(O"&J*ILM?L9+1F(SY+D920?[2
M.%<>ZBNJHH _G8\7>%KSP/XLU31=1C\G4-'NY;&ZC_N2Q.4<?@RFLZOIG_@K
MI\,Q\./VX?$DL4?E6WB6"WUF$8ZF1-DA_&:*4_C7S-6@!1110 5+87\VEWT-
MU;R-#<6TBRQ2*<%&4Y!'N"*BHH _H4^#OQ B^*_PE\,>)X=HC\0Z5;:B%4\)
MYL2N5^H+$8[8KI*^<?\ @DWXQ;QA^P?X+\Q]\^E_:M/D]A'<R;!_W[,=?1U9
M@%%%% !1110 C*&4@@$'@@]Z^?O'?_!+;X&_$3Q;-K5]X)B@N[J3S9TL;ZXL
MX)F)R28XW55SWV!>OK7T%10!RWPI^"/A'X&:"=,\(>'=*\/V;D&1;. (TQ'1
MG?[SGW8DUU-%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^9O_!=;
M]GB+1?%7AOXF6%N$36A_8^K,HP&GC0M;N?5FB5U^D*5^F5>#?\%-/A<OQ7_8
MD\=6BQA[G2;+^V;<XR4:U83.1[F-9%_X$:: _$"BBBK **** "NG^"?CMOA=
M\8_"GB169#H.KVNH$CN(IE<CW! (([@US%% ']&ZL&4$$$'D$=Z6N+_9O\5'
MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
MDXOQ]_V,>H_^E4E<56B **** "BBB@#]JO\ @DG_ ,H^?A__ -Q'_P!.5U7T
M=7SC_P $D_\ E'S\/_\ N(_^G*ZKZ.J& 4444@"BBB@#\^_^"^OB$VW@#X<:
M3OP+W4+V[VY//DQQ)GTX\_\ 6OS+K]#_ /@OY>22>(OA?;DCRHK;4I%&.C,U
MJ#^BK7YX5:V ****8!1110!^G/\ P0.\&K:?#/X@^(3&-^H:I;:<'(/2")I"
M!_X$#./;/:OO^OCC_@AS:QV_[&^H.BA6G\37;R'^\WD6RY_)0/PK['J'N 44
M44@"BBB@ HHHH **** "BBB@ HHHH _,3_@OEX8%I\4/A[K.PAK_ $NZLBV.
MH@F5\9]OM!_.O@*OTF_X+^V"R:)\+;HLV^&?4X@.Q#K:$G_QP?F:_-FK6P!1
M113 **** /UG_P""%VMG4/V1M;M&=2VG^*+E%49R$:VM7!/U8OT]*^T:^%_^
M"#)_XQV\8C!Q_P )'U['_1H:^Z*A[@%%%%( HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *H^)_#]OXL\-ZAI5VH>UU.VDM)E/\22
M(58?D35ZB@#^<_5=,ET75+FSG7;/:2M#(/1E)!'YBJ]=S^T]HX\/?M*_$/3U
M"!;'Q-J5N GW0$NI5X]N*X:M "BBB@ HHHH _<G_ ()NZTVO?L-_#:=]V8]*
M^S<XZ12/$/T05[?7SC_P24F\[_@GWX R^]D_M!3SDC_B8W6!^6*^CJS8!111
M0 4444 ?S^?M)_\ )Q?C[_L8]1_]*I*XJNU_:3_Y.+\??]C'J/\ Z525Q5:(
M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
MU^UW["7[$VB_L9_"R.QB$%_XIU1%EUK4PO,TF/\ 51D@$0H<A0<9.6(!.!XI
M_P $6?V6-!\'_ RU^*,H%[XD\6_:+>&1UXTVVBN)(3&G^T[1%F;TVJ,8;=]N
MU+8!1114@%%%% !1110 4444 %%%% !1110 4444 ?B'_P %./A(GP>_;6\:
M6<$0AL=7N%UFU &U2MRHD? [ 2F51C^[^%>!U^@7_!?'P(ME\1/A]XF1!NU+
M3KK3)7 Z>1(DB G_ +>'Q]#7Y^U: ****8!1110!]>_\$2O%)T#]M(V>X@:Y
MH-Y9[>S%6BG_ /:)K]>Z_$;_ ();Z\?#O[>GP\GR )KJXM3D$@^;:31=O=Q^
M.#7[<U$MP"BBBD 4444 %?F-_P %Y?BXVI_$7P7X(@F_<Z392:O=(IX:6=O+
MC#>ZK$Y'M+[BOTYK\,O^"BWQ./Q9_;2^(&I+)YEO::FVEV^#E?+M0+<%?9C&
M6_X%3B!XI1115@%%%% !4MC93:E>PVUO&\T]PZQQQH,L[$X  ]2345?2'_!*
M/X*CXS_MH^'#/$)=/\*A]?N@>G[@J(?_ ".\)QZ T ?J_P#LB_ 2V_9H_9W\
M,>#X4C%SIUHKW\BX_?W<GSS/GN-Y('HH4=J])HHK, HHHH **** "BBB@ HH
MHH **** "BBB@ JAXI\+Z=XV\.7VD:O96^HZ7J4+6]U:SH'CGC8896!Z@BK]
M% 'XJ?\ !13]@_4/V./B3]HL$N+SP+KDK'2;Q@6-LV-QM96Z>8H!VG^-1GJ&
M"_.5?T'?&OX,Z!^T!\,M5\)^);07>E:M$8WQ@20..4EC/\+HV&!]1SD9%?SX
MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
M%%%%, HHHH ***]4_9 _9.\0?M@?%RV\-Z,K6UE%B?5=29-T6FV^<%STRYZ(
MF<L?0!B #WK_ ((]_L9/\:_BR/'^N6A;PMX-N%:U61<IJ&H##(H]5BRLC>YC
M'()Q^M5<W\(_A/H?P.^'&D^%?#EH++1]&@$,$><LW.6=S_$[,2S'N23725#8
M!1112 **** "BBB@ I&8*I)( '))[4,P5220 .23VK\N_P#@J%_P4\E^)-UJ
M'PX^'=\\7AR%VM]8U>!\-JK X:&)AT@!X9A_K.@^3[[2 ]%_;X_X+#0>"[F\
M\(_"6>UO]33,5YXB($UO:MT*VRG*R./^>C90=@V<C\U?$OB;4?&6NW6J:O?W
MFIZE>OYEQ=74S333-ZLS$DGZU1HJD@"BBBF 4444 %%%% !116KX8\"ZWXVG
M,6BZ-JNKR@X*65I)<,#]$!H RJ*]:\/?L'?&;Q1&'M?AEXR52,@W.FR6N1[>
M:%KK;#_@E)\?]2C9X_A[.H4X/FZM81'\GG!-%P/GBBOIV'_@CW\>Y849O"EA
M&S $HVM6F5]CB0C/T)I__#G?X]?]"OIO_@YM/_BZ+@?+]%?4'_#G?X]?]"OI
MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
M**** "BBB@ HHHH **** "BBB@ HHHH ^<?^"MG_ "CY^('_ '#O_3E:U^*M
M?M5_P5L_Y1\_$#_N'?\ IRM:_%6KB 4444P"BBB@#M?V;/\ DXOP#_V,>G?^
ME4=?T!U_/Y^S9_R<7X!_[&/3O_2J.OZ ZF0!1114@%%%% !1110!A?$_X<:5
M\7_AYK/AC7+<7.DZ[:/9W*=#M88W*>S*<$'L0#VK\&?VB/@9K'[-WQBUSP=K
M:'[7I$Y2.8*52\A/,<R9_A=2#[9(/(-?T!U\B_\ !63]B!OVD_A:GBSP[:"3
MQIX2A9ECC7,FJ68RSP<<EU.70>I=<9<$-,#\@:*""I((((ZBBK **** "BBB
M@"2TNY;"ZBG@EDAGA<21R1L5>-@<A@1R"#W%?=7['W_!:C7?AW;6N@_%&UN_
M%.E18CCUFWP=2@7MYJDA9QT^;*OU)+GBOA&BBP'[[?!']JOX>_M%Z>DW@_Q5
MI6K2LNYK,2^5>1<<[H'Q(O?G;CC@FO0J_G*M[B2TG26)WBEB8.CH2K(0<@@C
MH17K?P__ &^/C+\,(HX](^(OB588L>7%>7'VZ) .@"3AU ]L8J>4#]VJ*_&W
M1_\ @LC\=M,AV3:_H^H-@#?<:/;JW'?]VJ#GZ=N,5->_\%F_CG=P%(]7T&V;
M.=\>D1%OI\V1^E+E8'[&5SWQ$^+/ACX1Z,VH>*/$&CZ!9J,^;?W:0!_9=Q!8
M^@&2:_%?QM_P4B^./Q A:._^(^O0(W4:=Y>G'\[=$/ZUXYKOB"_\4:E)>ZG?
M7FHWDO+SW4S32O\ 5F))I\H'Z>?M+?\ !</PMX2@N=.^&FE3>*-2P534[]'M
MM/B;LRQG$LOT/ECIR:_.WXZ?M%^,_P!I+Q:=9\9:[=ZQ=+D01N0D%HI/W(HE
MPJ#IT&3C))/-<3132 ****8!1110 5V?AWX"^)?$OP<\0^/8K%HO"_AR6&WG
MO9<JD\\LB(L,?]YAOW-CA1C)!90?6?\ @G[_ ,$_=:_;*\:?:[O[1I7@72I@
M-2U(+AKAA@_9X,\&0C&6Y" Y.255OO/_ (*C_#W1?A3_ ,$V=6\/>'M.M]*T
M;2IM/@MK:!<+&HNH_P 2Q.26.2Q)))))I-@?D!1113 **** "OV\_P""7G_)
MA?PZ_P"O.?\ ]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "B
MBB@ HHHH **** "BBB@ HHHH _G'HI]Q ]K.\4BLDD;%65A@J1P0:96@!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =;\ ]
M3;1?CKX*O$!+VFO6,R@'&2MQ&1SVZ5_077\^'P-LGU+XU^#[:+!EN-;LHTR<
M#)G0#^=?T'U,@"BBBI **** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^
M_P"QCU'_ -*I*XJM$ 4444 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_
MX))_\H^?A_\ ]Q'_ -.5U7T=4, HHHI %%%% !117YM?\%1/^"HG]I?VC\-?
MAKJ/^C?-;:YKEL_^N[-;6[#^'J'D'WN57C)9I =;_P %%O\ @K3%\.I]0\"_
M"ZZANM>C+6^I:ZN'BTUAD-%!V>4="_*IR!EN4_,;5-4N=;U*XO+VXGO+R[D:
M:>>>0R23.QRS,QY9B222>34%%4D 4444P"BBM;P+X$UGXF^+;'0?#^FW>KZQ
MJ<HBMK2VC+R2MUZ=@ "23@  DD $T 9-%?I3\'?^"$&EW7@.SG\=^+-7MO$4
MX\R>VTCROL]H#TCWNC%V'=A@9X (&X[E[_P03\$R3YMO'7BF*+'W9+>"1L_4
M!?Y4KH#\NJ*_3&Z_X($:&]PQ@^)6JQQ'[JOI$;L/J1*,_D*S)O\ @W]1IG,?
MQ998R3M5O#&X@=@3]K&3[X%%T!^<-%?H4_\ P0&U@9V_$S33Z9T5QG_R-67-
M_P $$?&*PN8_'OAEI IVJUI.H)[ GG ]\&BZ ^":*^X[K_@@Y\2TMV,'BWP-
M)*/NJ\MTBGZD0G'Y5F7G_!"OXP6MN737/A[<L/\ EG'J%V&/_?5L!^M%T!\7
MT5]>7_\ P1*^-5G"&C/A&Z8G&R+5&!'O\T:C'X]ZRM4_X(U_'6P13%H6C7Q(
M)(AUB $8[?.5Z_T[470'RQ17N/BW_@FO\=/!<;M>?#?79@@R?L#17YZ \"!W
M)Z]O?T->2>+_  %KOP^U$V>O:+JVB78_Y8:A9R6TG_?+@&F!DT444 %%%% !
M1110 5[;^P]^VQK_ .QG\3H]0M&GO_#6HNJ:SI._Y;J,<>8F>%F0$E6XS]T\
M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>lgnd-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20210930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20210930.xsd" xlink:type="simple"/>
    <context id="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ab881cb617a4e59b38742bf90e782ca_I20211105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="i18d2cf420ac940fd8835832f3cb25bbf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id5e66a6b4d374ca2982d0e908c81c057_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65684440034d4351bbb21abccb7fca41_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib4670676853e4b26a40950b991482733_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e4308d8a255413492511fffb9a26412_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a6e84a61d1143bcacd2e9bc175b9653_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85f271f1a4be4452910a076e9e38a6b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id27dffce40b144a3bbcefdd5cdb11b20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0a809d62daa64f1f84d03e014e249993_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4953df0e32ff45209345ad4e8b35fb8a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3900ef9761864a5da679ba7019815ea2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i22edb6dc65c04766b217ddab8475edd8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifbba22d1af0c4452af7b0fe4b452c084_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i15280da5985442f1b70dfcfa3a99ba5f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e91036a56e048da812d1bbbff52ea15_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idf86e369b16b4f3d80c4a30e22e652cc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4a4a9f3d2bb74346a035eb74bdbf6297_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id39bf6178fe24db2893e758597f0029c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i889f7f0228dd4a588bb93484a5eccbf0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i360c33d3bf9d4071a521470504bb754a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib5d0533630774219a96e8ae0dd341679_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i55c6430609ca42e2af4e70d120723e15_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0669b1b589ed4c0aa5c0f53d9af109bd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9c8ef6df76594ccf9ac7aa43bca3d664_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0bd7d1d9820346ebbdd910ea23ae5fb5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1cb3e3ce39174efb90c579734662ca3c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0c504584f2b44bccbb4c98df81a0c187_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i40e9fc954e0f4c6fac4befb25a43a7e8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48d0b1e6a3e246f8a27e20041ff8cda9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icb20171945fd40e794706d8def23874e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i77dec1bdfce142efad4f356566506009_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i350b26fa15fe439082f315dc8c0738d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f9e33b34b6a4201ae924131d1884ef5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8a4a953d5304f198ee6f152d7aeea35_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iaada7c634ba8474da512d18baf189633_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia085df13296843368baeb5805a91e5d8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i884da06b4bd14a7fb79a03bb4da156cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia51a04f07e094d73b253c1b38304f355_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24fe1222cc784553a37d8ab3fd25236d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fa5703dfd6f42c5a03262f6a827081a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id70967578d4d40a9bde681ed44e00bf3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4b2271fc765142b1beb4cf28d365bb6a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib91f3032f13b419e96960180df7a57a0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia056a39a1d1646b08db6232475f0fe3d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if07b2a7f22b749b2b75f7867f5ca9d61_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9e955a2670f14c5589acd8fae1849f37_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7133362acc234799828e1697270f098b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1f36701c729b4ca08acd79e998f584cf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0af9313f05af401bb4da9b72af20c7bc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i3084043063c5478084965f63fc694456_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i70eb5532b8c24ecf95a7e0ba1196f93b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic2891e29ad7f442385683c6dfa1a990e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iede4b1a3266f4aa58150416db0b81f06_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i94c5045f7c634a6ab1162b5156068143_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f74d78b3bfd465285b4b70819f120ae_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b76151e50a6468f9778c0f3285a6571_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i575ac8d86a424cc58611058fbd63c5d1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i187e0f90eac444ea9e476b4465539595_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i37bf04a171f0407a9f1eae38a860495c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iefcbd9042e284860925ad7c76171bca1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1beb885c5fe44118a5ef2fec26cf4658_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1812aa7c1c1b4a55a887fd5a81b76005_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i338e6d6b14a34c75b7c70afa3376340b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf6cdf3e9b474d958a8885100478e940_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i98ab67b2c0b5427699d1f2b18bf6cf19_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id41307110e644f0fa0ec6bccf02baa95_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i99683383c51c4f64a11dd4f2001eed52_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i81c5115227a34d9b8c71c751709c5dc9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d50949db3fb4c8aaa647abb0dbf5f7a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e9177b057824c699d52a5f241543660_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i54af25c4d01847cf80e2bfe3bc7d5119_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f737ae0746f4857a06c25988e3ad3d7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbb87c5273d146209b4f863fa73a6737_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i16580774194c4717bd816e227f16cca5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75ed1e446ea84220b26d564c3e4eb9c9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i76396c119fc8437783313ddfc6cfdce7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i461496e85d77458ab7ad2e0d7ef7035a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8b56fbe0a9734483b1566fbe6d710406_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iccff4fa6edd34cabbf684004d8ce7bb6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46272602a5184253a54dc8e71c5e30ca_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10c95e2f17f3492394642693fb62d437_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic079e130627446e2a4e0b9df6ba59cb4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf39d65d4fbb4562aa99ab8d91883b55_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if2328ebe1a164a53b66ea3c341bceda4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id40d8cfc06804c0eb44c421fe185a680_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02ec86bd000d4ef392d002af71a86521_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iae1a8e7f867144aaa2ecf955647862c6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3bbbf8570b35483cb6acbd8cd74c10ba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i52b324e462494e6681ed114f944bd643_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6c3a84cd253749ea9fae2626a480c65a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa74fac6c40441aa82875bbb7072f25c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i13fb0509abe448b48aa3be427fb2214b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iee78cc743adc4dee82bb5d8535f1915c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24164d9e30c34985b56c25ee4de80416_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ac4a748fde44c7aa04060686b7378eb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i54b3650ee47e452aa4bc7e9df71daf81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic429da61955a4b0a825e11e538db02fc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60fb236ee191431e8dfccfe51b11abf9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3227affd81a14c3eae170a2fd39475dd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i74019a59687e417d98beaf331bbdb8f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfb7eed4859c41008e742eb80e557048_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9b7cdf10102d42dd915fbd5b67034260_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9bec6bae658f4fa7839b638d3604a63a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib1fa6499d48549af8abfb01bffe3a576_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0d1d2fa5d245408d983a4eb034d356e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf1294789ba14efbb689b8629eb271e2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic31bf65152af4864ae4e36dee4c10d04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e028d5aaf364cd69142f7dd1151088f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i484d55887cae433799cc6b8679c28aa4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8bc73161fcc4ebc8b15c8add0abbd14_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id89c1cb7076440ad94b910f7aabb5992_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iec7576b07ee146738bfb748a0c5802e7_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ic56a2e7b63464878884da9238110c721_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia13653d6cd24412d8f8718d38b9e8dd6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04aa132902b04c0394bce82d31a3aea7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if38b3b2a600a4d90a5c8c264715751ed_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a5c0b007c8b4715b662376286f1223b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2639d0217d149f5a491911c423590de_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a349547525942fc9fe678c81267030c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5adab605aa64ca4a227d25b36436eb0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ide5a19e841914942abfdf74c94be909b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idd91366449ba49d1aa56a98935674623_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i209bcfbff39f4fdaa13d185301232981_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45bb77fbcc47480fa1a19f213a179fca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id664afa77ed0445894209a436e750c43_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36100db0e0244c6aab5bd1dbbe08da68_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4b3ffe50d97d4d3b8818bb0bb6714741_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i91d127590aa94e20919836ce48cf0d97_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i389fe86124f84f77a8cf5138a6d5f5cf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6406808991da4d8689a188fd3b01c562_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42236ee785824a1fb48480728bac6789_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27307c85e21e4232ae8eaa32a61b7cc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70323bb3497a4894a0db2dbb77b08b1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6381e6f32971476bad6e8099cd489312_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia5724a75532a4b8aa3826f98fb49e10f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie1f8ca28e64840a497f16c8486d31fb2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i337849ef0f8b47ed813360d98632e23a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id4feeb449c4040e18a03705d479e0b73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39511b4bf4784d1ab377144f67fa01de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id65d2a27498648b69fe545f62a7d5f0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9d827596d8a47a3824b013dc8178a8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ecd386015e54ceabc014a87406ce863_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17b7b001fd454c5589ff4e2973cd3067_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9135bb25b9b145eab714c4c7ad20594b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i564faa262c604481a02c2694f4fb73f3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9ecbea11385c435cbb9af9cce9cfa738_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64b74fc269564f20a9b090e4b7124600_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ac63adf2bb546c4ac1aba900b398602_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i785d8e5ecc03429cab75cc6262c02576_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4355ca159edc4fa99ebca7d202c8bce3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i327b2c0b89c844f99e545089828c950b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb44ca12568c4d3c9fa23dbe60549105_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id4a65f889aa34725ad89d69cd8592c90_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if7a388749dd0497c8d72fc543e8ad75a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cb97d5feddd466b911da2f1c55fb194_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i227b26c77357461d805f1d914f51e920_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d6329169fbc411e8411d28d90ca9499_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3a1b93f4a934aabbecad2ea88faedbe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic536e4be36ac4c8db8f4378ad775ac07_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0d989500a4b14828af3c71491fd9283e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i610ac4aaf38a415c8790607ee1e3c93f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8bebc96ed6eb487a9164a823ad5cf0f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b076ad76aa4482185948f46fd1db7af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06afbcfccbc64bc492f4c8c17e3822a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia21eb2218a714e87a27850a3da35a362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0745304b68584347a2623a146af292f6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifd7b4e075dc6495e89f3147135f0148b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i231808f85c2e4134b7396905d29aba89_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9e8416b02586494b9c68ce1aaeefd509_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i78104f24516b4de29f3df2b385f1639f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i234d3d3b2e13452b972aad1617983de9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bbd5e7581044241879711dfbcd50002_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9850a097083942e0afabbbac0b9129f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i359cff11df50436c9bb95a65ae993fd1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a4d6516a3084dba85ee9f2d9965e059_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic73643b6707d4e4c9a71b01e7b7dcf93_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i96d90de4a6434ddbb1f5058962f04c17_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6ed9ab31d41044b192fcdb3349f39fb3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa31522c2e4a440db343ae979020b192_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f5ff1254de64bb8b8d9981154c1f445_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65b70c37f9aa42fe9d9b2c0a5569f3ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17521c0433c44b8a80fc0dd1145be9e6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie8ec3cae99b848a1b973526b515df54a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2126d7fd9f75438580dfe001ae6fa752_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i97fcc3aebae546f7a142fac3cc2c0745_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23ec7efead9b4761baa234b4bfb65a32_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib92d652ad5604f02a1b2e862f88b1646_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia655880e41b0499a8b88d4a727ed9eab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic40690754d3a44cc8d92472abaff4f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb63d9bffe134ab4a8487fdb45a691f8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i861dcf90c1e74fe880857a9b4b3c9a79_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i750b151cf9fe4b5bacc45d083dfefabc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9efb83e898004cea87bab8cb9c0988da_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ieda651849d114d4abd488d8ecfe42755_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b6a4eeb00954ec987c7739f3c9775dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31f9c1943c5c42278fc70e863c8ee407_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i025eaa94559140439e978745a70ab345_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i103235a0480d438fb3c8952921afef6d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7ceaecbf981d488e903c7845de55f9ce_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i103f057e0945407ba3313d8490b9be67_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i53807a156d9c4b8a877570a1cad4e9d2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if97d00b4fc204934b6f74c46e2902d97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0f9e34d26c64081a716e4ad38102b2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i116e95e42f624c0ebdee627175c1f44b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32596f59df27404580fe06db3f0a6a33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i582ba6e6a3d048fa858bc097e375efbb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0cb687c8f41345a1b1a390788c8b3eab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20539e1cd2eb4b4990f8905b457891fe_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie7ed509cd26a488e8fc504b51723e946_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i653b721956384c858144b850891af87b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i577bc815500b4aa4bc23468486976592_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bda237598d54cafa9c0a35ab7f63129_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fe0e390a595409686d2fee6e8fe8450_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i4a7423268c1947ffaad3d4a234a16758_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia7fe0d08f8814b26bb6d850aefa0bf38_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iefccc513badf4ac697660d63ce351a27_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyPfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i845a05cd969041fba7ad46f78c0e09ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75913a021dca4a82866b4b9298cecb68_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i785fd0e4a68b40ff8674243d934db225_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ib1a044c5eca64972a0b2cca378908568_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="iaa5a82595b87414eb6672c3977e9fe8f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if47943aab20d4716931dd955f73d9f68_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="i49460a614c3741bd9dcb93c1082e254c_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="iac2e38018c524066aae124ee0322449c_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i24d097ca8d274dba82a4146da4cefe5c_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i3b99f5d261b2424984f7c2048cf94154_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i6ee708bc3f874ea4a64ff9eab6bc8b78_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i24a5667057b941dcbffe8705e96b7a08_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i23982d6bb19f46ada4a2da4c208bef75_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i62b604edf45a4273b85b6a9dd018b41b_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i1107fe7113ce41d3aebe65bed5bc350f_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="ica1eb82f11c04cea9b0171a30ecb9c64_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i86a9860367d34127b2a08e3c03d11f2e_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i08d4e4d3980d4dff9c9d86c7ec2dcb16_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i64d969dd64874a7db0f0480d82e40efc_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i3b57fd5414fe448ca4dc3bd49c273738_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="if60b6d14d66a4cb9ba4bd253315c186c_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i6d9c69e09e534351bc10468027e76940_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i9b376b9aa5864554bbc41743970ed458_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i1575170f30d94fd0bbbe0cee59a6431f_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="ia09d2bdfc41645b2b379612921c6d7c5_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i2c2b96408b9c412a9768198f8e8f606a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0685149320e54ff89544d4e3f7a97265_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4a008f555614be384f97c9b5a03d5a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9674c13420bc41deb65d3656daee3f18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i37978277e2ef4b739181ad403af7290d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3896ae5368254d08ac76230cffd63481_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ideff198686944e55a0cc2ee1e0f927b5_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="i1e665f31d61e468db6b421188680776a_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ibdf23659d72440e581b8103b1bb8431a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1c555247c8274906932e6bde7b7a204a_I20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-09</instant>
        </period>
    </context>
    <context id="i8779d8bb6434411d8ba83dacb2886ad1_I20211109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lgnd:OmniAbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-09</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="contingent_value_right_series">
        <measure>lgnd:contingent_value_right_series</measure>
    </unit>
    <unit id="pure">
        <measure>lgnd:pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <unit id="company">
        <measure>lgnd:company</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV8yLTEtMS0xLTA_c8dd2b81-335b-40c0-8d90-ea7cf8ae8fbb">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV8zLTEtMS0xLTA_9f03d29e-712f-4d14-829e-22ee77ee0235">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV80LTEtMS0xLTA_a47219a4-6e8f-4d20-9605-b7cc890ff725">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV81LTEtMS0xLTA_ce29a229-d1bc-42e2-8556-8747f06c9846">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180L2ZyYWc6NGE4NWQ4N2ZkNDI4NDAxNGJhNTk3MWYwMTA4ZTIxYWIvdGFibGU6NjQ0OGEwMDNiOGRjNDllMDk1YTU5MzkwMmYwYjI0ZjUvdGFibGVyYW5nZTo2NDQ4YTAwM2I4ZGM0OWUwOTVhNTkzOTAyZjBiMjRmNV82LTEtMS0xLTA_ac21bbf4-e3ce-4f5c-9b28-8e6aa43db9a3">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i884da06b4bd14a7fb79a03bb4da156cf_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS0wLTEtMS0w_7e5cfe48-374e-473f-971c-bd2c1bc9a38d">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180Ni9mcmFnOjkwMGFmMTNlMTU2MDRjOWY5MWZlZWFlNTQ5OWMzYzY5L3RhYmxlOjFkNTM2NzY5YzAyYTRkNjY5ZmU3NWIxMjRmZWY3ZjM4L3RhYmxlcmFuZ2U6MWQ1MzY3NjljMDJhNGQ2NjlmZTc1YjEyNGZlZjdmMzhfMi0xLTEtMS0w_c5e60c25-c37c-4acc-875e-64b47b9d70fc"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8xNzI_e291e53a-6230-47d4-8541-41c90387fb4f">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6NTZhNjU1MGI3MTUzNDczNjlkNzU1ZjA0ODBmNTBjZDAvdGFibGVyYW5nZTo1NmE2NTUwYjcxNTM0NzM2OWQ3NTVmMDQ4MGY1MGNkMF8wLTAtMS0xLTA_4f0a6521-1868-493b-bf25-6aa07ee58dc5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yOTY_52f32836-ac6d-4a2a-9a88-1d4987121d12">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6ZmZjNTdjNTA3MjBhNDc0NWE5OWFiOGQ3ZTczZTM0OWQvdGFibGVyYW5nZTpmZmM1N2M1MDcyMGE0NzQ1YTk5YWI4ZDdlNzNlMzQ5ZF8wLTAtMS0xLTA_3204c4a4-8435-4058-b404-340e82e2b291">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE0_71f14c71-9aa5-454a-983f-81837dadcbb9">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8zOTg_18e50b9c-afaa-4d03-b0dc-205f2ef327ba">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8wLTAtMS0xLTA_71ae09a3-6fcc-4ae2-936f-802151df7c9b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8wLTEtMS0xLTA_b5fecb61-5b3f-4d6e-9888-17829d9577e8">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV8zLTAtMS0xLTA_a7073950-bded-4d87-bca8-7cf9cb37272b">5980 Horton Street, Suite 405</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV80LTAtMS0xLTA_5b1647ab-56df-48a5-b58d-984eb5b71315">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV81LTAtMS0xLTA_e9a0a722-1b4d-4ed8-aa45-a8b8bc33a09f">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6MGMxZDgxNDc4ZThkNDZhMjk2YzExYWEzYjdhMGEzYzkvdGFibGVyYW5nZTowYzFkODE0NzhlOGQ0NmEyOTZjMTFhYTNiN2EwYTNjOV81LTEtMS0xLTA_819c7d6b-1e50-4772-9426-b7cec2344ed8">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE1_89d1ffc0-9fd3-47a1-99cc-39073ee69283">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzE2_554b9056-c25c-4575-866a-951bc73f233b">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTAtMS0xLTA_dd269d1e-1912-4757-80c8-62da1a8fa080">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTEtMS0xLTA_999039f5-3452-4893-adc0-99cf6e24ac08">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6Y2IwNTVjOWEzZDQ4NDA1NjkyNGE4ZWU2ZDUxODA1NWUvdGFibGVyYW5nZTpjYjA1NWM5YTNkNDg0MDU2OTI0YThlZTZkNTE4MDU1ZV8xLTItMS0xLTA_38698b1b-d736-44b1-b54c-06c687e9b34d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzIx_94da4e81-ec69-42a1-909a-9268dc528a71">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzEz_fca28036-7eca-481f-8b61-6cb2c621a62f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8wLTAtMS0xLTA_83c05d98-3924-4b64-adff-ffa0d083f829">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8xLTQtMS0xLTA_ede73804-565c-4418-925d-24aed39bd97c">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGFibGU6OTk5NWFlMGUzZDBlNDg5MWJmMzYxZTE5YjJmNTczOTQvdGFibGVyYW5nZTo5OTk1YWUwZTNkMGU0ODkxYmYzNjFlMTliMmY1NzM5NF8yLTEtMS0xLTA_c1023d7d-f7f9-42f0-a0d2-0bb7a006bfed">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMzIy_dfdc1e7f-93e2-4619-93cc-156ef9a49ad3">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7ab881cb617a4e59b38742bf90e782ca_I20211105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xL2ZyYWc6YzNlMzZiYzEyM2RiNDBkMWE1ZTcyMDZkOTI3YjI1MTAvdGV4dHJlZ2lvbjpjM2UzNmJjMTIzZGI0MGQxYTVlNzIwNmQ5MjdiMjUxMF8yMjc0_257ab17c-9b0d-432d-8fbb-e25953e29da4"
      unitRef="shares">16711641</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMy0xLTEtMS0w_d3e220e7-872d-44e4-8666-7047506b1e3d"
      unitRef="usd">23430000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMy0zLTEtMS0w_48f4fe77-543e-4890-bb87-722580e40cf3"
      unitRef="usd">47619000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNC0xLTEtMS0w_68968f6b-6706-4df1-8986-7f5263b72d8c"
      unitRef="usd">299781000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNC0zLTEtMS0w_6905e1ac-14e7-41db-91a1-17672ec598c8"
      unitRef="usd">363567000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNS0xLTEtMS0w_e1744f93-647c-4efa-a1bb-b9bc4fd71338"
      unitRef="usd">64336000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNS0zLTEtMS0w_a7d6de1c-ae65-4e2e-b470-eee20d2f3f22"
      unitRef="usd">56847000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNi0xLTEtMS0w_c31b5a3f-0433-49ec-8ee8-584d63b9bfc3"
      unitRef="usd">32996000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNi0zLTEtMS0w_648e8c29-f1ca-498f-99aa-0ea067176116"
      unitRef="usd">26487000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNy0xLTEtMS0w_bc7e53c2-b819-4469-a338-95fc9cf6ac63"
      unitRef="usd">6378000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNy0zLTEtMS0w_350e5256-763a-4cbf-abd6-8843a95b2a09"
      unitRef="usd">2217000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOC0xLTEtMS0w_938cf480-18a7-4754-943f-67709b63856f"
      unitRef="usd">5161000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOC0zLTEtMS0w_ec79bd69-77e9-42d8-83a3-09d6a6d27f5e"
      unitRef="usd">3822000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOS0xLTEtMS0w_e36f57b8-35e3-4aa9-b2de-e2e81c10968c"
      unitRef="usd">432082000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfOS0zLTEtMS0w_daaea6c2-4f26-41dd-9a78-bb44a9103d1d"
      unitRef="usd">500559000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTAtMS0xLTEtMA_400c9625-f75c-4170-8e33-fb7478c3a3a6"
      unitRef="usd">26728000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTAtMy0xLTEtMA_7d366db5-dfee-4f61-9e91-799ab6a5a005"
      unitRef="usd">24320000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTEtMS0xLTEtMA_eb7a35c9-d3f0-4672-bb32-cd45ee87d046"
      unitRef="usd">562372000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTEtMy0xLTEtMA_2d1e7f59-480e-43ae-8465-599401036746"
      unitRef="usd">595330000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTItMS0xLTEtMA_a904b888-66a2-468d-a9e0-2de581f671c5"
      unitRef="usd">190183000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTItMy0xLTEtMA_0526cfb9-799d-4d3f-83e1-517834d92084"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTMtMS0xLTEtMA_618ea646-cc6f-40d2-b22e-e0d0e8ef5859"
      unitRef="usd">10748000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTMtMy0xLTEtMA_df7636f9-739e-41c0-b24d-8244fd4b5ba7"
      unitRef="usd">10979000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTQtMS0xLTEtMA_eb590857-2808-40b6-908a-493e08077813"
      unitRef="usd">18702000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTQtMy0xLTEtMA_8828eebf-7f1c-487a-9a30-012b2a4fe9da"
      unitRef="usd">14434000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTUtMS0xLTEtMA_24143c5b-77d4-4966-ad50-0f32820cbfac"
      unitRef="usd">12951000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTUtMy0xLTEtMA_07b65cc0-4eb0-412a-90dd-8b3bca1e764a"
      unitRef="usd">6892000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTYtMS0xLTEtMA_4771be63-6632-4149-91be-340c08d705e6"
      unitRef="usd">16795000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTYtMy0xLTEtMA_4cc85bf2-b49c-413b-a2e1-d849e9c9ce40"
      unitRef="usd">15842000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTctMS0xLTEtMA_73cf6fd2-d6d9-4d60-a310-c36e35522b8d"
      unitRef="usd">3095000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTctMy0xLTEtMA_78efba8d-f65a-4086-8786-9b7508838ce7"
      unitRef="usd">4267000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTgtMS0xLTEtMA_592017ae-4b1e-4ce4-b824-c1120de588a1"
      unitRef="usd">1273656000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMTgtMy0xLTEtMA_ea22ee87-a27b-4c10-9da5-28dc2a505a5d"
      unitRef="usd">1362285000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjEtMS0xLTEtMA_2f16cdc7-45dc-4915-8da7-b62ab7df2dcd"
      unitRef="usd">7233000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjEtMy0xLTEtMA_e0aae9c2-cc77-4eca-aed2-a7aa20184ddc"
      unitRef="usd">3784000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjItMS0xLTEtMA_bf668153-bbe4-41b2-8461-99d6910b1d8d"
      unitRef="usd">12237000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjItMy0xLTEtMA_2461ceb0-4ba1-4c40-aa53-278648c2c1af"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjMtMS0xLTEtMA_d1a03270-8eb9-477b-8b0e-8555fb24fd0f"
      unitRef="usd">2594000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjMtMy0xLTEtMA_45fdd229-00d6-4a74-a9ad-a46689629020"
      unitRef="usd">39884000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjQtMS0xLTEtMA_fd9068cc-00bd-4767-b423-f6b39607f2df"
      unitRef="usd">12007000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjQtMy0xLTEtMA_e319b42d-4dd7-4d24-8ccd-a3f8daaf20dd"
      unitRef="usd">29435000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjUtMS0xLTEtMA_65e4eb7e-9466-468e-8c5e-92e1a0e04fb8"
      unitRef="usd">2181000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjUtMy0xLTEtMA_0485ee35-47e8-4317-99f1-358d8e879b86"
      unitRef="usd">1885000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjYtMS0xLTEtMA_15b21f60-8eaf-4365-95dc-57de9c376e6d"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjYtMy0xLTEtMA_44fc5ec2-d161-416c-9bbd-0a1446e9546b"
      unitRef="usd">6593000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjctMS0xLTEtMA_8c9cc5a3-5362-4ff0-841e-cf9501720a66"
      unitRef="usd">36297000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjctMy0xLTEtMA_8dc5561b-754d-4a81-b593-32ade2851154"
      unitRef="usd">100111000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjgtMS0xLTEtMA_15fe66f4-c9b1-413a-8ef1-d7b63a4a11ff"
      unitRef="usd">316889000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjgtMy0xLTEtMA_e199d34a-c1c0-46b3-a274-7fd777e5efd7"
      unitRef="usd">442293000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjktMS0xLTEtMA_05a4327b-f968-4890-9a52-f0f60737d046"
      unitRef="usd">6782000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMjktMy0xLTEtMA_f988ac91-8415-4a7e-822c-4e3eb57dd513"
      unitRef="usd">9249000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzAtMS0xLTEtMA_ea741e01-e27b-4387-8a41-2c5ee7f9518a"
      unitRef="usd">63026000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzAtMy0xLTEtMA_8f5a9998-d5cd-405f-b185-068f6d7cd900"
      unitRef="usd">64598000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzEtMS0xLTEtMA_14fc541d-dcb5-41d1-a254-212a89093b1b"
      unitRef="usd">11467000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzEtMy0xLTEtMA_c2fe509e-7828-4604-81a0-526854277a9a"
      unitRef="usd">5643000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzItMS0xLTEtMA_35a3c3ab-ad56-4d32-a723-056e715e5058"
      unitRef="usd">27129000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzItMy0xLTEtMA_42c4cc01-cd7e-4c05-8490-eb64c35ed5f7"
      unitRef="usd">30866000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzMtMS0xLTEtMA_b39ebf54-61b1-46a1-b7be-976dd7732642"
      unitRef="usd">461590000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzMtMy0xLTEtMA_ba36ff0c-eab8-4f0c-a5ce-f990eba03b7c"
      unitRef="usd">652760000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzQtMS0xLTEtMA_f4a1fb77-86be-4e1a-9b4e-97a0e2958c54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzQtMy0xLTEtMA_8e8cd217-d7e8-4e10-b1bc-b1e6a58d2385"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzI0_c44a7adf-5ec9-4b32-91e2-f4d5a84f29d5"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzI0_ee7f374e-17f1-40ef-86c3-6ab667891fa5"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzM4_701decf6-9fbf-4d2d-a3cd-7820b69a78ce"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzM4_f027113f-d906-4d17-9f89-e27bcd57f079"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_2deb7c53-ab35-499f-ada8-997eff6e35a7"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_38af3857-67f7-4d09-86cf-8ff6b0112e6f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_85c7237d-524f-49af-9086-4edcd7580363"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjYWQ5YjU1MmNhMjQ2ZmU4OTY3ZmY2MTcxNjRlODI0XzYw_ac677f7f-59fc-48bf-a95e-184f2ba11a61"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMS0xLTEtMA_0ca80b77-9b72-421c-8185-1e8aca5481a7"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzYtMy0xLTEtMA_9982ab60-cee6-41bd-9358-0e788f490815"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzIx_7b523ca4-4d68-4462-b9cd-e19954c87fbf"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzIx_c25dd3a4-f489-4362-9345-b75155154a13"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzM1_938f2f3e-1447-41e4-98e7-c6ac245bf82b"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzM1_df03e072-c1c5-4de6-88c0-b5932adb9ce7"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzU3_35284cb0-fdad-42da-905d-ae1eecf93e46"
      unitRef="shares">16707000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzU3_e0d63792-adba-4a3f-b519-82ee9abb6e8c"
      unitRef="shares">16707000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzY0_59d87f4d-7494-46cd-8d69-50b7c332bb48"
      unitRef="shares">16080000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjc4ZmQyYjVkNWMxODRmZGY5MjNkNTFkMjMzOWY0MDE3XzY0_c959aee5-165a-4753-a979-4bfd013e5eeb"
      unitRef="shares">16080000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMS0xLTEtMA_7d5aeb38-79c6-4382-bceb-17b6f35d0aa4"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzctMy0xLTEtMA_e9f6b208-4339-4b3c-b0c7-78aa43fb9462"
      unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzgtMS0xLTEtMA_7741229e-2197-4826-bfaa-8e09233ca15a"
      unitRef="usd">358418000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzgtMy0xLTEtMA_35c96a92-3df6-40e4-a5ba-29a06622b0e3"
      unitRef="usd">318358000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzktMS0xLTEtMA_44e53dad-c1e7-4f4e-8651-02b9e95c3b16"
      unitRef="usd">-875000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfMzktMy0xLTEtMA_5f1aa5b3-6aa9-4b21-b3d5-043ab55ea1cb"
      unitRef="usd">-801000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDAtMS0xLTEtMA_b30c33d2-4c1d-4286-accc-f408e9f796da"
      unitRef="usd">454506000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDAtMy0xLTEtMA_ebf42bc4-8054-466d-999f-75beb15a53b5"
      unitRef="usd">391952000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDEtMS0xLTEtMA_c3a7c4e9-a5e1-4ad4-b6f6-fa4697d124e6"
      unitRef="usd">812066000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDEtMy0xLTEtMA_c6b74fb2-3e3a-40a0-b3c5-4b083d39f122"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDItMS0xLTEtMA_ea971f3e-a06c-4f66-abaf-7233e591bf44"
      unitRef="usd">1273656000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xNi9mcmFnOjNmNDEzNmM5NDRkOTQ4MTdiNTk1ZTU1MWYzMDJlMjM1L3RhYmxlOjJmZWM2NTEwODk0NzQzOGQ4NDdlNTc2ZDlmNTQ5ODIyL3RhYmxlcmFuZ2U6MmZlYzY1MTA4OTQ3NDM4ZDg0N2U1NzZkOWY1NDk4MjJfNDItMy0xLTEtMA_7a3d1a66-1161-4618-a42f-8dd7e5dbda9b"
      unitRef="usd">1362285000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC0xLTEtMS0w_07b91d9f-a6be-4c44-86e7-84c847fa2186"
      unitRef="usd">15648000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC0zLTEtMS0w_73cb0a2a-a353-4096-8188-20d533d16246"
      unitRef="usd">9005000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC01LTEtMS0w_59defe78-107c-48fa-94c5-42b9dbb6c0a1"
      unitRef="usd">31376000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i65684440034d4351bbb21abccb7fca41_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNC03LTEtMS0w_df0e125d-3663-4d63-90f6-b409b55f18ce"
      unitRef="usd">22751000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS0xLTEtMS0w_d019b96f-acdf-4d48-b0b6-6ee122274c8e"
      unitRef="usd">35093000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS0zLTEtMS0w_c75bc198-6320-46e4-992f-b1bb9e96b408"
      unitRef="usd">23389000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS01LTEtMS0w_0a151fb9-2cae-45ff-9a75-592bd08dc415"
      unitRef="usd">128875000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib4670676853e4b26a40950b991482733_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNS03LTEtMS0w_82f1bfd8-7f8e-4915-90ec-aa1321aa9573"
      unitRef="usd">68966000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi0xLTEtMS0w_1ae28e74-d3c3-4222-a868-aae9464e3aa3"
      unitRef="usd">14094000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi0zLTEtMS0w_13fdec2b-2698-4823-8a8c-22defb4498db"
      unitRef="usd">9454000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi01LTEtMS0w_ab5f4cd2-8dce-4b90-b957-9dcb73e1a2fa"
      unitRef="usd">44409000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNi03LTEtMS0w_ddb7b15c-03b7-46cd-aa05-86b849920a75"
      unitRef="usd">24712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy0xLTEtMS0w_a17198cb-d513-45c6-929f-9189e734df28"
      unitRef="usd">64835000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy0zLTEtMS0w_bcb1ce1e-1a86-4de1-b463-5ee07b8e11ba"
      unitRef="usd">41848000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy01LTEtMS0w_fa524a00-ee77-4eac-ba89-e619a4df8a84"
      unitRef="usd">204660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfNy03LTEtMS0w_653f381a-0239-44f7-8bfd-780639ef5513"
      unitRef="usd">116429000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS0xLTEtMS0w_784dd07b-969c-4fb0-9b75-23d6c03426e1"
      unitRef="usd">11446000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS0zLTEtMS0w_4f1a190a-7d92-4a34-b5a7-93bcb2b9a577"
      unitRef="usd">6353000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS01LTEtMS0w_b1e9ce8e-96e1-40b4-a61e-4c2c24cba8a7"
      unitRef="usd">50192000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfOS03LTEtMS0w_74335d90-b49e-44bc-b38c-590a141f32e1"
      unitRef="usd">18680000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtMS0xLTEtMA_a70ef5d9-33bd-48bc-87bd-4ce1345a91e6"
      unitRef="usd">11827000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtMy0xLTEtMA_35307989-3d25-4a1a-8066-d89aae8957d8"
      unitRef="usd">3875000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtNS0xLTEtMA_dc89e906-3a75-4820-b6e6-5c1ed50a2b3d"
      unitRef="usd">35391000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTAtNy0xLTEtMA_f794c7ef-05ff-45cb-a16d-7d8c509f0007"
      unitRef="usd">11285000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtMS0xLTEtMA_921b5be4-095c-47b0-9edd-d1b2010b9a68"
      unitRef="usd">16938000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtMy0xLTEtMA_e90034ad-d16f-42c4-8de6-7653e46fbb38"
      unitRef="usd">12853000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtNS0xLTEtMA_bc95fd69-117e-46dd-be65-8d2af6cfb48f"
      unitRef="usd">50769000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTEtNy0xLTEtMA_cc176ca9-25c1-44dd-8ec7-96f971fed29f"
      unitRef="usd">37476000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItMS0xLTEtMA_5a163cd8-8a71-46f5-88b5-7f60842bbf34"
      unitRef="usd">12718000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItMy0xLTEtMA_5a2f219a-4a75-49ac-91ee-abc668fdd19e"
      unitRef="usd">15020000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItNS0xLTEtMA_a0c7f2a3-45c1-4df1-98df-e83748f66cd0"
      unitRef="usd">39747000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTItNy0xLTEtMA_eaf2b3c1-2d08-4e01-b446-502c474d1859"
      unitRef="usd">34353000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncome
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtMS0xLTEtMA_6df8551c-d5fe-4867-97dc-569c3bbd1330"
      unitRef="usd">3800000</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtMy0xLTEtMA_b0fae43a-fc8b-4f85-96c6-8abd50aceb77"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtNS0xLTEtMA_62207610-d319-4056-86cb-c162b0b26aa7"
      unitRef="usd">37600000</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTMtNy0xLTEtMA_76583598-fe76-49d3-9a6a-c1b6cd240cff"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtMS0xLTEtMA_83e24685-5e6b-43ea-ba84-9f432f56d9f5"
      unitRef="usd">49129000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtMy0xLTEtMA_3fb8c34b-7115-4bc5-b745-37287eec0e23"
      unitRef="usd">38101000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtNS0xLTEtMA_5bc3b4f2-35ae-4fd1-a612-d7681db25f22"
      unitRef="usd">138499000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTQtNy0xLTEtMA_c9a33c80-aebb-483b-974a-aa3aef8271b5"
      unitRef="usd">101794000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtMS0xLTEtMA_335b2da8-2011-4d98-b1da-3162444b2142"
      unitRef="usd">15706000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtMy0xLTEtMA_82eb8de4-da4a-4d52-b5aa-bda6e61b3c4d"
      unitRef="usd">3747000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtNS0xLTEtMA_d1207552-0764-42e7-8511-d64f0998eefe"
      unitRef="usd">66161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTUtNy0xLTEtMA_de0976a2-a3a9-4b71-9268-12e19b8d071f"
      unitRef="usd">14635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctMS0xLTEtMA_7d03335d-5c1d-4945-a1ff-e10acabe13d2"
      unitRef="usd">1937000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctMy0xLTEtMA_9f7cd697-2843-48e6-b098-54a0a07ff168"
      unitRef="usd">-9862000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctNS0xLTEtMA_64538605-ef4e-4ce1-985f-a4fe390bc586"
      unitRef="usd">8135000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTctNy0xLTEtMA_a6585aff-5bb8-4e9d-92d5-5ef5a025e3ce"
      unitRef="usd">-17143000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtMS0xLTEtMA_45bddb9b-cf7e-46c3-ba44-aa2e1c943ea0"
      unitRef="usd">169000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtMy0xLTEtMA_ec11ff44-651d-4efc-9653-f02a50c7af72"
      unitRef="usd">991000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtNS0xLTEtMA_048a7612-271a-4549-8742-868cf450c5ca"
      unitRef="usd">698000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTgtNy0xLTEtMA_259a7227-704f-4096-a0d5-977e3e564428"
      unitRef="usd">7690000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktMS0xLTEtMA_fa6d1323-40a1-4932-8997-fa947fe9f0e3"
      unitRef="usd">4439000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktMy0xLTEtMA_e66aa34d-d4a2-4ddc-b1d7-a7468d825d0b"
      unitRef="usd">6269000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktNS0xLTEtMA_bee2ad7d-dae0-48ef-8794-0fd0e8ca5340"
      unitRef="usd">15154000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMTktNy0xLTEtMA_f4647e1d-fe9a-4f36-b8ae-0c62dd99085f"
      unitRef="usd">21030000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtMS0xLTEtMA_3ac9cd2b-a625-4581-b79c-0c9ed5cdef66"
      unitRef="usd">1886000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtMy0xLTEtMA_33bc43bb-640d-4612-9298-0427d27e108c"
      unitRef="usd">-219000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtNS0xLTEtMA_f326a173-7127-451e-a44b-f2be8fac0f7b"
      unitRef="usd">-5516000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjAtNy0xLTEtMA_0c705b73-8172-4193-9001-1da544da6e9d"
      unitRef="usd">1940000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtMS0xLTEtMA_a4c058f2-8117-408e-8502-366b8b05384c"
      unitRef="usd">-447000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtMy0xLTEtMA_3b2527af-4400-4653-a79a-d8929755d579"
      unitRef="usd">-15359000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtNS0xLTEtMA_d1402c1e-2cbc-42b3-bc8f-241f34a9df8c"
      unitRef="usd">-11837000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjEtNy0xLTEtMA_6fe21d0c-1b4b-441b-a06a-8ec3b9f970e5"
      unitRef="usd">-28543000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItMS0xLTEtMA_f5092021-6036-4bab-b05e-ac09b4312615"
      unitRef="usd">15259000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItMy0xLTEtMA_349055e4-4898-4b36-8dbf-f8821f4f1dc9"
      unitRef="usd">-11612000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItNS0xLTEtMA_ae50c7d9-81c3-4fd9-8faa-c96868173fe0"
      unitRef="usd">54324000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjItNy0xLTEtMA_27e657eb-7eca-4d30-a144-c41289d4e8a8"
      unitRef="usd">-13908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtMS0xLTEtMA_b64273cb-13fc-486e-8731-3eb502c2680d"
      unitRef="usd">1536000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtMy0xLTEtMA_11d3d868-aaa8-4409-877f-ecf3e9782335"
      unitRef="usd">-4911000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtNS0xLTEtMA_fe3ebd4f-ecfe-48e3-8a49-9409af05f351"
      unitRef="usd">-8230000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjMtNy0xLTEtMA_48145f6b-75a6-484c-8259-6f6516178810"
      unitRef="usd">-5162000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtMS0xLTEtMA_b283494e-24e9-4ff8-a3a4-335c672525ba"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtMy0xLTEtMA_2ff27c57-d5aa-49c6-9604-c0efe01b0a30"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtNS0xLTEtMA_e33857d6-c624-4751-8688-c7f9047dd13e"
      unitRef="usd">62554000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjQtNy0xLTEtMA_388c5292-95bf-44a9-9da6-0726c136f84e"
      unitRef="usd">-8746000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtMS0xLTEtMA_a6b2c22d-b537-49fc-811f-d95cd8352429"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtMy0xLTEtMA_00bcb5ba-2a2a-4e7c-88e9-9179a2524efb"
      unitRef="usdPerShare">-0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtNS0xLTEtMA_18513e21-c3fc-45bc-ab07-6660f211b2ae"
      unitRef="usdPerShare">3.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjYtNy0xLTEtMA_9fa0ebdc-947b-4cf0-baf8-07d9254ebd28"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctMS0xLTEtMA_0150144c-58cf-470b-8e37-2216dc65ddb2"
      unitRef="shares">16688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctMy0xLTEtMA_fb7f9353-7346-46b6-9109-d2c8d1e5cfba"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctNS0xLTEtMA_2515663d-e35d-4958-8613-31023ec76713"
      unitRef="shares">16595000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjctNy0xLTEtMA_970d173b-4275-4773-b14b-e02f865f3d62"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktMS0xLTEtMA_6173bb06-b369-421b-9395-d448dad37016"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktMy0xLTEtMA_3e7ad77a-6118-4c9d-a384-253017dd3296"
      unitRef="usdPerShare">-0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktNS0xLTEtMA_fbdc0b6e-0183-4fb7-b291-5e8544ac0192"
      unitRef="usdPerShare">3.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMjktNy0xLTEtMA_daebe81c-c19f-4ba4-8d70-9296f18c9a8b"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtMS0xLTEtMA_8ca28295-3672-44ba-b0e2-9542b364713f"
      unitRef="shares">17142000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtMy0xLTEtMA_a03ac432-b965-4524-a8ea-58e4d27e7506"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtNS0xLTEtMA_7c2f5bb1-6a06-4483-aff3-7927b7623799"
      unitRef="shares">17187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18xOS9mcmFnOjJmYTRjMDAwNmVlNjQ5YTY4ZDZhMTgzNTVjMzE3MjA3L3RhYmxlOjE3ODA5Njg4MDQwNjQ2MzlhNTFmNjY0ZDZmNjc2MzU1L3RhYmxlcmFuZ2U6MTc4MDk2ODgwNDA2NDYzOWE1MWY2NjRkNmY2NzYzNTVfMzAtNy0xLTEtMA_aede1396-7c47-41bd-aa01-97734c396e66"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy0xLTEtMS0w_b0a1d0cf-8745-4dd5-873f-3dfef5538ac7"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy0zLTEtMS0w_45bbfd18-c30c-4281-8345-08f4a8cedb27"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy01LTEtMS0w_e5c03746-34f5-4be6-a11a-2e72102c1fe2"
      unitRef="usd">62554000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfMy03LTEtMS0w_b8b67be3-2553-4e9b-9092-01ad90195a16"
      unitRef="usd">-8746000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC0xLTEtMS0w_dd5b21f0-7e62-4433-ad50-b39e4e0b9057"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC0zLTEtMS0w_eaa1a986-ac1a-42a2-85bc-2dccb3120297"
      unitRef="usd">-54000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC01LTEtMS0w_0497e17a-3a77-4875-a887-3fd261483ce8"
      unitRef="usd">-74000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNC03LTEtMS0w_61b4f5b9-b732-4ce3-ba29-1c283a370a52"
      unitRef="usd">-84000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS0xLTEtMS0w_ab666839-06e3-4e86-b7be-20b3b02e9346"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS0zLTEtMS0w_0132cd63-bc90-4884-b354-d0a5eae76691"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS01LTEtMS0w_997c0d08-27a3-4724-9913-1ebc2f815af7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNS03LTEtMS0w_f477a5ca-6b86-4a53-97a7-f45465012956"
      unitRef="usd">-1141000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy0xLTEtMS0w_3b2d6f90-c4cd-4cd7-952d-925c3aea7787"
      unitRef="usd">13709000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy0zLTEtMS0w_6c0af412-1d70-40c4-a272-7b9be6e28b8a"
      unitRef="usd">-5832000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy01LTEtMS0w_954b1540-59f1-40ca-8a7a-2a302ed690a9"
      unitRef="usd">62480000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yMi9mcmFnOmM5ZTdjOWU0MDNjMDQwNzVhYzE2MTA1NWJiOTYzNjU2L3RhYmxlOjMxMDU1MWY3ZWI4ZDRhODM4NTU4Nzk5MDY0Zjk4ZWQ1L3RhYmxlcmFuZ2U6MzEwNTUxZjdlYjhkNGE4Mzg1NTg3OTkwNjRmOThlZDVfNy03LTEtMS0w_0e150cbc-81f4-409b-ae23-17d5134ab8cd"
      unitRef="usd">-9971000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0xLTEtMS0w_2c18483d-ea82-4188-a206-18fa6722dc09"
      unitRef="shares">16080000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7b4ff542806a470289cbdfa1c07eb9c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0yLTEtMS0w_45c8d0a1-27fa-478b-b2e2-51ceedcac134"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a6e84a61d1143bcacd2e9bc175b9653_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi0zLTEtMS0w_b3e483bc-8bbb-475c-a39a-6325540a3c6a"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85f271f1a4be4452910a076e9e38a6b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi00LTEtMS0w_7a71375e-e7aa-470d-8b96-112f0ec21519"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id27dffce40b144a3bbcefdd5cdb11b20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi01LTEtMS0w_e1a4d580-a80a-438e-a6c9-9ce994738ece"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMi02LTEtMS0w_97f5aa42-8fe8-4846-a6c2-c429a53e5c2a"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0xLTEtMS0w_04686d2c-6c09-4a73-845b-264ae79edb4e"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i299fd8837f3a4e94911ef50677944a7d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0yLTEtMS0w_6033f445-c87c-42a0-b1b4-6963004be5c0"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy0zLTEtMS0w_ddacecef-71cd-4956-a65a-ab786d820d56"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMy02LTEtMS0w_5d486bff-53f0-4564-990f-1e17b37263c2"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNC0zLTEtMS0w_fbdc82c7-2f4c-486c-be23-6bd015c3b984"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNC02LTEtMS0w_44b5f166-c4bd-4fec-9038-701965da6b3b"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i0a809d62daa64f1f84d03e014e249993_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNS00LTEtMS0w_9abd9ee6-601f-46ae-979c-bfa25c64b940"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNS02LTEtMS0w_a25042f4-b5cf-4b8b-870f-5728da0ed07a"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNi0zLTEtMS0w_782c7667-e1e6-4688-9489-7f05a21b482d"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNi02LTEtMS0w_22f76b75-eb82-49e8-bb64-3083301e5787"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNy0zLTEtMS0w_c2e7430a-00a3-4673-b4b3-ce40b4ea8f2e"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfNy02LTEtMS0w_5d7211d0-2f77-4c74-9b95-97288c0b7594"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i9ac77a6641084797a82e60743e3a717b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOC0zLTEtMS0w_8ceba7db-6df9-4d2b-b52b-1e778f92f75e"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOC02LTEtMS0w_3d189678-9e29-466a-9e2e-5a08f62d68fb"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i4953df0e32ff45209345ad4e8b35fb8a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOS01LTEtMS0w_2229073e-d07c-4cb1-a697-983d8425ad46"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33eef467e9284bf88d251d2a9568dae4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfOS02LTEtMS0w_8da2c93b-db0a-4661-8489-cc1b352d9a61"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i3900ef9761864a5da679ba7019815ea2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMS0xLTEtMA_e16059dd-8c21-4fef-a3d0-1a167df48f9e"
      unitRef="shares">16652000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3900ef9761864a5da679ba7019815ea2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMi0xLTEtMA_dcf41b09-4faa-4a46-a4be-5bdc1c4337f3"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i22edb6dc65c04766b217ddab8475edd8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtMy0xLTEtMA_1492ddf7-a3fe-411e-b866-7d69819fa7de"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbba22d1af0c4452af7b0fe4b452c084_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNC0xLTEtMA_d1522b25-9bca-4805-b5d7-ae475587dd05"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15280da5985442f1b70dfcfa3a99ba5f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNS0xLTEtMA_e78164e6-fc70-4a41-bf30-15cd86b9f9fe"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0e91036a56e048da812d1bbbff52ea15_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTAtNi0xLTEtMA_7df2fb6a-463d-4ef2-8b6a-3080062a1946"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="idf86e369b16b4f3d80c4a30e22e652cc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtMS0xLTEtMA_82ec2216-7d4d-4157-afac-9edaa0ce9337"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtMy0xLTEtMA_f7ea1b14-fe30-4772-8271-0056ba95bfa4"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTEtNi0xLTEtMA_8588222c-cb82-4d92-9f52-ff5917628b3c"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTItMy0xLTEtMA_61de69b3-cb2e-40e5-a6b4-b8c4670c439e"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTItNi0xLTEtMA_9f66c41f-e12b-4f0c-9684-04ed9dc23d6e"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i4a4a9f3d2bb74346a035eb74bdbf6297_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTMtNC0xLTEtMA_528b1a6e-cb1b-456e-98b8-741046293759"
      unitRef="usd">-5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTMtNi0xLTEtMA_e733759d-3680-4670-ae71-87d768b3517c"
      unitRef="usd">-5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTQtMy0xLTEtMA_85518aa8-c785-40b4-b0e3-d82b768f4b58"
      unitRef="usd">-1073000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTQtNi0xLTEtMA_fdf225e0-00cd-4685-aa43-8364fad51fca"
      unitRef="usd">-1073000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i25fd1602c4ad463db133eee5d22fd887_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTUtMy0xLTEtMA_dc1109fa-0823-460b-a883-ff78a785b65f"
      unitRef="usd">289000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTUtNi0xLTEtMA_11a342c3-c957-4eb1-8205-1dc2b1d77666"
      unitRef="usd">289000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="id39bf6178fe24db2893e758597f0029c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTYtNS0xLTEtMA_072c6fc2-6dd8-4e5f-af08-ffd0e0058de1"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3fb0bcf199d3413cb2d3b547b2e9b47c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTYtNi0xLTEtMA_9b1eab27-aa8f-4c95-8da8-971f2f6723e3"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i889f7f0228dd4a588bb93484a5eccbf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMS0xLTEtMA_4498fc68-f156-4b98-952f-d52fa50683fd"
      unitRef="shares">16676000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i889f7f0228dd4a588bb93484a5eccbf0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMi0xLTEtMA_46b90b9e-33b6-4ab0-a83f-faf07203e35d"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i360c33d3bf9d4071a521470504bb754a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctMy0xLTEtMA_00de3e6c-e852-47f4-8902-9ff841187e30"
      unitRef="usd">346578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib5d0533630774219a96e8ae0dd341679_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNC0xLTEtMA_dbcfd820-7956-40be-a4dc-4f3119622f72"
      unitRef="usd">-861000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55c6430609ca42e2af4e70d120723e15_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNS0xLTEtMA_ba16bad4-1982-4bb5-9c68-04d6a422187c"
      unitRef="usd">440783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0669b1b589ed4c0aa5c0f53d9af109bd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTctNi0xLTEtMA_6a5b5763-92f7-458c-8cb5-e24c7aea7ab4"
      unitRef="usd">786517000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9c8ef6df76594ccf9ac7aa43bca3d664_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtMS0xLTEtMTY1_4f2b1139-f508-4c03-92bc-d37fd6d9566b"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtMy0xLTEtMTc1_e3c39f7f-7a7c-463f-891a-702aab1d8814"
      unitRef="usd">1898000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTgtNi0xLTEtNDM2_cf93770a-f241-437e-b975-b23733a23e57"
      unitRef="usd">1898000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTktMy0xLTEtMTc1_88e789e2-2ef0-4379-9fbc-7f3ed5bb2d37"
      unitRef="usd">9754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMTktNi0xLTEtNDM5_99b0d25b-93ff-43c5-b01b-286fa397cfd4"
      unitRef="usd">9754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjAtNC0xLTEtMTc5_9ce2c5a7-8964-43b7-9fac-aec93f121528"
      unitRef="usd">-14000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjAtNi0xLTEtNDM5_bd0c6560-fe39-42e8-a5cf-37b1325bc50a"
      unitRef="usd">-14000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMjg1Njc_e5ad5331-5a0f-41cd-b724-9b30ecfcd190"
      unitRef="usd">-32000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtMjg1OTA_38665fac-32e5-4a71-a6bb-ad82e6370fcf"
      unitRef="usd">-32000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMjg1MTI_22bd8440-b622-4a34-8bf1-69e55d08fdc7"
      unitRef="usd">96000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtMjg1MzM_b00b238e-6312-4a88-8960-30d7e822f7ab"
      unitRef="usd">96000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i48eecaf7dcdb42c6af14668aaaeeac01_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtMy0xLTEtMTc1_39eed239-0358-4318-8cbb-6131429bcaaf"
      unitRef="usd">-124000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i4dd908c239474b8fab32391b7a4ebeaa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNC0xLTEtMTc5_d03d22a1-4972-4893-930c-eea095ab6992"
      unitRef="usd">0</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjEtNi0xLTEtNDM5_05b187ec-6fdb-4d0e-8ec8-cdca0e924ddd"
      unitRef="usd">-124000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i0bd7d1d9820346ebbdd910ea23ae5fb5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjItNS0xLTEtMTgy_fb42a169-246a-40c5-aa67-f01d4370b7b7"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjItNi0xLTEtNDM5_7f80e2ec-be3e-4891-bb88-d6cec9bc6a7f"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i1cb3e3ce39174efb90c579734662ca3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMS0xLTEtNDQy_a9c6d457-8355-4c45-a2a8-b4dce4adec7b"
      unitRef="shares">16707000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1cb3e3ce39174efb90c579734662ca3c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMi0xLTEtNDQ1_db420cf3-604f-4bb0-9621-521785fc1911"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c504584f2b44bccbb4c98df81a0c187_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtMy0xLTEtNDQ3_289a20f9-c1fc-48ea-9cce-d42e55e8c357"
      unitRef="usd">358418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40e9fc954e0f4c6fac4befb25a43a7e8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNC0xLTEtNDQ5_26a67c2d-b4cd-46dc-b22e-0a3548e0a4c0"
      unitRef="usd">-875000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48d0b1e6a3e246f8a27e20041ff8cda9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNS0xLTEtNDUz_dea911cc-a629-46bc-816e-5fa814a8b5d1"
      unitRef="usd">454506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOjJkNzNhNjM4NWEyYzQ0YWM4MTU2YjUwN2I4OTJjNDNlL3RhYmxlcmFuZ2U6MmQ3M2E2Mzg1YTJjNDRhYzgxNTZiNTA3Yjg5MmM0M2VfMjMtNi0xLTEtNDM5_4d3a0598-5df5-43d5-b173-d32f23dfc66a"
      unitRef="usd">812066000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="icb20171945fd40e794706d8def23874e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0xLTEtMS0w_2cccc8e4-da45-417c-b0d5-cada14d25787"
      unitRef="shares">16823000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icb20171945fd40e794706d8def23874e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0yLTEtMS0w_597e0df1-d78d-47ea-a076-311a42c7b479"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i77dec1bdfce142efad4f356566506009_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi0zLTEtMS0w_1d7311e7-4da8-4576-b5f9-01561a9c5a63"
      unitRef="usd">367326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i350b26fa15fe439082f315dc8c0738d1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi00LTEtMS0w_c2d21567-4cc8-4053-bb3f-076751769b3d"
      unitRef="usd">-216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f9e33b34b6a4201ae924131d1884ef5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi01LTEtMS0w_079faa88-d389-4b1d-9314-7c6f433d4439"
      unitRef="usd">400105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic8a4a953d5304f198ee6f152d7aeea35_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMi02LTEtMS0w_dc2371e0-c046-446c-a4c6-4410d7aa504b"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy0xLTEtMS0w_a55ef00b-43c0-4c3f-b039-ac5272a0e5e7"
      unitRef="shares">105000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy0zLTEtMS0w_e4f586d6-2fa6-4c36-b57d-cdb1532d7d5b"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMy02LTEtMS0w_4fe78e7c-ddb9-4a3f-a305-bc244fffc061"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNC0zLTEtMS0w_46877318-a33b-41d5-91c2-ef0f1148d5a1"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNC02LTEtMS0w_f683c0e6-16b5-45d9-85d6-ab18aff1e376"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0xLTEtMS0w_276cee97-d841-423c-a068-e8fecf2a7e0d"
      unitRef="shares">878000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0yLTEtMS0w_f32a312b-740b-4880-8020-7af940da4114"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS0zLTEtMS0w_ee485937-3cec-48b1-8641-a43e1211d744"
      unitRef="usd">73286000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNS02LTEtMS0w_8332d2b7-db3c-45db-8e86-5111f201829a"
      unitRef="usd">73287000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ia085df13296843368baeb5805a91e5d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNi00LTEtMS0w_d80680ac-9d35-4a5f-a7f5-5a02b54f0b44"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNi02LTEtMS0w_7e4ffd23-7777-4374-b4b4-b22464a418d8"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ia085df13296843368baeb5805a91e5d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNy00LTEtMS0w_129675ea-24c7-4742-950a-bb56358a5b4a"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfNy02LTEtMS0w_5058c678-9ba4-4e96-b748-82dd3a103a11"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i1d050b96fcd04c5fa7c17fe7e6bb9cdc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOC0zLTEtMS0w_70337904-5763-44e8-9336-f4e2c124f228"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOC02LTEtMS0w_23bfaee6-c670-47b1-a9f6-ce2d51790b8d"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockholdersEquity
      contextRef="ia51a04f07e094d73b253c1b38304f355_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS01LTEtMS0w_dca2d9f6-fa0b-450a-b0ee-16c9277bde03"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24fe1222cc784553a37d8ab3fd25236d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfOS02LTEtMS0w_524391ba-b86c-48e4-9030-19daee8f72ba"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2fa5703dfd6f42c5a03262f6a827081a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTAtNS0xLTEtMA_46f7b893-f45b-4114-bc23-8d722b6bc666"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaada7c634ba8474da512d18baf189633_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTAtNi0xLTEtMA_16313fd8-bc52-41cf-bee6-2d5d53e9d0ce"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="id70967578d4d40a9bde681ed44e00bf3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMS0xLTEtMA_0ba53c08-bca5-4311-ae7d-b9e2733a8334"
      unitRef="shares">16050000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="id70967578d4d40a9bde681ed44e00bf3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMi0xLTEtMA_54eb8fc4-95c3-48bf-8fc2-7f6a84afa4dc"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b2271fc765142b1beb4cf28d365bb6a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtMy0xLTEtMA_79145239-400f-4e43-9454-d8931ddb867e"
      unitRef="usd">295940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib91f3032f13b419e96960180df7a57a0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNC0xLTEtMA_1be8da91-e69c-4a78-8b4e-b02ac895595a"
      unitRef="usd">-4867000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia056a39a1d1646b08db6232475f0fe3d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNS0xLTEtMA_10990d89-aff8-456e-8f2b-dce37d84cc6d"
      unitRef="usd">370807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if07b2a7f22b749b2b75f7867f5ca9d61_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTEtNi0xLTEtMA_ab089060-6a57-44da-98db-58af1a270b96"
      unitRef="usd">661896000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9e955a2670f14c5589acd8fae1849f37_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItMS0xLTEtMA_00d1c02f-7a82-4662-97a9-bcebe4395e40"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItMy0xLTEtMA_12ca323f-8d2f-48b9-948b-0f9122f83f36"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTItNi0xLTEtMA_dba39d93-3853-48ab-b5b0-92bfa63758cf"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTMtMy0xLTEtMA_2cd19119-d606-4eef-96ca-ef0b25aa147d"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTMtNi0xLTEtMA_83a3be18-fd30-49d2-93cc-cac0ea22ce56"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i7133362acc234799828e1697270f098b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTQtNC0xLTEtMA_9102a8bb-8477-4dd3-8205-ef84807b5fac"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTQtNi0xLTEtMA_0ee0d2b0-f4df-4f52-ad01-decfbc58c82b"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i7133362acc234799828e1697270f098b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTUtNC0xLTEtMA_bbc6c204-596c-4bbb-a93f-225b4cab389b"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTUtNi0xLTEtMA_70d343ce-28bf-4201-ac1a-10ec160694d7"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ib7cd49b71791465987ea10bac5e2cee3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTYtMy0xLTEtMA_10e22ed5-3330-47f5-9882-a48106fb40c4"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTYtNi0xLTEtMA_971b5c16-1e40-4dc9-82d8-0bdbf8cc9a36"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i1f36701c729b4ca08acd79e998f584cf_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTctNS0xLTEtMA_b32b8f57-9731-4192-8684-e6f608eb8d1d"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iea6d9482600c479fadc3593d1d0badfb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTctNi0xLTEtMA_797ede9b-d21e-443d-b366-9c0f1aef01f1"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i0af9313f05af401bb4da9b72af20c7bc_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMS0xLTEtMA_8f35cc47-bdc8-4da5-98cd-264a13a29aa5"
      unitRef="shares">16071000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0af9313f05af401bb4da9b72af20c7bc_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMi0xLTEtMA_997d5465-9632-4353-8a9c-b58b9d41b664"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3084043063c5478084965f63fc694456_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtMy0xLTEtMA_f7d4af22-d451-4540-a47c-932f2c27e221"
      unitRef="usd">304404000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70eb5532b8c24ecf95a7e0ba1196f93b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNC0xLTEtMA_c52eee97-6fe3-4487-8ffc-adf1764cfc4a"
      unitRef="usd">-2310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2891e29ad7f442385683c6dfa1a990e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNS0xLTEtMA_b3fbca6f-fae5-414d-9fb1-14641fb336ea"
      unitRef="usd">392893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iede4b1a3266f4aa58150416db0b81f06_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTgtNi0xLTEtMA_638d9993-9135-4f15-b344-c1ca1a79446a"
      unitRef="usd">695003000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i94c5045f7c634a6ab1162b5156068143_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktMS0xLTEtMTI3_ea1dd252-7b80-4ce4-bdd7-ad48cb7d2f89"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktMy0xLTEtMTMz_f065cbda-9bee-4924-b9ad-404fbb81b115"
      unitRef="usd">910000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMTktNi0xLTEtNDYx_6007dad2-e0fe-4d8c-90ef-a55014559fe2"
      unitRef="usd">910000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjAtMy0xLTEtMTMz_2a1f71e8-b705-4233-8c4e-b8a9d5241be7"
      unitRef="usd">7740000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjAtNi0xLTEtNDYx_b7611f80-eb58-41f9-b694-bee1ee44bb8d"
      unitRef="usd">7740000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjEtNC0xLTEtMTQw_9319ed17-7b37-4656-9de2-3d55a1f8cdc7"
      unitRef="usd">-54000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjEtNi0xLTEtNDYx_80ea1552-c49f-4885-9175-2f88e03817e8"
      unitRef="usd">-54000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ib3f537cdaae041d5a631c4a5edd8ef6c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjItNC0xLTEtMTQw_1d2a7bc6-7e47-444c-8996-b9cdf9ee19d1"
      unitRef="usd">923000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjItNi0xLTEtNDYx_8f508f77-8ad1-4403-b445-0697f13fc1f5"
      unitRef="usd">923000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:StockholdersEquityOther
      contextRef="i460fe5c76c8648eea51c783be8ae1e0e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjMtMy0xLTEtMTM3_0fa4dc06-bacc-4cbc-965c-a1d5cc7ca378"
      unitRef="usd">-3000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjMtNi0xLTEtNDYx_304737e1-ed21-4543-95f6-4f0b5e654bf5"
      unitRef="usd">-3000</us-gaap:StockholdersEquityOther>
    <us-gaap:NetIncomeLoss
      contextRef="i2f74d78b3bfd465285b4b70819f120ae_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjQtNS0xLTEtMTE1_3ae17eb0-21d7-4587-ab3e-af9a07aa6a25"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjQtNi0xLTEtNDYx_2fca15d5-8849-4f21-8707-265ee8b009af"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i0b76151e50a6468f9778c0f3285a6571_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMS0xLTEtOTA_7f5813e6-a7d8-4d4b-8661-cdcb90a60f4b"
      unitRef="shares">16091000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0b76151e50a6468f9778c0f3285a6571_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMi0xLTEtOTE_d28effb5-c7e0-49b5-a57c-ab474175cb38"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i575ac8d86a424cc58611058fbd63c5d1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtMy0xLTEtNDY4_0424320a-1ef4-4399-883f-19236126499d"
      unitRef="usd">313057000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i187e0f90eac444ea9e476b4465539595_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNC0xLTEtNDcx_cba490f8-a213-4c95-abeb-786c09510d9d"
      unitRef="usd">-1441000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i37bf04a171f0407a9f1eae38a860495c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNS0xLTEtNDc1_fa53d935-aee1-4749-9f98-880cfb2a5a1d"
      unitRef="usd">386192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yNS9mcmFnOjJhZmUzZDZkZjNiYzRjYmNhNWNmOTIxNTVmOWYyY2QwL3RhYmxlOmEzNDQ4MDA5MzUxMTQ5OThiOGJhZjU5NzA0OTcyMWY4L3RhYmxlcmFuZ2U6YTM0NDgwMDkzNTExNDk5OGI4YmFmNTk3MDQ5NzIxZjhfMjUtNi0xLTEtNDYx_60162d59-941f-45d7-af4a-c096ab488f59"
      unitRef="usd">697824000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNC0xLTEtMS0w_c0e00740-6572-4a7d-8599-02a5f5ceec42"
      unitRef="usd">62554000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNC0zLTEtMS0w_67d3df48-1245-4128-b884-314a1de1940f"
      unitRef="usd">-8746000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNi0xLTEtMS0w_3c8b36bc-6810-4b03-904a-b9a5be1acc01"
      unitRef="usd">39377000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNi0zLTEtMS0w_4d07ee97-7d87-47d1-991f-3947dd3612d7"
      unitRef="usd">397000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNy0xLTEtMS0w_8b27db70-8e46-431e-a9dc-58ea98ed3b3b"
      unitRef="usd">37902000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNy0zLTEtMS0w_b52d652d-ac7e-429f-a311-7a03dde28baa"
      unitRef="usd">12645000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOC0xLTEtMS0w_b614ef6a-32ab-418a-9ff5-5dde8640adf2"
      unitRef="usd">-145000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOC0zLTEtMS0w_f67540e9-0725-4359-b386-99093cb6c8ac"
      unitRef="usd">-1507000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOS0xLTEtMS0w_9e525a26-7d69-46f6-8305-3ae37025c73c"
      unitRef="usd">12863000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfOS0zLTEtMS0w_639dec98-487e-47bd-86e8-417536f33ee4"
      unitRef="usd">17743000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTAtMS0xLTEtMA_964c5391-2cc1-48f2-ba92-6ca4eebf5628"
      unitRef="usd">96000</lgnd:AmortizationOfOtherEconomicRights>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTAtMy0xLTEtMA_520a960b-3382-47c8-a8bf-6213b5926415"
      unitRef="usd">2505000</lgnd:AmortizationOfOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTEtMS0xLTEtMA_a30ebaee-ad30-44c0-a7e7-b0b80a8fe5f3"
      unitRef="usd">-7303000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTEtMy0xLTEtMA_451ca436-b11e-4ac6-aa1a-f434176e1b74"
      unitRef="usd">659000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTItMS0xLTEtMA_64702d19-6f4c-4844-af02-f47568efa0f0"
      unitRef="usd">28375000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTItMy0xLTEtMA_69cefb8a-74a9-4dbb-bed9-639f34af6067"
      unitRef="usd">20752000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTMtMS0xLTEtMA_b9ca859f-144d-4916-adc8-4f347a9a26cc"
      unitRef="usd">8229000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTMtMy0xLTEtMA_6f3a2b7e-e537-42ab-8316-28ffd5681476"
      unitRef="usd">19311000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTQtMS0xLTEtMA_7d5c3403-131b-419e-b708-83ea9c7bf420"
      unitRef="usd">8135000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTQtMy0xLTEtMA_b5cdb3ec-168b-4a45-9837-e84f2cc2443e"
      unitRef="usd">-17143000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTUtMS0xLTEtMA_2e445de8-8b54-4485-9c8b-06cd18526315"
      unitRef="usd">658000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTUtMy0xLTEtMA_be161cb1-b7af-4092-b981-a780b7238fe0"
      unitRef="usd">-1525000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTctMS0xLTEtMA_14de75fc-5de5-463c-b562-41ba4fbe7266"
      unitRef="usd">8838000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTctMy0xLTEtMA_e3af3eeb-b4cc-48e8-8d69-020b5537c3aa"
      unitRef="usd">5080000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTgtMS0xLTEtMA_f8ae679a-9712-4641-97cc-cc09cefdceee"
      unitRef="usd">3103000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTgtMy0xLTEtMA_2ba44d2f-a806-444e-a08b-14d746714f22"
      unitRef="usd">4914000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTktMS0xLTEtMA_56725997-d452-4104-8b0a-ad21d8b80d7d"
      unitRef="usd">-3635000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMTktMy0xLTEtMA_1f8b332c-b80a-4015-99bf-57c359644af2"
      unitRef="usd">9639000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjAtMS0xLTEtMA_26387ee2-fbfb-46bf-91ed-fdaf385d80ba"
      unitRef="usd">-4167000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjAtMy0xLTEtMA_6d4e618a-4d00-4067-aefc-7e5835d9ec14"
      unitRef="usd">12026000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjEtMS0xLTEtMA_970d8036-dd0c-413a-b145-7e2437fd6841"
      unitRef="usd">-20696000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjEtMy0xLTEtMA_54416046-972f-4650-9aec-71487c0201d9"
      unitRef="usd">5603000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMS0xLTEtMzQzMTU_ae26d705-df7d-43cf-8e4e-a5a314013565"
      unitRef="usd">6120000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMy0xLTEtMzQ1NTA_8b5627b3-8cfb-4fdf-a8f2-1d2f7b786481"
      unitRef="usd">-226000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMS0xLTEtMA_fd534e4a-798d-4557-9706-83411df31f71"
      unitRef="usd">8680000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjItMy0xLTEtMA_7575d426-c1f4-4d92-aa87-0b0ed37065cf"
      unitRef="usd">4656000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjMtMS0xLTEtMA_ac9163c3-3c17-438e-b7a4-955c58024ba1"
      unitRef="usd">51156000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjMtMy0xLTEtMA_2b495cc9-3f3d-4a4f-b017-67601d2464b0"
      unitRef="usd">54049000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjYtMS0xLTEtMA_607cbc65-98eb-42c2-ab1f-bd59427915bd"
      unitRef="usd">116898000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjYtMy0xLTEtMA_4ed82fd5-f700-4975-9ce5-495aa4365939"
      unitRef="usd">337016000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjctMS0xLTEtMA_fff6d96a-21e0-46f2-82f6-164dcf353b3f"
      unitRef="usd">152465000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjctMy0xLTEtMA_21ea7bb7-c191-43f1-a666-a0e4e1e1ede2"
      unitRef="usd">389296000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjgtMS0xLTEtMA_22d7ce61-df4a-4d76-bb6e-e966374f0a1e"
      unitRef="usd">37100000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjgtMy0xLTEtMA_4541f872-9228-4017-b95a-47f5c705d1c4"
      unitRef="usd">589155000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjktMS0xLTEtMA_02edcff4-497e-4e9d-8e67-39389d06790a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMjktMy0xLTEtMA_cb44bd9a-6512-4662-a9b1-9e3b695de0ae"
      unitRef="usd">26857000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzAtMS0xLTEtMA_54ab2ccb-c736-43ab-9788-7917be4f4f81"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzAtMy0xLTEtMA_c86bae91-7f67-4139-a1e3-5f01aaee13bc"
      unitRef="usd">500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzEtMS0xLTEtMA_06482211-5cb7-4bfb-861a-640df426edb3"
      unitRef="usd">6566000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzEtMy0xLTEtMA_52986e7c-a972-4b69-a17e-898b7dd0eb1f"
      unitRef="usd">2828000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzItMS0xLTEtMA_4296218c-e944-4d0b-8011-0d547b19647f"
      unitRef="usd">-135000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzItMy0xLTEtMA_33a652d3-f9cd-472a-869c-81d0252b6562"
      unitRef="usd">-2600000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzMtMS0xLTEtMA_639d335b-49ae-4012-ac55-4c495b47d652"
      unitRef="usd">66236000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzMtMy0xLTEtMA_d576f785-6314-4fd1-9567-9284c4e9576d"
      unitRef="usd">613850000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzYtMS0xLTEtMA_8d636661-72cd-4e6b-a81e-ea97c6d65832"
      unitRef="usd">155760000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzYtMy0xLTEtMA_07d8b248-f723-4128-903a-53d539777df5"
      unitRef="usd">203210000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzctMS0xLTEtMA_af3e6da1-99e8-4517-b558-08519c7d1fe0"
      unitRef="usd">9188000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzctMy0xLTEtMA_445acef4-7650-4dc3-9c3e-288dd34772aa"
      unitRef="usd">5224000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzgtMS0xLTEtMA_8a1bbacf-c940-404a-aa5c-620653950bd2"
      unitRef="usd">18938000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzgtMy0xLTEtMA_631292de-fc91-4595-8098-3b037edb7f0a"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzktMS0xLTEtMA_d36e4add-7f57-4727-b89f-629a69b7f020"
      unitRef="usd">18446000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfMzktMy0xLTEtMA_abeca20a-6c8d-4e61-a53b-0091d0ee6cdc"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDAtMS0xLTEtMA_d9a4a047-111f-4ae6-862c-0dca44d3439a"
      unitRef="usd">29484000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDAtMy0xLTEtMA_e39ae222-d486-451e-bb68-0ee2692ff1c2"
      unitRef="usd">2459000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDEtMS0xLTEtMA_f990d56e-9524-405f-895e-2206ac6bdbd3"
      unitRef="usd">5903000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDEtMy0xLTEtMA_c79ad91f-93ea-49ef-a68b-ca7d0ae02c3a"
      unitRef="usd">1429000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDItMS0xLTEtMA_713e32dc-eefb-49f9-857b-fdbec3bbf26b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDItMy0xLTEtMA_a5b3f870-5d4d-44f4-bd74-74dd7f7b3e9b"
      unitRef="usd">73287000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDMtMS0xLTEtMA_7bde4de8-6858-41cf-b069-e972822ac93f"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDMtMy0xLTEtMA_9d22de39-fb1a-4476-9490-4011d6dbf030"
      unitRef="usd">2325000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDUtMS0xLTEtMA_b4864678-8f18-4e3a-b27f-610f7fe00d84"
      unitRef="usd">-141925000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDUtMy0xLTEtMA_f38a7a17-90cc-4a8e-88e9-e4b2e9a015ef"
      unitRef="usd">-283016000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDYtMS0xLTEtMA_274083b7-24c9-40cc-ba7d-4f5326a80d5f"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDYtMy0xLTEtMA_c317b9bf-4c28-4862-9269-95f255662965"
      unitRef="usd">-50000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDctMS0xLTEtMA_02a91144-4b02-4d2b-ba82-5f1b6a416bc0"
      unitRef="usd">-24533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDctMy0xLTEtMA_76b6f258-2654-476f-a994-ca477be0e6dd"
      unitRef="usd">384833000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDgtMS0xLTEtMA_67115e36-beb5-4c9e-ad01-4229c663cfc0"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic8a4a953d5304f198ee6f152d7aeea35_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDgtMy0xLTEtMA_587837de-d52c-40d6-8e60-601145c7052a"
      unitRef="usd">72273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDktMS0xLTEtMA_50a53a0b-42d2-4622-bd29-4077a6b4039a"
      unitRef="usd">23430000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOjYzZDJkYWEyMWI1NDQ5ZTU5ZjliYmM2ZjhhYzc4YzQyL3RhYmxlcmFuZ2U6NjNkMmRhYTIxYjU0NDllNTlmOWJiYzZmOGFjNzhjNDJfNDktMy0xLTEtMA_95ef2118-c090-4d2c-86e7-31d42b713bd3"
      unitRef="usd">457106000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMS0xLTEtMS0w_10eef2bd-3986-4464-a014-38c7420dcfb2"
      unitRef="usd">1740000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMS0zLTEtMS0w_b06bee74-62b7-49e0-ae5f-929c983c9a27"
      unitRef="usd">2531000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMi0xLTEtMS0w_85bd1dba-3d62-420c-b48e-b8dedb2db48d"
      unitRef="usd">3720000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMi0zLTEtMS0w_cf60e57e-73a2-4aad-8fb8-b0092302d23c"
      unitRef="usd">2130000</us-gaap:IncomeTaxesPaid>
    <us-gaap:RestrictedCashCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMy0xLTEtMS0w_05dba053-5187-4e17-92b5-c5714a1a2acb"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="iefcbd9042e284860925ad7c76171bca1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMy0zLTEtMS0w_61ae38b9-93c8-40e0-8b32-192a8f296c49"
      unitRef="usd">190000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfOS0xLTEtMS0w_e9c28c5a-f79b-433f-a044-45126524f2b0"
      unitRef="usd">557000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfOS0zLTEtMS0w_7861255e-9fa1-4531-9e1a-6a6f4eaf0ea9"
      unitRef="usd">381000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTEtMS0xLTEtMA_c7a67f37-c389-4764-ac7d-2c46a9248544"
      unitRef="usd">4968000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTEtMy0xLTEtMA_fee62e09-d9ac-4713-aba9-c2eaefb1404e"
      unitRef="usd">1390000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedLeasePurchases
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTItMS0xLTEtMA_68e88eb4-66f2-401f-8546-39a72c590b29"
      unitRef="usd">0</lgnd:AccruedLeasePurchases>
    <lgnd:AccruedLeasePurchases
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTItMy0xLTEtMA_88d37a79-9fa8-4109-bcc3-dd9b637c404d"
      unitRef="usd">2500000</lgnd:AccruedLeasePurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTMtMS0xLTEtMA_5576ced4-1695-4fea-8164-13cf5b886ef4"
      unitRef="usd">-74000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18yOC9mcmFnOjMzM2VjMmNiNTI4NTQyNGFhYmViMGFlMmMxMWZkYWNkL3RhYmxlOmZiN2ViNDI3N2QyOTQxMDNhODM0ZTBmZTQyZDIzMzBjL3RhYmxlcmFuZ2U6ZmI3ZWI0Mjc3ZDI5NDEwM2E4MzRlMGZlNDJkMjMzMGNfMTMtMy0xLTEtMA_51f7f85a-4490-4904-b255-21f547245fb0"
      unitRef="usd">-109000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDk_c4b97b41-129b-4612-853b-9bf69556cbff">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2021, the amount recognized as revenue that was previously deferred was $7.7 million, and $22.8 million, respectively. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at September&#160;30, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of September&#160;30, 2021, we have zero Viking warrants outstanding.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of eleven positions which were in an unrealized loss position as of September&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $0.01&#160;million and $0.1 million of allowance for credit losses, respectively, as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $50.2&#160;million. We have applied credits for such inventory purchases of $24.4&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License and Other Economic Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial license rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.0 million as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2017, we entered into a Royalty Agreement with Aziyo Med, LLC (Aziyo) pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of September&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of September&#160;30, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2021, we further considered the current and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the conversion price. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2020, all of the 0.70&#160;million and 0.65&#160;million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjA_591b41c7-ca8f-473a-9225-a3bd8631348c">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMzk_b9e645fc-8b44-470b-9e58-902e5c3205cb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjI_c22db029-9e87-4e30-8508-d1e63ed2a712">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjM_9ac55efe-ca55-4306-9a3f-e4c1392e0249">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI0MDY_7b7409c1-6fb6-46bc-9656-39be4b3fdc4d"
      unitRef="usd">7700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI0MTQ_8052a439-37b9-46f4-98e3-6f92d1648913"
      unitRef="usd">22800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI1MTY_4e868e60-1fef-49a5-98d6-9baa4c799360"
      unitRef="usd">5800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI1MjM_76fc498b-c6bf-42b5-bb63-6aae7344a39c"
      unitRef="usd">8300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTE_55c5a9d8-369b-407d-ab80-c8e5273d6d50">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1beb885c5fe44118a5ef2fec26cf4658_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC0yLTEtMS0w_52f1e3bc-5ba3-4f4b-a7ec-3663c234ec89"
      unitRef="usd">8821000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1812aa7c1c1b4a55a887fd5a81b76005_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC00LTEtMS0w_2ebc3669-5e12-465f-b2eb-f69b5b6910ab"
      unitRef="usd">6923000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i338e6d6b14a34c75b7c70afa3376340b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC02LTEtMS0w_e26071f3-cc50-4fa8-8a25-edefd8827480"
      unitRef="usd">18548000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idf6cdf3e9b474d958a8885100478e940_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNC04LTEtMS0w_f129899a-feec-4c05-adbb-67a036043ac3"
      unitRef="usd">16809000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i98ab67b2c0b5427699d1f2b18bf6cf19_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS0yLTEtMS0w_ed1df367-1b16-4e1c-a02c-6ee1c7cb8996"
      unitRef="usd">2665000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id41307110e644f0fa0ec6bccf02baa95_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS00LTEtMS0w_fa929aa4-5619-4658-afc4-f615528b9109"
      unitRef="usd">1802000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i99683383c51c4f64a11dd4f2001eed52_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS02LTEtMS0w_29e42eeb-b06b-4224-af5f-bac3d141151d"
      unitRef="usd">7191000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i81c5115227a34d9b8c71c751709c5dc9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNS04LTEtMS0w_fe2f38f3-d588-47d8-a066-85d5c259f789"
      unitRef="usd">4577000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2d50949db3fb4c8aaa647abb0dbf5f7a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi0yLTEtMS0w_4bde14a8-b20f-4b3b-a83c-16a2dd0c1fb1"
      unitRef="usd">4162000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1e9177b057824c699d52a5f241543660_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi00LTEtMS0w_118bea3a-45e5-423c-8858-6862a58cb59a"
      unitRef="usd">280000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i54af25c4d01847cf80e2bfe3bc7d5119_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi02LTEtMS0w_867d2a4c-13d5-42c4-9829-3df01547bf2b"
      unitRef="usd">5637000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2f737ae0746f4857a06c25988e3ad3d7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNi04LTEtMS0w_7a475acd-47f2-4804-ba22-76b825614171"
      unitRef="usd">1365000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i765ba6fa0a7645489d181b0103a6df7d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy0yLTEtMS0w_3bab0ffe-d6d2-40b3-8471-e788b2501fa3"
      unitRef="usd">15648000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifc481a6010ad4826a5d56f11ae30f0da_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy00LTEtMS0w_c92ecdce-3335-4f53-8242-f9f0401ff69e"
      unitRef="usd">9005000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic9a77facb91643e4b4c0fbdd596aa0f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy02LTEtMS0w_6c15de90-7628-4624-bb92-2cc2bc2d888c"
      unitRef="usd">31376000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i65684440034d4351bbb21abccb7fca41_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfNy04LTEtMS0w_08bf7759-ce9c-415a-815f-317a48809648"
      unitRef="usd">22751000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i35c9dc4f60cd4dcdbfcf5e70126edbf5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS0yLTEtMS0w_d019b96f-acdf-4d48-b0b6-6ee122274c8e"
      unitRef="usd">35093000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b8a132caa9d44c49fcfe9a7b5e6fe6a_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS00LTEtMS0w_717e217d-ef26-4766-9308-508793b859c3"
      unitRef="usd">23389000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib844df174f3e4d4b83740aa92f061c88_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS02LTEtMS0w_0591e5db-c23a-447a-99bd-efe3926a7541"
      unitRef="usd">128875000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib4670676853e4b26a40950b991482733_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfOS04LTEtMS0w_d2e8f328-9a70-43a9-89ed-94987d98fdb5"
      unitRef="usd">68966000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbb87c5273d146209b4f863fa73a6737_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItMi0xLTEtMA_9976b9f7-3e4a-4bc3-82ed-0ae32fdb5f2a"
      unitRef="usd">4828000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i16580774194c4717bd816e227f16cca5_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItNC0xLTEtMA_f7ccf8e8-477e-4b69-b18d-94ef5f9e567c"
      unitRef="usd">7341000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i75ed1e446ea84220b26d564c3e4eb9c9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItNi0xLTEtMA_c3b197b2-4812-4c2c-9ed3-6cf7ca81d666"
      unitRef="usd">17650000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i76396c119fc8437783313ddfc6cfdce7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTItOC0xLTEtMA_16e354b1-e762-467f-8765-7d016deea4fa"
      unitRef="usd">15280000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i461496e85d77458ab7ad2e0d7ef7035a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtMi0xLTEtMA_fcaea7f4-5a49-4a43-ab00-0f41a9bb788c"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8b56fbe0a9734483b1566fbe6d710406_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtNC0xLTEtMA_5630a5c3-0a66-44da-81f2-618cca630689"
      unitRef="usd">158000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iccff4fa6edd34cabbf684004d8ce7bb6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtNi0xLTEtMA_2e571611-3cca-4666-adfc-74a2096a1710"
      unitRef="usd">2293000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i46272602a5184253a54dc8e71c5e30ca_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTMtOC0xLTEtMA_c16a7da3-fff2-41e1-83f2-197461b7ff3c"
      unitRef="usd">1793000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i10c95e2f17f3492394642693fb62d437_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtMi0xLTEtMA_3c9796ca-d2f1-4dce-9529-03fb9aec07de"
      unitRef="usd">7419000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic079e130627446e2a4e0b9df6ba59cb4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtNC0xLTEtMA_b9159ca9-71d8-4b20-85bf-3d750417cea9"
      unitRef="usd">960000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idf39d65d4fbb4562aa99ab8d91883b55_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtNi0xLTEtMA_0866bf9a-430a-4534-8bfe-2d03fc62b375"
      unitRef="usd">19436000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if2328ebe1a164a53b66ea3c341bceda4_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTQtOC0xLTEtMA_d184c128-e2ce-4fb7-ae68-57f8d14d15ee"
      unitRef="usd">4766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id40d8cfc06804c0eb44c421fe185a680_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtMi0xLTEtMA_42bce28c-fe60-4992-ae62-d54c3cf57ee1"
      unitRef="usd">1647000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i02ec86bd000d4ef392d002af71a86521_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtNC0xLTEtMA_de6709a8-1b20-4938-82a5-3db1c24d8070"
      unitRef="usd">995000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iae1a8e7f867144aaa2ecf955647862c6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtNi0xLTEtMA_b107d702-343a-446a-a8f8-16ee72e2bb40"
      unitRef="usd">5030000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3bbbf8570b35483cb6acbd8cd74c10ba_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTUtOC0xLTEtMA_d6b7c6d8-1ad8-4c3b-923d-d588742164e7"
      unitRef="usd">2873000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i24b735ef0a384973a91d09046cf2cf12_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtMi0xLTEtMA_72af334c-a3be-4a46-a249-79487b85ee00"
      unitRef="usd">14094000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i97c03612828b45c598507ebd2c6577d2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtNC0xLTEtMA_09f281ec-165c-41f8-a581-b35ae2502987"
      unitRef="usd">9454000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i673e60829d3c480ebab74157f9f621ce_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtNi0xLTEtMA_77d07fe4-9d57-4bb9-ae96-e6c2589ae25f"
      unitRef="usd">44409000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id10bf7497c2445d7bff992cd3b0cf1bd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTYtOC0xLTEtMA_bb9fa316-4565-4c56-8de4-1d2080f9f376"
      unitRef="usd">24712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtMi0xLTEtMA_b67cee7e-0ad2-4b8f-802d-ae0ebb2d7344"
      unitRef="usd">64835000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtNC0xLTEtMA_c8f3ef2b-21e6-4707-a6bf-f77a99505473"
      unitRef="usd">41848000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtNi0xLTEtMA_b6919173-e1cb-43f6-80dd-a3a431bf9bd9"
      unitRef="usd">204660000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjExMTM4YTFjYmVlNjQ2ZjFiNWMxNjEwMWVmMzZhNzViL3RhYmxlcmFuZ2U6MTExMzhhMWNiZWU2NDZmMWI1YzE2MTAxZWYzNmE3NWJfMTgtOC0xLTEtMA_9f45e9fb-58fc-4599-af02-e4be4750487b"
      unitRef="usd">116429000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDU_81e04c5c-0bc5-484c-8c30-fc2d87a2c535">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at September&#160;30, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.722%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Treasury bill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;299,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i52b324e462494e6681ed114f944bd643_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xLTEtMS0w_fa7e6e4b-ae2e-492a-bef0-381e9e446524"
      unitRef="usd">47739000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i52b324e462494e6681ed114f944bd643_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0zLTEtMS0w_d5eb8f21-0f3d-4d87-b066-0935ec64ed3a"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i52b324e462494e6681ed114f944bd643_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy01LTEtMS0w_56b409a7-8e0c-442e-8b1f-e34985f24d83"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52b324e462494e6681ed114f944bd643_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy03LTEtMS0w_a4cef8a3-c7d1-4da5-9af6-20c9aa225fc3"
      unitRef="usd">47744000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy05LTEtMS0w_f7a9fa5e-e88c-4ca4-b576-44517d30b7cb"
      unitRef="usd">84120000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xMS0xLTEtMA_aa265dc6-d736-44ff-8ed1-7627232263db"
      unitRef="usd">35000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xMy0xLTEtMA_321f151a-396c-40c1-9f72-fcc43ef0e59e"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c3a84cd253749ea9fae2626a480c65a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMy0xNS0xLTEtMA_cc75707d-235e-463f-8b21-bbbc69e1d3d2"
      unitRef="usd">84154000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xLTEtMS0w_a585cacb-4d94-4313-9efe-bb0a48c28f71"
      unitRef="usd">25914000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0zLTEtMS0w_16d8c6a0-147d-4211-a03a-2308582232a6"
      unitRef="usd">50000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC01LTEtMS0w_676d4724-e0c7-466d-a1c1-f0949faa4439"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa74fac6c40441aa82875bbb7072f25c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC03LTEtMS0w_bdfdfe2c-7f82-4cea-a9b2-2f1922b21423"
      unitRef="usd">25964000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC05LTEtMS0w_3dd93098-b6dd-4c12-b9e0-cedfa8799bdc"
      unitRef="usd">30512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xMS0xLTEtMA_e69fd9af-1eff-42e3-86ff-16e6816b278b"
      unitRef="usd">99000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xMy0xLTEtMA_25c6fbfc-df2d-41cb-b16d-ae167bb13006"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i13fb0509abe448b48aa3be427fb2214b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNC0xNS0xLTEtMA_678f7dc9-ae79-402d-ba74-47486d6e615f"
      unitRef="usd">30610000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xLTEtMS0w_b7d6c6db-7c70-4c70-8cfd-2e1af8560320"
      unitRef="usd">2501000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0zLTEtMS0w_5775b085-265f-4fa2-ad21-8a6a2767cce5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS01LTEtMS0w_ebcf4d7d-b53e-49cb-a38f-909f7d92a69f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e0b6e61d2e2425583eb16ac3e8c1915_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS03LTEtMS0w_05eb0a1c-8fac-4826-8a69-f80f2751c6d5"
      unitRef="usd">2501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS05LTEtMS0w_78d851e6-6f4c-4dcb-b164-1b509044e810"
      unitRef="usd">4499000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xMS0xLTEtMA_2378ebce-ef91-47e6-a612-a7bc0669ea8a"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xMy0xLTEtMA_9f49b0c5-8d66-4ca8-ab2d-89eb4a6dd8c0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iee78cc743adc4dee82bb5d8535f1915c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNS0xNS0xLTEtMA_45fdbfc2-552f-428e-aa30-077f02d06cae"
      unitRef="usd">4501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xLTEtMS0w_c6895d92-8ada-4207-81e9-51eb731a3dae"
      unitRef="usd">23264000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0zLTEtMS0w_91efdefd-9ffd-4fb3-8dc0-2e6e735bd4a6"
      unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi01LTEtMS0w_d7b05e0f-11d8-4040-9b2d-6d4f6b1f048e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2bbe6ec63b034ba898af910cfdbfec2c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi03LTEtMS0w_4cbc75bd-474d-4e4d-8e64-d51615d6f111"
      unitRef="usd">23274000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi05LTEtMS0w_50d494fb-146e-4a17-b88d-abcbbb2f5077"
      unitRef="usd">45459000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xMS0xLTEtMA_7bebeecd-50f8-4500-9062-1d985cde5e12"
      unitRef="usd">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xMy0xLTEtMA_fb6026fc-5d9f-4709-8c0f-6c9a2eb9fa6b"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24164d9e30c34985b56c25ee4de80416_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNi0xNS0xLTEtMA_8d8557ab-9c43-486c-bccb-2300515f7d35"
      unitRef="usd">45485000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xLTEtMS0w_d96e1707-60d8-4d15-8f9d-34bf9558dcd8"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0zLTEtMS0w_4ed1ed05-d2d4-44aa-8372-4d4840db4c44"
      unitRef="usd">307000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy01LTEtMS0w_9cdb9afd-3cf8-4de6-abeb-740507f2c5fb"
      unitRef="usd">723000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ac4a748fde44c7aa04060686b7378eb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy03LTEtMS0w_2218bc61-3919-454e-b664-7c8d12c1b069"
      unitRef="usd">5391000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy05LTEtMS0w_e28c4ab9-11e7-44e6-8dd1-f11905e6cbe1"
      unitRef="usd">4466000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xMS0xLTEtMA_31b21941-7bba-49d3-bdd6-983258acf4d7"
      unitRef="usd">360000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xMy0xLTEtMA_90f0575d-bf84-4293-9f45-08fae2899d33"
      unitRef="usd">1388000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54b3650ee47e452aa4bc7e9df71daf81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfNy0xNS0xLTEtMA_9e3c1dc0-f59a-4583-83db-d6f673ad4f1a"
      unitRef="usd">3438000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xLTEtMS0w_de155b3b-3fea-463e-aebb-7aa1d8f5011d"
      unitRef="usd">152041000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0zLTEtMS0w_701e442c-c05d-41b9-829d-e85701523bf4"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC01LTEtMS0w_ff33b4a6-ed0c-4cb1-a02f-78ea62a24095"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic429da61955a4b0a825e11e538db02fc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC03LTEtMS0w_c00af69f-34ae-4699-86c9-a87bd04b93b9"
      unitRef="usd">152094000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC05LTEtMS0w_4814ad00-be6e-4c8d-bab8-9f6f91fcded4"
      unitRef="usd">151512000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xMS0xLTEtMA_beb47f9c-823e-431c-9b01-27c4c22d0969"
      unitRef="usd">386000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xMy0xLTEtMA_d1e2af73-4f5c-4704-b622-b6aabfe58520"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i07ffd1b96b0d4ccd8b60c29149bca7d8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOC0xNS0xLTEtMA_e461b28f-916b-4660-b24b-b8df4788e01b"
      unitRef="usd">151898000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xLTEtMS0w_be4f0c27-4bf2-4386-a889-277818b8b944"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0zLTEtMS0w_98231950-cc06-45fa-a76e-569ec307f86c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS01LTEtMS0w_2fb47e35-dbd7-4acd-9683-60598d14e9f6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60fb236ee191431e8dfccfe51b11abf9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS03LTEtMS0w_b872dd3b-c297-41eb-bbcd-4d4439b32253"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS05LTEtMS0w_c3f5b528-5271-4b5b-9692-cfac80fa7f32"
      unitRef="usd">3999000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xMS0xLTEtMA_62e24ec8-8b5d-4323-94ef-ac2790d4fd5c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xMy0xLTEtMA_95ecf6ac-c043-4f16-9cd0-35e9a379cc64"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifcb3bdd1c7bc433ea6a1423c1de69cac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfOS0xNS0xLTEtMA_277599a5-d4f6-45a2-930c-d4ab4b6d2850"
      unitRef="usd">3999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMS0xLTEtMA_53c3fbd6-7dcc-4881-938b-6dce04146f93"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMy0xLTEtMA_c18ffcdc-899b-4643-94c6-232090ba1f28"
      unitRef="usd">642000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtNS0xLTEtMA_d198f9ad-b8ce-4720-8270-6f81fc647130"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtNy0xLTEtMA_c9f0af27-1c27-4dd7-8f3f-bb525723608e"
      unitRef="usd">642000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtOS0xLTEtMA_7e6604ba-0cf6-4802-a933-2c1e99c5f5c2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTEtMS0xLTA_deb17076-409b-4e67-a7ab-b6f44a795b23"
      unitRef="usd">393000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTMtMS0xLTA_de34ceb4-b952-4f9e-afa8-911520c713a7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTAtMTUtMS0xLTA_848a5526-dcbc-4960-bb29-2908d5d283b1"
      unitRef="usd">393000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMS0xLTEtMA_52b828bd-95c0-40ad-9b1f-ca0c4320076d"
      unitRef="usd">257266000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMy0xLTEtMA_3bbe7757-590e-49b9-bb1a-0550f7cf82d0"
      unitRef="usd">1070000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtNS0xLTEtMA_353e3a02-98ed-4d37-8000-37e1e9c41894"
      unitRef="usd">726000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtNy0xLTEtMA_f6d2a183-4545-4dfe-99b9-0e6056c6de76"
      unitRef="usd">257610000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtOS0xLTEtMA_55c38161-c1f7-43e4-a06f-e1404b3b03d8"
      unitRef="usd">324567000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTEtMS0xLTA_2521b5c4-781d-42ca-9be6-be2f673a87ed"
      unitRef="usd">1302000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTMtMS0xLTA_e9f1139c-949c-4a04-b3d1-89940c3ca04e"
      unitRef="usd">1391000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTEtMTUtMS0xLTA_cfec76da-b6e6-4eda-b81d-fda3d3e4b377"
      unitRef="usd">324478000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3227affd81a14c3eae170a2fd39475dd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTItNy0xLTEtMA_97683091-df94-45d0-a629-f17fdbc89adc"
      unitRef="usd">42171000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i74019a59687e417d98beaf331bbdb8f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTItMTUtMS0xLTA_397d56a9-583d-488d-b3da-889b0266da93"
      unitRef="usd">32763000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i332c602c73e741d4bbc0fa8e7847b9b6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTMtNy0xLTEtMA_3e1a0a49-406a-4ea0-8bfa-e9ed7f6f5230"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iae26c1ea6dc742ac85f179e5bdfddaa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTMtMTUtMS0xLTA_3b146934-deeb-44bd-bb67-041d3d31d4c5"
      unitRef="usd">6326000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTQtNy0xLTEtMA_8518028b-1c8b-4f04-bc15-cc789c39ccb6"
      unitRef="usd">299781000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZkOGE1NmExZDk5NDQxZWViMWNiZGUxMzAyZmNkZGEzL3RhYmxlcmFuZ2U6NmQ4YTU2YTFkOTk0NDFlZWIxY2JkZTEzMDJmY2RkYTNfMTQtMTUtMS0xLTA_be366bdf-8977-4178-90f7-6d4e3a91f3f2"
      unitRef="usd">363567000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="idfb7eed4859c41008e742eb80e557048_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI4NjI_8b22b902-28d6-4129-a416-c1604642fef7"
      unitRef="shares">1500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i9b7cdf10102d42dd915fbd5b67034260_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI5MjE_ff36658c-3c6f-4527-8541-4dc81f9ab6d7"
      unitRef="usdPerShare">1.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTI5NTM_fc6a75fb-b2fe-4004-85ce-8261c950bd12"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjQ_318eb3bd-1363-4730-af4b-8a52b197b14d">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMi0xLTEtMS0w_5f52438e-d580-4b37-b9d3-273492cf36ec"
      unitRef="usd">76055000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMi0zLTEtMS0w_a23af999-3ae1-4972-b5dd-c0da70a6f4ee"
      unitRef="usd">76086000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMy0xLTEtMS0w_bf5c5480-f204-4572-acaa-20b4baddfb04"
      unitRef="usd">23363000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfMy0zLTEtMS0w_2395cd1c-e413-4886-858e-c81e4a79ca8c"
      unitRef="usd">23396000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfNC0xLTEtMS0w_3f3d2a62-c476-4eda-a2d3-19f9ed0db29c"
      unitRef="usd">99418000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjZlOGYyZmM2Y2Q5YzQzZmViYWRiOTg3YmE3Y2NkYTE3L3RhYmxlcmFuZ2U6NmU4ZjJmYzZjZDljNDNmZWJhZGI5ODdiYTdjY2RhMTdfNC0zLTEtMS0w_a908908c-2e31-4294-9393-5f8c29512ab6"
      unitRef="usd">99482000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTM5MTk_dcbea56a-d6f1-40ee-84f7-63ab3ce3492e"
      unitRef="position">11</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTQ1Mzk_66bb7107-e8b4-4acc-8210-455c37355d35"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTI_a8e7e253-8001-4878-8aeb-bfad70fe6dd9">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU1NzQ_75812d8c-fce5-4fd3-8496-b79868478d4d"
      unitRef="usd">10000.00</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU1ODE_7d55b93d-b585-43bf-8e24-282f99da80ad"
      unitRef="usd">100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:AdvancesOnInventoryPurchases
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTU5NzU_21191e98-28d2-456a-bfd9-ba3c8c434317"
      unitRef="usd">50200000</us-gaap:AdvancesOnInventoryPurchases>
    <lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTYwMzU_7bf3c588-3bfa-4487-9700-1ea26c2a489d"
      unitRef="usd">24400000</lgnd:CreditsAppliedOnAdvancesOnInventoryPurchases>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTc_ce901d55-1d29-4069-81ec-d4f333747e2b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;784,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMy0xLTEtMS0w_a904b888-66a2-468d-a9e0-2de581f671c5"
      unitRef="usd">190183000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMy0zLTEtMS0w_8c7b2601-2775-4ddb-a5bc-79e12a7b7d54"
      unitRef="usd">189662000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9bec6bae658f4fa7839b638d3604a63a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNS0xLTEtMS0w_29cf1a35-35a3-4099-ba03-250dbdef9e72"
      unitRef="usd">280173000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib1fa6499d48549af8abfb01bffe3a576_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNS0zLTEtMS0w_093e9b7d-4407-4f12-8b7e-a5fe2cf250eb"
      unitRef="usd">277740000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9bec6bae658f4fa7839b638d3604a63a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNi0xLTEtMS0w_55916860-0d29-4bf2-bd29-d0903b229d29"
      unitRef="usd">75159000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib1fa6499d48549af8abfb01bffe3a576_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNi0zLTEtMS0w_2de8f8a0-43d8-47c4-aab0-4abff606415a"
      unitRef="usd">63600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNy0xLTEtMS0w_1777f6dd-aa79-4015-a215-51fd3ea8ce12"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0d1d2fa5d245408d983a4eb034d356e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfNy0zLTEtMS0w_a4dd6711-cd14-450d-a9c8-c151e4469820"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6bcb46755dc4fa4aad37e02ad6f1bc5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOC0xLTEtMS0w_83cf3daa-45da-422f-94f5-008ef66911e6"
      unitRef="usd">1411000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0d1d2fa5d245408d983a4eb034d356e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOC0zLTEtMS0w_5cbd8b0a-f52f-4a0a-9ca9-e4e8af137e80"
      unitRef="usd">1312000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaf1294789ba14efbb689b8629eb271e2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOS0xLTEtMS0w_f1a44e68-e0d3-49c3-af97-bb70860ab756"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic31bf65152af4864ae4e36dee4c10d04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfOS0zLTEtMS0w_dad38452-e319-417e-ac1a-ede3a3a49a3b"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaf1294789ba14efbb689b8629eb271e2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTAtMS0xLTEtMA_b693144d-249d-48a5-838c-b546712505f4"
      unitRef="usd">17599000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic31bf65152af4864ae4e36dee4c10d04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTAtMy0xLTEtMA_2cdcee13-0d47-4b4f-be88-2d28431edec6"
      unitRef="usd">15597000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTEtMS0xLTEtMA_cef7992f-e880-4532-808c-656ee8b278dd"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTEtMy0xLTEtMA_08c92637-52c6-450e-97f5-b3f3d66bf97d"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if762f36c75ca4d65aef97cc6b4ffd0a1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTItMS0xLTEtMA_20dedc17-7536-4b17-9565-1ad18dc74b92"
      unitRef="usd">28974000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieb061a83a0784f3ab59c22d36b9d3ddc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTItMy0xLTEtMA_89e94731-8b6d-4da0-a300-b38e1b265048"
      unitRef="usd">7243000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTMtMS0xLTEtMA_6d177599-adb5-48d0-8cea-7a88d6736e2c"
      unitRef="usd">752555000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmVmN2MxMjU3MDZjMzQ4NzBhODQyODQ5YmFmMmQxNDM4L3RhYmxlcmFuZ2U6ZWY3YzEyNTcwNmMzNDg3MGE4NDI4NDliYWYyZDE0MzhfMTMtMy0xLTEtMA_e1a85c16-c82e-4dd7-8fd9-09f293a2320e"
      unitRef="usd">784992000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTg_49e44675-f4cc-44ea-85d9-7751d748dfdf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial license rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,979&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.0 million as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0yLTEtMS0w_e1fe2a43-e6af-4bc1-92ca-817310347e88"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC00LTEtMS0w_6d8e1303-6a7f-42d2-b931-cdcd2b38c2be"
      unitRef="usd">17550000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC02LTEtMS0w_ec9254c4-794a-4a8b-b8e1-6af7e96a8217"
      unitRef="usd">10748000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC04LTEtMS0w_0885e684-aaf2-4b96-9517-60a9265543c9"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0xMC0xLTEtMA_0726e391-4a4c-4878-8935-9abe6b86e5ce"
      unitRef="usd">17319000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmExNTU1MzFiYTNmODRhZGZhMzE4MDc5NGYwNTI4Njg4L3RhYmxlcmFuZ2U6YTE1NTUzMWJhM2Y4NGFkZmEzMTgwNzk0ZjA1Mjg2ODhfNC0xMi0xLTEtMA_27c0c328-9752-4e20-947d-b5170e764be9"
      unitRef="usd">10979000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY1MDE_22c5f4ee-8559-47ad-a0ee-79cefcdfd2fa"
      unitRef="usd">11600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i2e028d5aaf364cd69142f7dd1151088f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY1MzU_5c2b04d9-ea9c-4de7-a863-bfa4cb43cbb4"
      unitRef="usd">6000000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY2MTE_2dce6ed9-ac00-47e3-8d2d-676352163ae3"
      unitRef="usd">11300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i484d55887cae433799cc6b8679c28aa4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTY2NDU_299aa4d3-e83e-4aa1-a649-f1c4334b4395"
      unitRef="usd">6000000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="ib8bc73161fcc4ebc8b15c8add0abbd14_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTc4Mjc_85bcb145-adca-4324-adcf-de468b399d5b"
      unitRef="number">0.23</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="id89c1cb7076440ad94b910f7aabb5992_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTg4NTU_75adad8c-b5a1-4889-ba22-751de2444ce0"
      unitRef="number">0.21</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss
      contextRef="iec7576b07ee146738bfb748a0c5802e7_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTkxMjc_89ed3653-6186-4a22-a242-3d632fa47e28"
      unitRef="usd">5500000</lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjE_ebc20442-e14e-4bbc-9d02-5f957a16025b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMi0xLTEtMS0w_afe35258-cbe4-425e-a243-77d253288f74"
      unitRef="usd">4564000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMi0zLTEtMS0w_bf22f793-7b27-4c22-b1e2-403c7e24fe72"
      unitRef="usd">8810000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMy0xLTEtMS0w_26e0eaed-a9c7-48f6-b191-8a92852d51fd"
      unitRef="usd">1327000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMy0zLTEtMS0w_5b9cba67-5294-4c7e-84c9-bf609961016b"
      unitRef="usd">977000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNC0xLTEtMS0w_cfafbe2e-2f99-442e-b54b-cea0631ca6c2"
      unitRef="usd">579000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNC0zLTEtMS0w_96335860-62ef-43a4-8cca-7e57c60fd409"
      unitRef="usd">421000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNS0xLTEtMS0w_fb734edd-7e22-44b1-ab1f-012a661f0f15"
      unitRef="usd">103000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNS0zLTEtMS0w_b74e4b03-c8c9-4874-a1ab-3c934afd745a"
      unitRef="usd">693000</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNi0xLTEtMS0w_dbdcf782-b2d8-4b27-991b-64e41c54d2ba"
      unitRef="usd">105000</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNi0zLTEtMS0w_d6446b21-4f8f-41b9-ab35-9adec3df1f86"
      unitRef="usd">687000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNy0xLTEtMS0w_4b3be0eb-4474-4e39-8d83-5372f4ac0f88"
      unitRef="usd">1004000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfNy0zLTEtMS0w_e4fbca12-a6a4-44b2-ac55-35adf51bb84f"
      unitRef="usd">1500000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOC0xLTEtMS0w_aea0daa0-022a-472c-b532-416cbff46729"
      unitRef="usd">0</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOC0zLTEtMS0w_dab283e2-22cf-47df-9d66-8348de737b8a"
      unitRef="usd">733000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOS0xLTEtMS0w_e5378bd8-de38-4fb6-9470-61d4a71a1122"
      unitRef="usd">1031000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfOS0zLTEtMS0w_0d2edb28-c837-415a-aab5-d5ccb04c0d86"
      unitRef="usd">604000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTAtMS0xLTEtMA_e9d0b4c7-bfc4-47d8-a752-6ebca9663cc6"
      unitRef="usd">0</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTAtMy0xLTEtMA_dcd5dbdd-953c-4c8e-a97d-773974f38ef3"
      unitRef="usd">464000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTEtMS0xLTEtMA_bfb3010e-63aa-4b87-9240-39190cb16cb6"
      unitRef="usd">3524000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTEtMy0xLTEtMA_753c89eb-ffb0-499e-a3a9-e8b074c4cb1c"
      unitRef="usd">3641000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTItMS0xLTEtMA_9f3ce905-6c1a-46b3-b0cd-10b294b62d87"
      unitRef="usd">12237000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYwNmEzZDhhODg5MzRhYmNhZTAxZWQ1YzQzYTFlMTliL3RhYmxlcmFuZ2U6ZjA2YTNkOGE4ODkzNGFiY2FlMDFlZDVjNDNhMWUxOWJfMTItMy0xLTEtMA_f3f2bd04-6f13-4ecb-ba41-730b48407b57"
      unitRef="usd">18530000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMjk_96878290-42bb-444c-9a6b-86e069dd8383">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNTQ_b14846be-fef6-4385-a475-ed5eb48d3558">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic56a2e7b63464878884da9238110c721_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy0xLTEtMS0w_ca09cd18-d8bd-4fa2-912d-bf68fdd904ef"
      unitRef="usd">4480000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia13653d6cd24412d8f8718d38b9e8dd6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy0zLTEtMS0w_7334a074-f8e0-42ab-afb0-13fcf99f1b6e"
      unitRef="usd">3094000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i04aa132902b04c0394bce82d31a3aea7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy01LTEtMS0w_db25b16c-73cd-46f6-a364-3e865a8c2f95"
      unitRef="usd">12975000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if38b3b2a600a4d90a5c8c264715751ed_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfMy03LTEtMS0w_d87851ed-e573-4164-9053-ac3979198bb3"
      unitRef="usd">8510000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1a5c0b007c8b4715b662376286f1223b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC0xLTEtMS0w_0b9abf12-439c-4bd9-8a79-2a48243a7b7f"
      unitRef="usd">5274000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ib2639d0217d149f5a491911c423590de_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC0zLTEtMS0w_975e84ff-8bba-4bc1-bd6f-2069aea2dd15"
      unitRef="usd">4646000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i4a349547525942fc9fe678c81267030c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC01LTEtMS0w_45ab426e-7fea-4c0e-99c1-a45601d9f25a"
      unitRef="usd">15400000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic5adab605aa64ca4a227d25b36436eb0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNC03LTEtMS0w_5e3f9eb1-f508-4029-ace5-71b163225c94"
      unitRef="usd">12242000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS0xLTEtMS0w_cc6dbc5e-39da-4a86-83c0-13ed0f27fe5a"
      unitRef="usd">9754000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS0zLTEtMS0w_ffe70062-787f-4546-9043-ee2f6c0e9afd"
      unitRef="usd">7740000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS01LTEtMS0w_c5da2292-2109-41a3-9710-a5b740e745f5"
      unitRef="usd">28375000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOjc0YzJhMWQ2ZGMxNDQ0NjY5MTljYjk4MjQ3NGFjYWM0L3RhYmxlcmFuZ2U6NzRjMmExZDZkYzE0NDQ2NjkxOWNiOTgyNDc0YWNhYzRfNS03LTEtMS0w_0f75191d-2123-4b3a-8087-f812a85ba346"
      unitRef="usd">20752000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMTQ_38c814ad-2afb-4c11-8de2-bdc57f2025a1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy0xLTEtMS0w_aca4396c-be4b-4c66-844c-fb315b81e126"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy0zLTEtMS0w_1355e86f-85df-4b92-9c5d-62dfb5979f26"
      unitRef="number">0.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy01LTEtMS0w_09e53beb-cdbb-4063-8c3a-062dca6f2f42"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfMy03LTEtMS0w_1fac4981-8101-46d9-98de-1638df3b9a1a"
      unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC0xLTEtMS0w_60a84986-315a-4116-b624-7ac98e12eca2"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC0zLTEtMS0w_80b69fbf-b583-43f3-9c77-6ff6b427a4a3"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC01LTEtMS0w_63ca7535-088e-4f98-95d1-deead6eca5c5"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNC03LTEtMS0w_bef835e2-92eb-4f0a-bcfb-b68cee9a313f"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS0xLTEtMS0w_69323045-15c2-4afe-b103-a19ca098cf71"
      unitRef="number">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS0zLTEtMS0w_1354e588-f68b-4260-9320-f45c30d24568"
      unitRef="number">0.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS01LTEtMS0w_6f6051c7-bb71-40fd-bc47-d4fa96d9007a"
      unitRef="number">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNS03LTEtMS0w_bf01c77b-209c-4b7e-96d0-2dc34bddbe0c"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi0xLTEtMS0w_d5dd8b9f-f048-4d8b-b28b-bf566e9d4cc7">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi0zLTEtMS0w_8fab3976-5661-4e80-a549-a914381d9dee">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi01LTEtMS0w_43c5f538-7f06-4d26-85bc-5234f5e24ba3">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmQ5MWExMTc5Yzc4NDRiYjY5MzRmZjY0OGI2ZjliNDEwL3RhYmxlcmFuZ2U6ZDkxYTExNzljNzg0NGJiNjkzNGZmNjQ4YjZmOWI0MTBfNi03LTEtMS0w_b5e1b678-2431-491d-a8a2-3172dca3fb3c">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMTU_b9775161-d13b-47b9-be6b-566a00a27863">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="idd91366449ba49d1aa56a98935674623_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjA5OTk_a4b9f471-e69b-48d1-911a-9bc18134216c"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i209bcfbff39f4fdaa13d185301232981_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjEwMDU_40798669-1501-4bc7-91ac-4cd5f8da7fdd"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwMzg_e8dde48b-9ea8-44d9-a8f6-7300bea6e7c8">Net Income (Loss) Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the conversion price. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjMwNDg_a0f09750-bbe0-4f35-9dd5-ff19d3045def">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy0xLTEtMS0w_ba2cf2ec-704f-4223-8de5-9c0f93d7ddd6"
      unitRef="shares">16688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy0zLTEtMS0w_c8074097-006f-45ff-8a39-f140bde8b0c7"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy01LTEtMS0w_dc149213-d6fb-4a8a-a335-9e4f482f77d9"
      unitRef="shares">16595000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfMy03LTEtMS0w_76d06dbf-834a-4e37-ab39-d12bd3b80326"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS0xLTEtMS0w_a3bebfb6-3432-400c-a485-ce6b7735e621"
      unitRef="shares">75000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS0zLTEtMS0w_327f6562-188e-4158-ad50-6bf5bb00c11b"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS01LTEtMS0w_a20a8db3-7bb4-4d64-9f09-7e0cdb535133"
      unitRef="shares">85000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNS03LTEtMS0w_67af817e-693d-4775-8f08-0301cb820177"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi0xLTEtMS0w_f0b9ee33-73f4-4531-8901-d00c633d4a7f"
      unitRef="shares">379000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi0zLTEtMS0w_80b127cc-7ea4-42d3-b704-024ee2719f40"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi01LTEtMS0w_96c2b393-c92a-4c10-adaf-7eeb415befee"
      unitRef="shares">507000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNi03LTEtMS0w_df3e9201-94ad-47ed-bb7f-f079d99ccb52"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy0xLTEtMS0w_13da8bb8-bcab-4e0c-b057-ab5020a97013"
      unitRef="shares">17142000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy0zLTEtMS0w_b3f2ef2a-b8fc-43be-bd06-982c63c6f2ed"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy01LTEtMS0w_8dec8628-6090-4501-91a7-700dc3c879ce"
      unitRef="shares">17187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfNy03LTEtMS0w_a19e19fe-080c-4a5f-8356-27f80caf6f40"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC0xLTEtMS0w_71d52cf5-6b23-4ffe-a38c-f36976a0611d"
      unitRef="shares">5574000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC0zLTEtMS0w_411071cc-28f6-4d1d-9e8f-cde602eb131c"
      unitRef="shares">7028000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC01LTEtMS0w_53869f7b-23a6-443a-82d2-cca80f7df3e5"
      unitRef="shares">4984000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RhYmxlOmYzMzY5YmZhYzc4OTQ2ZWVhMGNmNjY1ZGYwNTMxNGY3L3RhYmxlcmFuZ2U6ZjMzNjliZmFjNzg5NDZlZWEwY2Y2NjVkZjA1MzE0ZjdfOC03LTEtMS0w_2ad23376-e4b1-455b-ae57-e947b51bd948"
      unitRef="shares">8330000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i45bb77fbcc47480fa1a19f213a179fca_D20200701-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMTA5OTUxMTY1MDg5Ng_04ccda35-b9af-4d44-b377-50bc7de82de2"
      unitRef="shares">700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id664afa77ed0445894209a436e750c43_D20200101-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNC9mcmFnOjI5NjI1NDAxMTliMzQzMWQ5NWZmOWVjNDczOGNmOGNkL3RleHRyZWdpb246Mjk2MjU0MDExOWIzNDMxZDk1ZmY5ZWM0NzM4Y2Y4Y2RfMjI4OTI_c2c983fe-9a9b-469d-a231-3466e461873c"
      unitRef="shares">650000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzNQ_c8fefde3-7907-473c-87aa-234b2337c316">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;251,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;251,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the nine months ended September&#160;30, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and nine months ended September&#160;30, 2021, we reduced the contingent liability by $3.8&#160;million and $37.6&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3, Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the nine months ended September&#160;30, 2021, management recorded $0.7 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of September&#160;30, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In anticipation of our plan related to the OmniAb business, additional aspects of resource allocation and performance assessment may be made at the OmniAb business level and it is possible that the OmniAb business could become a separate operating segment in the future. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9. Subsequent Event.&lt;/span&gt;&lt;/div&gt;At September 30, 2021, there were no indicators of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzMA_9c5c84be-14af-492b-8185-b0c26e402799">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;251,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;324,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;251,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;363,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pfenex contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in Viking warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the nine months ended September&#160;30, 2021, we exercised all of the outstanding Viking warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and nine months ended September&#160;30, 2021, we reduced the contingent liability by $3.8&#160;million and $37.6&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3, Acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the nine months ended September&#160;30, 2021, management recorded $0.7 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i36100db0e0244c6aab5bd1dbbe08da68_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0yLTEtMS0w_eb53769d-34d1-466e-aa38-4280dd5fd542"
      unitRef="usd">5390000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4b3ffe50d97d4d3b8818bb0bb6714741_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy00LTEtMS0w_1e97897b-2b33-414b-ad07-3f8ff0e75b60"
      unitRef="usd">251578000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i91d127590aa94e20919836ce48cf0d97_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy02LTEtMS0w_139fefdb-29c8-461a-bf53-072c5903a6b0"
      unitRef="usd">642000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i389fe86124f84f77a8cf5138a6d5f5cf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy04LTEtMS0w_01bb9e08-f4d4-424b-bf39-c35578ac3ddd"
      unitRef="usd">257610000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6406808991da4d8689a188fd3b01c562_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xMC0xLTEtMA_5b54c438-1f52-4c3a-8270-1dc9e5626b14"
      unitRef="usd">3438000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i42236ee785824a1fb48480728bac6789_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xMi0xLTEtMA_c1b79252-f1a6-4132-8864-3e8259574199"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i27307c85e21e4232ae8eaa32a61b7cc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xNC0xLTEtMA_01380bb7-c0f1-4f7f-99db-7db26726b15e"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i70323bb3497a4894a0db2dbb77b08b1e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMy0xNi0xLTEtMA_3eea7df4-3afa-4c6c-9c49-31fc90a3b72e"
      unitRef="usd">324478000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6381e6f32971476bad6e8099cd489312_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0yLTEtMS0w_237af760-f2fc-424e-820c-2f9117fb662c"
      unitRef="usd">42171000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia5724a75532a4b8aa3826f98fb49e10f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC00LTEtMS0w_7ed797bd-1549-4032-b799-13145d33060f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie1f8ca28e64840a497f16c8486d31fb2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC02LTEtMS0w_3f60e5b3-22bd-402e-9b38-a1a516a20306"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i337849ef0f8b47ed813360d98632e23a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC04LTEtMS0w_d60b5991-3872-4c64-8ca8-1ad0421e1683"
      unitRef="usd">42171000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4feeb449c4040e18a03705d479e0b73_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xMC0xLTEtMA_07f290f6-a91f-46ae-8771-a634e3e8d8f1"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i39511b4bf4784d1ab377144f67fa01de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xMi0xLTEtMA_f834ae06-5d8f-4130-8bae-3c138ab756be"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id65d2a27498648b69fe545f62a7d5f0d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xNC0xLTEtMA_4b7cb295-db79-42a3-be80-6b9b977812bf"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie9d827596d8a47a3824b013dc8178a8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNC0xNi0xLTEtMA_a0a6372c-eac4-44d5-8f4b-8f77d24e4b75"
      unitRef="usd">32763000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2ecd386015e54ceabc014a87406ce863_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0yLTEtMS0w_7b1a9dae-d7ab-4127-b94f-2652a5a2daa9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i17b7b001fd454c5589ff4e2973cd3067_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS00LTEtMS0w_df925ce9-e6a5-4bcc-93a3-8fbf79bd64e7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9135bb25b9b145eab714c4c7ad20594b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS02LTEtMS0w_71279f6f-5fa0-4a26-920f-b5f88b0f2f55"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i564faa262c604481a02c2694f4fb73f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS04LTEtMS0w_cf1b99b7-c8b7-4fc0-bedc-04c24b299b4b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9ecbea11385c435cbb9af9cce9cfa738_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xMC0xLTEtMA_c2638fbe-ee7c-4a90-a612-9c6dba5f6a3c"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i64b74fc269564f20a9b090e4b7124600_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xMi0xLTEtMA_7f6b41c1-0df0-45ad-ad4f-7004d4805dda"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3ac63adf2bb546c4ac1aba900b398602_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xNC0xLTEtMA_16ab9a11-ae29-424d-a065-4193ece61793"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i785d8e5ecc03429cab75cc6262c02576_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNS0xNi0xLTEtMA_8701cb5f-6b20-4b29-b390-4c79e343cfe2"
      unitRef="usd">6326000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4355ca159edc4fa99ebca7d202c8bce3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0yLTEtMS0w_52a2a274-98c2-4a7e-a70a-754f1c0e701f"
      unitRef="usd">47561000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i327b2c0b89c844f99e545089828c950b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi00LTEtMS0w_93fef31c-243a-45d4-87de-13f749e1d45c"
      unitRef="usd">251578000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibb44ca12568c4d3c9fa23dbe60549105_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi02LTEtMS0w_2ebf6361-9c70-4b40-8d6d-e664ae17a679"
      unitRef="usd">642000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4a65f889aa34725ad89d69cd8592c90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi04LTEtMS0w_558cf96f-4e33-411e-8c59-0e63cfd50037"
      unitRef="usd">299781000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if7a388749dd0497c8d72fc543e8ad75a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xMC0xLTEtMA_5fe30d37-7d28-4df8-a8a1-002370fd209b"
      unitRef="usd">42527000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8cb97d5feddd466b911da2f1c55fb194_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xMi0xLTEtMA_bb8e727b-f1ff-4648-8da8-d818eeac7094"
      unitRef="usd">320647000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i227b26c77357461d805f1d914f51e920_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xNC0xLTEtMA_202f2dbe-a66e-421b-8792-435922c20dc2"
      unitRef="usd">393000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3d6329169fbc411e8411d28d90ca9499_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfNi0xNi0xLTEtMA_57c8613a-dd18-4445-9aaa-00adcc29d71a"
      unitRef="usd">363567000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie3a1b93f4a934aabbecad2ea88faedbe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0yLTEtMS0w_bce7d413-d14c-4818-9277-7d96f5f20b76"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic536e4be36ac4c8db8f4378ad775ac07_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC00LTEtMS0w_87d052f4-3d8f-460f-8084-4f5be0057599"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0d989500a4b14828af3c71491fd9283e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC02LTEtMS0w_b2e5f804-dd59-422e-8a85-f61d04856118"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i610ac4aaf38a415c8790607ee1e3c93f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC04LTEtMS0w_18a60981-2e05-4c8d-96d9-8939a9d0cdd9"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8bebc96ed6eb487a9164a823ad5cf0f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xMC0xLTEtMA_a135a2e7-55a5-4388-8ff6-86d6f39fe35f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3b076ad76aa4482185948f46fd1db7af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xMi0xLTEtMA_a02c0fde-bc95-4ec8-b41e-54685fe22fe3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i06afbcfccbc64bc492f4c8c17e3822a3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xNC0xLTEtMA_c7dfe92f-eb01-4b17-a022-bfc0575b4d62"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia21eb2218a714e87a27850a3da35a362_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOC0xNi0xLTEtMA_704620a7-447c-40d8-a757-fd7fa115bb2a"
      unitRef="usd">800000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0745304b68584347a2623a146af292f6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0yLTEtMS0w_5b9cd086-1277-4f0a-b511-383db13471e4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifd7b4e075dc6495e89f3147135f0148b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS00LTEtMS0w_56b13529-2c74-4555-81ab-96e49b15f54e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i231808f85c2e4134b7396905d29aba89_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS02LTEtMS0w_215e80fa-204d-407e-9383-92ff27c0a524"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9e8416b02586494b9c68ce1aaeefd509_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS04LTEtMS0w_ca86d98e-7ddb-4ece-a5d5-3be91fe5e6e5"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i78104f24516b4de29f3df2b385f1639f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xMC0xLTEtMA_1bacae25-780a-4237-b5ad-f71c95f76177"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i234d3d3b2e13452b972aad1617983de9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xMi0xLTEtMA_c5d6525a-4c64-4fbe-a9dc-18fcb9ec1686"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6bbd5e7581044241879711dfbcd50002_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xNC0xLTEtMA_1f110a3f-07c8-4c5d-afd5-8bfc34dca18d"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9850a097083942e0afabbbac0b9129f1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfOS0xNi0xLTEtMA_b9e1697f-1658-4453-83a3-c35b55ccdf32"
      unitRef="usd">508000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i359cff11df50436c9bb95a65ae993fd1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMi0xLTEtMA_860203ab-0ca4-4a91-8dd9-a627d78402b7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2a4d6516a3084dba85ee9f2d9965e059_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtNC0xLTEtMA_349edce5-42b4-4b5a-8c50-53f0754cf63c"
      unitRef="usd">2699000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic73643b6707d4e4c9a71b01e7b7dcf93_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtNi0xLTEtMA_3eac9856-e6a4-4877-91b7-06ff5e7bf128"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i96d90de4a6434ddbb1f5058962f04c17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtOC0xLTEtMA_26fb37f7-9b27-42d8-826b-631b5bd2e6eb"
      unitRef="usd">2699000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6ed9ab31d41044b192fcdb3349f39fb3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTAtMS0xLTA_36e327a2-45d7-495f-9d67-604e386f2de5"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifa31522c2e4a440db343ae979020b192_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTItMS0xLTA_c87e2761-b4f7-40c3-a4a3-09856694e313"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2f5ff1254de64bb8b8d9981154c1f445_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTQtMS0xLTA_3fbc64b6-7d66-481d-a967-2fd5f63758e9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i65b70c37f9aa42fe9d9b2c0a5569f3ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTAtMTYtMS0xLTA_b4f9161a-2c3a-46ca-9993-f4374855da87"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i17521c0433c44b8a80fc0dd1145be9e6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMi0xLTEtMA_197fd744-966e-4486-afdf-2629b381ea4c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie8ec3cae99b848a1b973526b515df54a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtNC0xLTEtMA_18fc8940-0ecd-46ea-9966-7ed1711ae097"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2126d7fd9f75438580dfe001ae6fa752_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtNi0xLTEtMA_3b5631b7-4212-4c96-bb71-87608f1b5f81"
      unitRef="usd">4808000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i97fcc3aebae546f7a142fac3cc2c0745_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtOC0xLTEtMA_b643e38c-8954-4146-b3d5-5c6af662208b"
      unitRef="usd">4808000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i23ec7efead9b4761baa234b4bfb65a32_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTAtMS0xLTA_4315598b-599e-4237-a0a8-a076b5108edd"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib92d652ad5604f02a1b2e862f88b1646_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTItMS0xLTA_7b148f73-8f94-4833-921b-851bf1b621e9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia655880e41b0499a8b88d4a727ed9eab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTQtMS0xLTA_b00e6856-9bb8-4ed9-a380-d77778e51663"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic40690754d3a44cc8d92472abaff4f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTEtMTYtMS0xLTA_6083b1cf-c1b1-4904-a5cc-2d9d841bb54f"
      unitRef="usd">6404000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icb63d9bffe134ab4a8487fdb45a691f8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMi0xLTEtMA_3de02a85-3840-4d28-99ec-a01c2e2d8ac3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i861dcf90c1e74fe880857a9b4b3c9a79_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItNC0xLTEtMA_37c6c3ef-5bd0-446b-8898-75a8f0d3045d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i750b151cf9fe4b5bacc45d083dfefabc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItNi0xLTEtMA_f4550257-9dad-4080-a8cc-f35b36f9ae47"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9efb83e898004cea87bab8cb9c0988da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItOC0xLTEtMA_c6059c3e-173c-42cd-9844-04860b8b5fe1"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ieda651849d114d4abd488d8ecfe42755_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTAtMS0xLTA_85ebec0c-5218-4579-bae9-c5ee6e89819b"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8b6a4eeb00954ec987c7739f3c9775dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTItMS0xLTA_592b39ec-87b2-49af-b58f-b4a6a634bb34"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i31f9c1943c5c42278fc70e863c8ee407_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTQtMS0xLTA_7f58ba96-4f01-40ea-9cb6-c678996c55e3"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i025eaa94559140439e978745a70ab345_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTItMTYtMS0xLTA_a3be0829-1efc-4c17-b38f-6ab74c56616f"
      unitRef="usd">37600000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i103235a0480d438fb3c8952921afef6d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMi0xLTEtMA_761728c0-be0f-4b3a-beb0-1e441f90b536"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7ceaecbf981d488e903c7845de55f9ce_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtNC0xLTEtMA_42e86adf-a0fb-4517-a2af-299e38b6dddf"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i103f057e0945407ba3313d8490b9be67_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtNi0xLTEtMA_03871f62-67fd-4053-9915-836d20ff2aa7"
      unitRef="usd">720000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i53807a156d9c4b8a877570a1cad4e9d2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtOC0xLTEtMA_015a84df-2721-4316-b4d8-91b6b02b0596"
      unitRef="usd">720000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if97d00b4fc204934b6f74c46e2902d97_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTAtMS0xLTA_0a7cf327-04f6-4bb2-ba5b-3cdc7fc97aad"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia0f9e34d26c64081a716e4ad38102b2b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTItMS0xLTA_1c3f09f0-a188-44be-b321-ba8202d517ef"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i116e95e42f624c0ebdee627175c1f44b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTQtMS0xLTA_de04256a-0829-4d2d-ad26-c2bca87d8c85"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i32596f59df27404580fe06db3f0a6a33_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTMtMTYtMS0xLTA_a29913e9-1372-4a36-9798-c0664a24413c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i582ba6e6a3d048fa858bc097e375efbb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMi0xLTEtMA_78f0ee9f-7b93-4cc4-9b63-45656a00e03f"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0cb687c8f41345a1b1a390788c8b3eab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtNC0xLTEtMA_5473e3fc-7bb1-426e-a1ec-18878006688f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i20539e1cd2eb4b4990f8905b457891fe_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtNi0xLTEtMA_b7b783f1-c827-4bc7-a3d5-adeccac82877"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie7ed509cd26a488e8fc504b51723e946_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtOC0xLTEtMA_7d39fe6e-8119-4df3-af71-5e7b9aab1459"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i653b721956384c858144b850891af87b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTAtMS0xLTA_7005599b-2c5f-4f3b-968e-f08b5a667cad"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i577bc815500b4aa4bc23468486976592_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTItMS0xLTA_383fb821-183f-4537-9ed5-e75c0b61e665"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9bda237598d54cafa9c0a35ab7f63129_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTQtMS0xLTA_4b20326c-4e80-4b6c-9aa1-dd67a126ce67"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9fe0e390a595409686d2fee6e8fe8450_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTQtMTYtMS0xLTA_55e56d70-41a9-4fdc-8d9e-e4be2238ca38"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4355ca159edc4fa99ebca7d202c8bce3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMi0xLTEtMA_6263c9ee-c432-4a09-8fd9-34d6f0ea306a"
      unitRef="usd">31000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i327b2c0b89c844f99e545089828c950b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtNC0xLTEtMA_5ddb02e0-5907-4b17-a0a7-47b39605d710"
      unitRef="usd">2699000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibb44ca12568c4d3c9fa23dbe60549105_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtNi0xLTEtMA_43b22391-55e3-4caa-bab3-5183c52fd84a"
      unitRef="usd">6677000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id4a65f889aa34725ad89d69cd8592c90_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtOC0xLTEtMA_8ccdba90-6238-4fec-925a-becd3b0da0f0"
      unitRef="usd">9407000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if7a388749dd0497c8d72fc543e8ad75a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTAtMS0xLTA_a650afbe-be18-4baa-aa9f-20c3f58bff9d"
      unitRef="usd">60000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8cb97d5feddd466b911da2f1c55fb194_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTItMS0xLTA_07ce2ed1-0eff-4d28-bff0-bd052c7e33fc"
      unitRef="usd">3821000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i227b26c77357461d805f1d914f51e920_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTQtMS0xLTA_3e590793-993b-448a-8735-1561b9fb3297"
      unitRef="usd">45312000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d6329169fbc411e8411d28d90ca9499_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOmI4MmRiMDQ0MDVmYzQxMjU5MmY3ZmUxMGE0NjUxMTc0L3RhYmxlcmFuZ2U6YjgyZGIwNDQwNWZjNDEyNTkyZjdmZTEwYTQ2NTExNzRfMTUtMTYtMS0xLTA_0260d5d8-948f-425c-ad99-fd429d978e43"
      unitRef="usd">49193000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjQ5Nw_8027aeed-cd68-4639-a4e8-a2e9da2606d5"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjUxNQ_93df1670-aaac-4c5d-99aa-f2b9c25732bf"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjUzNQ_60fde0ad-aa89-494f-8e31-6e08c757fbf5"
      unitRef="contingent_value_right_series">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="i231b812d92ca4b5fa28f1a4b0df82219_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjY3MA_720e39ae-4fb5-4639-8f2c-847548ca1f2c">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="i4a7423268c1947ffaad3d4a234a16758_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMzQ3Mg_733224cd-d072-457f-b17e-6c7d1208ee89"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="ia7fe0d08f8814b26bb6d850aefa0bf38_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMzU4Nw_c06d2b6c-43ea-4cf2-9cca-0ec4ab02d19c"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="iefccc513badf4ac697660d63ce351a27_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDE5OA_30261a2a-491f-4e63-a300-b8d00e959c6c"
      unitRef="usd">1100000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDU5OA_51a21d21-e6a6-43d5-97d1-29fd097112e2"
      unitRef="usd">-3800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNDYwNQ_192734ee-1c7f-4b5e-bd98-a020f8f5e9aa"
      unitRef="usd">-37600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfMjE5OTAyMzI2MjYzMQ_5b0050fe-602b-436e-b5b0-56eb7f628bf4"
      unitRef="usd">700000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RleHRyZWdpb246MjI0YzIxNTgxMmE3NDk5MzgzZTVhMGNiZjcyN2NhNzdfNjYzNA_340525a9-8b3f-457b-b140-182344458b87">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of September&#160;30, 2021 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i845a05cd969041fba7ad46f78c0e09ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMC0xLTEtMS0w_13e18699-4c11-4023-880c-f1d93c57b7bc"
      unitRef="usd">45312000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMS0xLTEtMS0w_d836767e-5da4-4ec1-9742-390f5c3bb019"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMi0xLTEtMS0w_216cc976-de13-4d16-a0c4-1af670e5c2e8"
      unitRef="usd">-38305000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="i68693c0ee54f452baa84e3402b932c27_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfMy0xLTEtMS0w_9ac03ac7-27a9-49b3-b6f7-a38f96583343"
      unitRef="usd">720000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i75913a021dca4a82866b4b9298cecb68_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN18zNy9mcmFnOjIyNGMyMTU4MTJhNzQ5OTM4M2U1YTBjYmY3MjdjYTc3L3RhYmxlOjQwMWJkMDhjY2E1ODQ3MDdiNjIzZjJiNGQ4Y2RmMjZiL3RhYmxlcmFuZ2U6NDAxYmQwOGNjYTU4NDcwN2I2MjNmMmI0ZDhjZGYyNmJfNC0xLTEtMS0w_ee35b1cd-b32e-4fc1-a6d8-379f72a7ccb8"
      unitRef="usd">6677000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDg_053a57d3-1e99-4fc1-a653-b1ec2f4fb813">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Pfenex Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the nine months ended September&#160;30, 2021, we wrote off the entire CVR liability primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(52,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using a discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share-based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net loss per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Taurus Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which was settled and paid in September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for the CVRs in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;xCella Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations to be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. The holdback was not settled as of September&#160;30, 2021, and we expect to have it settled by the end of 2021. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three and nine months ended September&#160;30, 2021, we recognized $0.5 million and $0.7 million, respectively, in earnout rights when certain contingencies were resolved during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Icagen Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 2, Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and the actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzQx_f31e2cbf-a1e1-4dd3-adb0-2924d61816b9"
      unitRef="usd">465100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzUz_7f02a9f8-d65d-46f3-b287-89198d829aea"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDM2_f41a2b7d-4e2b-4574-bb96-441f779ab7f2"
      unitRef="usd">77800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTI2_8caa6eb2-bc17-4c6f-82cb-34274543217b"
      unitRef="usd">37000000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjY4_662a3270-443b-443d-9e0f-33600d69e385"
      unitRef="usd">1500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ib1a044c5eca64972a0b2cca378908568_I20201001"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc3_503ce969-775f-42a2-97b2-a198cf8ef0a1"
      unitRef="pure">0.071</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions
      contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTU5MQ_bc833bc9-b917-41cf-933e-189b7292d6de"
      unitRef="usd">17300000</lgnd:PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTc0NQ_7f02a9f8-d65d-46f3-b287-89198d829aea"
      unitRef="usd">429600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="iaa5a82595b87414eb6672c3977e9fe8f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTg1Ng_4d6ecd8f-3ea4-4c87-91d2-1c232d748550"
      unitRef="usd">8700000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MTA_963f9033-c56b-464e-bd48-797edf86e7f1">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts and unbilled receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangibles acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(52,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;465,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMC0xLTEtMS0w_791dc8df-4150-4a27-8631-a8302d7d6f2f"
      unitRef="usd">51407000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMS0xLTEtMS0w_9f838ba6-0e3e-45f2-8e85-bfd566836e8c"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMi0xLTEtMS0w_cbb6e53a-9346-40d8-8b77-a831d495d302"
      unitRef="usd">1359000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMy0xLTEtMS0w_901c7d2c-8f7f-482e-b609-fd475c5ad39c"
      unitRef="usd">7823000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNC0xLTEtMS0w_a16eb1fe-85d2-4711-99d0-664b547a2846"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNS0xLTEtMS0w_0b897304-3428-4558-b3a9-ec250c1aa8cf"
      unitRef="usd">1338000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNi0xLTEtMS0w_5cab5962-620e-4f74-acc5-f90ebd509bae"
      unitRef="usd">385000000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfNy0xLTEtMS0w_4a2e6283-f519-4e23-aed2-6460f0258d14"
      unitRef="usd">91271000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfOC0xLTEtMS0w_0602800d-8d95-48c0-b0eb-353eac9d0ac9"
      unitRef="usd">6814000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfOS0xLTEtMS0w_1af4bf51-5e02-4374-a51b-b8df3e13477a"
      unitRef="usd">8466000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTAtMS0xLTEtMA_8aea4a5d-8ad2-40f9-bee9-d1f97db2e3f2"
      unitRef="usd">3908000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTEtMS0xLTEtMA_ba4d38af-42cd-4d5f-8fdb-9d2bf0cd0c4f"
      unitRef="usd">3070000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTItMS0xLTEtMA_87bba8f2-e5ff-47e3-bcee-5c08f6583aaa"
      unitRef="usd">1382000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTMtMS0xLTEtMA_90727e00-0b7c-40c6-8643-7be59eb5a541"
      unitRef="usd">52730000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOmNhZjE3ZTkxZTI1NjQ3Zjg5OGNjY2I5MDc1ZmIxMDcwL3RhYmxlcmFuZ2U6Y2FmMTdlOTFlMjU2NDdmODk4Y2NjYjkwNzVmYjEwNzBfMTQtMS0xLTEtMA_14508372-24de-45a5-b699-1530d18b7d9f"
      unitRef="usd">465098000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i785fd0e4a68b40ff8674243d934db225_I20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjU3OQ_2bab1e44-0274-4e8a-8a5a-3cb2931fa171"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if47943aab20d4716931dd955f73d9f68_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjY3Ng_fc7bd076-8da0-4cf9-b771-8356c3886e98"
      unitRef="usd">362000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i49460a614c3741bd9dcb93c1082e254c_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjcxMg_5e7f68b7-2e8e-4c0e-abbf-7661f5f4d6c9"
      unitRef="usd">23000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iac2e38018c524066aae124ee0322449c_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzE5NQ_357811bc-486c-4d5b-a8c2-9deeb0d0e2bf">P12Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i24d097ca8d274dba82a4146da4cefe5c_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzU5Mg_46947624-58ee-4407-a0f8-63f6abe01aee"
      unitRef="number">0.12</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i3b99f5d261b2424984f7c2048cf94154_D20201001-20201001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzU5OA_d922018e-eb39-4b4a-8d2c-f1179c392d17"
      unitRef="number">0.15</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMzcyOQ_153dad6d-be23-45e0-b5e7-d321482fc850">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDc_56ec5f28-8a7e-4a77-839b-75f72ffb866f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following summary presents our unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share-based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net loss per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMS0xLTEtMS0w_51d12930-7ec7-4be9-99b1-9de6501e7687"
      unitRef="usd">43082000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMS0zLTEtMS0w_69069b18-8ebc-4508-a719-23ba471e6ecf"
      unitRef="usd">119126000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMi0xLTEtMS0w_20932d3d-1843-4260-b541-63df2669fef0"
      unitRef="usd">-46845000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfMi0zLTEtMS0w_b6b70f9e-4148-4445-8846-4b56e253b7e3"
      unitRef="usd">-77349000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0xLTEtMS0w_2285e63d-a70b-4735-9d82-04c429689f4b"
      unitRef="usdPerShare">-2.91</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0xLTEtMS0w_3f5da870-8f75-44be-a33a-944e01946806"
      unitRef="usdPerShare">-2.91</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0zLTEtMS0w_44d40396-5892-42ff-b1c4-cf0c2ab13584"
      unitRef="usdPerShare">-4.77</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i1078e063b64d4baeb05679c4ae853663_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RhYmxlOjlhODdjNGQ3YzYzYzQyODZhMWZlNzZkNDEwZDYyYzQ3L3RhYmxlcmFuZ2U6OWE4N2M0ZDdjNjNjNDI4NmExZmU3NmQ0MTBkNjJjNDdfNC0zLTEtMS0w_d4a14896-cba5-4b23-918f-339b0bc75624"
      unitRef="usdPerShare">-4.77</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk0Nw_6090fac0-8610-47f2-aa16-25f75c1757dd"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk1OQ_442c223e-c679-4c67-b496-8d0cfe6f6e8b"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNDk3Nw_3f3751e9-2773-4d93-9736-b87baec9579c"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6ee708bc3f874ea4a64ff9eab6bc8b78_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTExNg_0246a052-eb5d-4830-b9d6-a53859a3e636"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i24a5667057b941dcbffe8705e96b7a08_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTE4OQ_4b4fda6d-f62d-4118-9a1a-bc3629b67f08"
      unitRef="usd">25000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i23982d6bb19f46ada4a2da4c208bef75_D20200909-20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTE5Nw_800a8c1e-857c-4db4-8ab6-21c1dc5736e9"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if74d6071013e4d84a2524f47dc61bcad_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTY3NQ_ba75dfda-078c-48e6-a809-d61ab80b6055"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i62b604edf45a4273b85b6a9dd018b41b_I20200909"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTcyMw_6f4ea727-ac4e-4c92-a5a3-cb04c82f0fd5"
      unitRef="usd">50000.00</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1107fe7113ce41d3aebe65bed5bc350f_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTc2Mw_e5911218-a986-41e3-9d31-14077b2e4d42"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ica1eb82f11c04cea9b0171a30ecb9c64_D20200909-20200909"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNTkxNQ_a0f68587-3324-4108-b563-27b05a0bf9b3">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i62b604edf45a4273b85b6a9dd018b41b_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjA1NA_6a6b860f-0f3e-4e60-aa05-200829f487ba"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjE5Ng_e1f46a20-e47d-4cf1-a430-53acb8e4bd93"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjIyMA_e4ac62ec-cbf5-4018-bb60-7abba31e892a"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i86a9860367d34127b2a08e3c03d11f2e_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjM0OQ_f6136d40-5328-4c3d-b024-c1caff6ad753"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i08d4e4d3980d4dff9c9d86c7ec2dcb16_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjQ0Ng_1e4906fb-fa25-4729-b40e-efb021ff40e3"
      unitRef="usd">25750000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i64d969dd64874a7db0f0480d82e40efc_D20200908-20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjQ1NA_fc7f04aa-e085-4351-a526-c66a4ae99df4"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i53bbd4159f784372aec848e6158a7bc5_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjk0Mg_3c8d2460-28d4-404c-ab15-e26fd7ba81a8"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNjk5MA_79716420-5881-49cf-98e4-aa0096df2bc9"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzAyNg_992f125f-2ca5-4232-a431-2da6b9efa92f"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3b57fd5414fe448ca4dc3bd49c273738_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzA1Nw_f24fd343-c80e-4ff1-b8b8-1dcac5e264e9"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzEwNw_9cbcf09f-a74b-46c4-9306-a145ade8b8e9"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if60b6d14d66a4cb9ba4bd253315c186c_D20200908-20200908"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzIzNQ_db806582-9eff-46b3-b4c6-d11b0d3a2069">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia55cc8e4d6854b60b4a4fb50572715aa_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzM4NA_cedc2304-8bf4-4b4f-99b2-6f62370f98aa"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="i6d9c69e09e534351bc10468027e76940_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfNzU1Mg_10d2d13c-4f31-4ec6-9704-3fff34a3c1ab"
      unitRef="usd">500000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="iec839ce408ae4324a9f9076e158050a5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMjE5OTAyMzI2NjQzOA_ffc4e785-0a2a-4f10-a893-5be920d3337a"
      unitRef="usd">700000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODA5MQ_54103e29-d73f-4a16-8426-595dfda79e25"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODE2NA_85d87495-47f1-45ed-aab8-d8ac9570b98b"
      unitRef="usd">19900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODE3Ng_eec8abf7-ebe7-4dd3-9525-9430f9d3a7e8"
      unitRef="usd">15100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODI2NA_cd3ec1b8-80ae-40b4-a422-e5e4e78a864a"
      unitRef="usd">25000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfODM1Mg_66c5802e-d0b7-4dcb-88c0-2f3deb897774"
      unitRef="usd">4800000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTM2Ng_02775db3-84ae-428e-ad27-38131041a6a1"
      unitRef="usd">1800000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQxNg_f0da373c-6aaf-4db4-8384-5b4631300893"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQ0Nw_2606e9b3-362d-43b8-b2f3-d37768b45bbd"
      unitRef="usd">12800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTQ3OQ_4d25c9fb-c817-4a48-a7fd-2be2318d90e4"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i9b376b9aa5864554bbc41743970ed458_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTU5MA_769f87a8-a72a-4f00-9bfc-cd8d7e8e2018"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTY2MQ_c4f5020b-1035-490c-881d-dc0601487284"
      unitRef="usd">9000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1575170f30d94fd0bbbe0cee59a6431f_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc2Mg_d9a87501-9747-4806-8b57-6ca720b71cf4"
      unitRef="usd">11100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia09d2bdfc41645b2b379612921c6d7c5_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfOTc5NQ_83772ad7-f791-4621-877d-463c557ce280"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTAwOTA_3a09871c-9a33-49b9-9422-59fdf51e5c22"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iac4c13bd554c437188e7d34a5ddf5281_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTAyMzQ_aeefd7b6-027d-4177-8ef0-bbba7062921b">P9Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA1Njk_fbd5ffcf-5bd2-4371-9b9e-2d8cd393d8a3"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2f07e411b9f04f3991ecc80f09da5ef1_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA2ODk_d3e293b3-8b80-4642-a7fc-200ac250caaf">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0013e3f39d5c4d978961d13c6a8e6226_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180MC9mcmFnOmE2OWEyMWUyYTUyZTQwODk4MWMwZmViNDdkNTNhYjAyL3RleHRyZWdpb246YTY5YTIxZTJhNTJlNDA4OTgxYzBmZWI0N2Q1M2FiMDJfMTA4MDM_4e6906aa-93ef-401b-bd2f-9441dde27c04">P9Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjU5Mg_16dce038-42a2-4ad9-b32d-5e8fa211cf8e">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of September&#160;30, 2021, the &#x201c;if-converted value&#x201d; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.3 million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2021, (2) a $13.7 million reduction in debt discount, and (3) a $10.2 million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTk_e2485164-1a64-4ba1-90a6-f216aa45e63b"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTMy_6036bb54-381f-4738-8655-31cdcb5bc957"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjg4_614b1d27-1749-4a3f-a74b-2b9a61543842"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjA5_766100fa-0e93-41fc-8d9f-8a8be16de1b9"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTQy_1d79eb97-dd4a-4b75-acb4-64298277ca64"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfOTk4_f1ffbeae-562f-433c-9af9-2a9598b67620"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ibd3ee7a7960645bd94dab1b06a76505b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTE5Mw_63732639-d234-4521-9714-878577b3a76f"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTI1OA_66cf770b-75d9-47ed-8b8e-370a5d451cf9"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTMwNw_793a3a9e-4e2c-4e0b-9b97-f27e77a91f6b"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="icc1349a3ffab44ad9a257303833c4199_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTQxNg_37f9a231-6410-4359-9dc9-7abadaaa0714"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTg0MA_d9525996-9b4e-4170-b921-5917b7693155"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMTk5Nw_5667898d-71cc-4949-a54e-e50a9f07aae1"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjE3MA_2c1c5ffe-06b8-487b-99af-e85871e50d7e"
      unitRef="usd">13700000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjU5MA_af0c1950-35ec-4dbc-8e73-64d45611fa53"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjYyOA_f44279d3-4637-48a3-82fa-2199f29e182b"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjY3MA_aae24fa3-fa4b-479d-9902-0f45837571ca"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjc2NA_ae82d265-4443-4915-bb16-b694afdcc890"
      unitRef="usd">-7300000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjg4NA_0e3558bf-7947-4737-a169-c2547aefbc3f"
      unitRef="usd">-13700000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMjkyNQ_34d6632b-d165-4d1a-a718-614d1a02eaf9"
      unitRef="usd">-10200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzI1NQ_c3f0e45e-9491-477d-ba77-a29fb22e9189"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzUyOQ_fc8f6550-455d-462a-8d4d-e026982bb9b7"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfMzYxMg_4b21a259-f1b9-4bb0-94fd-64c26eefa3f9"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDUxMg_5fa1a401-3a42-4f20-888f-4cdbce344a94"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDU3OA_58cc6a0b-1f31-42b2-bf7b-e9996210f73b"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i516beb4875cd4ad9aa716192fbf80a10_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNDYzNg_d8c6cb68-7ce1-46f7-93d1-5489587f1ca6"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTY3NQ_b071912d-90c8-4c01-b643-f44b6f785eeb"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTcxMw_a612b44f-0a31-48f3-aa3a-b7568ab1b3c1"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="i9b9efab7754142a7966a156fc1e65791_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNTc1NQ_a14d7f8b-3f52-44aa-9bda-5ed66ac245fa"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjEwMA_27248dd9-5ec2-4542-b8da-3486636a5079"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i2a938482a2e04a368c8ecb7e4d5af0f8_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIwOQ_c3f0e45e-9491-477d-ba77-a29fb22e9189"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIxNQ_77956590-90eb-462f-b506-66f91c870569"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjIzMQ_dd7ec1be-041f-4ca7-8c82-6ca59d2cdc72"
      unitRef="usd">18900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjM1Mg_81617da2-ad1a-4550-8ae1-306170ec4fe3"
      unitRef="option">598021</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjM5Ng_a1fde391-33ef-46e1-9485-04712fd5ffdd"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RleHRyZWdpb246ZDQyMTRhMDg4OTU1NDQzZDk2YzdmYjM0NzY3ZDJmYTVfNjU5MA_ae99a59b-6e36-4e1e-9d5e-dc80e2a837e2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;442,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;466,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMS0xLTEtMS0w_01edfbb5-bb22-40ed-84c9-71db44bff960"
      unitRef="usd">343301000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMS0zLTEtMS0w_924c5969-7b89-4132-9c89-0b03b0d71161"
      unitRef="usd">495280000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMi0xLTEtMS0w_d0662955-485b-4ce2-973e-0b51be068f56"
      unitRef="usd">26412000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMi0zLTEtMS0w_e09f53ce-3178-4a6c-b336-26c2c8eaf98e"
      unitRef="usd">52987000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermNotesPayable
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMy0xLTEtMS0w_077ca9f1-2f18-47f0-b2b6-9c0cacc9e41c"
      unitRef="usd">316889000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfMy0zLTEtMS0w_afd80167-fbfa-4042-aad1-8621a5ed4293"
      unitRef="usd">442293000</us-gaap:LongTermNotesPayable>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNS0xLTEtMS0w_62828e96-0f5b-4c3b-bc1c-364676cfadbf"
      unitRef="usd">24124000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNS0zLTEtMS0w_05eac557-3f79-4162-bbd2-23f972ad5afd"
      unitRef="usd">48397000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i2c2b96408b9c412a9768198f8e8f606a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNi0xLTEtMS0w_b2b3cbca-a0e1-404f-9c6c-079636f01be9"
      unitRef="usd">343888000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i0685149320e54ff89544d4e3f7a97265_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180My9mcmFnOmQ0MjE0YTA4ODk1NTQ0M2Q5NmM3ZmIzNDc2N2QyZmE1L3RhYmxlOmJmZDBiNWYyOWE1NjQ1YmViN2E0NjM0MDIwYWZhYjQxL3RhYmxlcmFuZ2U6YmZkMGI1ZjI5YTU2NDViZWI3YTQ2MzQwMjBhZmFiNDFfNi0zLTEtMS0w_62abadd6-133e-4462-b26e-4f7c37392dff"
      unitRef="usd">466053000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTQ1NQ_575d59fe-593f-4626-b4bc-781c751187c4">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2021 was 10.1% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2021 was due primarily to the $3.8&#160;million and $37.6&#160;million tax benefits associated with the Pfenex CVR adjustment recorded during the second and third quarters of 2021, respectively, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR.  Also contributing to the variance from the federal statutory rate are excess tax windfalls from share-based compensation due to increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and nine months ended September 30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNDI5_2b3bd783-caba-4980-b761-8352aaf13aa3"
      unitRef="number">0.101</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNDM2_6e6df7bd-e9ed-4688-91bc-acbba7f341b1"
      unitRef="number">-0.151</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id23197a4bf2f4e66ac9cf9a2110f1899_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfNTg5_51a21d21-e6a6-43d5-97d1-29fd097112e2"
      unitRef="usd">-3800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4a415c7761694708b3c6f25f3487c440_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMjE5OTAyMzI1OTQ5Mg_192734ee-1c7f-4b5e-bd98-a020f8f5e9aa"
      unitRef="usd">-37600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3e4308d8a255413492511fffb9a26412_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTA3MQ_cba4b309-dba1-48a0-8cd6-e0cac474773b"
      unitRef="number">0.423</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3a7c0eb26da04a4ab754e11501092a88_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180OS9mcmFnOjUxZjZkODczNjZmMTQzM2Q4ZDI4M2JiY2U1ZjNkMzY0L3RleHRyZWdpb246NTFmNmQ4NzM2NmYxNDMzZDhkMjgzYmJjZTVmM2QzNjRfMTA3OA_c42af22a-4f40-4ae7-b59c-339ac5bff95f"
      unitRef="number">0.371</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU2Mg_1f9ace3d-5a24-4423-9da8-323596f8e604">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(564,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,239,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, outstanding options to purchase 1.4 million shares were exercisable with a weighted average exercise price per share of $95.53.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2021, 46,866 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any share repurchases during the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of September&#160;30, 2021.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU1Nw_99c221f3-3c38-4eb0-9998-964f4f984e8b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(564,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,239,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTU2MA_4908283d-9445-42bf-b5c3-6df54bfb2aee">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,561,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;165,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(564,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,239,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;266,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic4a008f555614be384f97c9b5a03d5a3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi0xLTEtMS0w_37f57766-5dde-4a1e-bc76-654a9e5a6bf2"
      unitRef="shares">2561822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic4a008f555614be384f97c9b5a03d5a3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi0zLTEtMS0w_52e9934c-9aba-455f-87d9-6336f82d5e61"
      unitRef="usdPerShare">85.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9674c13420bc41deb65d3656daee3f18_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi01LTEtMS0w_b28bf875-069f-48b0-b25b-cc1c9e853b37"
      unitRef="shares">206202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9674c13420bc41deb65d3656daee3f18_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMi03LTEtMS0w_20058f38-bf5d-4c61-8c2a-c04ca445a409"
      unitRef="usdPerShare">106.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy0xLTEtMS0w_07838e3c-56e7-4403-9360-3856c32ac2a7"
      unitRef="shares">363889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy0zLTEtMS0w_70380d9f-988a-46c6-ab45-776972dd7126"
      unitRef="usdPerShare">160.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy01LTEtMS0w_06e74de2-1726-4607-bb5e-2c9ff9b956a1"
      unitRef="shares">165117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfMy03LTEtMS0w_71e6a55d-aacb-4584-a698-87962f75e3de"
      unitRef="usdPerShare">170.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC0xLTEtMS0w_b4d3e3a4-a0fe-40b3-a6f7-c3bc34065883"
      unitRef="shares">564302</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC0zLTEtMS0w_95f13b50-d1b8-476f-a948-b7a513117ece"
      unitRef="usdPerShare">52.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC01LTEtMS0w_c4a2245b-a484-4dd6-bf24-ad7091ce8e79"
      unitRef="shares">95657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNC03LTEtMS0w_4008323b-82d0-4049-a13d-0329bc57e017"
      unitRef="usdPerShare">126.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS0xLTEtMS0w_4d762ced-52fc-4050-9dde-b0948acd7a7c"
      unitRef="shares">121472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i2bc372ccc91341b6832099dc520b6f6d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS0zLTEtMS0w_cf1ea7c6-2c87-44b7-9744-33ac8b6b1feb"
      unitRef="usdPerShare">109.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS01LTEtMS0w_13f8bfc7-5c05-4ae3-87da-7005522e6d42"
      unitRef="shares">9575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ide5a19e841914942abfdf74c94be909b_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNS03LTEtMS0w_a7358957-3f81-4d92-ab1a-3e11cf259fba"
      unitRef="usdPerShare">138.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi0xLTEtMS0w_a18d7091-d2b5-4c2e-918e-05bb79f4be13"
      unitRef="shares">2239937</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i44bcc6d4beab49dd820c970d6df6f0e7_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi0zLTEtMS0w_6414db6d-8311-4d1d-af24-607fef4029ae"
      unitRef="usdPerShare">104.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i37978277e2ef4b739181ad403af7290d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi01LTEtMS0w_fe71a06b-09b4-475d-8e81-ec1f0696c1e9"
      unitRef="shares">266087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i37978277e2ef4b739181ad403af7290d_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RhYmxlOmE1OWZkZWM5NWFhNDRlZWVhYTc3MjBkZGFjMmVkZThkL3RhYmxlcmFuZ2U6YTU5ZmRlYzk1YWE0NGVlZWFhNzcyMGRkYWMyZWRlOGRfNi03LTEtMS0w_e6966a34-7a46-48f7-97ee-deeede47e3b4"
      unitRef="usdPerShare">137.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNDUw_3cdf23b2-b53e-418a-945f-1d84d51a0978"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNTI5_9ac77917-5aad-4840-8a7b-6f8b3b808715"
      unitRef="usdPerShare">95.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i3896ae5368254d08ac76230cffd63481_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfNjc4_913d9ced-93cb-4050-8578-74ce4972ff7e"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i3896ae5368254d08ac76230cffd63481_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfODA1_135388cc-0777-4f79-aa8f-71f332b4855a"
      unitRef="shares">46866</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfODk0_a3e9e324-a6c1-4b20-bf5c-ba987cd4e295"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ideff198686944e55a0cc2ee1e0f927b5_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTA4Mw_d5270c98-5c66-46d2-8abc-1b754baaa14d"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i1e665f31d61e468db6b421188680776a_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTEzOA_18f7e3bc-72a4-4c48-bc50-faa389b19f6e">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181Mi9mcmFnOjY3NTI2YTEzNDkzNDRkMzBiNTRkYjMzYTA1N2VhODY3L3RleHRyZWdpb246Njc1MjZhMTM0OTM0NGQzMGI1NGRiMzNhMDU3ZWE4NjdfMTUwNQ_bf4ef881-fac0-42a4-8631-4a7fd1ab6893"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfNzY2Ng_3349222d-0ad0-4d7d-acc6-21a3aa60e6e1">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revise our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;CyDex and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayments and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#x2019;s Counterdemand. On June 30, 2021, the parties&#x2019; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfMjU2MA_e70b46c1-d103-4474-a3f5-084c5e8d4017"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN181NS9mcmFnOjdmYmMzN2UzYWQ4ODRhYWE4NWVkZGFkYWY5MjM4Mjk2L3RleHRyZWdpb246N2ZiYzM3ZTNhZDg4NGFhYTg1ZWRkYWRhZjkyMzgyOTZfMzE0NQ_93305f56-ff46-435a-b73a-8334208b3d26"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzEyNjQ0MzgzNzIzOTI3_287f5d32-1a1e-4629-83b4-d5762671cf25">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2021, we entered into several new lease agreements including our Emeryville headquarter expansion and a new Icagen office lease, which resulted an increase in operating lease assets and liabilities of $8.7&#160;million and $9.2&#160;million, respectively, for the portion of the leases with a starting accounting lease commencement date during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzEyNjQ0MzgzNzIzOTI3_eaaa8572-f978-46a7-a904-6539062af8fc">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2021, we entered into several new lease agreements including our Emeryville headquarter expansion and a new Icagen office lease, which resulted an increase in operating lease assets and liabilities of $8.7&#160;million and $9.2&#160;million, respectively, for the portion of the leases with a starting accounting lease commencement date during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ibdf23659d72440e581b8103b1bb8431a_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDE2ODM_a7155e42-7f99-4e8a-b6a4-d6d1be2ac00f">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ibdf23659d72440e581b8103b1bb8431a_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDE3MDM_5948ed33-cae8-4ba1-8cdc-088fa846d752">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lgnd:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUxOTc_5c5f3225-19c6-455b-b913-3a04da160267">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEtMS0xLTEtMzA3MjQ_d962354b-6728-41d9-bba2-33d0e101619a"
      unitRef="usd">12951000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEtMy0xLTEtMzEzMDQ_c668b71b-490b-4f45-93a1-ea7a96a99e36"
      unitRef="usd">6892000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzItMS0xLTEtMzA3MjQ_873ded3b-c4af-4155-a1af-f719720ca9dc"
      unitRef="usd">16795000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzItMy0xLTEtMzEzMDQ_7fd32253-120f-4e7c-a90f-3ace75d2d1ba"
      unitRef="usd">15842000</us-gaap:FinanceLeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzMtMS0xLTEtMzEzMDQ_f92d1c7d-c547-49ed-a39e-ec3ef6e5dcc5"
      unitRef="usd">29746000</lgnd:LeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzMtMy0xLTEtMzEzMDQ_82814548-04d2-4533-b9d2-233ab957345b"
      unitRef="usd">22734000</lgnd:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzYtMS0xLTEtMzA3NTk_b4e6a13c-e599-4e59-b253-3f6c07e5928f"
      unitRef="usd">2181000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzYtMy0xLTEtMzEzMDQ_5017a4fc-7ae0-401a-abc3-ac4ec30f2fc5"
      unitRef="usd">1885000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzctMS0xLTEtMzA3NTk_72c525b8-28df-4178-9fa8-41373980f8df"
      unitRef="usd">45000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzctMy0xLTEtMzEzMDQ_17fcb238-381e-42e2-bffb-5e852fa96ae0"
      unitRef="usd">6593000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzgtMS0xLTEtMzEzMDQ_7673a6ad-96f3-40e8-bee7-c5f63589530e"
      unitRef="usd">2226000</lgnd:LeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzgtMy0xLTEtMzEzMDQ_35f121aa-52b3-40d7-b5f9-6d9661c8de71"
      unitRef="usd">8478000</lgnd:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzktMS0xLTEtMzA3NjU_3dcda3ad-9eeb-4347-9cf1-220d9a9ce993"
      unitRef="usd">11467000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzktMy0xLTEtMzEzMDQ_3e6267cd-a0f4-4d4b-8b03-4c148a5bd9e0"
      unitRef="usd">5643000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEwLTEtMS0xLTMwNzY1_1d1ab282-0da8-4e48-b654-51e4bee4421e"
      unitRef="usd">72000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzEwLTMtMS0xLTMxMzA0_f6ff72a8-c305-425d-a319-c6abb071a7f6"
      unitRef="usd">112000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lgnd:LeaseLiability
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzExLTEtMS0xLTMxMzA0_8232708f-462d-48e2-ba9c-1e6bf8998cfe"
      unitRef="usd">13765000</lgnd:LeaseLiability>
    <lgnd:LeaseLiability
      contextRef="id5e66a6b4d374ca2982d0e908c81c057_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZTowYjJlOWU2MWJlMDQ0MzMyYmVhZjZhYmNiM2QzY2VkYy90YWJsZXJhbmdlOjBiMmU5ZTYxYmUwNDQzMzJiZWFmNmFiY2IzZDNjZWRjXzExLTMtMS0xLTMxMzA0_61504e26-a7e4-4fea-861d-db5f11e2deaa"
      unitRef="usd">14233000</lgnd:LeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMTQ_a37ebdd0-97b1-4d8f-a061-ddbc110c1174"
      unitRef="usd">8700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMTQ_d183efa0-2bab-467f-983c-29b58de5fe78"
      unitRef="usd">8700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <lgnd:OperatingLeaseLiabilityAdditions
      contextRef="idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMDA_9567ee04-0b86-46db-9f3f-2cf6d6cc3476"
      unitRef="usd">9200000</lgnd:OperatingLeaseLiabilityAdditions>
    <lgnd:OperatingLeaseLiabilityAdditions
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUyMDA_ee1cae79-8e42-4057-89b0-edbda38a456a"
      unitRef="usd">9200000</lgnd:OperatingLeaseLiabilityAdditions>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90ZXh0cmVnaW9uOmY3NjU5YTQ1MWQ1NjQwMjU5NDUxYTkyYjViM2EzNWE0XzM4NDgyOTA3MDUxOTg_f50fd8de-c8fd-4f2d-b03c-a403e1c26046">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzEtMS0xLTEtMzA5MTY_482f85bc-9f69-48f9-a6fd-2c458a44bce5"
      unitRef="usd">690000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzItMS0xLTEtMzA5MTY_90abd252-c652-4b22-acf8-74eedfb267b5"
      unitRef="usd">357000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzMtMS0xLTEtMzA5MTY_6c4cb7d3-8646-4fd6-bf24-a90155b037af"
      unitRef="usd">2279000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzQtMS0xLTEtMzA5MTY_b595472b-e0d0-4e54-a377-6778b1cbf3fe"
      unitRef="usd">2114000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzUtMS0xLTEtMzA5MTY_57cb8ac5-ec0a-47a5-82e3-c313111aa316"
      unitRef="usd">1990000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <lgnd:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzYtMS0xLTEtMzA5MTY_7175b233-6785-4c85-b2ac-ddfb75c5a5e0"
      unitRef="usd">9081000</lgnd:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzctMS0xLTEtMzA4MjM_ea02bf02-bc1a-4d5e-b63f-12d326e2b99d"
      unitRef="usd">16511000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzgtMS0xLTEtMzA4NDQ_322140bb-809e-46a4-a7bc-172a200ee54b"
      unitRef="usd">2864000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i18d2cf420ac940fd8835832f3cb25bbf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NTkvZnJhZzpmNzY1OWE0NTFkNTY0MDI1OTQ1MWE5MmI1YjNhMzVhNC90YWJsZToxY2JmY2QzMjQ0YmY0ODlhYjI1MjhkZTU0NTFjMmEyYS90YWJsZXJhbmdlOjFjYmZjZDMyNDRiZjQ4OWFiMjUyOGRlNTQ1MWMyYTJhXzktMS0xLTEtMzA4NDQ_dae55be4-1a41-4917-a045-150500bdcdb8"
      unitRef="usd">13647000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MDE2ODE_b1e7ebca-f113-4145-ac4e-b222a0daf068">Subsequent EventOn November 9, 2021, we announced we are pursuing plans to split Ligand into two separate, publicly traded companies with one featuring the OmniAb platform and its large and growing customer base, and the other featuring Ligand&#x2019;s existing collection of core royalties and the technologies, pipeline and contracts associated with the Pelican protein expression platform and the Captisol business. Based on initial management and advisor review, an IPO and eventual distribution of OmniAb shares to Ligand shareholders is the leading option under consideration at this time. The IPO would be of newly issued shares of OmniAb, Inc. (formerly OMT), including Ab Initio computational antigen design, Icagen&#x2019;s ion channel technology, xPloration high-throughput screening technology, and the suite of OmniAb animals used for antibody discovery. In an IPO, we expect OmniAb to issue less than 20% of its common stock, with us retaining the remaining interest, which would eventually be distributed to our stockholders in a manner generally intended to qualify as a tax-free transaction. Our Board of Directors has not approved a specific course of action, and we will continue to evaluate other options to optimize value and ensure flexibility to invest in growth. There can be no assurance that this process will result in us pursuing a particular transaction or consummating any such transaction. We do not expect to disclose further developments relating to this strategic review process, unless and until our Board of Directors approves a specific transaction or otherwise concludes this review. There can be no assurance that this process will result in the Company pursuing a particular transaction or consummating any such transaction.</us-gaap:SubsequentEventsTextBlock>
    <lgnd:NumberOfEntitiesIntoWhichEntityPlansToSplit
      contextRef="i1c555247c8274906932e6bde7b7a204a_I20211109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MTI0MjQ_d642ab68-9049-4faa-b61c-3d16a5c3c19f"
      unitRef="company">2</lgnd:NumberOfEntitiesIntoWhichEntityPlansToSplit>
    <lgnd:SaleOfStockPercentageOfCommonStockExpectedToBeSold
      contextRef="i8779d8bb6434411d8ba83dacb2886ad1_I20211109"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZiZDMxNTc1OGY2NzRkMzJhMjcxZDczOWI2NTRmOGE3L3NlYzo2YmQzMTU3NThmNjc0ZDMyYTI3MWQ3MzliNjU0ZjhhN180NjYvZnJhZzowYWUwMjVhODZiNzI0NDhiYjdiYzBiOTkxNzQ1NjhlOS90ZXh0cmVnaW9uOjBhZTAyNWE4NmI3MjQ0OGJiN2JjMGI5OTE3NDU2OGU5XzM4NDgyOTA3MTI0MTU_8c78d766-a396-4d24-b13a-64e184ccf6bb"
      unitRef="number">0.20</lgnd:SaleOfStockPercentageOfCommonStockExpectedToBeSold>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703828503864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5980 Horton Street, Suite 405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,711,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703834230856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,430<span></span>
</td>
<td class="nump">$ 47,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">299,781<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">64,336<span></span>
</td>
<td class="nump">56,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">32,996<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,161<span></span>
</td>
<td class="nump">3,822<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">432,082<span></span>
</td>
<td class="nump">500,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">26,728<span></span>
</td>
<td class="nump">24,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">562,372<span></span>
</td>
<td class="nump">595,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">190,183<span></span>
</td>
<td class="nump">189,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license and other economic rights, net</a></td>
<td class="nump">10,748<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">18,702<span></span>
</td>
<td class="nump">14,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">12,951<span></span>
</td>
<td class="nump">6,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">16,795<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,095<span></span>
</td>
<td class="nump">4,267<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,273,656<span></span>
</td>
<td class="nump">1,362,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,233<span></span>
</td>
<td class="nump">3,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">12,237<span></span>
</td>
<td class="nump">18,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">2,594<span></span>
</td>
<td class="nump">39,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">12,007<span></span>
</td>
<td class="nump">29,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">6,593<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">36,297<span></span>
</td>
<td class="nump">100,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">316,889<span></span>
</td>
<td class="nump">442,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">6,782<span></span>
</td>
<td class="nump">9,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">63,026<span></span>
</td>
<td class="nump">64,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">11,467<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">27,129<span></span>
</td>
<td class="nump">30,866<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">461,590<span></span>
</td>
<td class="nump">652,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,707 and 16,080 shares issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">358,418<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(875)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">454,506<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">812,066<span></span>
</td>
<td class="nump">709,525<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,273,656<span></span>
</td>
<td class="nump">$ 1,362,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703747798392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,707,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,707,000<span></span>
</td>
<td class="nump">16,080,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703747807256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 64,835<span></span>
</td>
<td class="nump">$ 41,848<span></span>
</td>
<td class="nump">$ 204,660<span></span>
</td>
<td class="nump">$ 116,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">11,446<span></span>
</td>
<td class="nump">6,353<span></span>
</td>
<td class="nump">50,192<span></span>
</td>
<td class="nump">18,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,827<span></span>
</td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">35,391<span></span>
</td>
<td class="nump">11,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">16,938<span></span>
</td>
<td class="nump">12,853<span></span>
</td>
<td class="nump">50,769<span></span>
</td>
<td class="nump">37,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">12,718<span></span>
</td>
<td class="nump">15,020<span></span>
</td>
<td class="nump">39,747<span></span>
</td>
<td class="nump">34,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other operating income</a></td>
<td class="num">(3,800)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(37,600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">49,129<span></span>
</td>
<td class="nump">38,101<span></span>
</td>
<td class="nump">138,499<span></span>
</td>
<td class="nump">101,794<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">15,706<span></span>
</td>
<td class="nump">3,747<span></span>
</td>
<td class="nump">66,161<span></span>
</td>
<td class="nump">14,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="nump">1,937<span></span>
</td>
<td class="num">(9,862)<span></span>
</td>
<td class="nump">8,135<span></span>
</td>
<td class="num">(17,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">7,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4,439)<span></span>
</td>
<td class="num">(6,269)<span></span>
</td>
<td class="num">(15,154)<span></span>
</td>
<td class="num">(21,030)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="num">(219)<span></span>
</td>
<td class="num">(5,516)<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(15,359)<span></span>
</td>
<td class="num">(11,837)<span></span>
</td>
<td class="num">(28,543)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">15,259<span></span>
</td>
<td class="num">(11,612)<span></span>
</td>
<td class="nump">54,324<span></span>
</td>
<td class="num">(13,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(1,536)<span></span>
</td>
<td class="nump">4,911<span></span>
</td>
<td class="nump">8,230<span></span>
</td>
<td class="nump">5,162<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="num">$ (6,701)<span></span>
</td>
<td class="nump">$ 62,554<span></span>
</td>
<td class="num">$ (8,746)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="nump">$ 3.77<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (in shares)</a></td>
<td class="nump">16,688<span></span>
</td>
<td class="nump">16,082<span></span>
</td>
<td class="nump">16,595<span></span>
</td>
<td class="nump">16,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="nump">$ 3.64<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (in shares)</a></td>
<td class="nump">17,142<span></span>
</td>
<td class="nump">16,082<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
<td class="nump">16,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15,648<span></span>
</td>
<td class="nump">$ 9,005<span></span>
</td>
<td class="nump">$ 31,376<span></span>
</td>
<td class="nump">$ 22,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">35,093<span></span>
</td>
<td class="nump">23,389<span></span>
</td>
<td class="nump">128,875<span></span>
</td>
<td class="nump">68,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 14,094<span></span>
</td>
<td class="nump">$ 9,454<span></span>
</td>
<td class="nump">$ 44,409<span></span>
</td>
<td class="nump">$ 24,712<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703838702712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="num">$ (6,701)<span></span>
</td>
<td class="nump">$ 62,554<span></span>
</td>
<td class="num">$ (8,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of tax</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,141)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 13,709<span></span>
</td>
<td class="num">$ (5,832)<span></span>
</td>
<td class="nump">$ 62,480<span></span>
</td>
<td class="num">$ (9,971)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703746998872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings (Accumulated deficit)</div></th>
<th class="th">
<div>Retained earnings (Accumulated deficit) </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 367,326,000<span></span>
</td>
<td class="num">$ (216,000)<span></span>
</td>
<td class="nump">$ 400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(73,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(73,286,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">367,326,000<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(8,746,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">697,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">313,057,000<span></span>
</td>
<td class="num">(1,441,000)<span></span>
</td>
<td class="nump">386,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">695,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">304,404,000<span></span>
</td>
<td class="num">(2,310,000)<span></span>
</td>
<td class="nump">392,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">7,740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="nump">923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(6,701,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,701,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">697,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">313,057,000<span></span>
</td>
<td class="num">(1,441,000)<span></span>
</td>
<td class="nump">386,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
<td class="num">(801,000)<span></span>
</td>
<td class="nump">391,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">20,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">20,580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,086,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">745,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">336,621,000<span></span>
</td>
<td class="num">(856,000)<span></span>
</td>
<td class="nump">410,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
<td class="num">(801,000)<span></span>
</td>
<td class="nump">391,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">62,554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">812,066,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">358,418,000<span></span>
</td>
<td class="num">(875,000)<span></span>
</td>
<td class="nump">454,506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">745,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">336,621,000<span></span>
</td>
<td class="num">(856,000)<span></span>
</td>
<td class="nump">410,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">10,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(1,073,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(289,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(289,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">30,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">786,517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">346,578,000<span></span>
</td>
<td class="num">(861,000)<span></span>
</td>
<td class="nump">440,783,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,898,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,898,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(14,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(32,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="nump">124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">13,723,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,723,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 812,066,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 358,418,000<span></span>
</td>
<td class="num">$ (875,000)<span></span>
</td>
<td class="nump">$ 454,506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703828681720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 62,554<span></span>
</td>
<td class="num">$ (8,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(39,377)<span></span>
</td>
<td class="num">(397)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">37,902<span></span>
</td>
<td class="nump">12,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">1,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">12,863<span></span>
</td>
<td class="nump">17,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfOtherEconomicRights', window );">Amortization of commercial license and other economic rights</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="nump">7,303<span></span>
</td>
<td class="num">(659)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">28,375<span></span>
</td>
<td class="nump">20,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(8,229)<span></span>
</td>
<td class="num">(19,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="num">(8,135)<span></span>
</td>
<td class="nump">17,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">658<span></span>
</td>
<td class="num">(1,525)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(8,838)<span></span>
</td>
<td class="num">(5,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(3,103)<span></span>
</td>
<td class="num">(4,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(3,635)<span></span>
</td>
<td class="nump">9,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="num">(4,167)<span></span>
</td>
<td class="nump">12,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(20,696)<span></span>
</td>
<td class="nump">5,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">6,120<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(8,680)<span></span>
</td>
<td class="num">(4,656)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">51,156<span></span>
</td>
<td class="nump">54,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(116,898)<span></span>
</td>
<td class="num">(337,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">152,465<span></span>
</td>
<td class="nump">389,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">37,100<span></span>
</td>
<td class="nump">589,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,857)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(6,566)<span></span>
</td>
<td class="num">(2,828)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">66,236<span></span>
</td>
<td class="nump">613,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(155,760)<span></span>
</td>
<td class="num">(203,210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(9,188)<span></span>
</td>
<td class="num">(5,224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">18,938<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="num">(18,446)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">29,484<span></span>
</td>
<td class="nump">2,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,903)<span></span>
</td>
<td class="num">(1,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(73,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(2,325)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(141,925)<span></span>
</td>
<td class="num">(283,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(24,533)<span></span>
</td>
<td class="nump">384,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">47,963<span></span>
</td>
<td class="nump">72,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">23,430<span></span>
</td>
<td class="nump">457,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,740<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="nump">2,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">557<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">4,968<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedLeasePurchases', window );">Accrued financing lease payment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (74)<span></span>
</td>
<td class="num">$ (109)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedLeasePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Lease Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedLeasePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703741002280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2021, the amount recognized as revenue that was previously deferred was $7.7 million, and $22.8 million, respectively. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,712&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,848&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,429&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we exercised all outstanding Viking warrants to purchase 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. As of September&#160;30, 2021, we have zero Viking warrants outstanding.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of eleven positions which were in an unrealized loss position as of September&#160;30, 2021. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2021, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $0.01&#160;million and $0.1 million of allowance for credit losses, respectively, as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of prepaid inventory and finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we have made advanced payments for inventory from our supplier of Captisol totaling $50.2&#160;million. We have applied credits for such inventory purchases of $24.4&#160;million and will utilize the remaining advanced payments to offset a portion of the purchase price for future Captisol purchases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,555&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial license rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,550)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,748</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.0 million as of September&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and development as further discussed below and in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2020 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, we entered into a Royalty Agreement with Aziyo Med, LLC (Aziyo) pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2021 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to 2020, we accounted for commercial license rights related to developmental pipeline products such as Selexis and Dianomi on a non-accrual basis. We continue to account for commercial license rights related to Dianomi on a non-accrual basis as of September&#160;30, 2021, but starting in 2020, given the expected cash flow from the Selexis program, we started to account for the Selexis commercial license right as a financial asset in accordance with ASC 310, and amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the royalty agreement with Selexis as of September&#160;30, 2021 is 21%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. The payments received during the nine months ended September&#160;30, 2021 were accordingly allocated between revenue and the amortization of the commercial license rights. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the credit losses standard (ASU 2016-13) on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2021, we further considered the current and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the conversion price. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,330&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2020, all of the 0.70&#160;million and 0.65&#160;million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703741013032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the nine months ended September&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and nine months ended September&#160;30, 2021, we reduced the contingent liability by $3.8&#160;million and $37.6&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the nine months ended September&#160;30, 2021, management recorded $0.7 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In anticipation of our plan related to the OmniAb business, additional aspects of resource allocation and performance assessment may be made at the OmniAb business level and it is possible that the OmniAb business could become a separate operating segment in the future. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9. Subsequent Event.</span></div>At September 30, 2021, there were no indicators of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703743047992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 1, 2020, we acquired Pfenex, which develops next-generation and novel protein therapeutics to improve existing therapies and create new therapies for biological targets linked to critical, unmet diseases using a protein expression technology platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary purchase price of $465.1&#160;million included $429.6&#160;million cash consideration paid upon acquisition, and a contingent CVR payment of up to $77.8&#160;million in cash based on a certain specified milestone with an estimated initial fair value of $37.0&#160;million. The CVR will only be paid in full if the milestone is achieved by December&#160;31, 2021. The amount of the CVR included in the purchase price was reduced by $1.5&#160;million that was determined to be post-combination expense. The fair value of the CVR liability was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on market participants' cost of debt reflective of the Company, which was 7.1%. The liability is periodically assessed based on events and circumstances related to the underlying milestone, and any change in fair value is recorded in our consolidated statements of operations. During the nine months ended September&#160;30, 2021, we wrote off the entire CVR liability primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by Pfenex CVR.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition, a portion of Pfenex's equity awards that were outstanding and unvested prior to the acquisition became fully vested per the terms of the merger agreement. The acceleration of vesting required us to allocate the fair value of the equity attributable to pre-combination service to the purchase price and the remaining amount was considered our post-combination expense. We paid $17.3&#160;million in cash for equity compensation, which is attributable to pre-combination services and is reflected as a component of the total purchase price paid of $429.6&#160;million. In addition, the fair value of equity compensation attributable to the post-combination service period was $8.7&#160;million. These amounts were associated with the accelerated vesting of stock options previously granted to Pfenex employees and were fully paid in cash, which was recognized as general and administrative expenses during the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $362&#160;million of contractual relationships and $23&#160;million of core technology. The fair values of the contractual relationships were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated contractual relationship period. The fair value of the contractual relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 12.9 years. The fair values of the acquired technologies were based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, collaboration and product revenue streams derived from the licensing of the related technologies over the estimated useful lives. These projected cash flows were discounted to present value using a discount rate, which varies from 12% to 15%. The total acquired intangibles are being amortized on a straight-line basis over the weighted average estimated useful life of 13.0 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share-based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,845)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which was settled and paid in September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations to be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. The holdback was not settled as of September&#160;30, 2021, and we expect to have it settled by the end of 2021. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. During the three and nine months ended September&#160;30, 2021, we recognized $0.5 million and $0.7 million, respectively, in earnout rights when certain contingencies were resolved during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology, from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition-related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and the actual amount paid may be materially different than the carrying amount of the liability. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703742469224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of September&#160;30, 2021, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. We accounted for the repurchase as a debt extinguishment, which resulted in (1) a loss of $7.3 million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2021, (2) a $13.7 million reduction in debt discount, and (3) a $10.2 million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703838336808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2021 was 10.1% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2021 was due primarily to the $3.8&#160;million and $37.6&#160;million tax benefits associated with the Pfenex CVR adjustment recorded during the second and third quarters of 2021, respectively, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR.  Also contributing to the variance from the federal statutory rate are excess tax windfalls from share-based compensation due to increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. The effective tax rate for the three and nine months ended September 30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September 30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. offset by tax deductions related to stock award activities and tax deductions related to foreign derived intangible income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745498232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2020 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(564,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,575)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,239,937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, outstanding options to purchase 1.4 million shares were exercisable with a weighted average exercise price per share of $95.53.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2021, 46,866 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any share repurchases during the nine months ended September&#160;30, 2021.</span></div>On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $248.8 million of our common stock remained available as of September&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740897272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revise our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span>technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayments and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties&#8217; held a Preliminary Hearing before the arbitrator. The arbitration is in its early stages.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740994728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, we entered into several new lease agreements including our Emeryville headquarter expansion and a new Icagen office lease, which resulted an increase in operating lease assets and liabilities of $8.7&#160;million and $9.2&#160;million, respectively, for the portion of the leases with a starting accounting lease commencement date during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, we entered into several new lease agreements including our Emeryville headquarter expansion and a new Icagen office lease, which resulted an increase in operating lease assets and liabilities of $8.7&#160;million and $9.2&#160;million, respectively, for the portion of the leases with a starting accounting lease commencement date during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703838336808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent EventOn November 9, 2021, we announced we are pursuing plans to split Ligand into two separate, publicly traded companies with one featuring the OmniAb platform and its large and growing customer base, and the other featuring Ligand&#8217;s existing collection of core royalties and the technologies, pipeline and contracts associated with the Pelican protein expression platform and the Captisol business. Based on initial management and advisor review, an IPO and eventual distribution of OmniAb shares to Ligand shareholders is the leading option under consideration at this time. The IPO would be of newly issued shares of OmniAb, Inc. (formerly OMT), including Ab Initio computational antigen design, Icagen&#8217;s ion channel technology, xPloration high-throughput screening technology, and the suite of OmniAb animals used for antibody discovery. In an IPO, we expect OmniAb to issue less than 20% of its common stock, with us retaining the remaining interest, which would eventually be distributed to our stockholders in a manner generally intended to qualify as a tax-free transaction. Our Board of Directors has not approved a specific course of action, and we will continue to evaluate other options to optimize value and ensure flexibility to invest in growth. There can be no assurance that this process will result in us pursuing a particular transaction or consummating any such transaction. We do not expect to disclose further developments relating to this strategic review process, unless and until our Board of Directors approves a specific transaction or otherwise concludes this review. There can be no assurance that this process will result in the Company pursuing a particular transaction or consummating any such transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745246312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2020 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures. We intend to adopt this standard on January 1, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income (Loss) Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the conversion price. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745004056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,712&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,848&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,429&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2021 and December 31, 2020 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:21.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.909%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.509%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,388)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Treasury bill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">299,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,555&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784,992&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License and Other Economic Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial license rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,550)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,748</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,979</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.0 million as of September&#160;30, 2021.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.3 million and credit loss adjustments of $6.0 million as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,330&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703742281784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pfenex contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in Viking warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. During the nine months ended September&#160;30, 2021, we exercised all of the outstanding Viking warrants. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2021, we paid $1.1&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Pfenex contingent liabilities was determined using a probability-adjusted income approach. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of the Company. During the three and nine months ended September&#160;30, 2021, we reduced the contingent liability by $3.8&#160;million and $37.6&#160;million, respectively, primarily due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR. See further detail on Pfenex CVR in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div>7.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the nine months ended September&#160;30, 2021, management recorded $0.7 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2021 is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">720</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2021</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703742406488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table sets forth an allocation of the preliminary purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed, with the excess recorded to goodwill (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts and unbilled receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangibles acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,814)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,382)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(1) Goodwill represents the excess of the purchase price over the preliminary fair value of the underlying assets acquired and liabilities assumed. Goodwill is attributable to the assembled workforce of experienced personnel at Pfenex and expected synergies. None of the goodwill is expected to be deductible for tax purposes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summary presents our unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2020 as if the Pfenex acquisition had occurred on January 1, 2020, which gives effect to certain transaction accounting adjustments, including amortization of acquired intangibles and share-based compensation expense for retained Pfenex employees. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of future operating results (in thousands, except per share amounts):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.469%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,845)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703742370152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740946264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(564,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,575)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,239,937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(564,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,575)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,239,937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740974760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Operating and Finance Lease Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,892&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating Lease Liabilities as of September 30, 2021 (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703744043608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from milestone method revenue</a></td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="nump">$ 22,800,000<span></span>
</td>
<td class="nump">$ 8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="nump">10,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesOnInventoryPurchases', window );">Advances on inventory purchases</a></td>
<td class="nump">50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases', window );">Credits applied on advances on inventory purchases</a></td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">5,574,000<span></span>
</td>
<td class="nump">7,028,000<span></span>
</td>
<td class="nump">4,984,000<span></span>
</td>
<td class="nump">8,330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Aziyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Selexis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc. | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Outstanding warrants to purchase shares of Viking's common stock (shares) | shares</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credits Applied on Advances on Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forecasted Cash Flows, Effective Interest Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ForecastedCashFlowsEffectiveInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesOnInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesOnInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703748027048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 64,835<span></span>
</td>
<td class="nump">$ 41,848<span></span>
</td>
<td class="nump">$ 204,660<span></span>
</td>
<td class="nump">$ 116,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">15,648<span></span>
</td>
<td class="nump">9,005<span></span>
</td>
<td class="nump">31,376<span></span>
</td>
<td class="nump">22,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,821<span></span>
</td>
<td class="nump">6,923<span></span>
</td>
<td class="nump">18,548<span></span>
</td>
<td class="nump">16,809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,665<span></span>
</td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">7,191<span></span>
</td>
<td class="nump">4,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,162<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">5,637<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">35,093<span></span>
</td>
<td class="nump">23,389<span></span>
</td>
<td class="nump">128,875<span></span>
</td>
<td class="nump">68,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">14,094<span></span>
</td>
<td class="nump">9,454<span></span>
</td>
<td class="nump">44,409<span></span>
</td>
<td class="nump">24,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,828<span></span>
</td>
<td class="nump">7,341<span></span>
</td>
<td class="nump">17,650<span></span>
</td>
<td class="nump">15,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,419<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="nump">19,436<span></span>
</td>
<td class="nump">4,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 995<span></span>
</td>
<td class="nump">$ 5,030<span></span>
</td>
<td class="nump">$ 2,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745549976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 257,266<span></span>
</td>
<td class="nump">$ 324,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(726)<span></span>
</td>
<td class="num">(1,391)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">257,610<span></span>
</td>
<td class="nump">324,478<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Estimated fair value</a></td>
<td class="nump">299,781<span></span>
</td>
<td class="nump">363,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">47,739<span></span>
</td>
<td class="nump">84,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">47,744<span></span>
</td>
<td class="nump">84,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">25,914<span></span>
</td>
<td class="nump">30,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">25,964<span></span>
</td>
<td class="nump">30,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">4,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">23,264<span></span>
</td>
<td class="nump">45,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">23,274<span></span>
</td>
<td class="nump">45,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(723)<span></span>
</td>
<td class="num">(1,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">5,391<span></span>
</td>
<td class="nump">3,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">152,041<span></span>
</td>
<td class="nump">151,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">152,094<span></span>
</td>
<td class="nump">151,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">Treasury bill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">$ 42,171<span></span>
</td>
<td class="nump">$ 32,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745246312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 76,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">23,363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">99,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">76,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">23,396<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 99,482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703828459208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,183<span></span>
</td>
<td class="nump">$ 189,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">752,555<span></span>
</td>
<td class="nump">784,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">280,173<span></span>
</td>
<td class="nump">277,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(75,159)<span></span>
</td>
<td class="num">(63,600)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,411)<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(17,599)<span></span>
</td>
<td class="num">(15,597)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(28,974)<span></span>
</td>
<td class="num">(7,243)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">28,298<span></span>
</td>
<td class="nump">28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (11,600)<span></span>
</td>
<td class="num">$ (11,300)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703743550360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(17,550)<span></span>
</td>
<td class="num">(17,319)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,748<span></span>
</td>
<td class="nump">10,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">(11,600)<span></span>
</td>
<td class="num">(11,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="num">$ (6,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703748312728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 4,564<span></span>
</td>
<td class="nump">$ 8,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">3,524<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 12,237<span></span>
</td>
<td class="nump">$ 18,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745529080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 9,754<span></span>
</td>
<td class="nump">$ 7,740<span></span>
</td>
<td class="nump">$ 28,375<span></span>
</td>
<td class="nump">$ 20,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">4,480<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
<td class="nump">12,975<span></span>
</td>
<td class="nump">8,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 5,274<span></span>
</td>
<td class="nump">$ 4,646<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
<td class="nump">$ 12,242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703838533768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740631048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Summary of computation of basic and diluted net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">16,688<span></span>
</td>
<td class="nump">16,082<span></span>
</td>
<td class="nump">16,595<span></span>
</td>
<td class="nump">16,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted stock (in shares)</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options (in shares)</a></td>
<td class="nump">379<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (in shares)</a></td>
<td class="nump">17,142<span></span>
</td>
<td class="nump">16,082<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
<td class="nump">16,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</a></td>
<td class="nump">5,574<span></span>
</td>
<td class="nump">7,028<span></span>
</td>
<td class="nump">4,984<span></span>
</td>
<td class="nump">8,330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703737842648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right </div>
<div>contingent_value_right_series</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right_series</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember', window );">Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember', window );">Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reduction in contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,781,000<span></span>
</td>
<td class="nump">299,781,000<span></span>
</td>
<td class="nump">$ 363,567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,407,000<span></span>
</td>
<td class="nump">9,407,000<span></span>
</td>
<td class="nump">49,193,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,808,000<span></span>
</td>
<td class="nump">4,808,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,610,000<span></span>
</td>
<td class="nump">257,610,000<span></span>
</td>
<td class="nump">324,478,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,171,000<span></span>
</td>
<td class="nump">42,171,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,561,000<span></span>
</td>
<td class="nump">47,561,000<span></span>
</td>
<td class="nump">42,527,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,390,000<span></span>
</td>
<td class="nump">5,390,000<span></span>
</td>
<td class="nump">3,438,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,171,000<span></span>
</td>
<td class="nump">42,171,000<span></span>
</td>
<td class="nump">32,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,326,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,578,000<span></span>
</td>
<td class="nump">251,578,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">2,699,000<span></span>
</td>
<td class="nump">3,821,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,578,000<span></span>
</td>
<td class="nump">251,578,000<span></span>
</td>
<td class="nump">320,647,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642,000<span></span>
</td>
<td class="nump">642,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,677,000<span></span>
</td>
<td class="nump">6,677,000<span></span>
</td>
<td class="nump">45,312,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Crystal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">508,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,808,000<span></span>
</td>
<td class="nump">4,808,000<span></span>
</td>
<td class="nump">6,404,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642,000<span></span>
</td>
<td class="nump">642,000<span></span>
</td>
<td class="nump">393,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCrystalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740629800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2020</a></td>
<td class="nump">$ 45,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingent payments</a></td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(38,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of September&#160;30, 2021</a></td>
<td class="nump">$ 6,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703739265928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 08, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="nump">$ 465,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="nump">429,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">77,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Post-combination expense</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions', window );">Gross payments to acquire business attributable to vested portion of stock options</a></td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Cash to settle unvested stock options recognized as share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="num">$ (52,730,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="num">(3,908,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Contractual Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 362,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">12 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Core Technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input (as a percent)</a></td>
<td class="nump">0.071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right for Internal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right on Product Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationConsiderationTransferredHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationConsiderationTransferredHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703748304248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 190,183,000<span></span>
</td>
<td class="nump">$ 189,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,407,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts and unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,823,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,070,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets', window );">Intangibles acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,271,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,814,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,466,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,908,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,070,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,382,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,730,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,098,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill acquired that is expected to be deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745456504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Financial Information (Details) - Pfenex - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 43,082<span></span>
</td>
<td class="nump">$ 119,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (46,845)<span></span>
</td>
<td class="num">$ (77,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareProFormaAbstract', window );"><strong>Net loss per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="num">$ (2.91)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="num">$ (2.91)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareProFormaAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareProFormaAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703748991640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,303,000<span></span>
</td>
<td class="num">$ (659,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="nump">$ 1,073,000<span></span>
</td>
<td class="nump">$ 9,086,000<span></span>
</td>
<td class="nump">$ 2,745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="nump">3,018,327<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703739649128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="nump">$ 495,280,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(26,412,000)<span></span>
</td>
<td class="num">(52,987,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">316,889,000<span></span>
</td>
<td class="nump">442,293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of the 2023 Notes</a></td>
<td class="nump">24,124,000<span></span>
</td>
<td class="nump">48,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 343,888,000<span></span>
</td>
<td class="nump">$ 466,053,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703743178584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">42.30%<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
<td class="nump">37.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember', window );">Contingent liabilities - Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reduction in contingent liability</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyPfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703747958408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">2,561,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">363,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(564,302)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(121,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,239,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 85.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">160.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">52.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">109.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 104.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">206,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">165,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(95,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(9,575)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">266,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 106.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">170.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">126.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">138.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 137.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703744852968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,287,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,866<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703742427304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703743455912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Increase in operating lease assets</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 8.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_OperatingLeaseLiabilityAdditions', window );">Increase in operating lease liabilities</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term of operating leases</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OperatingLeaseLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability, Additions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OperatingLeaseLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703748328504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating and Finance Lease Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 12,951<span></span>
</td>
<td class="nump">$ 6,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">16,795<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">29,746<span></span>
</td>
<td class="nump">22,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">6,593<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">2,226<span></span>
</td>
<td class="nump">8,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">11,467<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 13,765<span></span>
</td>
<td class="nump">$ 14,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745595768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remaining three months ending December 31, 2021</a></td>
<td class="nump">$ 690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">9,081<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">16,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(2,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 13,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703745014200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details) - Subsequent Event<br></strong></div></th>
<th class="th">
<div>Nov. 09, 2021 </div>
<div>company</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit', window );">Number of separate, publicly traded companies into which entity plans to split</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">OmniAb | IPO | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold', window );">Proportion of common stock expected to be sold (as a percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Entities Into Which Entity Plans To Split</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Percentage Of Common Stock Expected To Be Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lgnd_OmniAbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lgnd_OmniAbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139703740950680">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MS=VR:,//%K<:H9F]'-O8!(Z6M8$VJ@U.*J6>FN3SD2Q=X!=IY62^1O'[YR7
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MES*'YJ1KCI\VGT+/^^[3OONT\\=\W5]I+6N#1--(T[P*>&2]1]9YC'P>1;-
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MQ@#OSX70;Q.S[Y;GK/Y?4$L#!!0    ( ,*(:5,9A[R!_ 8  #T?   8
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M !32&%NDH0&)"&'2HB,MO*3O92F38K&N\V9I-DRFMJ95:XBQ<"? 8VKMA@F
M,K.TU]E%A4'$8XNRBZ(1BSA,.>XHQU[*?\C<;)FL9IPL3=M+2UUMH6<)D8X!
M.A&V20.HL"Z+!Z1=%(T-'XLT@&+[&^6 - [Z7AQX:=_JM2R0ZLI%FB_4!J3<
M.MJ?P3$5@<5F L!LPJ"GB-NN9EY7AWSWM =^1P]0GO((<L?.3%B,26QS=V%4
MX #;_%T8IH+%=IY#N !',1L( NF#0+Q!N*X7&:T*M7D+A<IAX@1(X2BPBS@
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M?HA-;@+ ##F.G<+FX@PSXF0_Y([&@8!C0'J=1/PZZ;JC:P*0RU6J^ST T2>
MQC&+:^<_ #/"PJYT $H0:LLE &7V"!E@WBLFXE=,-U(?ICU(%[L_8VE$J$W7
MA1WSR!%( (R3T"EUD#<1L8$? J271X1XA<(L*7*C#4MT9W;\O#IS^H*NDC)=
MU#IQFF8[+9<^W4!Z34*H-[B-V]P.,3*BK#GM0D?5X5?W" >_&4/LZ^030>S8
MNZCCX(39&PV T9/(KC6PLW! F9)>1Q&_CIHW)WR[4BZK8[W'.CQ],!9)MMAE
MC5Q%1P;0G C"40%T%>?"_HT&P@([>E,0%L:VL@)AA QMPEY8$;^P:I/NPYD2
M0IEB1\0%@8GBPN@)=_8HZ&PP47H!1OP"S$J491N?WTP5X.3(R&%G!P$P*%5
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MUZD>=2!QE/$DB]A$OVM%62PD[D"Z=R -.G ZT0ON;,H=3)D:I-^J,7O>Z>3
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M9LP;3HL@%D:061\]2P\J%B-1G#IJ$3,12Y]<"R+V?%/VHC8&U>XR1E(JG:Q
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M+PFQ/%-$(@C,%T$5B/$PJV])WV#F8VLGNP7T#S>B_E8@8[&(SJ[LWIFX(BD
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MYQ0NLLS$&RUG.M=>0XFX)A,4Y^*#2BMK=;D0KZ333GQ:*C$W.?*/GGDYRY5
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MBQ _"$>$2^-C'Y:PW(7)5'X6^!!3R9V:5^FRU%^KR&F]U.E2R#P'FT4)LZ6
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MJZ*5:I:1,C*PIL7N)BN0%U<5M(2&+<GMMH;6-2Z#H-> @IP,.4GV0%H>N[>
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MMN;KJ@K#R1-ON-">R^X1"[GT[O=^CSRP!P24:>M;OHAMSWW"YTI:M>55*XJ
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MXNM.JAX4<Y#&X*YS0%WHP3#=L8DWI?.8$0JD]\T! 0APB9#!% 38\;E.8!+
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MMY$#WT;7#Z[<\$WWHG2NS/GG6DDD#RW ]V4)A<(#,6C^Z\/;_P)02P,$%
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M[.71B&QZ(Z6%-UU\EQ3&XY43/QL\*]F& ]BOC?&[17"P?Z@N/@-02P,$%
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MPY=' _)Y^,F;Z)HT<"Q<Q/B2EA7F1?8B@/NEP]O2;02@GT#/_P)02P,$%
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M[73Y*Z*,>1WQ AO8N5U=L>_7%/L5$E#1>4\/MA:LE[98JK61E:7QH%J;PH1
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MG;C?WK$8[&@'.\XV<*>5NZ/W5OI7O!GZH%JYTE0A!46)K(G\JRA-8RT'#/&
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MF7(%<IQT%=Y@3S/ZY[PW5D46]_<>0*(,^C:*&"E1!,')RS&'55[?FTU :.3
MUC)>BH;KF#FMR%\3[4HO2(XNL!$2BA3KI>X@J0<\%,:4R?FY^N(_76UBPXN4
MBS"Q5!%H,7I/,@J7Z%CYX >:Z-S9\H :^DJ)_:FYZ^!X!=7!6M)JC+ZQ>L\
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MQ*]K80Y>'EN01("/RP']>8\^? 1]P=ZKQJX,NVPJ43V\?PQ6)G["D9_S<"_
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M]U4Y'!C%(.(;?T"+(5HJHF7+6%%SC-F=S!"^3COW3PE?F\AR09'E#06(GUV
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M7AH&J(,C5=93S+6,0FTXUNVU2U?<;N4.A7HK0B$)7>!"I'B^B=H^BOBN&#$
MPTME/-@(A8;*0@H(=XS+)-JV P:OO\L2"+FAG.YQ5&I46%AR.XF1 *B7*4O9
M"'K8#6<,([=?/P&L")QQ%_)*P0[$A"<"KU;14RC3L<9A:L)9S5-;? C!@[^)
MKJ!& ^A^2!)X-95NV8I%2&?1>>&!C 0"=PJ*.7U?9R/&>$D AX"KB)C*!='A
MT)1+'#\%S*&=NF5X+15G.'FZ;!!]*UMFJ\6## "UA94%["/!'@LQGTRG%XM
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M$4^!TQ7C?07R^*;\?U<?ZY)@*?,AVM&J&/8?37_VR)-!I?\7QQ\NCO]-?\:
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M<2""\;6+.>A3LN/A\S[ZSZ%VJF4C'%X;]:<L?'4Q6 Z@P%*TRM^9W:_8U1,
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M?;@KN,.]UP^W7\&?;Q^6?S#<)Z2="K9?X:1O!ZVO[,ELNG]?4$F6% :$4'U
M=TG8M$FO<,S';Q#DK?,<^\!7G"? 0 2A90IZ+%0/A-L<&8$=^9!CIIWJ>*MN
M&"ZT]+9W><U@;[X]0;3K0064OAVUCJ8#C"Y@R!:I"M+\X T24V&;;Q_A/F^=
M[ZPVASXPF&YVAIM)5LQ0'H&?%0I%',,(J[*%?]:AD%]S7!+4[23/(,P==;8.
MR6,JY]GG#&-:FNC\G+%\6GXRN<D^%.P]O_6NAE[-\Y%W-<X_B%3B\^\S]T3.
M6:(0IS-0Y38[8*W,/WGD-UHLLR/Z1Z&UB+/+!241E88 WL\$;!F*&Z.@_/ T
M^ =02P,$%     @ PHAI4S,=%%?E!   -Q<  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&ULM5C;;N,V$/T5PMB'7:"->-,M< PDMA===(,&\6[[4/1!
ML6F;6$ET1=K9_'VI2R29HIF@AE]LB3HSPYE#'9$S?A;%#[EE3(&?69K+F]%6
MJ=VUY\GEEF6)O!([ENLG:U%DB=*WQ<:3NX(EJ\HH2ST,8>!E"<]'DW$U]E!,
MQF*O4IZSAP+(?98EQ<L=2\7SS0B-7@<>^6:KR@%O,MXE&[9@ZOONH=!W7NME
MQ3.62RYR4+#US>@67<\)+0TJQ)^</<O>-2A3>1+B1WGS974S@N6,6,J6JG21
MZ+\#F[(T+3WI>?S;.!VU,4O#_O6K]\]5\CJ9IT2RJ4C_XBNUO1E%([!BZV2?
MJD?Q_!MK$O)+?TN1RNH7/#=8. ++O50B:XSU##*>U__)SZ80/0/MQVZ &P-L
M&M 3!J0Q(.^-0!L#^MX(?F-0I>[5N5>%FR4JF8P+\0R*$JV]E1=5]2MK72^>
MEPMEH0K]E&L[-;E+))= K,%#P23+55+3EZ_ HEXZY;,%W^1\S9=)KL#M<BGV
MN>+Y!CR(E"\YD^!7\,@.+-\S\/0"%F)?+!GX.&,JX:G\I)]^7\S QP^?P ?
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M?Q+[/T@=4&S]%8(I]Q?L:]O  \5.:5'58,.@HOSPB[_7B>@ 8'0&@&H ^EE
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M:H>]]D!9GD9'E(?L4A2%9QBW2H_&E=Z,.T:%"FJ:R S_YCA'@+0GI;$BHL[
M?)&)&;4RB\9E]C5=5+OL3SXHSXXK\I)9GW(KWVA\FGY%#T4G8_T5A,E)VP_;
MA2=M[W>.G_;L_Q>6:\H58&1E@,%U:F*6A^/T8:'%UIU('X4V'S5WN2%F(I+6
MP#Q?":&?%_:0V_Q38_8_4$L#!!0    ( ,*(:5/5A>I+S0(  *,'   9
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M& ,]7G"NGAOF"=0_>;?_ 5!+ P04    " #"B&E38D/S&C$#  "0"@  &0
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M/IU(\TS@._7UH%ZA^W:@G9!JB8EZZTV2)(JQAAIK*"/]NWH:TB",AFF45IW
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M2&P@92. =Q=V>_Y-)WOW34$48LUE:P]E&B@EOA\-WU$'4FT"6&U4?F4DJG5
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M-2$0S8[*#L8T,&!'%4O]B>VC*0>$'^V:C:5@Q$[&5&(I*3&\!;%S!\3]\$=
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M$U,$R5 _X"3V3;YA)=4?4S>%22D-@.EHT9]M5_M/"^@\A99 I@-"51:P4E(
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M!6;2K\G,)>W*2SP-I\!,BA/M.9=6EO3(7B1ZDP;H2'$Z?CE:EK1[X\FT4*\
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M3*(O+(6T [_LQT][\*XN5E,Q_UBQA=]+N(%B@ +O'/F>[W7I^6_X*SE!T\#
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M=:RJ@*%UP*Z1U> =>0$8G@#D0._KXPTX>G<<O@-]()=$4%G\;5NFW>HC3<\
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M#<#UK411[<2>--V7R.P?4$L#!!0    ( ,*(:5-'@?;MOP(  %T(   9
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M$K=HG+;\3T 7$GB_MI:>@]"GPU^F^ M02P,$%     @ PHAI4SKL7KZM @
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M?( *P^&XGY5TK.0CUJ"/E1RR*!WTLX8=:_@1*^YC#0]8='SLN$8=:W22]5B
MJ9LK!-5''!T0Q\&(]A/''7%\FBB1"2+<':[9JRFFV'M/QX=NDY@>@=/@O;0$
M)_%WH#7A9=T@Y*96&..@L;=.! <)? Y'R9&SI7NUC9Y,8&: QC/9,-& +6SM
M5HCW<M:;#3VXJC1*!O_?('^OZ-H'[)ZI-:^T8:Q,7' Y-'94^R:T'92UJ\,+
MB::JNV9AWE%0=H&97TF);QU;VKN7.?L+4$L#!!0    ( ,*(:5.[!3)O60(
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MZ_?@SOLH7+VGPO5_^X:_ %!+ P04    " #"B&E3EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,*(:5--M+YP#P0
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M^KT!  !Z'0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=D[;L)
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M9%4HLBH4616*K.H_97TW9OG7OP+;>UKKLCGDL^Y_Z_034$L! A0#%     @
MPHAI4P=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " #"B&E3.:F,#>X    K @  $0
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M965T-"YX;6Q02P$"% ,4    " #"B&E3;V=0+4H#  "T"0  &
M    @($I'P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
MPHAI4V%^!FT""P  Z4D  !@              ("!J2(  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( ,*(:5.);_&#>@D  *,H   8
M          " @>$M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " #"B&E3/3/<Q8H?  !_8   &               @(&1-P  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ PHAI4X=9OC/:#   @R0
M !@              ("!45<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( ,*(:5,4*6+EN \   XT   9              " @6%D  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ PHAI4]O\!%=J
M"P  !B$  !D              ("!4'0  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " #"B&E3[NIKV5L$  "T"@  &0
M@('Q?P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( ,*(
M:5-7@V<-C@0  -()   9              " @8.$  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ PHAI4Z6RL^ZO!   C0H  !D
M         ("!2(D  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " #"B&E3*F5MPE8'  "9'@  &0              @($NC@  >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( ,*(:5,[R.5<# 4  !\+
M   9              " @;N5  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ PHAI4P./?%)<$@  D30  !D              ("!_IH
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #"B&E3&5D9
M+^<*  !$'@  &0              @(&1K0  >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( ,*(:5,^]/']\0H   4?   9
M  " @:^X  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
MPHAI4WT!A2[]!   ]0H  !D              ("!U\,  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " #"B&E3@6^H-!L#  !L!@  &0
M            @($+R0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( ,*(:5/Q).3D.P,  !\)   9              " @5W,  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ PHAI4VG'<H!6 P
M60@  !D              ("!S\\  'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " #"B&E3?#R'X#H&  "$&@  &0              @(%<
MTP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( ,*(:5,S
M'117Y00  #<7   9              " @<W9  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ PHAI4YM7^]=-!@  ^",  !D
M     ("!Z=X  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,*(:5-B0_,:,0,  ) *   9              "
M@2OS  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ PHAI
M4ZX^SG4T P  .PL  !D              ("!D_8  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    " #"B&E3)3YXI:8#  "C"P  &0
M        @('^^0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   ( ,*(:5/!0QT"6@P  !UJ   9              " @=O]  !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ PHAI4Y=BV(7W @  @ <
M !D              ("!; H! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    " #"B&E3VW3I%LP(  #,-0  &0              @(&:#0$
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( ,*(:5."]%GD
M\@,  ,0-   9              " @9T6 0!X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ PHAI4UWRFGS& @  HP<  !D
M ("!QAH! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #"
MB&E3&-I)!\X&   4'@  &0              @('#'0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( ,*(:5-;0Y5<% ,  )4(   9
M          " @<@D 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#
M%     @ PHAI4T>!]NV_ @  70@  !D              ("!$R@! 'AL+W=O
M<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #"B&E3CA4ONB0$  !T
M$0  &0              @($)*P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM
M;%!+ 0(4 Q0    ( ,*(:5-6)#1]@0,  +0*   9              " @60O
M 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ PHAI4WT=
M'2\D @  <00  !D              ("!'#,! 'AL+W=O<FMS:&5E=',O<VAE
M970T-"YX;6Q02P$"% ,4    " #"B&E3.NQ>OJT"  "@"   &0
M    @(%W-0$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M ,*(:5/C)ZR:% ,  )4*   9              " @5LX 0!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ PHAI4TDZ6<^_ @  I0<  !D
M             ("!ICL! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    " #"B&E3NP4R;UD"  !U!0  &0              @(&</@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( ,*(:5-\Q#$KZ $
M %H$   9              " @2Q! 0!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ PHAI4^OH]\8T P  ^A,   T              ( !
M2T,! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #"B&E3EXJ[',     3 @
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8;6Q02P4&     #D .0"&#P  LD\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>312</ContextCount>
  <ElementCount>428</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>77</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114102 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118103 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140109 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Acquisitions</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2330305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Leases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Operating and Finance Lease Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SubsequentEvent</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="lgnd-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lgnd-20210930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lgnd-20210930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20210930.htm">lgnd-20210930.htm</File>
    <File>lgnd-20210930.xsd</File>
    <File>lgnd-20210930_cal.xml</File>
    <File>lgnd-20210930_def.xml</File>
    <File>lgnd-20210930_lab.xml</File>
    <File>lgnd-20210930_pre.xml</File>
    <File>lgnd_93021exhibit311.htm</File>
    <File>lgnd_93021exhibit312.htm</File>
    <File>lgnd_93021exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20210930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 312,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 567,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 7
   },
   "keyCustom": 60,
   "keyStandard": 368,
   "memberCustom": 33,
   "memberStandard": 41,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118103 - Disclosure - Acquisitions",
     "role": "http://www.ligand.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - Leases",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140109 - Disclosure - Subsequent Event",
     "role": "http://www.ligand.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.ligand.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330305 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - Leases (Tables)",
     "role": "http://www.ligand.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i1beb885c5fe44118a5ef2fec26cf4658_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2e028d5aaf364cd69142f7dd1151088f_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2e028d5aaf364cd69142f7dd1151088f_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i3f0c699a2cfd495fb9bedfb5bb0e8298_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i845a05cd969041fba7ad46f78c0e09ac_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i845a05cd969041fba7ad46f78c0e09ac_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ib0bb3e9cd53443099356a4a663971c0c_D20201001-20201001",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i785fd0e4a68b40ff8674243d934db225_I20201001",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422415 - Disclosure - Acquisitions - Pro Forma Financial Information (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
     "shortName": "Acquisitions - Pro Forma Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2a8176a0ce324e18a7065848945a54c1_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2c2b96408b9c412a9768198f8e8f606a_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i2c2b96408b9c412a9768198f8e8f606a_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Income Tax (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ic4a008f555614be384f97c9b5a03d5a3_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ic4a008f555614be384f97c9b5a03d5a3_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia66b7461181c4dd886ae284e862f03e1_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails",
     "shortName": "Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturity of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i18d2cf420ac940fd8835832f3cb25bbf_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i1c555247c8274906932e6bde7b7a204a_I20211109",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfEntitiesIntoWhichEntityPlansToSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "company",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.ligand.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "i1c555247c8274906932e6bde7b7a204a_I20211109",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfEntitiesIntoWhichEntityPlansToSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "company",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "idc5165556b2f432dba6ef0f6e908385c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "icb20171945fd40e794706d8def23874e_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ibaeac815eb9e4c1d9f386e0247d4aab6_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114102 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20210930.htm",
      "contextRef": "ia31a7df32c1e4661a7e2f40cf9f00cdf_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lgnd-20210930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lgnd-20210930.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 77,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedLeasePurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Lease Purchases",
        "label": "Accrued Lease Purchases",
        "terseLabel": "Accrued financing lease payment"
       }
      }
     },
     "localname": "AccruedLeasePurchases",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "label": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "label": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "negatedTerseLabel": "Tax effect for 2023 Notes transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Other Economic Rights",
        "label": "Amortization of Other Economic Rights",
        "verboseLabel": "Amortization of commercial license and other economic rights"
       }
      }
     },
     "localname": "AmortizationOfOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Leases",
        "label": "Assets and Liabilities Leases [Table Text Block]",
        "terseLabel": "Schedule of Operating and Finance Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_AziyoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AziyoMember",
        "terseLabel": "Aziyo"
       }
      }
     },
     "localname": "AziyoMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationConsiderationTransferredHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Holdback",
        "label": "Business Combination, Consideration Transferred, Holdback",
        "terseLabel": "Holdback from acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredHoldback",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "terseLabel": "Fair value of contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "label": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "terseLabel": "Proportion of milestone payments (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets",
        "terseLabel": "Intangibles acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "terseLabel": "Discount rate used to value intangible assets acquired (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities",
        "negatedTerseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLeaseLiabilities",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets",
        "terseLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "terseLabel": "Tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "label": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CommercialLicenseRights",
        "terseLabel": "Commercial license and other economic rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right for Internal Research and Development",
        "label": "Contingent Value Right for Internal Research and Development [Member]",
        "terseLabel": "Contingent Value Right for Internal Research and Development"
       }
      }
     },
     "localname": "ContingentValueRightForInternalResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContingentValueRightOnProductRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Value Right on Product Revenues",
        "label": "Contingent Value Right on Product Revenues [Member]",
        "terseLabel": "Contingent Value Right on Product Revenues"
       }
      }
     },
     "localname": "ContingentValueRightOnProductRevenuesMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CreditsAppliedOnAdvancesOnInventoryPurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credits Applied on Advances on Inventory Purchases",
        "label": "Credits Applied on Advances on Inventory Purchases",
        "terseLabel": "Credits applied on advances on inventory purchases"
       }
      }
     },
     "localname": "CreditsAppliedOnAdvancesOnInventoryPurchases",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "totalLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ForecastedCashFlowsEffectiveInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "label": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "terseLabel": "Effective interest rate for forecasted cash flows (as a percent)"
       }
      }
     },
     "localname": "ForecastedCashFlowsEffectiveInterestRatePercent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Icagen",
        "label": "Icagen [Member]",
        "terseLabel": "Icagen"
       }
      }
     },
     "localname": "IcagenMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Current",
        "label": "Lease, Liability, Current",
        "totalLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-Of-Use Asset",
        "label": "Lease, Right-Of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCrystalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "label": "Liability For Contingent Value Rights Company, Crystal [Member]",
        "terseLabel": "Contingent liabilities - Crystal"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCrystalMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Icagen",
        "label": "Liability For Contingent Value Rights Company, Icagen [Member]",
        "terseLabel": "Contingent liabilities - Icagen"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyPfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Pfenex",
        "label": "Liability For Contingent Value Rights Company, Pfenex [Member]",
        "terseLabel": "Contingent liabilities - Pfenex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyPfenexMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyXCellaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, xCella",
        "label": "Liability For Contingent Value Rights Company, xCella [Member]",
        "terseLabel": "Contingent liabilities - xCella"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyXCellaMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "verboseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments",
        "label": "Milestone Payments [Member]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "MilestonePaymentsMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfEntitiesIntoWhichEntityPlansToSplit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Entities Into Which Entity Plans To Split",
        "label": "Number Of Entities Into Which Entity Plans To Split",
        "terseLabel": "Number of separate, publicly traded companies into which entity plans to split"
       }
      }
     },
     "localname": "NumberOfEntitiesIntoWhichEntityPlansToSplit",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_OmniAbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OmniAb",
        "label": "OmniAb [Member]",
        "terseLabel": "OmniAb"
       }
      }
     },
     "localname": "OmniAbMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_OperatingLeaseLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability, Additions",
        "label": "Operating Lease Liability, Additions",
        "terseLabel": "Increase in operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAdditions",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "label": "Payments to Acquire Businesses, Gross, Attributable to Vested Portion of Stock Options",
        "terseLabel": "Gross payments to acquire business attributable to vested portion of stock options"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGrossAttributableToVestedPortionOfStockOptions",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedTerseLabel": "Payments to CVR holders and other contingent payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SaleOfStockPercentageOfCommonStockExpectedToBeSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Percentage Of Common Stock Expected To Be Sold",
        "label": "Sale Of Stock, Percentage Of Common Stock Expected To Be Sold",
        "terseLabel": "Proportion of common stock expected to be sold (as a percent)"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfCommonStockExpectedToBeSold",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis",
        "label": "Selexis [Member]",
        "terseLabel": "Selexis"
       }
      }
     },
     "localname": "SelexisMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TaurusBiosciencesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taurus Biosciences, LLC",
        "label": "Taurus Biosciences, LLC [Member]",
        "terseLabel": "Taurus"
       }
      }
     },
     "localname": "TaurusBiosciencesLLCMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20210930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r51",
      "r53",
      "r118",
      "r119",
      "r272",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r471",
      "r474",
      "r476",
      "r477",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r471",
      "r474",
      "r476",
      "r477",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r471",
      "r474",
      "r476",
      "r477",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r368",
      "r370",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r623",
      "r625",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r368",
      "r370",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r623",
      "r625",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r182",
      "r346",
      "r349",
      "r568",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r182",
      "r346",
      "r349",
      "r568",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r271",
      "r310",
      "r357",
      "r368",
      "r370",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r623",
      "r625",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r271",
      "r310",
      "r357",
      "r368",
      "r370",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r566",
      "r623",
      "r625",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r52",
      "r53",
      "r118",
      "r119",
      "r272",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r126",
      "r127",
      "r128",
      "r129",
      "r190",
      "r191",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r254",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r423",
      "r424",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r526",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r25",
      "r185",
      "r186"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r58",
      "r59",
      "r60",
      "r610",
      "r633",
      "r637"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r57",
      "r60",
      "r66",
      "r67",
      "r68",
      "r122",
      "r123",
      "r124",
      "r461",
      "r628",
      "r629",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average estimated useful life of finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r410",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r407",
      "r408",
      "r409",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "negatedLabel": "Adjustments to additional paid in capital, equity component of convertible debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r371",
      "r373",
      "r412",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r266",
      "r324",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvancesOnInventoryPurchases": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer.",
        "label": "Advances on Inventory Purchases",
        "terseLabel": "Advances on inventory purchases"
       }
      }
     },
     "localname": "AdvancesOnInventoryPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r101",
      "r291",
      "r300",
      "r301",
      "r512"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r114",
      "r171",
      "r174",
      "r180",
      "r210",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r457",
      "r462",
      "r492",
      "r530",
      "r532",
      "r585",
      "r609"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r50",
      "r114",
      "r210",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r457",
      "r462",
      "r492",
      "r530",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r194",
      "r222"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r199",
      "r200",
      "r602"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r192",
      "r195",
      "r222",
      "r591"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r367",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r367",
      "r369",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Post-combination expense"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill acquired that is expected to be deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r447",
      "r448",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r100",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Reduction in contingent liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r446",
      "r449",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts and unbilled receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedLabel": "Deferred revenue",
        "negatedTerseLabel": "Deferred revenue acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability acquired in connection with the acquired intangibles",
        "negatedTerseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r33",
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r95",
      "r103",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r95",
      "r501"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "netLabel": "Outstanding warrants to purchase shares of Viking's common stock (shares)",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r248",
      "r593",
      "r614"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r245",
      "r246",
      "r247",
      "r251",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,707 and 16,080 shares issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r72",
      "r596",
      "r618"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r187",
      "r219",
      "r334",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r334",
      "r335",
      "r347"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized from milestone method revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships",
        "verboseLabel": "Contractual Relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r19",
      "r586",
      "r606",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r358",
      "r366",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r285",
      "r292",
      "r293",
      "r295",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r21",
      "r22",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r300",
      "r301",
      "r513",
      "r586",
      "r587",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component of the 2023 Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r270",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r41",
      "r270",
      "r325",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r268",
      "r298",
      "r299",
      "r511",
      "r513",
      "r514"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r300",
      "r301",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r113",
      "r120",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r294",
      "r298",
      "r299",
      "r300",
      "r301",
      "r325",
      "r329",
      "r330",
      "r331",
      "r510",
      "r511",
      "r513",
      "r514",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r281",
      "r510",
      "r514"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r281",
      "r510",
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r196",
      "r222",
      "r226",
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r204",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r101",
      "r169"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r346",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r139",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r477",
      "r478",
      "r597",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Summary of computation of basic and diluted net income (loss) per share",
        "verboseLabel": "Earnings Per Share, Basic and Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r477",
      "r478",
      "r597",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareProFormaAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Pro Forma [Abstract]",
        "terseLabel": "Net loss per common share:"
       }
      }
     },
     "localname": "EarningsPerShareProFormaAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Cash to settle unvested stock options recognized as share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r66",
      "r67",
      "r68",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r214",
      "r324",
      "r332",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r476",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r628",
      "r629",
      "r630",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r209",
      "r572",
      "r574",
      "r576",
      "r578",
      "r580",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Viking Therapeutics, Inc."
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r16",
      "r20",
      "r205",
      "r607",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r479",
      "r480",
      "r481",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r479",
      "r480",
      "r481",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r479",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r480",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r487",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r479",
      "r480",
      "r483",
      "r484",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r283",
      "r358",
      "r359",
      "r364",
      "r366",
      "r480",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r364",
      "r366",
      "r480",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r480",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r485",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of September\u00a030, 2021",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2020"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r283",
      "r298",
      "r299",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r487",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r517",
      "r521"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r224",
      "r225",
      "r228",
      "r229",
      "r294",
      "r322",
      "r467",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r240"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r235",
      "r237",
      "r240",
      "r241",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r240",
      "r570"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r235",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r240",
      "r569"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r79",
      "r101",
      "r193"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r101",
      "r302",
      "r303"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r230",
      "r231",
      "r532",
      "r584"
     ],
     "calculation": {
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r201",
      "r601"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r171",
      "r173",
      "r176",
      "r179",
      "r181",
      "r583",
      "r594",
      "r599",
      "r620"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r243",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r419",
      "r421",
      "r422",
      "r425",
      "r427",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r136",
      "r137",
      "r170",
      "r417",
      "r426",
      "r428",
      "r621"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r97",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r47",
      "r592",
      "r616"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r100",
      "r521"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r69",
      "r168",
      "r509",
      "r512",
      "r598"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r92",
      "r96",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r48",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r78",
      "r167"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remaining three months ending December 31, 2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r114",
      "r175",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r458",
      "r462",
      "r463",
      "r492",
      "r530",
      "r531"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r114",
      "r210",
      "r492",
      "r532",
      "r588",
      "r612"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r114",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r458",
      "r462",
      "r463",
      "r492",
      "r530",
      "r531",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "netLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r95",
      "r98",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r61",
      "r63",
      "r68",
      "r71",
      "r102",
      "r114",
      "r126",
      "r130",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r146",
      "r171",
      "r173",
      "r176",
      "r179",
      "r181",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r478",
      "r492",
      "r595",
      "r617"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r171",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r6",
      "r121",
      "r164",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r49",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r55",
      "r56",
      "r58"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net loss on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncome": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Operating Income",
        "negatedTerseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for contingent consideration liabilities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r91",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchase"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r83",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payments for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r88",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r86",
      "r402"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r61",
      "r63",
      "r68",
      "r94",
      "r114",
      "r126",
      "r136",
      "r137",
      "r171",
      "r173",
      "r176",
      "r179",
      "r181",
      "r210",
      "r255",
      "r256",
      "r257",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r456",
      "r459",
      "r460",
      "r464",
      "r465",
      "r478",
      "r492",
      "r599"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r242",
      "r532",
      "r603",
      "r613"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r32",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r365",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r365",
      "r527",
      "r529",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r414",
      "r567",
      "r647"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r7",
      "r15",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r332",
      "r410",
      "r532",
      "r611",
      "r632",
      "r637"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r214",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r476",
      "r628",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (Accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r165",
      "r166",
      "r172",
      "r177",
      "r178",
      "r182",
      "r183",
      "r184",
      "r345",
      "r346",
      "r568"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r522",
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Increase in operating lease assets"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]",
        "terseLabel": "Royalty Agreements"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/AcquisitionsProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r235",
      "r239",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r375",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r379",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r45",
      "r111",
      "r155",
      "r156",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r317",
      "r322",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r381",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r372",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r375",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r394",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r20",
      "r589",
      "r590",
      "r608"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r46",
      "r66",
      "r67",
      "r68",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r214",
      "r324",
      "r332",
      "r407",
      "r408",
      "r409",
      "r423",
      "r424",
      "r476",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r628",
      "r629",
      "r630",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r154",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r324",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r324",
      "r332",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r332",
      "r374",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r23",
      "r24",
      "r324",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r23",
      "r24",
      "r324",
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r114",
      "r189",
      "r210",
      "r492",
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r508",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r508",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r508",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r508",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r533",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Core Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r346",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r346",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r202",
      "r203",
      "r206",
      "r207",
      "r208",
      "r294",
      "r322",
      "r467",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r117",
      "r358",
      "r366",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "Treasury bill"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Investment in warrants",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (in shares)",
        "totalLabel": "Shares used to compute diluted income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "verboseLabel": "Restricted stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r648": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r649": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r650": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r651": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r652": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r653": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r654": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r655": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r656": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r657": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r658": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r659": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r660": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0000886163-21-000130-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-21-000130-xbrl.zip
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MJ\A,\V!MI:/B/*UR]@'2@S9,&VU543<D4($YQ;QSG.2JD;+2 7*>5CG[6"G
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M++-@G$$K*$\W(!/I-F[\\@$ZLY@V?W"E3"F#-LD)"SY;&REGB0*=TC9B@CF
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M \V<V@ZF!)-AR2LEA;=!0 K9*32)- /G3I-M^>6!:?YM!U."+ CK>!(.H\D
M0EJEK0RZK-./SK&T-)#-NNU@2OBDF,!SE$+K#(C*<L6 Z^B9MSRS&7J^>=6
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M#:NR'Y\.$BV$*)0TX!*ZC$EHH1$L"UI=KD>\B"NW+R(N;&H+LR,:R!AT  ;
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MV]_DMN:,'';9-=HBE!UHC6-ZO %DDH&TRHK;*SI]3\.(3SXXG:).'JQ!RE
MK9 85<@L\TJE)2N)NP3<GF+*[9G1)&@U(I ,X%8Y()6K<UG;W&!^&-Q>2=QE
MY#;3F'W((?B@P0=P(E,6%[A)T@J!U5II8 'IM)*X\^,V"IZ\('^-E+0E$B7"
M6,501I0*9<76!EY ;C\P.C$#2C+PVBH+$DR9(R.1 WE006Y35RIC6BB)^_-$
M.H_IK'KZ9%&2MQR-A\2,BB0"G$K69<G!<*DRXV!7@^E6S*XHLRFV6V:S54$D
MX!*\D4X[IJ)PZ/%R>?6J,/NADFFA=/>B,'N\-Z_V3"A+/AN\"]J&Q!%3RE&Q
M%;.KP.Q%(9.QG$$6H(A1$).@^%\FG4FK,H'N'D@+UTK:+@JSISC>3D*447J1
M*/HKX9T1B)%K;IR5,55KN-1*VJZ8_;$#U_NHDE'%=8, ;HTSG,?L X5_5K&Y
MP0^53$LD;:?';%=::9DSS$H'(C',Z+W'P+SC)$VJU9?\4)F]*&22RH6<BV-4
M#*0.SGNG4"M,SLD<'\B>O@LI;7?2$#T.6@]N%<\IMF\A1$U9&TIF(7JT*B67
M171.J\14M5H!EDO>KMC]T^P.1FJ07AMF(B0(#@WWC"?C30S956N5B(=,J"62
MN5-LP=71L9@ B>,0H_><)(JR3HO,(/!JS9QXR.Q>%$+I%!UZR2.4)@'/G<@A
M>BG!9>FRK]98KI7470IV3R^1RRBY$J)TY"( (V*#I"3..'I(X?K#8/=*ZBXG
MNT56.7.A("8-WEMO*8>SG"M2 AE 58K=#YE02R1UI]A7H;QA09KL$$'DY*(K
MJ[>A4IJT"59K7Z6'S.Y%(10W2O# 0,H 91]CRW)@,7(.RB>75F-Q%Y5 <S&X
M[8!TH")97+(IR%"Z)[P%6Q8.,5()[157,2NHUE:Q"Z5S5]2>=V\%%SJ:'%TV
M"J15EL6<&..8=$;RZ)6B]H-ETQ(IW"DVYIH<@L3D,2G0V2 GG8ODR /I7 .K
MY60K0>U%89.0*9B4$U*>!$9SCR@DE$V5O58H'TA;UTK>+@RUIY>Y>2>B5@*C
MT@PR$R1P1;):9&L]UU"M_2%6\G9%[1OSS;52UK($W#-P#JVW-@(:85)T"7VE
MJ/U@V;1$\G9ZU [ M&.4M46) "'8Z 08@1YSAJRKM7#Z@Z7VPK#):TG*-N<R
M*0<]H 5K<O2@4#N>;:62I862MS_-HY<Y=1_></,IKH.G>1F:R )/!G(B.6"5
M0<KBO"S#%ZLU('=QV?20A/>B4-LHYKGBQ.Z<P"N/(8"*S,J84T8?5M2N IN6
M2-Y.<S&%[*U,UEG&("2TQJ,O>[T$YBB'JU:?VX.E]J*P*474BEMP93Q")($;
M@4AD4R"_*8RJUEBNE;RM/K6GN/^5UP@I><:<@A2<-64K(Y=)W!JCX@,;R+62
MMTM$;<FS"]R!#"J $,;F8%BR6@:;$EQN9+*B]H*S:8GD[117+A4J(3I0RG%@
M(%URQAI0:!AZ^= &EU>5VHO")LZDD H96!9!VNS)0SHEG."84]:Q4LG2<LG;
M_WV:VFU\:-2>8A,7Y?XI^.PL+SE;<DP&8T'%I!2I@VIM^+10(G)%[3E3F[QV
M9LHD1C* U*Q'*;F,%ASSSB?]P&:;5Y5-2R1OIT=M)2TSR)6.+HPG QFC2-GR
M@!&2B]4:5OY@J;TH;,K.1,8\Y" 8. E>9P,!=!*.B>BJU0ZPDK?5I_84!RBR
M[)*$*'30P"Q'PW4"C-)R)KRHU@#%E;Q=4?N&O"4F.Y5 9"T@L.1C2EH8;M1X
M_81J4?O!LFF)Y.T4.R:$<CHK%[,PP$!9EA/3T5,^AYK2N!6UJT#M16&3LL*C
M3D2<R,!FM,KZP)Q)TJB4_0/9ZVEN\G8O#8;]5ABFN-U]3Y_''-K]D&*S1T<[
MJ?^B%>@9*3VXQ4&FE\&QX+4UP>:RXY-"[CE*QXRUP7IY-0]GZ2D^-YF[HO@,
M)@@S)5WB(8KDP8-S+%O'E =EK..Y6AT5#YY52R1[ISB*TJ2RCQE17&/IB[,Y
M* 9><2-D<E"M)9X>/,47A55:26\$=TI+"X'$+R_KARE&7A.S-=5J)UC)W^6A
M^!0S/&-\L%RITHN!"#X("=J"U<YHM5HH=T7QRE/<^8A"&N5L5! PHPL,I4)O
MLI9<5&M7OP?/JB62OU.D>$XL2<=0.07,::NCR"EITL')@F(KBE>)XG-DU:C;
MFE J7+>JOWU?WN-MO[2K7[.G,WFM"2Y?/O?J"5>G7GTOC_AR,X7DWG(1G0BD
M0U1&83.G3RQF*TB%O]TD"C/ZC]<G'Q:7S7^-!JUN(O*&?X]:@]:0#M[@\5V7
M=/X!'A#6_>$F#M.34D5UJBIVS82/QZXK+=XZ]2-IKHY,A31O!W1U&GP/=RXO
M^6X*R<R"=@Y%R!&<RF6T8LQ>><^2%<[.@4*+"MJM>@,T(*30MLQI,CDC1AFA
M+".(7!NUP&NL#/K#]9?]7AR%X6Y_/_7?D]N_86J;)8KW3LO-]M+1J(W#7O_\
M::]# 2*TL+W3:E/LZ)&I;G1CDPJ0XE[O'-O#UL_'C5*R/21J3XI3ON[@6:LS
MZDPK(C5;'3*=W=SL8W>04W\W/^_UXB?5<'WRY4GTBKOO4Y^N315IA4%#ZB8R
MFZWEX(7V7L>RZ6O*R'R6U27GRV,<)/FTW>JV K:;_4+(%36^J]DWAQ 4EQYC
M!@RES4*SJ&5(4G$4IOA[HL;$WR\F1ZJTOM?-0%50O&.@^A3PGPA4D42B,R0*
ML\B0M,;@0J9XSSG+W#IW";AY8(#?:9;B%  W,P<<$+@*QE#MDS)AULN@LU!9
M@C4!@#U0"Y\5X+.W\!2L="$!LYA "D"7'3,Z<649!7U5(<#_.0N<C$W[J]4;
MA%;JAC38[H9IA?^/U*%/ WJ7/I:G_W7>/#^]J4"VL-_MC883:A'E7A+"W50:
M5U)I)B-1?$- +R/;+"AD*D2G'0.>/1J,945^&UAB#D.E&LZ6OIE36^TD(9,4
M9%#"(UI($ICP3HI05;FW2+#-WR*-<EPBW3$&!+3":NW!.^%L2&6HWN)F>PL.
M[;TD8)YY+Y,+44D R9R32A-L6DMG>&!A;)'CEK;ZU8=%A>V?H_5,!!=Y2G9'
M@_ODU)\Q.*MR9&5G<>N!Y6RU 0$R.@G1"W&UWLL*N7^,<#?!^,$NE]-1/WVY
MD;P<^>ZV<,^1 025 FIP1B#S(@24QCIFU:4C76A<;_2=C5WC1_'ZM3,V6X/0
M&W6'>V0+T]+2U6;7[9945!11E5/>&N"0O-9&!'+5)KF<;)YXZRO]M-"R=R&\
M]9WET2<2^">\=0;C0")ZP2(83GJ8Q^B4RH8\=JZ"53]KD<=*+UKO2]<],?FH
MY=MI8S!(P\%?YSMXTNO?:!2YF=#V,0Q'V)XDJROK_HP:X$ SU!R").OVT<5
M>5'@S(HD%(0EI48SA>-NK]T[.O\+!Y]?N"+*YV$@B"0MXS8H 4QKQ,0%I,2D
M$ "N2J)]Y4P6(840$)DS 6T4AI(&TAA(\D)'A)!R4E4@U)=ZZXE;4^RM7SFW
MQ2.N],YE%87F7E#2ZRQD4U;RL2$[X HJ0-Q%IM?]#X%YJ,05:+G1R$*2%+FY
M1<.TLF =*"2IQR\SN<M^<+;(S:4+ >&=>[;9U!JZ.3,V,2V]A@@>DV=*&Q<
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MPKVG:6U%IG0N;432EL(X6,DQ3_\QD\6ZUN1(;V(EEM.76JS 0_R'IBJFB0Z
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M',IRD%$@Q8BUD;+*AY!X#0L&%SPO)2)0\#QG/%]-X)E$@K4!5ATN:N- XQ#
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MAFHK#.]>3'F9X,N#U%2W,,A_O%#?UX6.%QOP2"NS%+!^)O>^O1/F("JYMBP
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M=<A5FE/ZAA20VT0)+P-R:W )"\@]$LC-NW,N8"^%Q"A%9A"G42,K?$),.<+
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M&DN-K4<F,(&X%0E9E002%E,G>,(NN]*TK=35XY!+UXHHZED L $2WH"D[@*
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M?3/AZ"I/NCL6E4KRZP:=N8"S44%P"5 C&46<"8:T-1XYH9T)G#@I^3IZ$A;
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M@%1@=)"UPB-)L02G2& 7<F1#MPV[RCE*JM=34>HU\XX?'#0M^GP/^GPQEZM
MJ*$AHN1S54%A!-+8:,0<9BH&I](:BUR40,>= AVC_C7TH]\-<3"LCLF?V\'
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M/5H)$]^"5'+3Y7J1[(X7"_S=/<LS-8^^-2(7$%T*1!<*YF%J#2&Y09G#%/%
M'5 M39%(Q$G+B70^;ROPMF"KI$67 %3S<:5Q.XT%338#36:43$DG@7QI1*4
M2%$R(6L,1]YRI5S$48:PM<TT;^MKX.1NN8\-(V>;%[]Z=6L&UK*CEHN?.KU>
MWM?+3>,KY7I>"5=+P&0044HK'0],<6^IT33@:+#VFG@LU-&;C(Z$,O)8Z%C
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MF3 6#0$*E-ABX:L(67F6*9A4H[DKF*N%?^^@G9]T0_!!XQY;[K3CCX0_3%)
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M?3)>L!2D0,/?1T5T#(& ,0PYRGBB8D@4&*ALE^?-J_?NUA:YU<!? =C.+8+
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M&(B>6YYW5L4C?0F#HU@Z/Y0*MMT:B_&HM%?J 7Z3++Z%,Y_"]"KQE.7R"%R
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MO?/.&,NXKT&K9P#>Y*(M)[%TM"!-B39+3YF(P3)CP=8=\!5#\%+] D4CV?!
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M,+P42@5@RJ489 ;GD@]@(M)ZL#ZD*X8U*\/?!\/W.\D BD.3"4N<#9Q(,(F
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M=I!DK:[S#!#L4O96)"1O2F5(8(T';X-W@3IK8TVX6RT$=S;Y@Z;*H1(FS(A
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M _S@\0G^FWY 5=*0[?68$$W@HU#&?E+7=23^^%I$&;E@SH#TF6?$GH;@0G;
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MG-KMDA.4\SO'Q+I>V*GW3B7)PN'UL4J.7>:/>"H6)NQ2KRF3JC9BSN;,2SY
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MP"M@=USQU0<&?#^>=@4=^V&(U0]-D6Z).JMSI<%*N+)V3-T=W$P<4V7!=1'
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M@,^Z]!XXM?>@<EVT3H IKUGA35D$%9)*12QS\>B#^W#6W8QNA7W3W8PLU3E
M1@)S0+\\B\10'4DAG2M- D&@'+L9,6XV#%_1JKJ'0[@.OJV#;]^/*=X,#M=-
MBYX&"DX<2TI0$9P*1'.*#) &8C%Y0!5EBDD4S%A,WR[$9GE7$/B(0&Q-G^Z*
M/O'2E)J5960@-:[DH$JI#:+@-I7,%.&!Z=.Z<]'W!92)5RO%DMI".5(8)X@H
M)4!+!.,R>IH*992GT0"M4FJCT&M2M295SXE4W0PDUPV*?@" G/C<(H"@LER0
MT@I%A$X8RHL15%Z,(8HR<B?0YU;>78.B.W/&_3N/E'FY.&IN_O?*2;4P>_'*
M<8OUD]0'3>"TFK/>H)UGX>3Y..W/<3*DYA\O9CY5XW\Q^8AU /6CX<4?66CO
M?M=8HJ\U2PB;)<^X]Z;^?=R?^%2/(G']:#\!1X=[_<EVOMCSP8M_SSS2:;M+
MIM=O_M&OF&UVT8N73 J\<O+?W*3 @OJBA!- M>2B$,H +)J")Q9\Z10V-GRX
M28%;E_E@-UJ]B3TZGB4X[.%L0'\,:'OQB-^EI)GJP'P2K+#>B"(%K;G4G"7N
ML=FC2\OU 0ZEOT>78VUHX\&?X\8//'7^WB>4[6Z__W+(?4B,.T:<Y)& #%MB
MA$R$!BV"!.H+*A[@>W.QV+G53)BO9*&:PQLGJUL-U+6M+[7N;=EZJL-XW'DU
MLOP,!^[B)5!2__L&-.1F8L<>2NI^9,?/S65Q_XT\--:7I:$ED=8&H!*B(-J6
MCJBD'7<:#"PJL?)C4RZ.)%\<>CFC$]O= #OR$U?9/KE28WP'F,Y77#:O=/GX
MX]?-Q-9JW-.?#2+_V;'=5>=[/H3BP7&"U?FVPWIDK.^=GB)<5%-E!V,M$^"0
MX]Q9G'^Z=5K-^;[L\4%M]5NO__KSSPV\2OP/3CX%I;7B.'IME(V2*\VD"(4&
MT5.,%SZEH+C0]#H93'<$$3AP&ECN\-=^[W3']C_%8<:"YIG13GDT4^KO'QA.
MO#@TE >#V<F&8U,.S$[6LM2D%#X*4[*4RHBMZ!<GU#=S=1..#SK-B]OZC 9?
M\\*,4/:J*>^IW1\,4<@Z%OX;['GSYEY*$3L=H,YJ]T(]"SD"D*,DYMGQFZTK
M*->*?L@[$-,5U%QS[/Z*_<\@@LM%^O5@")\%#?86YT>#!5Y/]AWL]WZ)[^+X
M6+_I_MK,$_TQ<NMN+,1[VUOTD'+)M?:>%&59$I%*0ZS5B90T<<Z<T%+:%R^%
MVM!JL6W=#,FRGVV[DRD6;&TKC3"M:(RF@RDT19!<>1KTX]!_6:):$VD:/)+'
MN&HN>VB'BX\X<-BY\WVCH<R7G._4_@HP^2WV>TO;M4R=SNF>+3^$"^P6I_-3
M<6AY-)%CF;'RE C'"NRX[8FS1I<^B,@,<,]N;^%D#EO'8-BT;/>\MF+Z$YEM
MA;S(^2QV05I:H&J&Q\!9,L>Y0$7,'=C5O4X/(_O+?2E7^T;VNI.%:-$\RHZ:
MC3QP^I<>L*,\[Z[=CW[8ZP]:]NRLW_N,QF2MLB>K#72S=]2WIRT[&A[W^NUO
ML/(;+3<:MKH]T.:NTSZ"&\._X79,?0Z^8'2&#/)2XW,A]30E:K32R@@1 ;H+
M[UF,-!;)L-))-#JI*0R]W6B3V4/[9_6$6_4#@@UYBL21/EL7QL[^EMCY<A@D
M*PMO-)%>80?)P,!P=)Y0]. Y:RT5X<5+B6/ +W9CU%/.9PAA DK> K8343SR
M?WN?:]W:!5%HD+YV%,^Y):)2,G$:%$*[#DXYP2C5(#/  )1%:*\DA$Q$94HV
MX"#ZGP! OO3Z81"[UQ.-"L^1>?5]I,].&EY_V]LZI#IAU,&3DEE!A,>V,AY,
MAF0MT&E'35)@+0R/^V!>GD?;'\S[^S=;']!+=0:8@_MN_7]& $ -!0.K%@P)
M % 0@WYO='3<Z@$U)K5Q,01S;U")%J!5-X#1<=[*KOA6NPL7>S<"VD8+)PG%
M]V;/ZQD8M8,-_*ID?;L#'&D89RXZI5(V6VA9@RCB!_'Z-D, 2N\4I,W<Q1<0
M\)8#:A+A+N!S@)[N'.ZK:RN[M.6R$8Y' .0_HGE4(3A<L[X!$.R00Q!PFY66
MR[;]1JL3C\#Z[L>\0CD&EV^JAX$X?!H$;3"):L"J+@O/.76KJX#N_3B8EQZL
M=_'4MD&''TW =_*>-0R__[+[]M E$9/6%$Z:+XC TZ<5!S9ERQ2H=4H;3$$5
M>G,Q$G@I#/?SXF<7<F/Y7)I<OKG(FEJKV0_5_BD7.)6EU$F5(G!F64E#R8U3
M4B1MRT,I7]PC\5IN*96;K4OUT(U,C-DC =;_:7N8C_=6-[S*ZWH4N[X=!^B\
MZO0&8('NPS?^TH'M>F#AW_VK$?YP>G *HLK>?SOX\%;L;;\[/D"!_? W1L(_
M'7PXD#LG.V+GY!-;$'[VL7WP;8=_W-\]_KA])'9_^_7X8/^(?OR D?!WQQ]/
M/IWO?#LZW]O_F':_P3,<'7(N#&,LD,)B+X]0!F(]5KA2RZU5152HCV<CAT:Y
MR*@&E:3AZ !%"+%42!!8E%$6XD4K J*<H1.[#P;:R\D^9)2=V8B?6G]D+ :\
M\C&B7EG0:RL<@:5D_NK;G7T\)DT :TH*:6%-::%!"(&$)1GA4 $S6Q8870SZ
MI_R_G^_1A@=C S@7+#$L?^7J0JRQ+9!ST*;'L?(2YM_: WSF 9@#?8 GL$!<
MA4ZP.]5GX3>@$\?9;=/JM*U#_7Z>W=_3;Q[F=\!?;2O[B_$+FR\/U5?AV[J]
M1M^WJYNHW@R?.^W!YSOM3S'S$KAU-$@K-5SYOV<^L='Z,GY,_".P@O;IZ'3Z
M*\>WFO,4X"_(@-%AVK'M4[P82#=\/%?ZY$A?(T /$N;^ZU5+R&+C.]_#A3ZL
MY7<U>T"7W=N#2WMV5V,Z#9YR0(]VMV)*>.8=R =^U5CI9JFQ V"A@RP*9[TA
M0%$;/K946E"- XG-%!=>R^9WKYOEN!\_8P X\\U:Y( FOL._9LK:[LZ^AL=A
MV;?YWJB#%!N(+;P HM\^/0-"D3\,7'W4&>:/ I?NYR\?W,H;^N"[M==M[0&E
MQM/,QYZ2ZB3'-GI%+N32OOVYW3F$_01; ^R0>2^D4JX$A ;MZ44 6JUL9!H@
M7K%4\$@K4Y46O#)5\8?+O!K9<@74N<!R_0/0;'(RSF%M7B&F#'YM=QY=OO)]
MDXF=D_=L9^LPEH43Z(@,L-9$B%(0RY,DA19>@N85N3%8-F$7F73>Z]9XKP>M
MA O;X/_[OUK V8; !X: 3Z/^, <1\)7=7A_U17?R.AR=O>-VKY7!X-AV$OYE
M@/$N.(5OX&3#V8!WNL8LO?@*[0HQJB\$_33,O_X^"FV/)_I/VXT=_)H=.+)M
M,O[X'Q/8^.?__)=FK/CY]S]W_L@_TI__U0+C"P&I?83&05:!6??UNOA#;S1
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M4GXI%Y8G92BXOJK2H;BVOB/EO ^6K]A9) &(?.S;AB? $7 DCTIT?[IBWTC
M0=4 I5T6SD(D0IM5U27(^UJ](VL^/_1 2J1S8ZTK!R!?8[ I$IO-A?J4T#MJ
M+!:B.QRA0+>TY$L"B9PRVW F,W)V8K2>0M/8C@X'Q^R7E69<&!UEK?;LP007
M828U\>NEP'&!79.N.,,!?C0+*<G>K>R"FJ),6^B3*W>7<G"$DZ^6M EZ4*5#
M\\1K1P%+F.K$P(#<BI?*S \29PHK>JYX0NNM[I7\8OO7;9V,CHCY ]Y!%Y+Z
MI])UV%.[356'/8RHU2"\\E+Y#%9ZALY3C"/H"=ES2>4Y3B"!_:PE.ZXQWS-\
M1Q%Q\ :$!XN17-HN=IKV5$;DJ25*(JN$1'IL:?:4TG&54 %A&.%(L83CQ<=-
M*$#+$)5[N(-01!\X4%=F7..P^[(J'TU4@-0X<OT7M*?*^4NW8&H%G^J2TOBU
M\1S0=VMID?7%W;44>W3Q_N'AI$ONX4VC!3XE%F<<5.<6'* >+5 [DA$;6<^M
MW&SB/YNW6-^AT YHZB(B06VT,AV_<"M9V^;=-)HR%4!Y#]$KFJ@4;Q9TVH6L
MP58J$1Z=3X7"A+.%@HK/8XO:R>I/)B/=D(P3DR1K@,P%Q,'3E-/PJ-<J-THM
M\]!5.&?-/@XIOJRD(LU*S18O6Z/3X(BU*_?N@A /E/RQ%D-V/L(.R47H'[3/
M#;5HL)"IWH5BA:R7:#<!!_M4R-[H#"!-66.B_#>]'TNU'T!%7/4-!Q^4*0C[
MY=QZ8F=$/'E(EY9VF@=K81VJ>Z*=QU;RSDD<8QSU$X<8;T=UZ]W/MOK2OS>'
M?30Z_4<VY)Q?EJQWW" .\.(;;*3OM E;"76+9Y_L_GLAT"$*VUM,:H,"AO7B
MK5Y[0SL]-"LXPXMCD@\E!C;OKO-1.V 4L=UYS&E/Y+QR'X69L@G8OFRI:BS7
M>7G:<IZ^5)YKD#*GH/I&$99#^5)%D)^!W+\D?]$"+:06)5Q+*_!AG%FZ VII
M"\&]N4CBQ.1HL_.Z3-D&;4@LR>!SYL4"S5<>E/Q/)/TN*85_A8%N'$S\GFAC
MFZPB$)1JB:90SE)X;.6)_3DS7L0RDAL"1C*>J^0JR68]&6=EZD\M_TZ6.AN6
M!' 564LK21B*T/D&5FI!(.6RQ77$%*0H\T-G1>Q;%6FTM7 E %LE88K[<;*E
MK:;KP"W,N36X1MZ/5@#3I_H%LZ-L\$TE>JQR6 1?/>1B_ZH-WW&?:AO06<R^
MP(@B)\8)EJ/B>ZSA]9_@-:%P@!U4$"G3N69!F:Y%ZOVK>1@+4R'X7E<2OL,H
M!?SY4>>%G01@A(69RLYRGKY_]_'D&9'4'R&>(8C(A9@Z3W_Z^:S5\3K/J.YR
MPP&V/H*J1:SD1U4*T3Q'$1%-XZG4Z9P4QIFEI.^LX!@QTH4S_%L2G'\)RR+'
M:+58SF$'V\Z&34#/7+:#,T)E=@!1T?XP2ZHFR:A,5M:L_:\"@_]K03!^EO,)
M_I*9R(OS6_$U=+2\RIQ3O(E@+C^'BY RQ?[7?H4J/9V%:;:-+5:<!L8)A9;#
M2!_WD5+ZJS,R2>N)&BHC6'+V:QG)$KE@ER2YVLCQ0$;@-&/3%V3GF[-W'S"Q
MG3U%U.V7. 4'^NG-N[//']Z_:?4Z'DL0H'/<;<,9F&$+(FE5%BB:@\J*<[D0
MZD#C=5I?P@!EU)1=;J>GITZ<Q*UL@1$&'T5O5)C@&[#AV:N?7SWC&F-:'#FA
MK1?1I8-.!,3!48F&=%>!L2V!#3FE->"&WCD&5GP*.F !,=YL0O.(VD+X:B$%
M%L#-B@@3DS&JJ2\P[5^#MW"=6E; O8&RYNG'MV?/,/^RG-FENDM:>1+)M"P1
MCQ,ROS'#,.=Y4 #:42<-_TBLXRU(ZPG4XO4Y;3N1VA%LW/%?'=K43622I.22
MIW=;E=[PT,D9/$&T\AL&()%^5((3&J0_XY&]HB/CHYJ%+/K4G0GG ZR]4-1*
M+GSAL_]5;4/EK!3QD%\T7)AAW/O13+V;E4@]A!#(Y@Q[0+J/?<;+J(#=G</F
M::(G+:P&2B JU&[3-) ,$"XR$8G>%N5*ETR[1D)@E@(=_:<0"_0]X/D1\^H/
M%C(7Q&8^TQAH0L;[%*TXUU\77@1.M\7*X@7% 4M>(G<^KB,FY[PSZ/S0=MZ_
M/LG6F']M?M8$:M2N;/7JSZ.$.5Y%'H,?BQB)W]?=R[6$XB%*I4SX&%9D#PM=
MH'#QH<)@\B_*/ /.KE25C,=Y19W 5EPD5*6I3(3,@H]A4_2"KC#0&SR69)JB
MLV0A:X>"BL(2W5?"+X 0%BO09<+ B63Q12Y WWEZ\N[G9Z@NT3?!"D&O,CKQ
M51RD.-[3=Z_/GNE4_8 NL$7(N4CTAI./OW[H]X8J67PFP@BGXK7&#GE6Z:Y*
M0U;78$EDXFQ:9"FE!66M8(I:KDI.U?4*KWR%;N>$@H*<K_2S6DFF?7EJ9U[R
MUB13S-C'^S2!N:4V#_$/D#4(6R6;E\)R*3'*2&0&'_X.-F2,ES<+9?2-&Q$B
MR6=(B46K''/MJ?*'_(%F!T%F8_0)^6T:)4F@[V-S4B0CM'Q1^]DV&TNE/W7U
MP+(F2Y7.9-N\>NUU>\0_KU[W-NO*(.9 Y=/V[X),?:S3.]HDXK]A_0&658?)
M.U*$-4\%"0<S9Y;6K(Y&TT--0V 2Z[%.IV0Y;*:OK)J_O7PW\88>@K# X6XR
M:][ZG^)-9HV[^:Q4=@<%:!8KX,^YC(%WSU-Q <3Q]/S=3\]4#0;K+B)<Z/P^
M#I!O5A,PF:"<]IH\AV&-3=-VZMN'BM6-]I WK5NSJ4NKJ3J;C?N0SU<I2B^Y
MDCKG:VUBRF0**H.AIO<W$9_ Q?A2)]O23B#L 3,Q$ J%H-C:<ZV2/+EF]E$^
MPT_$M*F:_=/20_(WS$'[1X)NIG?"%P4]_EF$ER)^=J2\I;&F3(H5F[$82X_/
M3TZYNJ),+1%QF?*A 9+4CW^&P],E'$#<!5$(6=+D64IF^27AIYE$LH1";O$Y
M923A49;X1'H<]#U9,#'F64YB@.FI\\62L=3AZJ0C/:C7)3X85\6I6B[D+H-6
M1WD ,M"5C-K36*;RU=P5'T,LU7'>"C!][F7?[B+F\>@R*D:'DU&Q+^$1C35W
MLRC)H<J"SQ:ZWINRP."SR;#7\E-%4>S4B_V*;F\IW7C0,/>5I1NJ4$=D*K)3
M2;Y7ZM??Q1]_U#V5H%& #O+%=<YD6BR<TQ@D8EYP:>XIW)^LU)Q$%PFHC)BS
MB-G',Y6&C*\KDU94NBY7)5A>NFBE\Q]JZ )'>B/2AEJ:[*\G__/^S2^_GKQ_
M]4;3_T+F! (0+A9%C#L;(CJ#K4G+.%@F(8- @/FJ[8-E>$$]IEC35>!8>(%B
M&GN(2M!,4!X4LN+;UR=EW8<U"RX(":B8W!M32)",:J%0/"E]&$?[>Q'QI'A)
M>-Q9,5V$N?+8%LLE)X%1=;IQ^?.U3FHNEZ/J;*Q<34KGW6.1QSR, M"VVLX'
M4 O\/,%X7-?$X\A89Q0$?.@UJ^C*9H],T 55:9P5>3MI4W4D94DH:SXG7[(B
M1BZE5)+Z31GY%\+W0>/F-% N4-!^.88I#GE]0"04H*QN)>:!LJOI(WSZ[@-\
MV^U1R8!Q[L7G$>8!<YIRM]."8Z.:AE@6B\1/?$[2C7\OSE&7Y>E(^Y2& W5*
MYG@XO<SZ">61>A/<YF&?7ZW !=C'%:V03!8JKN9KX!P+/4+9/^Q^F"FHD^-D
MT4V2T.)8I#H3BL1"WE3.45&]D,IA _/(J:!-!$A GU:1^$-'^<DT@0-YI:W2
MCXH$G9^*,.#D0(JVQSY+;H;6*ZU2KH8CWPZZ<Y=P9")/5<R?3ENYWCC4.%7N
M->. J]K<\]42@2AB\O*I//HW;;P?0G@S8K&< ^UG%@2'"MDLEDELK&2I4A80
MSS6W/=J<<J"8X_Y5]3W(*II,,.RG4E@53,!+G=AWBXRK@V*<=P*LO<+F%5&K
M\R.B^Y"&Y%EE\UR3\YL"81U$O"'@;64%MV0LJ+#L7,3B*ZPKEFWG)_-W#!E@
ML87DY%O,7T$$$Y6"X:3 ) G"0@:810G</4U:/M\6.&;5SS:K!O4Q,@%KD\LP
MDDO$'\P4"B>Y=3$9$]$A#%B.\D)E$H4I7([13-F\W2.5FI_%%QF(FIS4._KQ
MY/WGO[WYI':6O(;D&I$7<&B(0PKJ*87#Q!_"7^58E"2W!K8X5:@BQF >ND[G
MW>LS%V10FH!\Y2@#.3Y7%2FH:GM:)!Z=DW<_P_T6,!*&P@@"J=X*Y(Q]^67P
MV0K&^=)X#4W6N]++\*@)[*8:: ;%BS>I1.$GA8G*(34=,8P/K;$6RX4S+9;
M';6K6H5R[Q[/87\%[ =22>IR]0C%*L'N?$[%!0*471>CRY,E<8H.O1M:THD'
M&M/*<.6G#Y_?O/IL92# C4\DA[:"<WI^XL1R":P$W#9?M9VS\NN2&W=.U$";
MCRNGM%!7-FN!B5 T29W-JH)[O:%S*26B RT2JG/%%V.9">C5@0J46,.IC#HJ
M:$O1V'#"="HSD>*$GR[_'.4O.FTX*@^C%VI/YS+"67\&/<@Y(2PWJL[328Z_
MM,_:QBBI[LXL(7$@SY6)<QYA3X,B2K"*G&KDG:=OSWXZ>Z83**KM-YCQ12TZ
MJ&X-#FC8EP8*0W1W<PHDQ;!U7HI)F:,QR?0OUU>+FV@;"VMK"\8[TN! U80-
M:9&-)I,S(A,-ZE:^3<_),N?(]-@P1XWYIXL+2VQCM2&D7,,$J\2(PP$UOJ_N
M3]67W*WG*Y@M@#?^&N(0K-/7_,T;_<Q:L&_41:ITP'J+ZYQ@? %^QY<+LO[_
M2H%9<^5AK)T^CC^E*X96AP\BR3CO3D[6MM,8910^-?!V13Y/TFLFAW];A$'K
MB+6/W^IAA)KB60LA<!#MD\R2(D7S_S7U:&N] @61;W7YU0=U!,7)209'JE(N
MRX =PH@2L$:I9/+14!:6*=K!0.M%B!_9!A&93P5"_!FD@I=O/J:)Y;%KJT\P
M&%^'':ABJY2YJ;4,;/T6I2.IS"%3<L=USY&!#0E,-2[^1);U^&P(4ZX!W3R5
M%)"0(,;@9S1=HYVO;X!*BYZ)"_@Y)NBHU 0L\H]UXJZ>$G%".1VJPJ;:Y"BS
M!'U<@*1-0%DT]=Z,S^%21H>!%,6&#+1%R=>084[YAM!A0PTAIT!?0IP-Z&Z8
M$F6V\$BYYDRF<'F'7Z_P=JCD="5=@,G05M+Y97:<_<W/)Z?OWSB>960I=9_3
M DR*(JC<R0S.8@;GZV!F39'QIB, "T&R@#J,3)4*2Q)7 O-O/OW?'\&<Z+8<
MC"5E&J)F/:< 0PUGGSQGH=K0M!VS9+YZLEIN)L\8ZS>E*A0K;;GU6[GM_&PO
M!ID5[ULV/^WD?]-822&?\#;J'7+UYG4)"Y O!<M@?A.%SL]AI-RM"CON+YGS
MZO4_^O31$!Z;A],0=9Y?9?J'C,-$.1^>BJF$DPV!GZ>H]R@=D58MM()0MUHW
MK/0[58GM_M2.Z'']AT>/VPUY?-,V>->#Z#W6<//X<,+-&T]V_""XKML(E")N
M>OHZ@5:1"'6L)6UJF<GG^B\O=,/2,*8!Z:$7ZP6PM7I%V@/^NMQG-,IPKU5O
M5O5F]76;OJJUW^7ONOWVI-O;^G6G[6W][JIAQ^U^IWNK4:_^;M#;_LYFKOLU
MUU&[,Q[=PUQ[XWXSUV:N]S'7R6YSO:8+=JT/N0U@@+B^6QN0?U\=@.Z+IZ_Q
M+DH5C"C8:Z *9\_J#=MOMD;6:1YFE6N7,ZWRGSW*=KC!LG;HYWZ .]!YQ#OP
MBKH-/.(-^,%Y]%OPK\^O'[L@4%O02()'O $;)<$U.LU4^%_.4W3DMM0L?5_*
MV>S% 2D[GS2,7OWLKUNC,N 10@B6Z%"IO:.G:V] Q]FK;=A\_'^ZO^7;RZ9X
MSSZMVQNXP[[Q>3T _7$3QGO;??SVAJ=PA42[EN'K4O%8F6CS61X_$VU>]\3M
M= 8-(3>$?.B$/(3+H'?<A&S&Z%X_QK<1]=Z=[JB_?T?[ -OPPPY63B,?&VUY
MP[I[GML;#1MMN5$R&B7CUNON=MW1P&LHN:'D0Z?DL3OL'KG=]XC5Y=YX_X[V
MP=7E&WO$9_2_0_*(ZY+0K6;"5:RP8;G[1NU;5-N!VYGT#D>UW4Q7]RHJ:Z^\
ME:@\ /K8HK7UW-YXTAS27A^2Y[FCSDV]/,TA?=]#&G0>Y( >7'5HB&.7>&QW
M[(Y'@^8>;@AD2XAF[$Z&P^:0]OJ0!A-WTFF4I?T^I/'H<=[#CR"IC9#ZK*:N
MMS+E-RQ[WPA[BP[1!U.^?S@JQ&;Z.A2OYS[3Q[9TI?[@EJD S1E]IS/JN\/^
M3>W$YHR^\QG=5,.[FP-Z< 6B(8X=+N%^W^UW)LTEW-#'%G]ZWQUYW>:0]OJ0
MO(D[G-S43&P.Z3O;\0^C)SWX-?P(0O&?$P;YWVC$7[=.E8>A,&-Z<,(!H?&9
M7(Q#3<+ZUIS<N]^?/>&:S1LS[+OCWN%%5.[N>![8B_QH^?1;DR6/ED^WF-.>
M.^[?-.>N89:&61XCLW2[[N2V :RC89;CCD\.;II:?B3QR4:2-N;!=]R8;J?O
M#H>=QCYH5)Z]$(8-HVY-;AZZ_>XMLZH:;FFXY5%QRWCL=GLWK;(]-F8Y;@-A
M]#!IP ]N(%#@XT<"AO_K+H#Y>]4?A3JO?:JVI.9N/+,B-BW'J$^Y2/-8IIGJ
M-VSZZV1"=[+!EAJJG1-RIVET+7+9=OZQ@@<B&-G^.*/>'-2:%]N_AM38R/X!
M[$0*+\$VRJ99&75!S'+ZN>I!TFMW?F@[;RZ2A8P$M6B&^8=?ZX-1DP_X83T?
MTPEC/RH"F YLX 5VJ55?N*IKEG1F4BW2ZC[DVOV>N6TU;@5V=PN<!3;XR;%7
MYU*L\-?'VEP'FVQS V@\"6ZJD$K5U#&KMSO'%M% ".>I6#S?I=>*:;[Q?;LU
M3";M\:!WJV8-O79O</= _5ZO[=VRJ\#5>.J3T>VPW^]ILM=!R@_V:;(/M+.[
M[<$1 >!37[\HPGY"QXI[[[S)\G!!;> ^\D7K?%07[!G>*L>V[#>SF>3V=EKY
M^ 2+/[95ZL,U:[RF_N/X<:U5DX.&W(^7W#M7DOLC*/?2ILZ=(?7LLQ_LOA$9
M]]+'M0V.L=L^(,B:&^W\77C.O@6S:Z_]85LB>>TC K+?:R_=EA8:C?Q]7/)W
MW##<GL&'[C/CW#=VZ%XRSI;LO=&H?<O:KT9[N*\S:=\UE.M>7^$[9N(UDNBX
M)=&P?<LB]ON50X^@MDT%3Q\7RJS7.R2#_6[R)1['R78[[</+H=WG"WI'&_O(
MJ:H]>FQ$U>2_[8QCU7X8)-W'L;LHT(]/JMZT .DHC]9KW[+,]D%4^\.+1W[(
MYS)]7)B3@\DAW=3W!-%SE"<[.B2]_@"@?>Y2KS]8HNJWNX^-J!I KYV!0 ;M
MFU:V- )]]^WM/-#N'HQ>?\ G>\OFW8W+?G<XN@:&KL&9N%6RXGAP@+&/HRD%
M;MBT8=.=(I2@?#9<VG#I7B@<#9=NZ\W<N[4/N^&5AE<>%:_<.DSZ\)RR&>E#
M3WP3:@&O\'H8A]IC#=C!@97D-V '#=A! W9PK37SK\^O&[2#HRW_-J?;P!W4
MMJ33D/GQK-*<:0-ST, <''6-SI8RVWZW?4#]:YI"Q?LEA^X!YLX<9HUD W/0
MR%\,"8T;\=O@'#35Q;< (>]U;YN2U*@/]W0FW1N' P[Z#F]P#AI)A'?X\,;Q
MX@;HH $ZN'VVW_"0RF::NM@&Z&#/MOEH2W*W5=D=D%.G 3KXSBI[]\8H38U$
M;Y .'I58W5)*>.-:MP;IH$$ZN ;"S#M =W!3&;O#T?8/J4#K (IR&Z@#1$8Y
MI'JB!NK@.[LE>]W; D$W$GV7_;UML&.?Q6J#=4 GVV^P#AJL@P/)ACG:DK,M
M-I+;\0[13?[P%6]-;6C#J-\S3.D=DLG;<&G#I8^12R?C4;O?L&G#IGM!C0V;
M;LL,.:@&E'O#I3N /(1Q(./\>7=$?,D+O![C8?VI.SL1KZ./A$9\'H*Q'/I7
M'Y*'E?6Z0?E%UG94]^:;+F)OEG[E0LE_X*1<J>F$L9]*D<G F:Z</W5[[8ZN
MN7>=)'4&@Q]<)T^</PW[[;'^!AYR]';YR6(I4G@<?]3W-OVHXRS3<"%26 J\
M=A9A86Q\[LQA3C)U,BS_=9*9\THL\Q"(V)G!>XL,I^;D<^G @HN9\/,BQ:?@
MAZE<!#(++\*TK0I/0QA!Q'BGQ'D*/]VPNBU35C-TG<LPG]/K]"/6I$6>I^&T
M8"@2> A_ANR5PS*MK9RER<))BM3Y.).Q_.H(_S]%F-&O\/4?_#R9PH)I1T3F
M7,HHPC]%7+X3?K94Y=%+51YM]D<7F=)*5>IFVW'6R&W/:/&&;&@JYY$/=7WQ
MOJ_QUOPV'K>[%7X;#16_=3O]]LCF);,Q%8[SO&&[;_\,:3,3"R!?F&T2.)'(
M<F<E17J/3/CJ2K;;./&MT_PF3ESC?YCHG\:E2"/6@0\&Y@/B61JE9%;:B%-?
MG$O:T1-X?:2X%AY7S%UC:!=>F2VYY#]: 5N>? -7V]*A-C=\1,V %HN;4>ZH
M_<94E>17I%-]V^%W./OVNA39R$3=]N VEYTW?A !LZ8+=BDQ!I8NB/9?)5FN
M]OWK4L99B4+Q?4&G0$EL=TA1O#GJ%-#R:'SG<$,P:G]R#SA.@][=(V0-V\/^
M[7;@^\^UV5?$\NHW<VWF>A]S'>PVUR-"2'N-=U&:L9:6%#!4<'Q0:<IN>\38
M63^@VM= B-7=,H]O!QI"J,#K/>(M:"BA@D#WB+=@*R4\@BH7-.%MM]6=00@<
M>?SOQLO?Z_">Y[G]_N'E\N]-E'W71/\=QMAI3=_R@CL'K-IS3K]OI)A]Y?3-
MZQZZO<%=PU8UW-9P6W.O;BR0Z[C>Y(#0+QI.;SB]N5=O5;,U=H?CNT8??%3L
M]@@*STX6"<SE#Z'S$,(X%_%Y.+VJ?<.!8Y=LM3?'W='AW(M[C JU+V,<.)UN
MZ<7HCD>#AE8:6MFEWFS@]B9>(]/VA,8:.MVFJ7IN=]P(M<<0W/DD,RE2?TXI
MFH&\D%&R7,@X/U8XC2W*YM"=] ZH>FF/@8KV98P#I],M@KGKCF_KFV^(Y6B)
M9:MG>32<-$)M3VBLH=-M%O3([8]N"E1[A,3R"+R;/\E8IB(B95,$BS .LQP+
MA2ZVI]<=N(&U1=_LNB/O@/3-([3M&D? +OKFP.UT'P8=?F\/NB&6;=[-B3OJ
M-Q&;?:&QADZWZ9O]6R2X'2&Q/ +O)C5H<!)3C1[&?K*XG:YY .;59K'\M.>.
M.YVU@L7'9%DU9OA.M^>XZW5?-'9X0RT[2961.VS$2D,HC5AIW'L5U'Q+W?(-
M^(^L@?_LJF\WX*+?;7_V1(ILZ4TU<;WN <6R[OQX#M#8W+/"[LWG.AIN[QRS
MPUJO/> ;EWP<N^#[UIJ0HQ5\6YQ58]?K>(WT.4[I,_&^2?HTPJ71JKZMF>O8
M[4\:M:H1;'>.(3!NU*H].(9&\FU+;.AX[FARTQZ*C?@Y$/$S'E7%S^8F&WL&
M<$\C[E,O#?6Z/@)L+Q/&1G^>RH@2]DI<;<1\M9Y2;-$I'Q%3X( BW_[(&BU]
M=ZHAU/+2P<1;8?]WGNK)+,6Y;$U3*;ZTQ SF^EQ$EV*5/?FQLJ1%&+?L_:LO
M_<H#V/[E'O9?Z.[F^74";FN@R;;:H\'S:CU1NI,?W$U-1*P^!4%![0E0+JG6
M!&OOKW4R8%!_U[F<A_[<N52@__B"I.PTX+FJV<#V]B&F@0-W&, V#@CZ[Q=I
M"N>@</_;SF>[6\ E#(,-"D(1P=R3V2R3.2Y=.'_J60U=XB1N^2*;.Q<B*A@%
M0 2_%UF.15E.*GV\6@+=,2*?AVG@_*> <3'/8<9;"RN540@4*'))/TOE0H0Q
M[HMJ:_#JUT].%(II&(7YJNV<R4J'AS"&%2T4! &_:--S.(E[,1UN(Q*)"M\G
ML."NZ[P58>K\"ALHG7>P^06L'W8O:Q]?KZ'N!GQ&B[76F$6U(JD1<(TU-[!=
MVUE["[(%DCI*;!")E>]T/PPD^E[OAVV-@;HCZZMK^@-I;J_A8_AB*7PD1I S
ML(?XZ5*LZ+CQY]@I*"N6RRAD_C SK"YYU]X<!T0:W6O01*YOV[2EC\GZF5#[
ME/JY)-PEIJ"V/!%]GLW#)5\*N?3G,>S!.365TD*8NJ=L;OURM >4PW[ =1##
M1L*X+EU**3!.DGY!^H3-7!11'BXCY(7D/!4+4/=.,B!J?TZ_/N>2"CR-!&Z/
MW,%M_T*$_^G/8K%\\;J\@O$R<;"#3C@+?3V>,Q59"(-^V/1$2234WB@!'9__
M9M&,1065JTS=P5F6^*' !CK$WIM[=^D[N:0M(""8%CX&U 1B"CY5#<@B,>6Q
M-S7F.@JJV%XF8ZE3\D[9U^I^A&\%02'/4^9F/D>@!%1O@HK WJ30U-I%F0F;
MWD@;.K=9JE9)<=D<EM*:TM]Q83 ,3T@->7S7>7=[SJI]RO!)5* 6>"/=$4X:
MCJ_PY5:%CC5635CXQLUJ7V8N8SX+'[DT2BZY]=94_P[X5OCS4%[@*E@-58(>
M)BRS'(5> =N=UB=T<IY*TMA*J9!<A('2M-7U7NKS],P\B6"DS"F6M!%YZ%O=
MN-Z^/H$_!3P#1P(T"WL3X/I^QUYB\'M0JR4P%^GYF*_4[;PXH3^]%_A\*I:R
M@!$=G#_LK8Q]W*8,[%6AGF>;6'-3Q((K2(MSY^V'3Y_??$#&> UO6>"%UF,3
M [2.ET3<V")-R@!=+Y4YNR0LX?07H&4!F^D&9ZYS$ETD(/A18P*N 5)!A9T8
M-RNFBS#7$^&%X\YG<(LH'A3(;\"1F=Y&X%;X088BUY=IG*GUX*DESA)TZAB9
M'/:+#(IPL2AB?'N(>I?+1*6/^,KS+X]]\VX ]>'5A_^)$R?,Y2*K6#S)-9S1
MV5$BW++#VEYY?W9KX7@4 G%WWX+9E*ISH3<LNSR2<Z$WK#D7] 9^DW=!=3,L
M^Q=67 A76EYZXE6?0<:\L,UK,&H/[U#TUWP 09CY48*F\U&Y .YYLE=.[?CT
ME;MU/VSL8:HY\UL<$),?MK9(51X(_9:=7!"D6,/=CT:4B'6;4?7%3W#'"6J2
MG*%!7"STI4W]PT[C(!2@U,!.P(_X01C?AS]8?P(M1=]S/G O7&^IV1]Z+UR'
M\9K'[V@-H9W]%SOUO_T^#HP;-K5M/!O[Y]DPU&2[-CRK;7OCV[A7W\9=L_8N
MW@B8CE;@["[5C6=B%\^$.:-R_RM.BANIJM78U4:ULZXQP.G@TS 6OG *S/PM
MUJ31.9IX^C?%TWN= X^GVXZ"[VG:;&FJ3@1[RF3Z5+53-P68!]-.O>?=NN'Q
M5<-.VH-1]T#:?C=SO9_VU,U<[VVNX]THJVG[?5A]39NVWTV_ZU=S$9\W_8T?
M-1<T+9XWL<$C0,CZ2<#]]C1*LNP9^T2R>9+F+3B;!=Q\%Y+-\MUQ&PZ\8UW3
MF[)2)>-.>@<$Z'A@O?*.E8>:KH\5.V+BCH?=&^-D-43<$/'^K-O#:LE)(XX/
MD9(;E:92&>IZO4&CTC0\U-P&MU=IO)'K]7N-3M-0\0%3<7?@=D?C/97'QQ-'
M.44_G\SRW;'7]QGC=EO[R+W%4+H_L7H#..-]/M$MP&R3JS'WFFV]G>8P[FYU
MA31;>BO9,YSL;1^QYD1O!TGK#B=7]]QJ-O9VTF?H3B;W*G\>0<#0Z',JU_F1
M-=/IN_W>Y"BZ7ASX^6QE\>ZP.9^]/1_/'?=NVD^R.:/O+..\@>L-^@T3/?P!
M;1%R7<_M](ZC]])1'M# '3]D0_/C<1YRR8NJS'JJ-,YGKA/+_#@=B>YX/&S,
M^0,]TZW2>JM"VFSI[4(WKM<9-+1Z#ZK?P!UXPX9:[]CFF?0;?]Y]2-:1VQ_<
M*[4^ G^>0M?:7=':,39^?"TV[C:1[HA:;&QSE?9'MTT1.H#6&G>30W1\7'*W
M249'Q"7;<ND&;F]P<X]UPR@-HSPJ1O'Z[L3K?E.Z7L,L#;,\#F9YZF&@K5&_
M&D9I&.4:Y^S8'=R^E*%AE(91'@>C>$-WU+EE3//AF:7I_WC L*,(B3^+"H1B
M)K10U?ON?#?D$FQ78J'"IN&%C'6;&I\@7S(]X@PQXR\(,SZ9$9AO<HG(W?-P
MB3_Y-?S"X/^+18*;D/A?"#;V4J2IP#<]A;TIXE3" ?XA YX@#/0GST(_M=JX
MB*P":5M]&-?%#WME\P*KU<6S8\6-KM4+::QD^Q 9"%QEH8HTYA8JU.IM(PG4
M^MH0U#,W*PFQGPPC""-2O(49;'?!V3JR,Q61B/UCQ?NMI_IJ3-^,=JC3'@U^
M@..ACCL$Z!NN_]Y@+^M]->B_PH<-UF#KV&T"+H[<><JOT'#W=5#V0$Z!,+*L
MP%TGH.QG^NB!*7H.=G\H^W'F\U1*!Y@UGV>.C!'W]TPN<VH[PS=9KV/UGBG/
MG'IUKG4"41#] L@'VPW07)(BSW(0 CAA10SU;HHU-C<-%5^7J/XQ;/U.\R1<
M]%0NBQ1$%Z)/_\D;=-LJN&@)"9A\[(=+#.S,Z VUW8''AA::><@'Z#KE[N/Q
M%#(HSQ1E4:?=T\]PPY ][/W1=YU724S: *H89S)&)J>EWYA-OS?#.?2_?9_E
M%4E9;JU-F=6$I]OV#+UM9@F7.*WD.^(Y>*ZD4VIBHW4 Z[:V\,.!3-])4/00
M^=\&=7_UZZ=ZG].])>%C[&![0^7V<;2WHJ4>O'K;;??MF\0&Y=]%OQVU)QL>
M;Q3<1L%M%-QK%-R=]<;[T&^W\7G9L:O1<!L-]R@U7+O/I&ER,RI)1]UN,?,0
MK GHK0BS.8E4),4DCE7K6=-OSJ+?DOSMUF\W8/8[DM8W%N7>>(_:I:A&*9_%
M5^>EC.4LS ^Y:4JGW1\U35,.9Z[CX>W:<#Q$<X]FKO<TU]%NHQY/O5[3-.5Q
M]$IHFJ8T35.:IBE-TY1'VC1%]V!D[^Q4SI)4:G,Q%U]ETR[EOI:_)SE26ZKW
M!VYWL+=(H TL\YXR40/+7$]='WI-PY2&B@^9BKM#=SRZ&D*XH>0]I>1&J:E@
M6?7=7K??*#4-$S77P3<H-3UWTADW2DU#Q0=,Q<.QV^U]6PEVTS%E9^]2+KXZ
M4QVXEK7 ]8'B.&T#G'4'O09U[&ZI".$2FAXF]P,Q?@6R4;.IMVS+V.UU]M7(
M:,[TEBC(WO!J;:'9V%MM;,_M#*]N7-=@']XBCD=5%LE2II2-W<3PCMS&V1+#
MZ[FC;F]?;Z+&4;"G3-0X"FHJ\JCC-=ZNAH@/F(B[';??[3?B^! IN=%I*G[;
MKCL8-"&\AHF:Z^!;6A>[H_Y6)W5#Q T1'P 1CSRWU[EE_\4F@K?S-K^9S;"\
M]X*#>*G(=^J26^[O!HC$P_-2>IWV-0EP.R_X%A3U  O^X2[J0(Z7'OK==J^A
MA]O7!>VV/3<H,'J$-/C4&[2W^Z4:^GM,M- ;-??3=Y9'FV&8]8!;D$0. TKJ
M-TD@2$4N":RI+ 9TEFER$6:(]3)=.6*YC%8:T45F>;@ Y3!P1!P7(G+DFMZ(
M@$IJK%IXDK#9>)-Y,'J6,-5$O"+ J53F=EFB$^9RD3G94OKA+/0U8!7#@S%"
MU(8)5,%4\:4[ ]$0SA2J@3_0<RQ\?W"=5.(<\#71BM][(=*0L*5HD?BZ7]IG
M;6<F@<)@7[)<Y$6>I*MR6K#,+HR[E2S4X?01F&699 31]3R5D<#7EG@LB,%@
M/:707#KE(V(*A@Z<ZM9'ULISOSMS$_WUO.I6V/^=IR5[G\O6-)7B2TO,8*[/
M170I5MF3'RM+6H1QR]Z_^M)O"1I4^\GWYM!O)>0,CACY1L1YM'+"Q5+X.6.;
M6IF:"-X4$4L#=SWUGB$P5*\]KL*7X;O_!-?/L/9QEB5^2 \;5*B/,QCW*Z*7
MVB"GJ?11^ 8V/%0^#]. AL[@6_CC/X5(X8A)(C"RFLUWKHT%R,!O(*BF8AI&
M84X(A,*?A_)"#V^D1B#A\61)\\"WI?*\@!4C<\)"0*0EL*FP*:^E3SOI]#S7
MX,0%L$>QVK3*ZER6$-UGB+'ER*^^S#+:UTL0[3,119D&P10I4# APZ&\E7'&
MV'FPMB)"G"W^78D]RT"6R9)^);_*U \S.'[<!ECHW8@]1Q%*AP@%#1V6>*AB
M7"GOLAL+O-O.2Z8VM*[(\S2<%@Q_I8A@$7[%ER#>)&RC00W]'4@L"T*?+QTB
M3":7<HXX/X1,%'&YDF0VR^ D%7<$&KBWPA\*8_12(.'R@822+[;M#V&M/7 B
M?(M8IP3?)^)S0L*SKCHX_2#<A)=[M4X1!O_])!Q.@YXW& W&L^&H'_2ZHCOR
M@E%O,AT.^K.Q&/U[.'KR':799G0SY^?P/T48(*_B?KT22P1&<S[)#-0/)*R=
M%"84[P>E9IV0.-N*'8FJ%^,\$@2GA"VZ$!%"I+* V8*AFV,/7,2:['5[[:Y&
M\7.=RWGHSPUL)N-8C\=U-$K#PL!].+M(9+FS C[2(G8&Q)VD*/U )PNG1+3T
MP'Z!2[["+7L+S.V<%0L0%*M[GM[50)%3N&4NV\Z'(E5R:^4P:=,6:^)W5>=B
M$CYX^O,D"DA\P:]N3@FN,P<!/I52 ;[.8 Y97?/F2>F;$L[W'&XQDM'\3$U/
M)_T?,66+K+S7X1H$^1\"Q\XB^3548UU*N/Y8S"TD2$\U2GSNJDG27W'ZZGFX
M[O"! \8%OY((_A;"%9&B^8P*"^S.7, =S8=/]\%V2&3<I1_AKD0L7524$(@3
M-PX) 78:="2XU^BZ00:EW63+;5ID, _0/FAC46D13E: V48([/AK.F5UJB03
MS#%9MQ@3R3;,;H8-Y9OR'.&:8QJ<9EE.S;4>:IVG(D ;,UTF1&MKOUT4.=J0
MLR(.^ [UT?6 "BO>SH0M3%9-V_E-;20,#0I F,T1S1NV5.()J,N6E*$$S$B8
M7,:C:-453%:]=PI'O+HVAQP#^+3:) ?,JKF3B9E4MY5A7]*&0!VSWBY2;9+R
MN<-T+D)Y*5FW7<#'LY!9)!=?$/K_ A1RQ"M&'.!4XN)A"JM01FH;#+XOJ2EM
MYT0!-ANB2BYCVBO$,[?H@H4_3L<'B9[Q:]$.V'*'S$7.V,6^),6$*(?54E*G
M+?683/?8*98@*^#803P3FO12K%BMAI?+*,(_AU;S'])]6;#9&.T&NOU(A<!I
M[+P3*[C@O3$=E^)HF(@X/P?K YFA1(,6"X+91BSGT:!C(4"OP42WG5-"XOV]
MB/U\XR]0B94IR5QX;Y$1SN\2 ;O+7P.)^R0HV#PI@&0,?#>I%2@6_M2?6.<(
MI&LA_':''1<VT#I=4F*L$SY\(.T3]#70X.6$0&+]J=?O6:#)E<F4Y[@&CKR@
MQ@,E,#D)M 60"!PF2&'6N>"T6%##P'.R*"J[+HP0L,<&HRHISN<HT.,6J!Q?
MX [.4Z!=P7:(O6K]VT\%6!Y>9SIH>?A;^FX9P3-*\\.;G>PW:\S*+L >DPYS
M"7:IJY3)<,%F&?S)!B/\C;8:!8?9&6L]]BQ!RP#A,<4K J64-KB!$4%,*E3_
MC%L*D-:*+2$, +V:(7H00K5FLRJXB>7ZB;A.!$P8P6Q J*L^)311ULR4\LO+
ML/::+-(XH5<9+'-QE7H/#(O8^.K&R;4#8IF _"0]# S./))JP(RV0I\2\-,4
M+GE:)?\,YZDU?+CNX5\A73<@TY,(Q+J1QHKB47. 56JGJ2%4+0]P*GB'P:O)
M?;)%6FO[7;DXU&Z64]8-.JP6#M47/0I8^L.XF4#L@)422E25\/9'P@1E/F,W
M%.IAROK0!D*PT8EO'M&F.[GPT27"7K#$TO91'0$]$$B18P/X%GHOV0U(7)=)
MRGU<V"/@ZK]PSPI@ZB)%GE7J8WJ!/&VSKFO$:,#*E2]U8R5X$*Q:5(J(UDL_
MH)S!F_'199(S(REJMP2=)1*,BAW&(&-(UT1Y0&*3_4*X6>=*_X,1X,*O7C@P
M7?;/\[#F@4I3E.,DNFL\(&0DP64_J3;EJ?;^X1,^QZ.C[C.!HD?01-FL)3=<
MS1W-S60J>P]G!=<,RU-R:LP*)"^EO]_4^[8OC0-^EH9>/\QFK9>J[<G9'$WR
M$VR&Q-=H=D/GXG[1$0BOB+L%82.HV0SE@%)7\/1!K@"GEI8M_U98JV>JN! I
MQS-!TRBOVW<D)KJ=7I>T;*UM$7EB'$5JH77IO%G A7D!E J$*T6@HA8HK6!Q
M1)/E<:A>;NJ3V_3&H"!$F/E%1OX\]#&II>(P3_;K6H7K% 2;3V;]!S#4SZN%
MJ0]!-4_00F8U!/4Y115@ABF:T!8_WD0Z!D,&N8IPI_0KHW_6.I3!@K,"Z,'Y
M2*KF*1S,5]2/9^%7^#W0(D98T=8OAY[*_!+==;UVYP>41WWX<V]5)#!@6;BT
M[WMVU[$^WA%Q@GS?TFV=,I)O%0X'G68K'P$[ZA"?^HKC?)WM]^ZCB\EW#R<F
MOV'K,-P<SE97:T?[<FEO#5X<3(N?$8BP[NT:W%PUK.>U^Z/>@?3-H<D.=AUV
M0U*:/L<XB>7Q_O(0*B4FCZ)A3'V5C[!7QHVV8)=>&?O';P_ P_L-K[,;<[]'
M1W(]6/J4XBAA_.SY#J3P;<5HNR0QW[1.\B$FN7_$NQ<,,:/_'1)#L*'$__VP
M(6E@YY+,#4M_X+K;W39@][K;32M\H.J*W98V\%QO,+QA:>UF$K[7.O#:*W>N
M V](;O](KN]V^I-]([G]NUGVXK8Z//7-OJU.=?KA;6ZK#4L_,M&Q:85[+3J&
M0[?;N^EMM9F$]QFUI"&Y_5G:T.NYX\$MP4>:ZZHQKFYP7;TM$V8:X^H(--VG
M7M]S)]W![O!;C675T-LWT%MWW',[W@W@WAJSZN[NJ9T0(GK# TO<._0D_EO,
MO[,^_VZO7\U,O';JW4ZO/;[%U(=E'2>%'/XTLHL-JN4 ]9(+UUF*D':[[=5?
M;5*X53::E1')M7F""S]H&IY7SJ,RP-=7,HH$_?ZS*-(BJV16[I:[>CU(RAYD
M9W1ZUV>R'60"Y><Y5C!0(1T5C,8)5L;!6+!&G=>&52J8#H?DDJ1 K5C&Z@.U
M992':Q*A557!EFUR5 Z+S)%T\CG5V '%4F7_"2?6?9)8'U IA\41=>8EOH$2
M/6L)G7;"[U-&F%!YY+E)[P-.PZ3N"XD],M0WM2HH3.1469F4%2K@,$2J_$4^
MUJM02CIPF-3YY $5,=Y")AY =M^>Y#U?G3"%98Z@@C@GY0%]Q%(:VU0Z1+Y\
MI4HY527=4JU)%SDP6RR7D2YII:(G4QKU>Q&<Z[*?A:!*"@W3I""7LJQ8+!5?
M8M6'(/ 0'I9*L_!5R!^<$L]72TS!7RX!,:7?B*!AU4OA")B;'"49UFC ZP.I
M,V.1BQ:PF91K'7/YXN=YDLDK9H>U(B;3=FY*J:D0) V1$>D1Q"))X/ZIE&LY
M 6;T!GJCJ#:+P%Y$EL3TSS)KV@]3OUA@-9XO59U7P?+-WDQ=C$:%+@4576V;
M>)AAHD",9<;2A1]/?Z<-3D"L!!)SC7'L(E8UNUA%C#2,XO4<2WJ5 .72VPS%
M;13 QF(MIY'0T<J";3 3P1VG!5PKV/7!:B:RI)PA.*KM*1>9$6 -'$J@Q?T-
MGJY 1^PL^Q7JC1+2%J.?8>FD2(/,^649K+_@%,C2 4$+]U& E<E!E8+?&@H^
M*RFXM8\B&13HER(+J63F(Y8OQ7E9QZX21:F<IL1VVB0/W0=%PK# ;X!PDTL&
M2DM2!7+C8/>J76OLO/ZU5M-N&#BCSCH&SC7W@[*-6^C'>#[H:^>&FEEKT/\.
M5\;FNY#HO=>V/8CV?_]9 %U@%2^"(B#EP >1_O=K2V*+*2A\6/R");2?PNS+
M<8+PL(!4!;PHGU'VY[9X5-JF+G>&G3 U'K> 7\,R741DJ8E/^Z[40FMTHN_]
M=0%Y/V!0H]Z3PZ/U_E9:)Q,DB?C^^8C@!@%N\-4DN:'4XC H&5$[19J&5(^&
MY>16-;QKJ3A9L<12V4Q?'0;'9XE6#KHO]$7+9*_52=M-@=^\FH=RYKSY*OV"
MA,<'JKM+&<*+OBOO5O6=JZ]O U(7J\)Q'+#D 2KJ-">W-"?GVKA[P":(5Y Y
M7D^TO,%3^8Q^[0T"]2_UKK,2!N7-5V9JN!?)L^)->OTVWJH:00!48'O3;KE,
MUK=@#82,$Y0%U=>O\&K4 )93%L)? L*&AJ-7A#'<I N-(4@60J#J6M6;.6VU
M(!G#BGT)]C(+(S3L408NX"8N">::#4055X,XNKP4+$A$91=U$J#@0.G;RI!
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MO@?E?E',Q_ 3\0_UL=8"J2+84DO0AG]4H 36#^=(/:D_:7<YJ]@J:YL]G[5
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MUR20YO\WD$T7J*6=(T@V,781+[$LP\_UU,)XSID#%&S4^V=K,^H!7/]Y(5#
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M%?(OL7T]6%I!A>T1'@$C<Y3N8/9+(R& A#8-)S0Z115DR&@.!ILGE:7JLFD
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M6#%$>,A23]D$J@ASP]!N;3B%9J"P<.QTIS)#BSQ%5SUMP/V+.!*7E&NC:V]
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M0R(\AXI'\%5$F'.PR#L\?L"7"*;NXDZH=)#!< [Y;[,#P1(OSA\+1FQU3Q4
M.O2GNUC:?$6I7)09^B![8!=7U=IA;W(U6 SXH\/5D*SDN9<@<XBV"GWBCO69
M6C-%K"H&?(63,<%Y'\[+1&&V"V'#DU?$>?S[G)ES^<,*%>2.^6AI,Z\P5)?"
M42'$'"1BX[L#+=_&5^AE7__0?<&/^+S]3(0%G$>FZZ*;@5AJ>EP$Q>0Q??$^
MV6#0F]]R)74<X@?T$UY$I82DL[?RW?GTJG[55#O!4J ZN,-(H8/I: Z9!EX5
M$]]GZ%:TBG)(--%N>''.R%_"N(:L*C!<M^,+(2L<>0E9 =CN&>AA_61&UJV<
MH?0@P:;6D(HP_Z9RO%=)ZG="K^.$J$1'[@5?=(DYSVI2,$\\',$?+LLHK1CS
MK\XS<ZSON/SE*&8[^0#:YA_W6&BB??8$<]>M:Q4[DC#>$=*V_L\/O6%NWZLC
MTM75A!?EW5.\6T!=ZDHUU"$F?AW=L6!S78?[ E]%/)[3!PAL,#UUHD<P&9\S
MKN[?#HATZ']B)OI(9UA_Y6(57X3XA=D0VL$<,*,;0PRD5C"!9T7ZW@-B'>23
MO0RU:EM6=.H^9X@7 VKKYE+W=1;4K7+;:UJAR[KLXCOSYE\=/G&I> JNS5WZ
MVS=@;-Z3LE9I');AD\LL&B@-HW;BU&E^+/@QW&AK?<,I=>A+0=UIHXT.?B)*
MXX*MV^Y7!P1?K2Y3 <./+DMD+.3(B5^%A9^P_1Y49WFW<V@I3'\BEY)VK*?M
M<Z5"^K_!]*M[S.61-%%-W6^<^&=-:#X'>^=+3!N4T-JZM\UTH*@"D=-:V]G
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M.!F$2W8S]^>^CQY25JP1)7:@@Y;UMLMY2,L_QLO#E\>+)<5A%T4;)^>#4 B
MX)9"L.02(1..EG!'7GO*#*7Q0:<^%56;H!M2ZJRQ36FNG-Y5>!=G*K2P3D8)
M:"N5-2.A&?TK9$_AG>12YKP#M_LA5'F$^KL65&FHD"ZYUAN(8G!<"ND ,X49
M2AH'3F8$=*G8HCDKH4^UU5VHAI1?:TR09LKH69R4<F&)(3G0P1!-N41PWA=
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M?_:':3KG?)PFC/8H-0H=]T \F^9] LI19A1KHM:B**-?CEW>87UL!>DTN7=
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M"BPCL,@2<=*B U]TQ82FR;;KS/'06_:GU*Y4\(!&MY=?U_-SWAKI-<"UC<7
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M*%$KP>!LL4*B"&@$;B&94">/J!6\TR9.]QJJL<9<CB?-1>DD/FM1-?[<_[*
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MB#)Y1Z+4.,.243BYF" LYPC4BRRRVL- ;Q#M?QGJ@@/+FTDG\JYPPW 7U[2
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MOR]YEK]=%O\[)I.CDPY]':G@0J33SQ3(P491, N6M@9Q[8C?/>;MPWLI(T/
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M5W&#2LI#A4A2*WEZ7DNO+A?;Q$4N,\L"C*R3BIVUX+B*4)2)+@?ZCK?)46W
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M>5\R'E5MV#4;LU0;M-T8+]*%IZ;M=%MP=9P.N@> I;=,]IXU_510C)I9ZT,
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M%XMX2LQ4R^U5(),+X_F$O,N01)9@2LU@8CX "J>!!^YDC((K[#8FY,%7_30
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MQ.4@1&C JR@:0$]4;&!D Z2U)9P1)NS_9DTD()4&<.!V3V[*!LNEO':W*I@
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M3'^>Y^IN0M0;G!+71A]&>!,QC0/.4["#P>F.XWZ&K]Y^]<.E%0-A-DH&_']
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M;ASX3A4"/28,":LI>6X95OF-UN46QY65WGZ)3 U+:UOU='S]0<LG!LY4(TF
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MLNDEO[W-@68,AIP#728+PP\U#%_$9+M;1_/8_CC]H3$KSR.R;=%D)LO,L]O
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MC_>@*E,[5:7Q#Z1F7))?E R'T''Z"Q7E=KBSIY(E@K\7+$CD$(_@ODQ-B;=
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M>-5!"6#T+DB+D<C_!T_R$"#5+\:^(: LJ.53Z!U:TU57)"NR03&18+KR'-<
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M.D"'C)I1;_J;?%'LQ"ODX6LG1:O*XZ7<<BZ\Y>#,']%7C 2(G[#+YCH!P+W
M,"('H?I+X8KK[:G.FFL<%-$+-4\.F/NWGV&I2SHG'O.,9OT8ILG"K^QC@JG,
M)^88SJY3]^_?*(@\J$YWET%E0>X.+,-" I\]+DWF&IL$5NYXO03;4UCCE'FA
M[!?^H3.)#!FOAX,/G_?[^E;XZ:9T(Y8H+1_H8<:&,!K'LL^7Q 8.W>\<:T9?
MN=94YT=#]ND9#-B*XEKG#@,PX2'Q0%YK$MD4E?6"HWQ.H\:VGY?R];;*+NCS
MB5T06:6$@-@%I0.:_8D*8-7$SA=!M0SA1XGY5"9='*RQJ[BT%G^T2O-.N:+N
MH=OOE-=95W9B$-Z)37N=,A!1S+'>TG4,<=!*CT+K!-HE9C4'*K7K)GA^_3?U
M5'N-DH\:+T"Q[((<'$^64H0780+$=,G4-]U9^X? NZ"L?A GK\*'K-GW];2%
M2$<$@H)%2E"[\.VND])<HUJ9EQC+D[)1:8-O=D$>L:?LH)N=Q1C^K'1P#K(;
M70Z.QKK .4^F38Y<;G.YW33HE%#7;'L# FZ/$9]5&0FS[3X'@DC_IK$D?">R
M&X6\IL"1KO>A!YVZ%WTR1V?-TJ$>G+<=;GA?O7Q TAMDPO(?,^WOS;0]CW(P
M'C;1\A2/FI@MF8BZ^_7:@N)*QN#7[ ME(?+'ES_<45]64\G'.1 >$?D*D)_&
M>,LZP"Z.R/Y7^E<4 I_JOC>0^9A$Y;D"*==6#@+^'2("$%$[RB,!0CS1(D42
MMY(:WY+"'IQD&W7O:.Y-V0ZP8*)1HOJBE7LBW9DZ<D!Z(&,<@TAT>GC1;R]0
MK+0ZH6'Q^'B"MD-P4VR; )?W@&#(WIEJ]NLE05'USG)CH9Y]59!F 4LLYX+A
MC7.;SQ%"%^E79G,/.0BIWLK?%*N<K&5+CZ AK>"T"/E$7Y+&PH)\$-DXT_G+
MFU47&>FG#W@$5P/PA[?F;I\;3]XX0;U;N"I6^O)(V.CQ&]?GYR^^8;W+()K&
MM80"MLHM)A++?#A:1712.LR$MWBF^8$[8?[Q07^QB1[(K1O9 !7,D\!7: %P
M\9[LV7UH\"PV8Y'%7_ZK(V'QJQ=E*'5N83CR:C\69XZ-]KK#&6/:Z?I<84PX
MELTM^U/LSI69Z\@64Q4\QV1'B"K;_*<<[XPF?M6 FQFJKI0A->B@%ZO9#DV<
M"Q[>,@;HM6@8ZR''-:KH4J>H![]78C;T\P@KM6PJ>>V1--DP5\<W=\S:63[N
MV_K(I>Z+NR"3&SK9'\ +<RM2P'8TXBH>IE9VU_([&7EG7*F_VK/6M5)*?%XB
MZ<#>OJ%JMM"&^3P6C2Z% Z3729K[I4.+Q<IH\?U*5LUI,>YP@Z_A1QI2%SKM
MIL3B/[F?,=+^+;N*Q@H=BMQ'3&S"@I4O3 T46$@S$>^:N<Z]2SP1WR'Y*((9
M-6J#O6<;S-M&_P1J#KPB)' (8!Z888D6M$LU2?/IN-6)ZW)2VB?Y)T(@@^,=
M^\_+)$R+*"@<,:Y=!SZ=05;I0G("7SGKX0;Q]M6O^%+J>L)5E<G%D8>)/P(P
M)]B;IA,4)'7$XG1>#4 ?_V\$,=#NM$.?\=H%<9K-YF;7<P59G9ZF_E50ZV=#
MR*U.1:\4'EW+6*.F.^32=_H8F$_"G4^0L #OM$*I0FEOH:\0^\=)CD7V;_N6
M,RZ]8$[JA,S!._U^CV+]>]+MX,_AN*L&Q!/BA$1"3",\I"IF1_Z3ZVN7A YJ
M=8FE91%5.&T:ZOO46M;\%=@2$"ANX!67-N,6_2[489E>IU7U9TBYY;KDAT;H
MV3SN4A^<$6+ZEON>[[;1NL#5WI,>[RY.?B-,^K:W5_([S:5<$(M7$BPY+6P>
M)A;W0([^^R5:935,XWH.DVX1M^Y#(0L5/K7%N1\.EY>61];$55B_] ?%Z8-
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M.Q2N8'BNR9TEETM_[C&%B?&<R"JTQ3""&ULY,ZJRS-QGS&[2*X8RM=2X]8N
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M11G%-CL5PW'GMH9L 8)*20#*C0@ :\AV.P]3^LWV$".0.O+:H!&#+6308KX
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M8A0)7S *XS! $"5!"%,2"L@P"0,N,$,!LBKB,9BR20Y7-;JS"#-3@\-I&-L
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MDNDCM%^I.*)I9"4RB"%CI6' P0$E47'Z^[OBZR_RZD8_R!^T6M *H>^>DR@
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MM2H 98U@;LN8?(B195]6:]+-3H!&I7+D!:C!?K%?[FZG^T5= ,)U3= +H&0
M6@B'?5V'\N>VUZLUBFG[OPXEZ45/V,$W&J;JUN=>G,E-PR-?57JUOBQ+555/
M#?;F>?N5=OS+;[C4"0LJW&E=]JK)GKJ]QZN;1QW6^[%8?95[#\X^/FD#)>#8
M\P(J8(B] *(X]F'*1 AC*@E/4LY)Q!=2[KQ@7VI<UF:*<C+\-EIA7XKQ%,0&
M),"U5 -W^4H=:.K^!QH#^%D?N%>6)^[3/149123&)()4!!RB!'-(0B'4HR%8
M@GTO\;+VJ7BW,G3]S_B96,LPT1/!I;G[XSP+9NOY+&=W9#M "P2)D@ATI08=
ML0%Y!MWOM:(#+?L%:*3O5)FLFF1M4$L"0,N 3NQN.) _:A;<&1*33YQ3 V0Z
M]),:+I-/RK[!,SV @8E?."_U/K33.^QO>7W_ZZH@%2]U_PG=2TSUHY#<2X.M
M26^2OSZ5I5R5=1.=C2VG[[5(?(Y12F*Y6\0I1%Y,89HF& 9)%C#JD]03@;U1
M- K6>1I 2E3P59_[R(5NJ0X"0+C.-L-R&COZ#NO&4&\YU6<$__8O?NS],?0O
M@'SC/<LDM%$>!NR%?AK[#":>JFE(I7&<J9A(:1X3H4"FQ+>UA6;R*(QO]]@_
M"%^D>NP^"9Y^$OPY/ EFEM"KS^W(5H^>4@UJM\?G-RDCZ K9=/W4[9LZ8NH@
MR49.'5)3=8Y-FMLZ3)\<<RK<IEV.@G3:=,TQR7Z1YCGJ8/;IH6];K\JMO'21
M1!FG$2*0"2I7#!ZG,(W#%$:![X<!IXQGPC0=M'OCN9TFK[$!!<X\V7.'JWZ=
M>@X#8\?3& EOE;IY2-)!J9H[-YHL-?,0_&XJYL'/AYG]?^9+=EO\!==/I7QY
MOZAWNHTG)G7[5_G;%_F:+_GZ6V]QS2\?BK)6D<M7155K#;#@7D1%J@H]"96C
M&20$IE&,(*,JPL^G*:'4I'BK>VA6K_M455_M[#"'\V1F?+T.^V.K&M6(9"O+
M!5!2PKJ :PDNP 8_4 )< "SD @ NE\OBFZY5H?SN5R5G>0T^%)6\1>?2I=9*
M;59*0\WF8Y6@[M @<S\]3JTPA_ F-;W<T[IO;XTPPNLGQ'[D]2(*TC0D?@;]
MS LA\D4,LX@$4&2<>"A)8N1%-NK?,;Y9K@% /I95SK0S=&B/%E?S9[8LO.*L
MC+PVC%5)UD4Q[I'9GVT>X<>IJH:/3/"HI5X'5RS746@?B]45KNZO=)O!Z]6[
MJLX?E VS.1>X$8<"U:J%.K05A(;0PSR1^C[R81KX$0P)EC_[D4<Q,TMI/PN'
MD0:9-#6]$4'5&N%K(8#8.;VEVY!.Z[+CYTU:OY(??R*F4>5#17 4+GLN@[VQ
MLH-O/EV@[+GR[T3)GGVS@7U1\PK?W96\J>%X(]J\:MW;;=OW+B 9YC[G4,2J
M7TT@M6&:9@GT.0H1(3QF/+'JBVHRZMP.+[N]!UO .E9##V#9)-6(=3-+U3F7
M8Y]-[.#MDCEF1T$KEMQV234:>=HNJ39DO.B2:G7Q;*-9/Q?+Y?NB5!<MDM G
M(O1CZ"694F](0(R\&*8\B#S._91F@5W!AVD%L'F[IZDD\5E"+'.J3,(OM7P>
MFN@URQ+!$S\%9NIVOC,[LMY^Q=A%'>6A8U[!;XH<T++C<'UXG6G]T2(;NR+\
M=PMO/# ]KQ#C> C%L#7T3SA?[=30_[!IGN(G!#$N'R*6!!BB*(Q@&JMZ?:HJ
M28J2E 56G6N.#S4W&UXAW6L;,;Q-30_#9FN)&]Y&UOM#*;-6P:?9<*HN>X:;
M5+6=%GM?#1E<\?JNLNM5+9^B7'ZY6J0!QE&0,ABF1-K7'HHAB9,01B%"(1$I
M\U-LHV]&PCDW9?4^7^4UA\O\JS2E\@W.MH'N#.K!=N=X>K?:P)G[,=UK[;/P
M03\+'<GGZ7,[,#6S];UUL?ZP/K@#A(_IBSLTW- .*6V-S\_\405^K.Z^U+A^
MDC9J)GB,B0<S+V$0$<)@EK 89D'",QY03V"C(^=3 \U-Z3=8-V5]-VA! ]>V
M0\H1=ONUM4O.1E:W0^D:T"&EGXLS.J0<N?'$'5+ZQ7O9(>7$]^W40576BZNG
M!U7W3*YP[X3@M/ZD,XYNQ"4K]";YDOW?IZKNE$HB&8T]P07$7D0A"OT0IE@(
MZ <>3U*?\909F95#!I^;VMCB,],0@PCOUQICTSBR)ME"!PWV"]"@5Z>/:_P7
M8"O!Z<I@QDKF'.KZ#"MYWXY1)7_;-Z@&#3R)8CJ'DK6R.NL>P]NU-B4;/^%'
M7K8O3IIA/_0QADD<RPUP&J0PRQ)?_B3\@!$2DLBJK-3!4>:FDCH%8A\52KM]
MZF$BS7:99],SMJK9,J,!.M0D1A0X[TK[<J3)N\\>%?90E]GC7QX06?BI+"CG
MK'HO<?VZ^I:OF+2&KM2!OK2+Y!;I3;%B?^;LCE>+C,KM"V8>](*,J"HY'L0B
M"F @$!&,<H\$1A:+Y;ASTPQKY$!-)7A:8U?Q@FOP@$CTX%[#MP@8M)B+?E4R
M(L,C*Y==<C>P00<W4,#!GT<DUZ**Z3@D3U2TU!79=H&7]I3UAEI:W&ZZX$I[
M&7?"*0=<[LQG<M5-=KDM\:IJ>M;X"T]X,4XP@C1E#*(H89"0E,%4!(*$@D:<
M6L51V@P^MT5@!RBHMTA51+GV;52YDVRAX],QV&?AA.17<43LLMZ!/JHCX21?
M8WL'C@-X[2/_D]08G..?OL? X'!.ZFW0RF?.^(/>,S=[Z-MOQ;H' $]P&GD)
M]&.YQT4T#6#J40HS' CY/[G:^%;Q)(;CSDVCZ:SK+6[E]5LCWYPE2?"6H>*&
M<V"FRT9@=F0U9DCJ"%MH2Z[<!HT;CCUMV+@=(2\"QRTO'[ 5/Z ;FPC2(\DS
MUU7UQ)D$T'H[N0[?6R0L0[&'$I@E7'6Q#0@D'/LP15GL)3CV(V2DSQQBFINN
MVP;F7OWU<P5R#5IW!FS#4GC3(M!B>^EH\@SV]=-/R:O8>ITY.MA;HP+7VVE;
MB]8$6D\_;18G!M-/WT2G"=--H]UY@UO">\\B' TUW3F%6VYVSC <WWK(T?8]
MKGAX)3_.*5[>EJH366-N8IK1C"4^Q!E71;!TP5LOA8+B*!$X#L(L,C_)/C;,
MW%8]#12$8 T5:*PV1ZA'"34YCG9!T]BGSP<9&M)$ZSA5-H?++BB;ZBS9[N&R
M/#(^143_"?'1JR<\$#XEP>[Y[\EO#SL2^22G[*.<Q,OO>;6(*/)(0B)(A$_5
MN4<&<8@(3!)/A)2F<A.1V9Q[=&\^.]4G?P,*'/A-P;-,E=FAS>RH8B@98RLX
M4QZLSQL.">ST4&%G@$E/#@Z)MG\\</ [ VO\ZVKA7#==TJ;1C?BU:N*:%VD:
M$TPC#@G-Y-Y>OJ?2A!$)3/TH]'T6)7&4VKRS/6/-[15NH"KWY%*A!:6""PL!
MGZIU4HEET?0>GLU><D?LC?S.MRC73=L^KWF34)L,CDWY3$J;<#.Y&VL+&?97
MO+,O4'Z:,+=EQGO&F[98^&G!7Y3\-KADP*;H"U]RJ:-:8S1)(N:G'H6,J8Z1
M21)"C#"'#%%*<!H(E!F%]KV\]=S41PO.PH3?9<I@AS-8_I$50(MKR#9FEP.+
MK<M@+B;:KIQZ'.SV)P>E[=V3[%XQW3[D(-*=O<?A;PPS99IDK$T1L+=Y19>%
MZE^PH#YC$0JDY9(&&412S< LE?_A?AJDJ9]BBK%=T9JC8]D\?=/4EVF@7G3J
M#=I9+L=I-;-;G% ULM):<[1MOP*V.-U9)">I<&J/'!]M4FODI-#[MLCI"P98
M(I?_S)_7_O]0T!@'B$../*D.0D] S(7<YJ188(]A::(8G47LWWAN5HB&9K'^
M=CDRL$ &2C[VJ[Q%Y6B]/2!G[VK;_?YT:^T!E#LK[:'/SVP+V/0 ^J#ZCOGM
M8\/3B"2889@%,8>("1^FB8K?%!DAGN^)D#"[E;9GM/FMM1I=TUMM:%.U Z0:
MG@^X(6KL\X%.@[,&Z 704($_0ER2 2?C=!H[,-[K] L[+OC1KE\]EPQ3&!]Y
MK>KU?BJ+KSGC[,WSKY6JBW"MZWCEJ[M+6N=?FYH)I*I+3.M%B..$T(A WP^D
M]D@IA23@&:1A( 2*1)@B:J='[$',3[TH 8!8%M_:)(I\#1[@#?H_V.F= 7-C
MIH[&Y7MD+27! TWV&KZJUOBSDD!R_CNP$0)LI0"_K>5PJ+^&D^A4K0V ,:FV
M&T[3OA(\XTYG&E.=RC%MVT5VL]IMJ/BB_^)N^\4WSYN.BU=+7%5OBP><KQ99
M0C,_Q!AZD>\ISRN2&QU$H)?YR"=I%#)BE5 ].N*Y;:,ZAP)2"VS[J6K(X+<&
MM*63=_QIMS0:YS"9DYF>@^9QN/$Y-K?CF+"CH7X=0WCL23AJ3H\^\+"%1Y?5
MO7G4F5#==4TM?^^EB:EJ%.E"O0M*HQAE:0I3YJN4I22!)(X%%,A+/,]#'DI#
MFP7$>.2Y+00:N)V>-V?93%^/PMW(>K>I6[X!W;&9+QHC6P$'&^3N%+ U64X5
MJ?GHDRI$:U+V%9O]#<[H^*T2-/.F_J*JG;;@2>*CU \@RC"!**09)"2)84PC
MCA).4$!BZ^[?>X/,3>ULFV%O@+;%^P:T!=\GM%_MN*)I9 TS@*%AO<./4'!>
M'_']FT[?4_R(6 ?[BQ_[[C KY'I%BP=^B[]OO7R6YTP]=YC1$]J@!!)FQ[$\
MRI&1 1].E[F^\29=V P$WU_*3"X9X&MN>H%7EX^/RUP9^Y?LJPJNJV[T.=)*
MSM_S)_E@J;#[:I$@YD=9P&$<1RF4)G4 TTA:UQF/TH@EF!**C)W1-B//;9EK
ML0/<@ =2A^,6OOHY7PL 'M<26+BVK:;$P/<]%M$CJZ$UQY=;CB\['&^P@T]C
M<VP1W3<6UQ,%_SGDW"YN80AOO8$-5C><+O)AB)P[H1&#;C P1I'2\HEWR\2W
MM:$O5^RCE+7]96T">:&7T!3YD(69!Q'C"&*>AE#0C'@L9H%'/,O 12L \W.!
MMOB[G1\LPQGM9L#,"!V/U9$7A -TCF*5#B/(;3BD'81I8R0'T?,B<'+8708G
MCN4UUTU6MBTNFM#-#YO>7B(.D(_]!'HAE<:MB%.8,>9#3A#UX]3CG%EE?9H,
M.C>[]D@[FG4_F^$]U8QFP- -Z)C7L3UY#B@=DDYFS)'KO++3 T^=8&9,Q8%,
M,_-KAZFF;A.>%=--=>^+I;R^:II++KQ ^&$B"$1^K&I+>PRFB=Q]QSP*4TI(
M("*IEHH:+\W4TJD!K5329MCQWI];-098=M9\U4RKZN#^GX!KY'8:Z23Q9MK(
M)9TC:Z(/>QR^ZV?-6NF84N%4X9P<=%)E8TK!OJ(QONX,__E1BVL1A3[Q8^K#
MB&<4HCCU81J'7/W*@M#/8A)'=CNW_@'GMU,;ZBT_SJF%B]P)3Y/XQ0_LP"[6
M/;H<N\)/DN+>_WU\R.F=WB?%/^CI/GW5T.XW*[T-^UM>WU\]R;7W@9?;,)_V
MB4>>'XD@2:&(DQBB"%&8<>S!)(PR06B8A&;N;IM!Y[9_>LO;6N<E_\I7MMFK
M1C2;*1;7Y(U]UM_"!=\D7K &?+$-?!Q!S=A0Y+BSCL' $S?:,:?B9=\=BVN'
M),.V.DU5^]BZ9+Q$I!B%&:2!RKFAH0=)Z!%(5;F?S(LBCYJ7\CTXQ-Q4RWKM
M%7O5?A[QLWE[P!Y&#1R)9_,TU0&Q)F:(6_ P-1;^O[,IFLC19TN5919R'PO]
M^<@'KYPP,[D/^6Z.<N\WA]E9NK#K&WDC=E4\//)5I9^"R[*44Z?#%*LWS]OO
M?&K>_,MON&0WNN1Z]>Z[:H$F@5RWY=?_QE6!),XNY3X*W_'UYY_*7.I'Y@D6
M(!K#3/BZ%S.!." !9%2JSS1D)$/<;M\WK0 SW$<V4@#>PF3@YU^_O-45G'79
M]-_9&803/P]FIN5\YWCDY44+!8F2"G1%!UW95;I.]XNM_$ 3< %:"B[ A@35
M%JFAX0*LB0 M$YMO <V%.]OW=>;0J14]L0B3VN.O,SW[EOTKH1@8K,*8CO15
M[3]S=KVZPH]YC9>+-.8HY#Z!6:9J^0H1P$P5^6"^1W& 4. 'L654RN&1YK<8
M;8'*34+.H%0TM,%J&85RA%JSY<(!76-O&[8\*8A*(5^=X,D^IJ2?!;?!(T?&
MFC9*I%_@%^$@)[X^T+G*JXHWA4+?\HJ6N=9+MRIU<8%BB@(:<$BQ4,9O(%6$
M"##TJ4B#C#*/)48]>PW&FMM10@/U8EWWM@,7_*8!6P9W]-%LZ$5U0][8#M3A
MO-D[4T\SXM:/VC/>M"[4TX*_\)X:7#+\Y%''>UQN&Y=VW*9"A#A(88)5>\20
MAQ#31$#N"8I8)J(@-.KZ:C+8W%1(!R(H>5,9NQ.C87_D=I1E\W-)%]Q-=$*I
MH8(NUM,.#GOJ[,\M75 X\0GF$"H'G6:>XL;D7//H/28_X3PES:&SSI/7C!,"
MMXEOQU'(!<(4!G[L0X22#*89P]!+$HY#SP]])NSV<J9#SV]S]^'Z\LWUA^O;
MZW=?P.7'M^#+[<W5__[SS8>W[SY_^9_@W?_[Z_7M?[D-B+-,,QB#VK'MNX,!
M<J/D&-BR,VG,W.OD%=A28AM#YRB7X#9_R%=W-V+=C_M&_*DHV$WYA9=?<\K;
MBE8Q4DUGA( QEF8AP@A!$N($QCY%A"JG=6+41\]JU+D9B0UHU>%R#5O]K(!+
MQD$+?6!1,K-I,%-5SLD=64\YXM5::5GQY%1CF8T\J;JR(F-?5]E=/$Q1O7MX
M7!;/G+?W/'R:ORZ$\TX(3G4Y255$\K;XPNMZR?5A?K7 )(DS1#S(@DS:7:H?
M:$8IE6HMCH/,(]PGPD:9.4,V-X6G*T35!:@T1O"D*W'R-EL!%*USN.2TN%OE
M_Y0?X*KQ"[?.0MKU*O+OZF?+$$)WDVZF.E]E*B?T\V[<MUNO5UL(3!?8E7/=
M"-'X=]VI6N>\.E7'[M!-JK*=D[JOUMT/8*?ZJ[)>_"5?Y0]/#^OV(4E(2,Q2
MZ"=,JFZ<!9!0$<$@RY*(^]0/0Z.*+2_N/#?5VX(STY8O>>K7=F=)/[*V:G$Y
M;$AP5-H^'2(OZN@/^=N^[GAYUTG>_:/"K-_=XU\89G:]Y:2^7LFMICX$O2JD
M#5#6*F_T"I?ELZI"^% \K6II^]WS9F.JE$.QTBD4?H 921(8!6D"$8HXS&(_
M@[[<-8K,#UGJ^3:&UAE8YO9^KQ$W7<'4?J=)^M0VDT:L_E;?<R"?NQ!\+&K;
M8AOG3)R9L331=(RL<)048"N&-(>V@BC;J)VG1A8U*>TQVD86=U:2 T*=VD7G
MX)G4$G) W+[MX^*6 YRTFU23]T6I4E'D0/*.NIBU[@U;J5'PZOFJ?*[J=;/X
M!0JR(,0^A0'''"*"$XBC)(1AC%CLH8!%@7DANT$09J=?-\!W<NTA:%%;N"6'
M38F!GW=THB?R+SP#*0#H,-X4^F]D *T0%VOFAW2G'38%%O[BT:=B(B_R6%-B
MYV$^B\U>O_.P.T_GC3Y+\AT?]7EW.K,B,*\^<\ISW11A00)?"#^)(&'*BF><
M0Y)D A(?>1['PDLRS\:*/SC*W-:/MFAPK5"J$\X6IIT)?IA/,^/Z;)9&5O[;
MJLJ2H"W"$1*;>YD8IY[RSDBO4TGYD+!':R@?_/(P'?#FJ<I7O%+JA>2KYH1O
MHW[D3U7.=/N!W<R)JWOUX_5J;10?N62CU/Q%@$22)%X,!?-#B&*&(4ZDR1IX
M6<S"%"<BXXL5OU.A>+?FRF4B^$8O8M:\B"^$&.^E_,S9$]7>%I4<\=($MJPI
M-=6S8*81YS2UT^C8M<2@(_)%UZK;$6$G;T]^30NN'H3MT<6Q2SN5*=SI[8GG
MR^E*,!7V2=>6B2=D?[6:>OC!-G#91-XW_UZO=IONM)D\'WF]8*'/(YY2F)'$
M4TL8@QD/,YBDS,-I&$6)2 8L8>8(9KH*-<6U<%,05 4>6D?2#Y@,8ZO:);>3
MF=H:+/AY#?MW2JV_Z.VU)7RGH)D4QJDQ;DF@:PO==/BIS79+6@[8\K9W&.-X
M>9&E6<(C0J' 40P1\CG$G"504(J]A.(X"7RSH'2S 6W>LXE"T8O5':QY^7#(
M@K9+!CI-MXMCXAFIJI-8ISIA='.:.*>3PV&GA.<H"]T?]49\D@_(^N2ZS34F
M08Q2FL$T(3Y$"4&0Q,*#:9KXW/.],&/FU<J.C3*W$T&-4VVBNDCM$HS[6350
M!2ZX&GO/.C9-%EX=%W1-Y+@Y2-OO'6G+4SST*LFC%T^G&T_AWU&))[]\3NV%
MC3FFL[,WVK<-JZW>/O'_XKB\_58L$,X0SY 'O2!C4D>JWG(XB*%/L)^).&.I
M;^4UL1Q_;MI313$-J<)@3KC9!G!$&L<VK=IJ#=L-7UNWH5-4MBX X;KJRP50
M$@ I@NL:#M;<C5#7P1S#*]1ZL";H</T'^]L,S*O1<=LWXMUWJH_:/N.:W^BH
M;O5_%=KT%2_5B)]Y59<YK3E3'URNV.X?.M]<4#_C/" I3!%'$+'8AS@E!$K#
M, AXG''D6:4+CH!Q;@JR$5$'@K9" CG]'#0_ZW:%5$I@F3XSPMR:Z=E7GK&1
M=?%VLM;R 26@FB0%NDVIZ6"_ %NQF@_5,=W^WSH7.$R]&6\FW";AC(!SVG2<
M\8A^D9@SXE"NTP3TCY5J6JYL<7_!6)B&-*(0A5$ D8\SB".:PCB.O2A&* I"
MJT)EQB//3>-?K_(ZQTMURMCB;#3^SSJ%LM)5=O_5O_ \S[+,KOE<F.GR41@>
M64.?B.K?4JZ13Q'"?X2KB0+V]T>?27C^$5+,@_&/W6#(<>=+__3G36KS-9,#
MYR+'FXYYNG!0R9E4JMU2'54E,;YHKZ>:W"O_M5+4BR2C2>HG6%K'GJKAJO+/
MHU"UYTPS%/%0)&9I49.BGIOV7&-K=.93F[W<9%/EV[:4:R]T*S;X&<M?E&JE
MDAE#O3KMTV%R##S#.1_[6/E@*-16:M 5>^T*7PN^[Q,'K>P7+QN87H#-@Z48
MF.,#8G, /L,'9:H#]9D],)8G]A-/7+\'8"HP$WH4)N9WUT,Q]>!GUS%\C_-2
M.Y75[9=%]53R1899G,1>+,V6((8H#;"T8N1F+J1A$I,HPFELV6VE?\ 9!HIT
MHZR$1-R8'X/+%!YBV="KX8RYD9?Q]TVW+[GK51KV8[$2FS_LL*FD:'/6MG*,
M4JZPAZ^QBA0>&O*U2A/VB-]3D+#OJF'*YE/9MIK4A0YUI9GJ\JF^+TJE%!=!
M%(4AEL1F:9A Y"&Y>?*$@!F7FZ8HHRDGS.;0J'^XN>UU-FC;REMX@W1]6&1Y
M0G2";3.EXX[#D97.ECZ-]*)I:"2-N@U8=YK%C!2GFN7$D)-J%C/Q]S6+X54#
M.^E\Q?E265/OB_(+7G)UEO2%TZ>R,:.HW(T\Z8+O?RJ+JOIU57*\5,/^">>K
M-UP4I4JP6U >IHRB%/J$JUA_+A403E64+ TR'J<9I58U YV@FIN>TEC!TP8L
MN)-H+4/^W4R7F0:;?!*F./3>"G !-@)""1966)U]=\0"S81M!0-*L@M M&PJ
MM]=AQR"77+OM+^0$V;3=B%R2^:)WD=.;VU?\NVKNGW_EC9NSZ;5V(RY94W'T
M\GM>+9 0A$5AU@35(?D^P,PG 0P"C 3S(I2RT+00H,F <U.U6\R@ 7W1=EU4
M00EKX. W!=TPZM:8^G[=.@:A(ZM-)UQ:E2.T(>CL*H5&@TU6O-!&]&Y-0ZOK
MS@GQ;8XHFO9+U2W_7K^1T/^^2 41F50VD$>)@"@,&,R(AV"8"!%@#P<AC>WC
M>0\/-C=ET\ ;$KY[A$S#4RU'%(VL/M:!N2W0)BRW K\IK$"#==Y'K9^3$0)N
MCPSX"M&U_:(?#J4]<8V=MF \7]R6F.6KNR_/#Z18+M(@1$'L41AY7J!2)C-(
MHC2!F8<3'Z7$P]PHHNG%G>>F!UIPH$%GI@]>TM7_\I]%PLAONJ'\QB_U45D/
MO,$5I[^_*[[^(J]I7E[Y@WYG]=OZ\DZ3O)I'!5B_A\>_,#3,L#DHVE0^:KQ>
MNAH#C4D610(FL2H-'GB)ZHS,8<@S@FC LB2SC"L\-M3<7LLU4I!WBI9=@%5/
MWK\MN68+MAO*1C\D:=G:5C#;N/*=EDHXS8;CV+^CPTT<['=*[)?1?2>O.-N#
MW5:EVS1]DVMV&ON^#R-$F%RS8P]B/XUA%'E8+MX"94$TV'N]-]C\/-<MP&Y5
M@S\,=EOO4QM'(DN()Z 7*VHIP3#E$88J7B!,LDC0""^D<IJ$UDWUF_I'IM1P
MO^3D"1Q[M]1U\Z])&[DEX1$VQO+O[P_W6K[](V+W^/6/7?'*T=1MO]:70!<H
MB@)/!)&<E4@:?7% (<%I '&*<2*".(V)9U&":SKD=LIKLM)=ZR[$P\K=3#/G
M_<IP9E/X0T='KY^&0SI[=H_%*X5%.WD\?NR8Z$&/R>O%0Y^<L<F"H8\C^3$C
MH4\R.UH8].F1G54#/5R68<$\/Q%)(""/60A1RGU(A$>@'P>("H:2C%/+*OEF
M(\_M-&I;GV2IBU:Z+/YYA'NS[=$HC(Z\L!\K_;E; V:,ZLW6;(U=Y_/(Z*]=
MYK.?%(,JGR=N,$QO_8FOY&V74E=>LH=\E:O]G/:=-TUX%V&4)CZ6B@JG*@4U
M01[, AK 6. ,41XQ@0VK?!J..+\SL!:P-FOP#F0[-76*:C/EY)"^D552E[==
MK.#=B1;/UDK(D!6GJN?4F),J'$,"]M6,Z64#<S7:$E2W16N3K2TYKL[L;X0N
M-=)::XN4!Q%+6 1%Z&&(6$)AYJ,4IE[F8\(X2E,QH$BZ#8:9GK7HDC^/.&=
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M$B(FPL!J@^B(TFFR4R4VX)!+L_7*$4,C+T';94'5KE1 +T!+&/BM0>OP$,J
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MTN))YUI]*I8Y?6[^NRWH%XLD0HA&TK17D?F>[T.,0PZ#$$=$!*%'/4O7G=G
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MW&#RRDJ638]*3VYP'/*4X]U# YZZJHO9I6V'8EFD.>-Z+D43K+DI)?HGI2A
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MT<I@S'KYQOVIXQ'18(_W&&KX4P;/*[MXT.1RSG+,4)S#'(B\D  F<0YH6B!
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MY=-9'L<Y1!0!2F4.(,DQ8 Q!D!<L1G&,4"J(2[VFG6=/= 79=>WX%&IVP_-
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M5L-^&R.+,)QT\%A=X?1E _/72JZ?8O8S="S1%!OIZFB; G68Z5!*JMBD9,2
M*9H A-*,$:H48L(I1^U<2U,;\4V"L2F9HH?\>6VSC%:FHHJKSOQ99.V^<2]X
M!?[:-S9&6R,OEW!WSQ*[!(7?3+"SK8V;[77)Z:.,KHLWN%&$D.7LSF3*KB2]
M6PHYHW$JF*2:$3#34P#$$T"41'K"A2&*:4H1*6P8X?#!DR. .HM;&Q<9Z^R^
M^B.P^C_R:R (_$U;>F_]$9]S]<0W6TG^U^_+G_^I;VD^5_U#_976W^?1@T;Y
M',^9WWU]9_]]V'C\5:YIN9"BDS&YY?SEZ65NXM@/4I6\7,\P4K&(3:F8F*4
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MA'">8\PS5A1<N*W+>P%[S-7Y>F5YM;4X$K7)IN9O7Z+50+PMQQ&?*(8>-6H
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M8V2,O(FV9OJCBHM(>*6*\ZV-2A47G3ZDBLLW7*F3]-M&+ WEE.HH@8.\$ Q
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M;N18 J94#O(<Y0G*29&FS.V444]KTUMPKZW[/_^/)(__K]1Q.Z\'5,O=/#]
MA=[,VYP*,KE.QM";J#UI%>!,M 4F?K?S>MH;=S?OLN-'FWD6MPQ44> _I'B9
MRWMUF("D ^>_+9?BSW(^?S3ALIELU7.M&<(LSU-%0)Y!K&-/1@##DH(LDUDB
M8,)SF3C**[A;,3V"Z9PPAQ<[FW=FO'LYAP.32J_I-3NF"MP3@1ELMPN.(*[[
M8M,Q?]1.A%E"N )$OSH0 ^P85R!B.%!'RA%7/&IHBF4K84"$C"$V]4)T" 4@
MRPD@7)-B@HD2G-%48"O5B,,'3VWMM<T(=%.#.$*KGX>NP2 PN=BZ/R#]\:)6
M@VVZXY@2#.?,/TYG]"*D<"CJMR_E=_NT7*U-VK4IU_V>5F4UPWFJ@Q'*@)18
M 8@S!ABG*1 *);C@2D^&J,L2F:L!4UOWVE@8\67/RH<?\.VBC9"0!F8#"XU0
M_;<-Y'=]D%^M&6J+6U#MT(M&O*F&J"U$E[1$K9\S( '&//]>-8)Y4K^G.I#Y
MKO]P5U<TJ/_\\=>SY&LI'I?OY;?E7,PDR[!,. %"4 (@3_5<#.(8<(RH@"PI
M4JFL$V3<VY]:B/*P6CZ;'EDNCDI!R-;T5DV@TM9'[ZB>%43/C:\NM2<']%0_
M(XZ ?^BYES8^NE>-R&9=&K)UP/RQ<:$5X.R<B!Z7T7L9&3_"0N^0_A.V"T9*
M#PK3%6[91,.![,TV&O#8\;*1AON\EZUTQ6.&A=:=\,;CLCVB>$J&<98327$"
M(4!I00&4*@884PR2!!&2YADA-)XMY'<C/O]HGZUDU;C51T::C^S(A(##32<E
MK >;RH/LJEU'V,76_G =9_SH[#7C<VMQ=%J@U5\<[821U^#9KN51(V8G, [#
M9+>; YX[>E!RL3EJD=(,":4*D$C% 11&@C^#*<!*4QB-8TD29!T=#[%@:O'Q
MV5-'C=$!3K[L]8=%#!P:Y< LYGC6I?$BY,FC/?P#'#T:V@_3/'MTX3,(<_CH
M%(1>3A_M/7AZQX].^3WH_-')!PT+A7^O=*3=U5"J9H5D N4\ 5(0 :!*!2 %
M,4,)+E0J)9.%U0!R^O%3&QU^;R+9C7UNP>L!='91ZG!  A/Y(1;C))^?AL-K
MY'G0Q*@AYFGW#F/),U<-+1-R78WNO^D+U]7G15/&\F^K957-,E4P+AD$.:0I
M@#G/ :$% PGE*,]1(A@O7.N+>+=R>@DRM9%21.^JNDJLHWIWB(ZTXZ@W[IS0
MZ[8[Q7EW_=NMT!NQU]-%?(V71KNW]O,F:CR-RD74^&K^HKWU64@E6%=XKL#B
MW\Z12[<$ _JXYDNXIJY-BOQ(5PL==5;ZV9T-);]=B _E_,6L,>ZGV,DLI@E)
ML1%30P!BHW."XQ1P*&@A(.5"9D,3(YTLF1[W[V;FF6Y^:29^YM?:DSHYK_4E
MZGPU.W,-[PQ-CW3K/\OA('R?A*;\G<[88/W087USHD?&R98<A&>@C$DW6]XH
M:W(08.<S)X<];FCVY+<?<CYO9_"SV)1D5P0!EJ(80)(1P"06(*-0%AD161P+
MMQS*W<=/;:+=IA+6)G:+3Z[IE'OP]3/7]: $)B0G/ ;D5YYR^XHLR[W'C9QK
M><J5XXS+DU<-KZ'P>5&M5R]-C:Q-59I'C6#U8SD7YIRUIHT/]+6:88A(D2#]
M]7+]/SKD*0!-90Z27.4$I46&"7=9,'-J?6J?^<;&:-T8&0EMI5LLXP:_7003
M#-3 -%'G7&X-OXEV3+^)MFBWUD<?^M >5 K#&37O%3+L+1B]<(8S.*?J:;@_
MY-HY7J?B76]<5V5S?O=UY[<Z[IEQ);#,2 R*!"H 19P#IM(8($;C1')!%"$N
MS.9JP-3(;7<2L1'<WW7AQJP:[?RAG418;G(.[B?729Q_]$><O?D!_HHIFQMZ
M@>9JED:\T23-#:+SLS/'YUPI(*"?;$[/W<VI;O%76<V23.24804X9IK_<A8#
MDF02D$P(S"24>>RT%7JVI:D176U=5)L7_6$,=&2P\Y#:4947H )SD@-&PX4"
MSOD?1B;@J+6W$0DXY_19B8"S-PP\=O==+OCK]L1+FTG$8I4G6#* E4B-!@ &
MU.0&<P@9,FLY,4I<V.!T,Y.C@MK*B"T7PG$:=P9&.P:X'IS0GW^#R];" 'HA
M_2#X/=EVNJEQSZ_UNGMT2JW_:O<EVM]T?\P??BP7\LM+_:9F*292Q@Q 8CYX
MQ/3T)\T8D#RAF(B<I78%0DX]?&J?>6U?5!L8-1;:+\X> 7=Y:?8:. )_V Y(
M."W+GG-YT*+LT<-&6Y(]Y\;N@NS9:P:.Q^*GT:RL[A<FL7ZA(7[M3J%4,ZP8
MA$1_I"DW&]""IP#'E.A '>44$<&)<E(2[FML:A]M9VND)[QE9VWTW)GK.%SW
MH6PY:'O"+O30O0/;QM#HX2)L[N.W!1Y^1_&^!L<=RRU</QK1;>X92"%-_5"8
MIZK("PR83 H <:H 0Y@!';EGG,-,1_?*21_#O7;O"*H7CZ:-B X0V;(JL#O<
M^3%FY#X_WQ/E1'U]J",6"CWMSM''=TT)SNXA_Y+FC((4MS_EBGYO1_][56=6
M5%]EM5Z5Y@QO?:!W)E$BJ/[P-#:8 #V)QH @(4%A\L9RD189S-U2QUR:=WEO
MQ\D7VQK8RC>\*Q?1H+QAIVZP^]A#01N8$CJSH];N-J(W^PB-Z:9&\@;VVGI_
M_#$$,Z\LXV3 J%PT!)I#QAKTC(%J ?JE^J)?LU;/C>4D491CH!"D0,\^"& 4
M%R 1,48X83PGJ<N<8__Q4YME&.LB8YZC#-X9\.SX9C@D@1G% 0WWL_DGG?9[
M"'^_B7%/VY]T[^A8_>FKAGVX.P(B#2_<OJQ_+%=&OFHFE8[V>:9 #KF./T11
M $JS'(@\09P4$B&>NL4?/:U-+]RXVU6*HAM#!QY5Z@/:[HOW!%[@SW]72NBF
MC2&BK:7^N, "#J_$T-?>J"QAX?@A9=C<,D!_XY;SU8L.(%Z>G^>E7!D%HD4E
MJZZJM<SSA)KU1H02J:. - =4QM*4$V<%S4B<X=Q:::._K:F%!)V9#N(-%\#L
MYPC/$(5>AV@,C3I+H\[4RR7"G7%SD+?PA]](0A97X.BF6F&'3*\^Q85'C*=$
M8>?+GN:$Y2U#*X(U55X>:"F^R/6,IB:PRB6@F.4 IN; H&(*8!JG&4\P36+I
M,G<Z>/[4F+(S+WK6]KE6V=I'SBZ,N@*/P+2X@<*8=J,_9CY_J7/6[^ASN:;S
M.OKL+KKIREOI?[_EZ_)GO<?OLW;529@\UYO:;V/D&E$G'3RNZW3ZLJ$U8I];
M4;1[]66YEM4#?:TSE)&4"4]H F0><P!CJ#_X/,D AT:47/(8YDZ9E.<:FMKG
MO[73+#DNELX*,V<1M6,#'S@%IH5]B&HCH]9*GQ5.^W'P7*WT3&,C5Q[M=_FX
MBNB%ZX=1PL>GY_GR5<IO<O6SY/*T\D&G?"/^GQ=:'^;KEG&-VJLVK-T%%I\7
MGY:FA*D>%1KI@QG"28%2F %8%"91"Q% 2") D:2*ISC1+"/<%G'"&CR]=:!V
M#8-VHN]U(6+ULGY9R6TJR<!5H<"=;\>!T^G0P$QZ4JYFJRFR6:[ZN"\+O^/=
M3?3%R!U\*JLZ!ZYVT!\)C],17JD\L,FC#@CCP'\XK(S4ZK4G(K\L:\U>*0XV
M#G]?E.NJG8"\'FBGJ%0/,D6< T1D:M3!,<!0Q[B8IS#-,I9R"(=JWPRP9X)#
MR\ZQO<-M]FY69RD"X:?'[ :,T7HA]'BP __&D^..J)W9=,=(NC=7(!OH1.40
MB][H>.45X)T_:WG-0X>N%E12W_3#R.V8\J[+9Q.FM,N/LP3B+$-4  H)-K6;
M&6 ZO@<PQCF+6:X$=JS=W-O>]-BS,[=6I1);@UT7$/I MEU%\ 1<\*6$'<1V
M+.TV#GRN)U@@XGE1H:_%D5<6+)P_7EZPN<F-2*K5>O:P6HH77I<\;4/,JDTT
MDJG"B9[^@Z1  L L%0 G' -$&8TYS64*K71Y>EN9VH)C:VC]!;26.J9M]8/:
M3QC>H I,%(-0LB8)*Q3ZR$$_8(<8]&^'I-#?PBAD8.5D1P)V%_L0Z^KV,[[J
MV>2WM9E2;NM)S2B/!95&U3XSY9Q8G;?)"Y#P'$F1X_^ONG=K<AO7T@7?SZ_
MTXPK(M&'%Y $>B).1/JVVW%<SAS;U1T]]:# U59OI91'E%QV__H!>)&H&P50
M )/5L=OE=)+$MSZ0"VL!ZY(ACH97ZNH;>FIJ8G<6M]8X!_4$'$"_G;$1AM3
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MZ7RR-JIN*3ZMENOV1]/!NJS[ D:$BR@C"L:"F7TF02!!-(-%BK#(E:"46>V
M>T<V-1_0"%;K+="QBZOBP WV2IUUA1G6VM'?W#HZDF/.6&"UN)^LF^9GN /J
MB\LP;NK-Z%[&F?5%ZD67U]L /M(4ZF\XCN-(%3*%611S[0$K#FE"4\@+HF+&
M\HPJJW. GC&FIFF[-LW'U?(;K.)YC\+GRV'*]1S%=FKR1N)&M -OX.S&S()P
MJNO<."^8*]"K3OHN'1"S\(ZNEZOMYK.I9%^^7ZT?Z7JSE.OSR9+-Z;0Y'Z0<
M13!3*84HC[3[:=I2)MK(2Q4I4AG;UYT= &!J*J41 =0R5.6+&BG I81@A]B
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M:Z<K/+$66%L<$O:A(>RC(<QT>]^832&-^ [<;S;K.=MNJA(CFY5)(O*2*N1
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MLPA2$:<P1C@5F!8286[G%-@-.#UWX+A_!E\]/<FU-H868#'G<EG*ZJ-=&5F
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M3*"*$(,($ZV43-%0P2BA<:04YXX'^CVC3>\\I@4+UEVTCC9/'[UQ4J1(Q+#
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MBFM1O@'30-.$4(XQQ(+GVA;*"T@$4C!1B$<"%2QCF5.QP["3,(8)=# %X6?
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M9,BXBU(B4^K(BIW[WKX?-+I/00X@VBX@\G).3R-Q3+_@L[ ..[8F+H?D6&2
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MAJ]Q?5[.D 73*EH#.CM'L4&@V !# !F2<LE*;QEOL[/=0]4XC37:H6@P#72
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MB513O)C7.OU-OU&C(@;D"$DJ76LC-,12)"0A@N+1D,7?JPGKX1"ZC:Q.$'6
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M-/ZA_7'T@$G-P\3< 5 HHEAB6.$SW/[Y<G[SZ.#=8C9[L5C^'I9Y4I*I(O)
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MFV-@I>3&D[NL\Z-6DQ\:V#1K2_7(AK&1ZCHX43D?HOW\:]I,"WA'<'^SG1Y
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M2U")EI8/1H-4D1?%LLV-S-$=!(W<PO0QMKLA5-$!HC8VF]Y<,\#O<?EE6OL
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MIGU7\20L6J_V*V79XV5[(<C^( @:3.K=H.CSY]D4;["2BI(Y:$:18RTQ+$:
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M"(?=#P'.E=AE$+%WX&"^G),5P0O)O*K_H JQ7@T-,2H*W O17GL->UX@6%;
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M?]  =YQ;4#C0#>75-_TR7<:S>?VR:XMI%0$JQ0!6: H,O9=0AUV36R7CQKA
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ME=K97C(#'01E>MI$GMK<+[;@9MQKG?;@'TOQ)Y2#7-@'O-<^X.KJG\SOB.V
M.H\69+0*1(:4SC$"&&VM%+$@&%-8W36.=1M172G)9>2N%.\;;6\_A0!F$J)@
MZ#DY+J[K*G9,]3I.@&0YJ<*B";+1OK6A6.@X7-D%>\W"E9U4W,&-_!7C+W_<
ML#MO%OD_S_,L_E@/JL@%91%" DLN@<K$'":I(1NMM5(,&38..1XFKA,\'A<V
M#X%W(!WV!,O[&-I,&LC>^RBC!Z(_@A).@6=*@64.8Q$A>R';PO)AXCJ!Y5"
M> AP VFG4\ MK\[M9O*$USJ+9!%(-M7#(/$4LP M>:'3RER(C=WW(]1U KFA
M(+$%Y [23U\W!"]_7/WRWZ=Y4:?N_/BUSMQ9GU4G2\S*&Y#K$M22#3@L IR-
M0ECN-7.-+=VC]'62Q??B@X?29*]6\6?^-N?;4N!=G @02IT%Q>A\!RL-Z."9
MMAX%"GT\\_@0F9W8R0%QLHVI'$1I/2%R?5>V7$N,7PZ&0NVE<0%J(VY=)V @
ML#I?+VGEN*80I]&L]$>(Z@1MPT/A(= =J)>^W/(-9L2&&:&<S0HSZ%BO89UR
MX)RLC8$8DN/%!M;XANMGHCIQP*. ;!^]= LR><F,=E9GI\%H9D %@R0D2M.L
MS3Q[5:PVC1.-GXD:MU9L7)#MHY>^0/;RQSH\?G6&R^4ZP@C.V*BT VL811C>
M24!7.)08L.129&"-G]#ODM0)P'I)(P[05T]QVH4X]WS]O"F%S=$.P7EOJG6W
M]1*!60.>,0O1195\%BHTZB9LQ5$G$>)A@'O\.64<[7=P"CY^F2]6=53#V]GW
MO%RMG=;&E:!4V00,$ U+H+ DJ$$R"=I8+GPNW+6QOP_3U D21\7,3[,[!E%@
M%[' Z_\\GZY^7!?!;_@@>HVSW!).4-3:=@8^UG<!Z6,P3%)LTR9KOI^>3G*9
MGD X@.*Z . _L;:NK2YC::FLL\9"XI[").DMA(P>"KJ8F"].W]U>,U1OUTTR
MN@HZ^X#;_FKJP./>B&<NX_<?US&-%QZ-Y (R2S5_BQ&0>T\@<=I+.C<6V\Q+
M>92L<0=D=9?X'*BWGD!X>/WG77%LSK=(*G+&,C@?,PE$9K+]BN2-F@ZW+DG)
M-F/BFK/621!Z. S;U00/@(FQEW!?,?!FOG@U7\\K(^VLY?.A=ATO:U<FSGZ\
M6OQ8KO#L<MF,<PZ9YA!4O7ZK-2LNI 0HC&(Q>>W<G6;;!]9E[/7UG2"S#_S,
MCZK,DX'KCY3_N@[/G95&@="Y=BUG!JA,'3B24"45K$ V+%BOO[R3).J$H;JG
M(L??-[0MA[_E%8:J@0V7S$B1:SNK6'>>6E, =8G  TM*I!P+VVX5T9X$=)*(
MG2YD#U'HJ=C7MQ'I!Y<.1";#!7*P7FE0VFEPQB!((:T47"@AXJ"(O?GMG>1L
MIPO7O55Y*EA]7_+LRH<$(55!K!LWI"4?HAS4[<,@/'-84/ HPJ!8O?GM6V%5
M_S=6AU?EJ6#U_WN5S\YPPV"168M:.B,23[7S-8$7UH!$="*S&,K=D48'8O7F
MMV^%5?/?6!U>E3UA]7I:XXUWMW=_YO1I3C_]FA>_3F/=N'?U%L*Y+R'$ ($%
M.I3T.P@^%Z" IUB=?-1*[(S97:G8"KOV;X[=IJKMX.[WY?ER.LO+Y8OXG^?3
MY72M_7IWR!PWD2'%WSD%4%YJ\/6ZP\GD4B$WHGB;XO@'".HD*!CUT6$(774*
MN?K+1<Z7SX&.":VE!\[J0M(J)'2HH:!,V22?,+294O@D:>->J@X"@"U M;\V
MQO;*=V\58K:1>SII9.U),LH5\,HJT,SGY,@)&,:W<K3[7/\<%0<'Z&P^D #'
M5OY%+/ER.E_&:9[%O'P[BQLV= B&#D(")BE/5X%R=TP:0?"4E8B1K#%NA8.'
MOV/<2^R&D!A(K".B8[E833[4*=1K:ZGJWL.0R49&8E])M("6C&?TQI&IS-F;
MK4IRZ5-O>!;ZW5VO<NMK.\D41PE@]I=_#Z#98-V5$HB\.N8R>:ADUH%6E*$R
MZXSDE&S(@6$SIJLY0&5WE;Z'_$96^V_XU_3K^=?+6PDN-#/1@XF*#"?CG&B6
M!9 1W2[Q(-Q6+71;*?[65X^L^GT4-Q]"BATD*9^F7\GNO2N?%CA;ECI(_A_S
M>7JW^)@7WRGC7Y\*S#X44Q"R,)%2?97!T1] (?'X@BJFTF;\Z1;$=7*Y,VJ^
M/+0.^X?E)M2+AK@AQL!;S8DIR@=#2!:2D(6",I9XHSU[6Y$W;NXT."AV ]T>
M&NH!=AMFZJG]GA?$XZ5S,'5U:U#KQE(251"9\D/R$#9;;H6E)%&E-E![B*2N
MX;6/^N\";!!=C!QAO5_,TWE<W3YVSDLMLT^P7LNB7"#ZC=*0+!><2TG&?JL6
MBZT"K?LHV HZ[GDZS4&TT@>JJN@V'%R^!5F-.G"9(?A87Q:-!@R2@_8\:AYE
MK9,>&EH_DS%>/'^X9G^&R8%B'ONV\)<Z*6'^K3[H?<B?S\_JW_U1%YOE15VM
M^]OT+"]7\UFN;'Z:9J+NP_P'GMWH:.,8N8MDQ;,D ZY"XL0W*C"9.PH4B."R
M7477P:2,#JQ#L3 ?33%CP_#]%UQF^8I^-HUX]FDQO:HXE^BD=M*!$A(O,F8D
MKL!EE2/3)KJHMX+7@U\QSI5U(]@,(\@.@NWK<IFZ!7Q*2MA4.7RB#[@8AHK1
M,D4RTJ[4Z[AL*'S,%#Y*F[2PUJ=&/=!/DK85HOSSC*#:Z*]?0%9V-H<6%4,1
M30%NZR33Z#DX:258GH-EP0FAVDS\?)*T<;/!@:&P'=#VU,O8CK#N,IR?KRZJ
M ]_,%^]QL9KE6H"5ZZRLNFCQ.C"X[/;V6B@2$VAE:K<W);N!U:Z7$+1F&9F]
M^Y3W@(O<X\N[1-:^NI\?41$=6+0A',6OTUE^N\I?EQ.34#G, HK+).F0<]WD
M("![;[)"F6RC.[!!V=@.S^QY^^[Q@-'!J;C@^9ZE)9-<1"H8-3!MZ_ @+(!&
M(8A"F13GTF?;:&WP0R1UTMU\?)C<71@\B,ZZF+=S0X3W\2-4,HC> B6!)*5D
MZGAIX8&D9Y)BH5C;9@+9XW1UTKL\.A 'U-[X7<F7U72OYE_#=+;6YN4^^7N;
M6=XNE^<YO<^+RYJ[]3;NB7)%E.09N%P?9-!J</55QF(P*@KR47F[-H]AZ.FD
M9WDTJ(ZEVK$SJ_U8KLOF7V/\<M]?^9@7I+1)L29858?]%U_'=CDZU!A%?2=W
MAM(.@;A=FV@K"CMI>SY%Q ^L_K'/P*,<;_AAB@ZOLW7$2U U8I+@Z5"#]B;H
M$G,);KOWG"V^[/3[F09 YM!*&1MD]YRTJZ52Q"4NO[S''Q<;V^?W\OSO\S-2
M_'(B"4_:A@(^U@<LQ@L$8R2P;'*VF)"%O0.'O2@Z_>KU-H:TO7H[N!>XT?DZ
M886KHBC0(:0A*&[(^IM8A[HFLO<:*>=LTQ=Z@XC3KVT=)N7:5R\=0*H>C[H%
M]Y_3U9=7Y\O5_"L%V%6>_UC,E\L)"JU4<1HRDYR,OK(01&(0O*+?>%6X;[/"
M]7&Z3K\^;!C@#:B]#K"X,=JW!E7<>E2YF@?P[MOZ3TBT<37]OI;[1 CKZ*3I
M>M+JE '+ )U2H)..%*#4)+'-@J6#R#[]=_IAD'P\W7< ]'OBEP>X?E%':G^^
MV%KTZDO]Y=O9BZ_S\]GJ9K!^OZ#XA*L@@R<WE#.CO%!27NBE<R"=U<*84%@2
M38[$D1A\!B]EPYR>'@&U^SGS%^=LEC_C*J=/S5+!!_C\!TYGOY+;K#-M/L^F
M_U5U=_57XX])R+4_3A5(7-<>ZU3 ,14(_I08HV=<XG:3+@<C:3O\/^/'MQ$U
M/)@;^7_^[2?MD5#^M?[1^B?U7WW(Y7_4__[QX>VMSS^;?L99^I]Q_O7BPQ]:
M=WUC2-.\7*RF>T.RFM4ZWK>SY6IQOOZ;O^053L^6MWE<3K]^.WL2V0-]\[]=
M\WU7(AL"?H+P,620_UKE6<KI_QZHW.7Z06[Y(BS7,3QECCX9S@)(2]A7.C!P
M%@WXX)1GCBOA&F\HNX>J'@I\+JI)4N+%N"A!H!246"<'&)"!UR@#&CJ:NO$.
MCD-9Z*14XE#LM2C5V5W%'83Q6^[D9E9CJ?>+28L"E'E[\,8D2-9IBJ?0L483
MW+:CKQ-4'A<\#V^1&4J3/>%SJ]VW,3G!0B83( PQI[D"S)&!D)GQR-!PU6:(
MPDYD=H+6 7'R$!0'5UI/B+QG1[))019++BA%Q-H$24*S-H"H224=:2^*:8N_
M/7=7MT?;\%#887?U+GKI"6*#)*7<\!!Y7F^Q6W?F.O L"(A1%9933++1 (_C
M5Y1W71HYH(L_.BYZ.A2'SWA^A6>QM@+3+S_,S\[>S!=_XB)-7$*35>2DBSJI
MQ0L%3L9$^E$JVRR$"(U;+UJQUHD/.#YLVRVB&P!#/1VJ&^ZY/L3^Q/R=RZ?E
MASO:V5ROKS]K$B7IJ+8@8M(.5/ &4+ ,,C$5DQ(ZQ#9O-DW8Z>3P] '9+2+]
MX^)G[T/T+2^F\_1QA8O5 (,7'JW5NBS58EHPSD, IYRB\#8["*)8D%IBM#)Y
M7^Y$8@\-8=CFZSJ)F+K";2-EC?].>.B!?. \7KXVO9W%L_-4]U;4AE[Z:\M)
M\B:&1#F5RX*!(I[ %])&SEC0&Y--4ET9^9U9[*3%I:L#U#?.QJ[9'E@J#SP!
MUVZ*&Z/9)TI*:[E%2,D64++NYW2*@Q;%Y&BD-\)LY59&(;^3MIJN3MF)@.G9
M)C LH<-B,WB)M4]$!4"7+ 3NE;-&6G=WI=;))S"GL .Q(S\V''X.3&!>SU*K
M0IP;9F&O<II;_WZ HIB'Z1FHM.6>*JP7L[2^M;JY"N6RX,"J"CO) +$.Q5&J
MD*FD-!5C*4XK6T)NNUEJ.SH;5/I>EU]\(M&_I+_]KPDW(;(2(G O$%02&5R,
M'HK4@L2DD:4V;Z_;T=?'DJ4&R-JBCO90=?59)WC3'*S?5@XV4IM/&=A4W4?;
M. 8K%BR>I0+6U-5NJD0(.2)$XYWQ6=O@VSQP'-=@?8Q?<CH_R^_*=9'LVT1J
MG)9I3IM'B(L!#.GV8P3][/QK3FN-71^54J1++-<IZ"F!LEY#B(6M6].MECI*
MT<;.#\S(29G 7;!ZUP2."8 .<J)[UK>]7ZPWS.+;6:G_64_WNV(O!\P>E8)L
M/7D;ERTXKACP+$.REL)GV:9!<D="^UB*=P3\ME1@_[[\=US4JXGO^8!*_D<_
M;V#__CB]XWAZ%56,,6B(2@F*[NI;FD($H3%IP84*>+2NN:-X^GN.S/+ECQN_
MVXQS9-*BJ8\Z2=8=9-8!&A'!8C0B&VZ5;!,![4KI2?GJ7=#VL*]NH,(^G?&Z
MOM;7BD:N#8CU1%WA!"5[E(0%Y&3-74&AC[>6>O02^K8HV'+U^2XJZ119M[?T
M4EC*2W$(F'C=56 I;O44P1)7E@)78T1I,T[@1%>?[P2 G5>?[Z*-L1\RWY<\
MRW]=;MM$'Q3S!7RP=<&82N"L%& T)_H%4Y:QIP*RGSZU/P0<H*WY$*(;6^>?
M\'QQOKRQFOO77U]MV+"V<!&M %]$[9GG"ER.' +E&\9)@49N-\SNX>_H([EK
M@(>!Q#HV.AY9W)YC\$Q@!B'K8M],4G&A+KQ,,1A4+)JRG7UX^#O&+<5IB(Z!
MQ#HV.MY&_)QG&\*3SL+&VC5FT-9%SY:$0;(1WJ822W89TU9XN/FIXY:)-$3
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MR0![7!5W@.U[G,[/XVKQJ@C^T8&UUQ7SRXFI_6;1!&!"U6F@W !:E\ X29E
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M*TN*N#[0_RZFD7ZU9OB/V73U$+NUL\SRA$"TD;0]B1R#59"$\I$"U:)SFVJ
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M%GRA7R6C*"0,2@;9QJ8==_W:-HT\%R.%.7JNZPN 2=4Q)A((ICJ@B D5O,/
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MCX"&1=#11*XQ9A9,[^?E&4XWZ^X4#0:B;F/PJTN4XEQ((DLPI19V,1\ A=/
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M9UVH#Z O]&*75]X1*S_M*Y[F9=/S_P%02P,$%     @ PHAI4Y4C>)RO"
ML#L  !@   !L9VYD7SDS,#(Q97AH:6)I=#,Q,BYH=&WM6VUSXC@2_GZ_0DOJ
M)IDJWB%O)),JAI ;ZK*$)<S-[J<KV9:Q*K+EE60(]^NO6S*!!'(ANYG*'L-\
MR&"K);7:?AX_W;+/?[J\Z8Q^&W1)9&)!!E\_7_<ZI%"J5+XU.I7*Y>B2?!G]
M?$V:Y6J-C!1--#=<)E14*MU^@10B8])6I3*=3LO31EFJ<64TK.!0S8J04K-R
M8(+"Q3F>@;^,!A=_._^I5"*7TL]BEACB*T8-"TBF>3(FWP*F[TBIE%MU9#I3
M?!P94J_6:^2;5'=\0EV[X4:PB_DXYQ5W?%ZQDYQ[,IA=G =\0GCPJ<!/C_Q:
MM=KTCH\.:;/1#&E8JWI>_:1^Q$ZJC>KAOVO@9 7,71]M9H)]*L0\*44,YV\=
MUU-S-N6!B5HPT-\+C^P,NS<E*O@X:5EOH364B0$O%(SJ?JX,_I:=YLV^%%*U
M]JKVWQFVE$(:<S%K[8]XS#3ILRD9RI@F^T4-U[*DF>*A,]3\/PS6!LNTA]-\
MW3".X F;QZ%6Q\5W[R/N<4,:M7)]$U]]N$),O9.SG>YPU+OJ==JCWDV?W%R1
MP;#7[_0&[6MRU>NWX2?\NKD"B^[P+[^8P=?A[==V?T1&-Z3[:^=+N_^/+FEW
M1F3X];I+:@U:JC4/Z,</>\WCL]IAX([^\JMJWY+VY<U@U+TDRPN\[7;L-6M4
MZWC=1E^ZY+8]_-SN=V]+-[]>=W^S*X>6>K6Z>A\^BZ>-P[ >BR^W?;_P-9^&
MK]F$\/6*Y&=J3 2C_5,JEGA,C8O$9\KP<$9,1,V'O<.3LS7>&NH)-G?7DRI@
MJ@1>"YIJUIK_. NX3@6=M7ABY[:=SF*JQL"/GC1&QJU#<'2"$_I4Y*&T477-
M"^8L5QU[&@B>">8SY\UEVU0QP9JV:KG9.'FVN5JN/=_U?PQ[<EQN'-4W&K9B
M779N0V1T2I-/A49AWB&E00!/L%8]O2<U",;2/258N!H<F7YWK*W<+#;TM8?;
M(%_Q6RWF/6Y_NZ(>B>B$$<4FG$U!2IB(:_)+1A4@6<S(D*52&2(3<B553&K5
MTB]$AN2:CVD2D$%$54Q]EMD%:=)+?*F@ XH20,WI$]0L;H6*A<$.33\VFNI;
MAZ;/5 .& "WQC-PE<BI8,&9%!RKEH!1(F"Z1(-YA-,H30I,9R1*C,KS[ 3E6
MV0/&*(GA2'$J2$A].*6(C$$W&NGL5@P2YC.MJ9JA24SO&,R[-*:&<P$X U,*
MFQ; '&C@<P5I )@ET!T\ >"1:<3]B.@,_RSZ3YEB^2"X@)AK ?D"IAY3;B)8
MH$Z9;QW$<5-P3>(UA4L$0?%FRV'8L<..'5[ 4N/'80=&0IX _A#*"[P5"3YC
M)32KI7:>A/ DIEA(@-^^R (8$S"]!*XB\ ''IW<*D$0V09818D$7.5+UDZF!
MD0);H2BB12;  #A" I#M=-KZXU,=D5#(J9X3B&)CKHVB,!'%D\YO\+*XQ -Z
M[LR*MSLJV%'!"\!I;AT5C![AYL/>2;UV?*9SL.?))SY891AR.+2(ZA&JF,4N
M8)$C" !CA&F\M[F.T!S-8A 5*"SP&%#@"ZDSZ(=R0T'8K$VJI,\".*W) 6 V
M8$ "#IC=>S^BR9B1-CS)AYD "UL8.3Q@'VU76QC!(W?(,>5/''G@^ 0?]TN<
MXC".OFP\4?AHHA FPG4^91JPP,QE37*^)>QQ4JXUGF_^H^QQ?%H^.MYLV._!
M'DN%H[Q_"8U=B7A^QE9G6R4\]TZ$\[3LMS6\$S -7@ "K;9_F1Z*F';X--.;
M=T'][S'R,)/+*&2F8 #0 A.NK<( *Y;8<;#&MM FR_I&,4$M=^0IQ0+_Q5S[
M8",'G0*^:"EX8+=#=.9I'G"J."Z N\3'*JX$1\HT)B.6:K7-7*P>D9J!0P;T
M#W9**5ZU3%"44; LZ\0BJ8$>+D5:SNS@E\?0$)0.]-_F$LB.F]Z/F[P?@YLV
M%A8K%+6Y)-F8J8#=)CQ  J):)A:F5 -Y8<T$68FJ8,X0P%F<>EQP,\,$:=VT
MR)>63"Q/.*I[9+I4<[$2[SY?4)JI%'A*VX3.]X$AK .V^C)F">1I N@*6EB*
M/(@F66(<)0%?\A14UHZ4=J3T]MCUMY64V(2*S*H*1"P+0^8;/@&LZ37UCWV]
MB3YRA^N+(99]H"-H&^U*+I[,S/-S;Z+@Z(,UPWI2^')UEGCS2I4EU#P&X(\E
M#YQ@1R [ GG;A_^V$DB.T%6DX[Y/7@*Q+6L+0J_0,IA%2=_/%.)Y*659,VHL
MM8'S^+X&C*4A5N1WM^5+#I[I$@(Q@<IX8IT[[@-=V"TKW,U*L@>_/CJO(JH?
M\CO4)Y;(6&"%FXU'+JIF1/ [)O+]JR?VQ3\=HNTFKUVQ^8T >[CEQ>;]%\O,
M]HV0!]XJ+M0 BI-E[E@( T3_*S*VE7H..$6S@!NI]$-Z9$_ 8'',C6%LK=SR
M)*1>V!)P\,EV/P!6 76C43W!_UA-FE,A^SWCX+*EO2SQ[:;6QUT%>:=G=A7D
MS1<F!,%Z"0?&P(T8W-+Q.0.(YZG-0R5WRN@=YBJN7F&S%5MIL6^RS#>57T4<
M>='5;8.M$0TT@(Z:/6B&-2235V; &/@"P%MTJ9*&/$EG,0 40F&7D:NTM1OO
MVZTD=K2Q*^Z^/6U MA,J>*07 <3,Z@^@ ?L:6<X719<L\&0BQ81AQI#0<?XV
MG,HE"XM3(6<,6J>1=#J%/F(C8(\UZ=3^*[*$\BLP_6?><_]_>3_^$BZ/E4@?
M]FI'U35_^Q#)V&/*'9T6W>=&[_Z^_!$D1+6C/T* IR?ET^I[,)7S_S%9/5[Y
M*EF]'U79SV2T_;OZ!<5S('H^5OD- 335@E 1NYM+YJO8ZD"^0?"V.C[=>^9G
M6/@F_X(DE0P4J,B X3L 5Y:^G5[K1)R%^1DD]!N7TNYB^2B6!P.W$0@!6@G5
M.NGQ^B???$7+WWZFTGWYVG(O=$S8LU^#YB&K+KI0#Z@@,ZM=7OA$+?_KOF6U
M7]5>_!=02P,$%     @ PHAI4Y4I^"NY!@  YBL  !@   !L9VYD7SDS,#(Q
M97AH:6)I=#,R,2YH=&WM&FM3VSCP^_V*;9BC,)/XD?>KS' A3'-'@4+:WGVZ
M46PYUF!;KJ00<K_^5G("(2GE%:"E89B,+>VN=E?['K??[!UU^O\<=R%4<03'
MG_XXZ'4@5[#M+Z6.;>_U]^!]_\,!E"W'A;X@B62*\81$MMT]S$$N5"IMVO9X
M/+;&)8N+H=T_L36ILAUQ+JGE*S^WT]8K^$N)O_-;^TVA 'O<&\4T4> )2A3U
M8219,H0O/I5G4"A,H3H\G0@V#!44G:(+7[@X8^<DVU=,171G1J=M9^]MVQS2
M'G!_LM/VV3DP_UV.N16?DIKCD0$IETFU1!RG[C6JI$9*M:I#2_^ZR*2-X!F.
M5).(OLO%+"F$5)_?K!53U1HS7X5-UW%^SQFXG7; $X6'"43.'C,:2Y04O5 %
M$K%ATC3RY#+4V;;'(RZ:&X[Y:^F=0D!B%DV:;_LLIA(.Z1A.>$R2MWF)=U"0
M5+ @ Y3L/XH\(7OF=3SE%^E$+*$S_MUR&9GN7H1LP!24BI9[G>/;>?V&F/.J
M(F*(VAIPI7C<K"(W<V0\O" J7DCF3O>DW]OO=7;[O:-#.-J'XY/>8:=WO'L
MW;^[G4_]WN<N+B-$]P2^KQ26^"A)LX3B/;DPY6\*TTO XTE"/>V$,&8J!!52
M^#@B C4<3>"$IEPHX $<L"%)?#@.B8B)1T>*>222T$L\+A#&.-V61M[<J!>+
M3JO#XY0D$_/FMK8!Z>]S$8/K%#Y"P(4YZ&MV$%#4A ^G-%4T'E"QN>%6G5;)
MR1L_S0.1$+ ((2XY/*7>2&#H0%5HKKH77DB2(44/CV,FI98&_S6DCYQ!2 5%
M&>;YRR2;L9>'7A[^Y&$"!Q:\9T,T/IF'3LAH@,3Q,,7.*1P% ?.0722E*4U%
MS .N*1;@0SH2<D3P'A4'MPZ?K%.K8VEFC7[=4L4QPA"?IUI?\^ SH(93G=$_
M)6) $BH+1Q<1G<"N9RZBZ#C%/.X3@Q9/X"SA8U3.D&YN5.JM^YB<(H.(SO8'
M7/A4%-#T(I)*VIP]M'PFTXA,FBPQ!F206M<=M(+6=JZ5@#8Q=5)S7+9]%>@L
M)PMV"EU?^;.3I]N6V;*5_XT]QRHVBC=N.Y9[,^IWR-9K5L6IWXFL;5C.V$;-
M2+SX=[E2;H:0$M_'A-,LIA?@7H]6$0V6E</3Y_=XH_HM=_O20J8RKTJ<RPSV
MW#+UT5>F@2H811BU/'3,2,>&RW@AZ-<1$U2G=JF=Z,HEMPC&)G&U4-GRMS,G
M39&&IXT]?^F05U'G,N),O=)ME,H96FR"&?IBHZ5CTT(F?U6V5'PR6WHI,V()
MIJ:8&%/ S*@(0OFX:JY_9F.$Z=28"BJU.>7U-HDB0#0\F$1H;#)%<Y)Y@Q6P
MA"2>7D>"OBEW3<Y"J%&462-/J3!GRH748EW3K[$;V\3?N?C^W&&\T;#JI<8#
MHWBY4EUY%"];I4IMY53=JE6OK9YLL6+5JZO70:EJ-4Q%]]R9+&:^']$7\M@]
M]+CK1<]B&*H^5*[,Y%](KD-^;NI@:&05\#VBK*.%RSTT(&>=U8\3DC<WRK66
M-+^+U?ER9+S=IF]4SK*9W$./=P"=!F549!-A0?*(^3!3W[WOXYE\;JG_-5>R
M> W8Q=_4)NF]K6/!,/NEF/Z6 +;OE-UN'Q;\(,VTKA^P>J!#KD=/64^(MV82
M/I,PH'HY&(F$R1"+"C0"BF4$]G#$\[)T/U]EW*F5Q#("*2=<S:B;+EEWUXB>
M<DGGB]VLJT9:]Z]FKQV%# UTI337^ \F6,X$V&0GGM[1,J$TR(UF:K%;'H<4
MWP762SY%2EIEN@(G@9X$++3L>:0[) +-71I1--DA3;!<BN8XT!J)D/\1&>KC
M08Z\<'JZ!;L@T6F022X86BPB&H90F#%*KRB"*SS03 ^G;8(1:+XA#XF^/P1-
M!3]G>E:!(LX)9=0S9E@$#G2O,2T;!Y,EF*OKGQ*XRR!# ,,Z$;D, ABEN*+9
MI%)92Q[Q:D=K^[W#77S$I_5H[6<<K7T@"@'&\!<Z>X)L#/-SZ> S)@,XQGZ(
MZ4O+P[[IF*@Y/LLM^Y<]U'H$MQ[!_>1SAO4(;CV"6X_@UB.X1XW@JK4'C^!J
ME=5/M7"SOOJIUA.1K5LU9_63O5+)<LMW8_:7&L$]6*Y?8 3W>J=U2P7_>E[W
M,O.ZY8L8B)U']5X+8[VE_<>.]=;3N_7T[G'3NQL;\/FO[U#!IA)L"AH1[0M+
MW^-=10-3FCE7*&2 ]S]2RRBW?,*7_8;B*B0-:6$@*#DK& 4V230F$YE;\6>#
M+^-1KWB&>M/$]"FP?@R;M;,O8,VWN#O_ U!+ 0(4 Q0    ( ,*(:5,.E K#
MH#@" ,1<&@ 1              "  0    !L9VYD+3(P,C$P.3,P+FAT;5!+
M 0(4 Q0    ( ,*(:5/)]>K\N1(  '?)   1              "  <\X @!L
M9VYD+3(P,C$P.3,P+GAS9%!+ 0(4 Q0    ( ,*(:5.FJJ*35"<  -V1 0 5
M              "  ;=+ @!L9VYD+3(P,C$P.3,P7V-A;"YX;6Q02P$"% ,4
M    " #"B&E3M(WJ5)-D  #(900 %0              @ $^<P( ;&=N9"TR
M,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ PHAI4S^.W(.#D@  *LH  !0
M             ( !!-@" &QG;F0M,C R,3 Y,S!?9S$N:G!G4$L! A0#%
M  @ PHAI4U2[,!>S"P$ BC,+ !4              ( !N6H# &QG;F0M,C R
M,3 Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( ,*(:5,1$TI)H)@  'GY!@ 5
M          "  9]V! !L9VYD+3(P,C$P.3,P7W!R92YX;6Q02P$"% ,4
M" #"B&E37\6J"+L(  #'.@  &               @ %R#P4 ;&=N9%\Y,S R
M,65X:&EB:70S,3$N:'1M4$L! A0#%     @ PHAI4Y4C>)RO"   L#L  !@
M             ( !8Q@% &QG;F1?.3,P,C%E>&AI8FET,S$R+FAT;5!+ 0(4
M Q0    ( ,*(:5.5*?@KN08  .8K   8              "  4@A!0!L9VYD
J7SDS,#(Q97AH:6)I=#,R,2YH=&U02P4&      H "@"> @  -R@%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
